{"id": "BioInfer.d267.s0_BioInfer.d267.s0.p0", "text": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "text_with_entity_marker": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 ([E1]XPD[/E1]), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of [E2]XPC[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "XPD", "entity_1_idx": [[107, 110]], "entity_1_idx_in_text_with_entity_marker": [111, 114], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "XPC", "entity_2_idx": [[168, 171]], "entity_2_idx_in_text_with_entity_marker": [181, 184], "entity_2_type": "Protein_complex", "entity_2_type_id": 5}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s0_BioInfer.d267.s0.p1", "text": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "text_with_entity_marker": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the [E1]HHR23B[/E1]/p58 and HHR23A subunits of [E2]XPC[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "HHR23B", "entity_1_idx": [[134, 140]], "entity_1_idx_in_text_with_entity_marker": [138, 144], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "XPC", "entity_2_idx": [[168, 171]], "entity_2_idx_in_text_with_entity_marker": [181, 184], "entity_2_type": "Protein_complex", "entity_2_type_id": 5}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s0_BioInfer.d267.s0.p2", "text": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "text_with_entity_marker": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/[E1]p58[/E1] and HHR23A subunits of [E2]XPC[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p58", "entity_1_idx": [[141, 144]], "entity_1_idx_in_text_with_entity_marker": [145, 148], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "XPC", "entity_2_idx": [[168, 171]], "entity_2_idx_in_text_with_entity_marker": [181, 184], "entity_2_type": "Protein_complex", "entity_2_type_id": 5}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s0_BioInfer.d267.s0.p3", "text": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "text_with_entity_marker": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and [E1]HHR23A[/E1] subunits of [E2]XPC[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "HHR23A", "entity_1_idx": [[149, 155]], "entity_1_idx_in_text_with_entity_marker": [153, 159], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "XPC", "entity_2_idx": [[168, 171]], "entity_2_idx_in_text_with_entity_marker": [181, 184], "entity_2_type": "Protein_complex", "entity_2_type_id": 5}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s0_BioInfer.d267.s0.p4", "text": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "text_with_entity_marker": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include [E1]ERCC1[/E1], ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of [E2]XPC[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ERCC1", "entity_1_idx": [[93, 98]], "entity_1_idx_in_text_with_entity_marker": [97, 102], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "XPC", "entity_2_idx": [[168, 171]], "entity_2_idx_in_text_with_entity_marker": [181, 184], "entity_2_type": "Protein_complex", "entity_2_type_id": 5}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s0_BioInfer.d267.s0.p5", "text": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "text_with_entity_marker": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, [E1]ERCC2[/E1] (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of [E2]XPC[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ERCC2", "entity_1_idx": [[100, 105]], "entity_1_idx_in_text_with_entity_marker": [104, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "XPC", "entity_2_idx": [[168, 171]], "entity_2_idx_in_text_with_entity_marker": [181, 184], "entity_2_type": "Protein_complex", "entity_2_type_id": 5}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s0_BioInfer.d267.s0.p6", "text": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "text_with_entity_marker": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse [E1]RAD51[/E1], and the HHR23B/p58 and HHR23A subunits of [E2]XPC[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[119, 124]], "entity_1_idx_in_text_with_entity_marker": [123, 128], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "XPC", "entity_2_idx": [[168, 171]], "entity_2_idx_in_text_with_entity_marker": [181, 184], "entity_2_type": "Protein_complex", "entity_2_type_id": 5}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s0_BioInfer.d267.s0.p7", "text": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "text_with_entity_marker": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 ([E1]XPD[/E1]), mouse RAD51, and the [E2]HHR23B[/E2]/p58 and HHR23A subunits of XPC.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "XPD", "entity_1_idx": [[107, 110]], "entity_1_idx_in_text_with_entity_marker": [111, 114], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HHR23B", "entity_2_idx": [[134, 140]], "entity_2_idx_in_text_with_entity_marker": [147, 153], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s0_BioInfer.d267.s0.p8", "text": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "text_with_entity_marker": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 ([E1]XPD[/E1]), mouse RAD51, and the HHR23B/[E2]p58[/E2] and HHR23A subunits of XPC.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "XPD", "entity_1_idx": [[107, 110]], "entity_1_idx_in_text_with_entity_marker": [111, 114], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p58", "entity_2_idx": [[141, 144]], "entity_2_idx_in_text_with_entity_marker": [154, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d267.s0_BioInfer.d267.s0.p9", "text": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.", "text_with_entity_marker": "However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 ([E1]XPD[/E1]), mouse RAD51, and the HHR23B/p58 and [E2]HHR23A[/E2] subunits of XPC.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "XPD", "entity_1_idx": [[107, 110]], "entity_1_idx_in_text_with_entity_marker": [111, 114], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HHR23A", "entity_2_idx": [[149, 155]], "entity_2_idx_in_text_with_entity_marker": [162, 168], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d357.s0_BioInfer.d357.s0.p0", "text": "Integrin (beta) chains, for example, interact with actin-binding proteins (e.g. talin and filamin), which form mechanical links to the cytoskeleton.", "text_with_entity_marker": "[E1]Integrin[/E1] (beta) chains, for example, interact with [E2]actin-binding proteins[/E2] (e.g. talin and filamin), which form mechanical links to the cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Integrin", "entity_1_idx": [[0, 8], [10, 14], [16, 22]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding proteins", "entity_2_idx": [[51, 73]], "entity_2_idx_in_text_with_entity_marker": [64, 86], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d357.s0_BioInfer.d357.s0.p1", "text": "Integrin (beta) chains, for example, interact with actin-binding proteins (e.g. talin and filamin), which form mechanical links to the cytoskeleton.", "text_with_entity_marker": "[E1]Integrin[/E1] (beta) chains, for example, interact with actin-binding proteins (e.g. [E2]talin[/E2] and filamin), which form mechanical links to the cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Integrin", "entity_1_idx": [[0, 8], [10, 14], [16, 22]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[80, 85]], "entity_2_idx_in_text_with_entity_marker": [93, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d357.s0_BioInfer.d357.s0.p2", "text": "Integrin (beta) chains, for example, interact with actin-binding proteins (e.g. talin and filamin), which form mechanical links to the cytoskeleton.", "text_with_entity_marker": "[E1]Integrin[/E1] (beta) chains, for example, interact with actin-binding proteins (e.g. talin and [E2]filamin[/E2]), which form mechanical links to the cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Integrin", "entity_1_idx": [[0, 8], [10, 14], [16, 22]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "filamin", "entity_2_idx": [[90, 97]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d357.s0_BioInfer.d357.s0.p3", "text": "Integrin (beta) chains, for example, interact with actin-binding proteins (e.g. talin and filamin), which form mechanical links to the cytoskeleton.", "text_with_entity_marker": "Integrin (beta) chains, for example, interact with [E1]actin-binding proteins[/E1] (e.g. [E2]talin[/E2] and filamin), which form mechanical links to the cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin-binding proteins", "entity_1_idx": [[51, 73]], "entity_1_idx_in_text_with_entity_marker": [55, 77], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "talin", "entity_2_idx": [[80, 85]], "entity_2_idx_in_text_with_entity_marker": [93, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d357.s0_BioInfer.d357.s0.p4", "text": "Integrin (beta) chains, for example, interact with actin-binding proteins (e.g. talin and filamin), which form mechanical links to the cytoskeleton.", "text_with_entity_marker": "Integrin (beta) chains, for example, interact with [E1]actin-binding proteins[/E1] (e.g. talin and [E2]filamin[/E2]), which form mechanical links to the cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin-binding proteins", "entity_1_idx": [[51, 73]], "entity_1_idx_in_text_with_entity_marker": [55, 77], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "filamin", "entity_2_idx": [[90, 97]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d357.s0_BioInfer.d357.s0.p5", "text": "Integrin (beta) chains, for example, interact with actin-binding proteins (e.g. talin and filamin), which form mechanical links to the cytoskeleton.", "text_with_entity_marker": "Integrin (beta) chains, for example, interact with actin-binding proteins (e.g. [E1]talin[/E1] and [E2]filamin[/E2]), which form mechanical links to the cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[80, 85]], "entity_1_idx_in_text_with_entity_marker": [84, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "filamin", "entity_2_idx": [[90, 97]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d797.s0_BioInfer.d797.s0.p0", "text": "We believe that this complex may mediate the cortical functions of profilin at actin patches in S. pombe.", "text_with_entity_marker": "We believe that this complex may mediate the cortical functions of [E1]profilin[/E1] at [E2]actin[/E2] patches in S. pombe.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[67, 75]], "entity_1_idx_in_text_with_entity_marker": [71, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[79, 84]], "entity_2_idx_in_text_with_entity_marker": [92, 97], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d142.s0_BioInfer.d142.s0.p0", "text": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "text_with_entity_marker": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind [E1]actin[/E1] monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and [E2]thymosin beta4[/E2] (Tbeta4).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[115, 120]], "entity_1_idx_in_text_with_entity_marker": [119, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "thymosin beta4", "entity_2_idx": [[190, 204]], "entity_2_idx_in_text_with_entity_marker": [203, 217], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d142.s0_BioInfer.d142.s0.p1", "text": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "text_with_entity_marker": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind [E1]actin[/E1] monomers, actin depolymerizing factor (ADF), [E2]gelsolin[/E2], profilin, and thymosin beta4 (Tbeta4).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[115, 120]], "entity_1_idx_in_text_with_entity_marker": [119, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gelsolin", "entity_2_idx": [[166, 174]], "entity_2_idx_in_text_with_entity_marker": [179, 187], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d142.s0_BioInfer.d142.s0.p2", "text": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "text_with_entity_marker": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind [E1]actin[/E1] monomers, actin depolymerizing factor ([E2]ADF[/E2]), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[115, 120]], "entity_1_idx_in_text_with_entity_marker": [119, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ADF", "entity_2_idx": [[160, 163]], "entity_2_idx_in_text_with_entity_marker": [173, 176], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d142.s0_BioInfer.d142.s0.p3", "text": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "text_with_entity_marker": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind [E1]actin[/E1] monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 ([E2]Tbeta4[/E2]).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[115, 120]], "entity_1_idx_in_text_with_entity_marker": [119, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Tbeta4", "entity_2_idx": [[206, 212]], "entity_2_idx_in_text_with_entity_marker": [219, 225], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d142.s0_BioInfer.d142.s0.p4", "text": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "text_with_entity_marker": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized [E1]actin[/E1] and at least four proteins which can bind [E2]actin[/E2] monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[67, 72]], "entity_1_idx_in_text_with_entity_marker": [71, 76], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[115, 120]], "entity_2_idx_in_text_with_entity_marker": [128, 133], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d142.s0_BioInfer.d142.s0.p5", "text": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "text_with_entity_marker": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind [E1]actin[/E1] monomers, actin depolymerizing factor (ADF), gelsolin, [E2]profilin[/E2], and thymosin beta4 (Tbeta4).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[115, 120]], "entity_1_idx_in_text_with_entity_marker": [119, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[176, 184]], "entity_2_idx_in_text_with_entity_marker": [189, 197], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d142.s0_BioInfer.d142.s0.p6", "text": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "text_with_entity_marker": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind [E1]actin[/E1] monomers, [E2]actin depolymerizing factor[/E2] (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[115, 120]], "entity_1_idx_in_text_with_entity_marker": [119, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin depolymerizing factor", "entity_2_idx": [[131, 158]], "entity_2_idx_in_text_with_entity_marker": [144, 171], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d142.s0_BioInfer.d142.s0.p7", "text": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "text_with_entity_marker": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), [E1]gelsolin[/E1], profilin, and [E2]thymosin beta4[/E2] (Tbeta4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gelsolin", "entity_1_idx": [[166, 174]], "entity_1_idx_in_text_with_entity_marker": [170, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "thymosin beta4", "entity_2_idx": [[190, 204]], "entity_2_idx_in_text_with_entity_marker": [203, 217], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d142.s0_BioInfer.d142.s0.p8", "text": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "text_with_entity_marker": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor ([E1]ADF[/E1]), gelsolin, profilin, and [E2]thymosin beta4[/E2] (Tbeta4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ADF", "entity_1_idx": [[160, 163]], "entity_1_idx_in_text_with_entity_marker": [164, 167], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "thymosin beta4", "entity_2_idx": [[190, 204]], "entity_2_idx_in_text_with_entity_marker": [203, 217], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d142.s0_BioInfer.d142.s0.p9", "text": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "text_with_entity_marker": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and [E1]thymosin beta4[/E1] ([E2]Tbeta4[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thymosin beta4", "entity_1_idx": [[190, 204]], "entity_1_idx_in_text_with_entity_marker": [194, 208], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Tbeta4", "entity_2_idx": [[206, 212]], "entity_2_idx_in_text_with_entity_marker": [219, 225], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d142.s0_BioInfer.d142.s0.p10", "text": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "text_with_entity_marker": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized [E1]actin[/E1] and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and [E2]thymosin beta4[/E2] (Tbeta4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[67, 72]], "entity_1_idx_in_text_with_entity_marker": [71, 76], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "thymosin beta4", "entity_2_idx": [[190, 204]], "entity_2_idx_in_text_with_entity_marker": [203, 217], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d142.s0_BioInfer.d142.s0.p11", "text": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "text_with_entity_marker": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, [E1]profilin[/E1], and [E2]thymosin beta4[/E2] (Tbeta4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[176, 184]], "entity_1_idx_in_text_with_entity_marker": [180, 188], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "thymosin beta4", "entity_2_idx": [[190, 204]], "entity_2_idx_in_text_with_entity_marker": [203, 217], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d142.s0_BioInfer.d142.s0.p12", "text": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "text_with_entity_marker": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, [E1]actin depolymerizing factor[/E1] (ADF), gelsolin, profilin, and [E2]thymosin beta4[/E2] (Tbeta4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin depolymerizing factor", "entity_1_idx": [[131, 158]], "entity_1_idx_in_text_with_entity_marker": [135, 162], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "thymosin beta4", "entity_2_idx": [[190, 204]], "entity_2_idx_in_text_with_entity_marker": [203, 217], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d142.s0_BioInfer.d142.s0.p13", "text": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "text_with_entity_marker": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor ([E1]ADF[/E1]), [E2]gelsolin[/E2], profilin, and thymosin beta4 (Tbeta4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ADF", "entity_1_idx": [[160, 163]], "entity_1_idx_in_text_with_entity_marker": [164, 167], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gelsolin", "entity_2_idx": [[166, 174]], "entity_2_idx_in_text_with_entity_marker": [179, 187], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d142.s0_BioInfer.d142.s0.p14", "text": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "text_with_entity_marker": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), [E1]gelsolin[/E1], profilin, and thymosin beta4 ([E2]Tbeta4[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gelsolin", "entity_1_idx": [[166, 174]], "entity_1_idx_in_text_with_entity_marker": [170, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Tbeta4", "entity_2_idx": [[206, 212]], "entity_2_idx_in_text_with_entity_marker": [219, 225], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d142.s0_BioInfer.d142.s0.p15", "text": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "text_with_entity_marker": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized [E1]actin[/E1] and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), [E2]gelsolin[/E2], profilin, and thymosin beta4 (Tbeta4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[67, 72]], "entity_1_idx_in_text_with_entity_marker": [71, 76], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gelsolin", "entity_2_idx": [[166, 174]], "entity_2_idx_in_text_with_entity_marker": [179, 187], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d142.s0_BioInfer.d142.s0.p16", "text": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "text_with_entity_marker": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), [E1]gelsolin[/E1], [E2]profilin[/E2], and thymosin beta4 (Tbeta4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gelsolin", "entity_1_idx": [[166, 174]], "entity_1_idx_in_text_with_entity_marker": [170, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[176, 184]], "entity_2_idx_in_text_with_entity_marker": [189, 197], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d142.s0_BioInfer.d142.s0.p17", "text": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "text_with_entity_marker": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, [E1]actin depolymerizing factor[/E1] (ADF), [E2]gelsolin[/E2], profilin, and thymosin beta4 (Tbeta4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin depolymerizing factor", "entity_1_idx": [[131, 158]], "entity_1_idx_in_text_with_entity_marker": [135, 162], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gelsolin", "entity_2_idx": [[166, 174]], "entity_2_idx_in_text_with_entity_marker": [179, 187], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d142.s0_BioInfer.d142.s0.p18", "text": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "text_with_entity_marker": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor ([E1]ADF[/E1]), gelsolin, profilin, and thymosin beta4 ([E2]Tbeta4[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ADF", "entity_1_idx": [[160, 163]], "entity_1_idx_in_text_with_entity_marker": [164, 167], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Tbeta4", "entity_2_idx": [[206, 212]], "entity_2_idx_in_text_with_entity_marker": [219, 225], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d142.s0_BioInfer.d142.s0.p19", "text": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "text_with_entity_marker": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized [E1]actin[/E1] and at least four proteins which can bind actin monomers, actin depolymerizing factor ([E2]ADF[/E2]), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[67, 72]], "entity_1_idx_in_text_with_entity_marker": [71, 76], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "ADF", "entity_2_idx": [[160, 163]], "entity_2_idx_in_text_with_entity_marker": [173, 176], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d458.s0_BioInfer.d458.s0.p0", "text": "p130 and pRb were phosphorylated before the infected myotubes entered S phase, despite the high expression of the cyclin-dependent kinase inhibitor p21, and E2F was released.", "text_with_entity_marker": "p130 and pRb were phosphorylated before the infected myotubes entered S phase, despite the high expression of the [E1]cyclin-dependent kinase inhibitor[/E1] [E2]p21[/E2], and E2F was released.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[114, 147]], "entity_1_idx_in_text_with_entity_marker": [118, 151], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p21", "entity_2_idx": [[148, 151]], "entity_2_idx_in_text_with_entity_marker": [161, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d458.s0_BioInfer.d458.s0.p1", "text": "p130 and pRb were phosphorylated before the infected myotubes entered S phase, despite the high expression of the cyclin-dependent kinase inhibitor p21, and E2F was released.", "text_with_entity_marker": "[E1]p130[/E1] and pRb were phosphorylated before the infected myotubes entered S phase, despite the high expression of the cyclin-dependent kinase inhibitor [E2]p21[/E2], and E2F was released.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p130", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p21", "entity_2_idx": [[148, 151]], "entity_2_idx_in_text_with_entity_marker": [161, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d458.s0_BioInfer.d458.s0.p2", "text": "p130 and pRb were phosphorylated before the infected myotubes entered S phase, despite the high expression of the cyclin-dependent kinase inhibitor p21, and E2F was released.", "text_with_entity_marker": "p130 and pRb were phosphorylated before the infected myotubes entered S phase, despite the high expression of the cyclin-dependent kinase inhibitor [E1]p21[/E1], and [E2]E2F[/E2] was released.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p21", "entity_1_idx": [[148, 151]], "entity_1_idx_in_text_with_entity_marker": [152, 155], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E2F", "entity_2_idx": [[157, 160]], "entity_2_idx_in_text_with_entity_marker": [170, 173], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d458.s0_BioInfer.d458.s0.p3", "text": "p130 and pRb were phosphorylated before the infected myotubes entered S phase, despite the high expression of the cyclin-dependent kinase inhibitor p21, and E2F was released.", "text_with_entity_marker": "p130 and [E1]pRb[/E1] were phosphorylated before the infected myotubes entered S phase, despite the high expression of the cyclin-dependent kinase inhibitor [E2]p21[/E2], and E2F was released.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "pRb", "entity_1_idx": [[9, 12]], "entity_1_idx_in_text_with_entity_marker": [13, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p21", "entity_2_idx": [[148, 151]], "entity_2_idx_in_text_with_entity_marker": [161, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d458.s0_BioInfer.d458.s0.p4", "text": "p130 and pRb were phosphorylated before the infected myotubes entered S phase, despite the high expression of the cyclin-dependent kinase inhibitor p21, and E2F was released.", "text_with_entity_marker": "[E1]p130[/E1] and pRb were phosphorylated before the infected myotubes entered S phase, despite the high expression of the [E2]cyclin-dependent kinase inhibitor[/E2] p21, and E2F was released.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p130", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[114, 147]], "entity_2_idx_in_text_with_entity_marker": [127, 160], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d458.s0_BioInfer.d458.s0.p5", "text": "p130 and pRb were phosphorylated before the infected myotubes entered S phase, despite the high expression of the cyclin-dependent kinase inhibitor p21, and E2F was released.", "text_with_entity_marker": "p130 and pRb were phosphorylated before the infected myotubes entered S phase, despite the high expression of the [E1]cyclin-dependent kinase inhibitor[/E1] p21, and [E2]E2F[/E2] was released.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[114, 147]], "entity_1_idx_in_text_with_entity_marker": [118, 151], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "E2F", "entity_2_idx": [[157, 160]], "entity_2_idx_in_text_with_entity_marker": [170, 173], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d458.s0_BioInfer.d458.s0.p6", "text": "p130 and pRb were phosphorylated before the infected myotubes entered S phase, despite the high expression of the cyclin-dependent kinase inhibitor p21, and E2F was released.", "text_with_entity_marker": "p130 and [E1]pRb[/E1] were phosphorylated before the infected myotubes entered S phase, despite the high expression of the [E2]cyclin-dependent kinase inhibitor[/E2] p21, and E2F was released.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "pRb", "entity_1_idx": [[9, 12]], "entity_1_idx_in_text_with_entity_marker": [13, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[114, 147]], "entity_2_idx_in_text_with_entity_marker": [127, 160], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d458.s0_BioInfer.d458.s0.p7", "text": "p130 and pRb were phosphorylated before the infected myotubes entered S phase, despite the high expression of the cyclin-dependent kinase inhibitor p21, and E2F was released.", "text_with_entity_marker": "[E1]p130[/E1] and pRb were phosphorylated before the infected myotubes entered S phase, despite the high expression of the cyclin-dependent kinase inhibitor p21, and [E2]E2F[/E2] was released.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p130", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E2F", "entity_2_idx": [[157, 160]], "entity_2_idx_in_text_with_entity_marker": [170, 173], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d458.s0_BioInfer.d458.s0.p8", "text": "p130 and pRb were phosphorylated before the infected myotubes entered S phase, despite the high expression of the cyclin-dependent kinase inhibitor p21, and E2F was released.", "text_with_entity_marker": "[E1]p130[/E1] and [E2]pRb[/E2] were phosphorylated before the infected myotubes entered S phase, despite the high expression of the cyclin-dependent kinase inhibitor p21, and E2F was released.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p130", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "pRb", "entity_2_idx": [[9, 12]], "entity_2_idx_in_text_with_entity_marker": [22, 25], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d458.s0_BioInfer.d458.s0.p9", "text": "p130 and pRb were phosphorylated before the infected myotubes entered S phase, despite the high expression of the cyclin-dependent kinase inhibitor p21, and E2F was released.", "text_with_entity_marker": "p130 and [E1]pRb[/E1] were phosphorylated before the infected myotubes entered S phase, despite the high expression of the cyclin-dependent kinase inhibitor p21, and [E2]E2F[/E2] was released.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "pRb", "entity_1_idx": [[9, 12]], "entity_1_idx_in_text_with_entity_marker": [13, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E2F", "entity_2_idx": [[157, 160]], "entity_2_idx_in_text_with_entity_marker": [170, 173], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d592.s0_BioInfer.d592.s0.p0", "text": "The cellular transcription co-activators p300 and the CREB-binding protein CBP are cellular targets for transformation by the E1A proteins of non-oncogenic adenovirus 5 (Ad5).", "text_with_entity_marker": "The cellular transcription co-activators p300 and the [E1]CREB-binding protein[/E1] [E2]CBP[/E2] are cellular targets for transformation by the E1A proteins of non-oncogenic adenovirus 5 (Ad5).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CREB-binding protein", "entity_1_idx": [[54, 74]], "entity_1_idx_in_text_with_entity_marker": [58, 78], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "CBP", "entity_2_idx": [[75, 78]], "entity_2_idx_in_text_with_entity_marker": [88, 91], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d592.s0_BioInfer.d592.s0.p1", "text": "The cellular transcription co-activators p300 and the CREB-binding protein CBP are cellular targets for transformation by the E1A proteins of non-oncogenic adenovirus 5 (Ad5).", "text_with_entity_marker": "The cellular transcription co-activators [E1]p300[/E1] and the [E2]CREB-binding protein[/E2] CBP are cellular targets for transformation by the E1A proteins of non-oncogenic adenovirus 5 (Ad5).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p300", "entity_1_idx": [[41, 45]], "entity_1_idx_in_text_with_entity_marker": [45, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CREB-binding protein", "entity_2_idx": [[54, 74]], "entity_2_idx_in_text_with_entity_marker": [67, 87], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d592.s0_BioInfer.d592.s0.p2", "text": "The cellular transcription co-activators p300 and the CREB-binding protein CBP are cellular targets for transformation by the E1A proteins of non-oncogenic adenovirus 5 (Ad5).", "text_with_entity_marker": "The cellular transcription co-activators p300 and the [E1]CREB-binding protein[/E1] CBP are cellular targets for transformation by the [E2]E1A[/E2] proteins of non-oncogenic adenovirus 5 (Ad5).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CREB-binding protein", "entity_1_idx": [[54, 74]], "entity_1_idx_in_text_with_entity_marker": [58, 78], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "E1A", "entity_2_idx": [[126, 129]], "entity_2_idx_in_text_with_entity_marker": [139, 142], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d592.s0_BioInfer.d592.s0.p3", "text": "The cellular transcription co-activators p300 and the CREB-binding protein CBP are cellular targets for transformation by the E1A proteins of non-oncogenic adenovirus 5 (Ad5).", "text_with_entity_marker": "The cellular transcription co-activators [E1]p300[/E1] and the CREB-binding protein [E2]CBP[/E2] are cellular targets for transformation by the E1A proteins of non-oncogenic adenovirus 5 (Ad5).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p300", "entity_1_idx": [[41, 45]], "entity_1_idx_in_text_with_entity_marker": [45, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[75, 78]], "entity_2_idx_in_text_with_entity_marker": [88, 91], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d592.s0_BioInfer.d592.s0.p4", "text": "The cellular transcription co-activators p300 and the CREB-binding protein CBP are cellular targets for transformation by the E1A proteins of non-oncogenic adenovirus 5 (Ad5).", "text_with_entity_marker": "The cellular transcription co-activators p300 and the CREB-binding protein [E1]CBP[/E1] are cellular targets for transformation by the [E2]E1A[/E2] proteins of non-oncogenic adenovirus 5 (Ad5).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CBP", "entity_1_idx": [[75, 78]], "entity_1_idx_in_text_with_entity_marker": [79, 82], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E1A", "entity_2_idx": [[126, 129]], "entity_2_idx_in_text_with_entity_marker": [139, 142], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d592.s0_BioInfer.d592.s0.p5", "text": "The cellular transcription co-activators p300 and the CREB-binding protein CBP are cellular targets for transformation by the E1A proteins of non-oncogenic adenovirus 5 (Ad5).", "text_with_entity_marker": "The cellular transcription co-activators [E1]p300[/E1] and the CREB-binding protein CBP are cellular targets for transformation by the [E2]E1A[/E2] proteins of non-oncogenic adenovirus 5 (Ad5).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p300", "entity_1_idx": [[41, 45]], "entity_1_idx_in_text_with_entity_marker": [45, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E1A", "entity_2_idx": [[126, 129]], "entity_2_idx_in_text_with_entity_marker": [139, 142], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d631.s0_BioInfer.d631.s0.p0", "text": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "text_with_entity_marker": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid ([E1]N[/E1]) and [E2]large polymerase[/E2] (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[99, 100]], "entity_1_idx_in_text_with_entity_marker": [103, 104], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "large polymerase", "entity_2_idx": [[106, 122], [127, 135]], "entity_2_idx_in_text_with_entity_marker": [119, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d631.s0_BioInfer.d631.s0.p1", "text": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "text_with_entity_marker": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with [E1]nucleocapsid[/E1] (N) and [E2]large polymerase[/E2] (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid", "entity_1_idx": [[85, 97], [127, 135]], "entity_1_idx_in_text_with_entity_marker": [89, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "large polymerase", "entity_2_idx": [[106, 122], [127, 135]], "entity_2_idx_in_text_with_entity_marker": [119, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d631.s0_BioInfer.d631.s0.p2", "text": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "text_with_entity_marker": "The interaction of bovine respiratory syncytial virus (BRSV) [E1]phosphoprotein[/E1] (P) with nucleocapsid (N) and [E2]large polymerase[/E2] (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "phosphoprotein", "entity_1_idx": [[61, 75]], "entity_1_idx_in_text_with_entity_marker": [65, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "large polymerase", "entity_2_idx": [[106, 122], [127, 135]], "entity_2_idx_in_text_with_entity_marker": [119, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d631.s0_BioInfer.d631.s0.p3", "text": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "text_with_entity_marker": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein ([E1]P[/E1]) with nucleocapsid (N) and [E2]large polymerase[/E2] (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "P", "entity_1_idx": [[77, 78]], "entity_1_idx_in_text_with_entity_marker": [81, 82], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "large polymerase", "entity_2_idx": [[106, 122], [127, 135]], "entity_2_idx_in_text_with_entity_marker": [119, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d631.s0_BioInfer.d631.s0.p4", "text": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "text_with_entity_marker": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and [E1]large polymerase[/E1] (L) proteins was investigated using an intracellular BRSV-[E2]CAT[/E2] minigenome replication system.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "large polymerase", "entity_1_idx": [[106, 122], [127, 135]], "entity_1_idx_in_text_with_entity_marker": [110, 126], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CAT", "entity_2_idx": [[181, 184]], "entity_2_idx_in_text_with_entity_marker": [194, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d631.s0_BioInfer.d631.s0.p5", "text": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "text_with_entity_marker": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and [E1]large polymerase[/E1] ([E2]L[/E2]) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "large polymerase", "entity_1_idx": [[106, 122], [127, 135]], "entity_1_idx_in_text_with_entity_marker": [110, 126], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "L", "entity_2_idx": [[124, 125]], "entity_2_idx_in_text_with_entity_marker": [137, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d631.s0_BioInfer.d631.s0.p6", "text": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "text_with_entity_marker": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with [E1]nucleocapsid[/E1] ([E2]N[/E2]) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid", "entity_1_idx": [[85, 97], [127, 135]], "entity_1_idx_in_text_with_entity_marker": [89, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[99, 100]], "entity_2_idx_in_text_with_entity_marker": [112, 113], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d631.s0_BioInfer.d631.s0.p7", "text": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "text_with_entity_marker": "The interaction of bovine respiratory syncytial virus (BRSV) [E1]phosphoprotein[/E1] (P) with nucleocapsid ([E2]N[/E2]) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "phosphoprotein", "entity_1_idx": [[61, 75]], "entity_1_idx_in_text_with_entity_marker": [65, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[99, 100]], "entity_2_idx_in_text_with_entity_marker": [112, 113], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d631.s0_BioInfer.d631.s0.p8", "text": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "text_with_entity_marker": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein ([E1]P[/E1]) with nucleocapsid ([E2]N[/E2]) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "P", "entity_1_idx": [[77, 78]], "entity_1_idx_in_text_with_entity_marker": [81, 82], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[99, 100]], "entity_2_idx_in_text_with_entity_marker": [112, 113], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d631.s0_BioInfer.d631.s0.p9", "text": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "text_with_entity_marker": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid ([E1]N[/E1]) and large polymerase (L) proteins was investigated using an intracellular BRSV-[E2]CAT[/E2] minigenome replication system.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[99, 100]], "entity_1_idx_in_text_with_entity_marker": [103, 104], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CAT", "entity_2_idx": [[181, 184]], "entity_2_idx_in_text_with_entity_marker": [194, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d631.s0_BioInfer.d631.s0.p10", "text": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "text_with_entity_marker": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid ([E1]N[/E1]) and large polymerase ([E2]L[/E2]) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[99, 100]], "entity_1_idx_in_text_with_entity_marker": [103, 104], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "L", "entity_2_idx": [[124, 125]], "entity_2_idx_in_text_with_entity_marker": [137, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d631.s0_BioInfer.d631.s0.p11", "text": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "text_with_entity_marker": "The interaction of bovine respiratory syncytial virus (BRSV) [E1]phosphoprotein[/E1] (P) with [E2]nucleocapsid[/E2] (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "phosphoprotein", "entity_1_idx": [[61, 75]], "entity_1_idx_in_text_with_entity_marker": [65, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid", "entity_2_idx": [[85, 97], [127, 135]], "entity_2_idx_in_text_with_entity_marker": [98, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d631.s0_BioInfer.d631.s0.p12", "text": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "text_with_entity_marker": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein ([E1]P[/E1]) with [E2]nucleocapsid[/E2] (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "P", "entity_1_idx": [[77, 78]], "entity_1_idx_in_text_with_entity_marker": [81, 82], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid", "entity_2_idx": [[85, 97], [127, 135]], "entity_2_idx_in_text_with_entity_marker": [98, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d631.s0_BioInfer.d631.s0.p13", "text": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "text_with_entity_marker": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with [E1]nucleocapsid[/E1] (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-[E2]CAT[/E2] minigenome replication system.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid", "entity_1_idx": [[85, 97], [127, 135]], "entity_1_idx_in_text_with_entity_marker": [89, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CAT", "entity_2_idx": [[181, 184]], "entity_2_idx_in_text_with_entity_marker": [194, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d631.s0_BioInfer.d631.s0.p14", "text": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "text_with_entity_marker": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with [E1]nucleocapsid[/E1] (N) and large polymerase ([E2]L[/E2]) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid", "entity_1_idx": [[85, 97], [127, 135]], "entity_1_idx_in_text_with_entity_marker": [89, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "L", "entity_2_idx": [[124, 125]], "entity_2_idx_in_text_with_entity_marker": [137, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d631.s0_BioInfer.d631.s0.p15", "text": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "text_with_entity_marker": "The interaction of bovine respiratory syncytial virus (BRSV) [E1]phosphoprotein[/E1] ([E2]P[/E2]) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[61, 75]], "entity_1_idx_in_text_with_entity_marker": [65, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[77, 78]], "entity_2_idx_in_text_with_entity_marker": [90, 91], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d631.s0_BioInfer.d631.s0.p16", "text": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "text_with_entity_marker": "The interaction of bovine respiratory syncytial virus (BRSV) [E1]phosphoprotein[/E1] (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-[E2]CAT[/E2] minigenome replication system.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[61, 75]], "entity_1_idx_in_text_with_entity_marker": [65, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CAT", "entity_2_idx": [[181, 184]], "entity_2_idx_in_text_with_entity_marker": [194, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d631.s0_BioInfer.d631.s0.p17", "text": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "text_with_entity_marker": "The interaction of bovine respiratory syncytial virus (BRSV) [E1]phosphoprotein[/E1] (P) with nucleocapsid (N) and large polymerase ([E2]L[/E2]) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "phosphoprotein", "entity_1_idx": [[61, 75]], "entity_1_idx_in_text_with_entity_marker": [65, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "L", "entity_2_idx": [[124, 125]], "entity_2_idx_in_text_with_entity_marker": [137, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d631.s0_BioInfer.d631.s0.p18", "text": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "text_with_entity_marker": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein ([E1]P[/E1]) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-[E2]CAT[/E2] minigenome replication system.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[77, 78]], "entity_1_idx_in_text_with_entity_marker": [81, 82], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CAT", "entity_2_idx": [[181, 184]], "entity_2_idx_in_text_with_entity_marker": [194, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d631.s0_BioInfer.d631.s0.p19", "text": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "text_with_entity_marker": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein ([E1]P[/E1]) with nucleocapsid (N) and large polymerase ([E2]L[/E2]) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "P", "entity_1_idx": [[77, 78]], "entity_1_idx_in_text_with_entity_marker": [81, 82], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "L", "entity_2_idx": [[124, 125]], "entity_2_idx_in_text_with_entity_marker": [137, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d631.s0_BioInfer.d631.s0.p20", "text": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "text_with_entity_marker": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase ([E1]L[/E1]) proteins was investigated using an intracellular BRSV-[E2]CAT[/E2] minigenome replication system.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "L", "entity_1_idx": [[124, 125]], "entity_1_idx_in_text_with_entity_marker": [128, 129], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CAT", "entity_2_idx": [[181, 184]], "entity_2_idx_in_text_with_entity_marker": [194, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p0", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1-E2]cytokeratins[/E1-E2] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [58, 59]], "entity_1_idx_in_text_with_entity_marker": [45, 57], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cytokeratins", "entity_2_idx": [[38, 50], [64, 65]], "entity_2_idx_in_text_with_entity_marker": [45, 57], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p1", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), [E2]S-100[/E2] protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [64, 65]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "S-100", "entity_2_idx": [[117, 122]], "entity_2_idx_in_text_with_entity_marker": [130, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p2", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and [E2]glial fibrillary acid protein[/E2] was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [64, 65]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "glial fibrillary acid protein", "entity_2_idx": [[234, 263]], "entity_2_idx_in_text_with_entity_marker": [247, 276], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p3", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen ([E2]EMA[/E2]), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [64, 65]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "EMA", "entity_2_idx": [[111, 114]], "entity_2_idx_in_text_with_entity_marker": [124, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p4", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), [E2]epithelial membrane antigen[/E2] (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [64, 65]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "epithelial membrane antigen", "entity_2_idx": [[82, 109]], "entity_2_idx_in_text_with_entity_marker": [95, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p5", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, [E2]type IV collagen[/E2], smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [64, 65]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "type IV collagen", "entity_2_idx": [[147, 163]], "entity_2_idx_in_text_with_entity_marker": [160, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p6", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, [E2]vimentin[/E2] CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [64, 65]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vimentin", "entity_2_idx": [[132, 140]], "entity_2_idx_in_text_with_entity_marker": [145, 153], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p7", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, [E2]smooth muscle myosin heavy chain[/E2], calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [64, 65]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "smooth muscle myosin heavy chain", "entity_2_idx": [[186, 218]], "entity_2_idx_in_text_with_entity_marker": [199, 231], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p8", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, [E2]smooth muscle actin[/E2], smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [64, 65]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "smooth muscle actin", "entity_2_idx": [[165, 184]], "entity_2_idx_in_text_with_entity_marker": [178, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p9", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin [E2]CD34[/E2], type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [64, 65]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD34", "entity_2_idx": [[141, 145]], "entity_2_idx_in_text_with_entity_marker": [154, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p10", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1-E2]cytokeratins[/E1-E2] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [77, 79]], "entity_1_idx_in_text_with_entity_marker": [45, 57], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cytokeratins", "entity_2_idx": [[38, 50], [64, 65]], "entity_2_idx_in_text_with_entity_marker": [45, 57], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p11", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1-E2]cytokeratins[/E1-E2] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [70, 71]], "entity_1_idx_in_text_with_entity_marker": [45, 57], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cytokeratins", "entity_2_idx": [[38, 50], [64, 65]], "entity_2_idx_in_text_with_entity_marker": [45, 57], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p12", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, [E2]calponin[/E2], and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [64, 65]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "calponin", "entity_2_idx": [[220, 228]], "entity_2_idx_in_text_with_entity_marker": [233, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p13", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] ([E2]CKs[/E2]) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [64, 65]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CKs", "entity_2_idx": [[52, 55]], "entity_2_idx_in_text_with_entity_marker": [65, 68], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p14", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1-E2]cytokeratins[/E1-E2] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [66, 68]], "entity_1_idx_in_text_with_entity_marker": [45, 57], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cytokeratins", "entity_2_idx": [[38, 50], [64, 65]], "entity_2_idx_in_text_with_entity_marker": [45, 57], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p15", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1-E2]cytokeratins[/E1-E2] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [60, 62]], "entity_1_idx_in_text_with_entity_marker": [45, 57], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cytokeratins", "entity_2_idx": [[38, 50], [64, 65]], "entity_2_idx_in_text_with_entity_marker": [45, 57], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p16", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), [E2]S-100[/E2] protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [58, 59]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "S-100", "entity_2_idx": [[117, 122]], "entity_2_idx_in_text_with_entity_marker": [130, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p17", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and [E2]glial fibrillary acid protein[/E2] was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [58, 59]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "glial fibrillary acid protein", "entity_2_idx": [[234, 263]], "entity_2_idx_in_text_with_entity_marker": [247, 276], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p18", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen ([E2]EMA[/E2]), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [58, 59]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "EMA", "entity_2_idx": [[111, 114]], "entity_2_idx_in_text_with_entity_marker": [124, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p19", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), [E2]epithelial membrane antigen[/E2] (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [58, 59]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "epithelial membrane antigen", "entity_2_idx": [[82, 109]], "entity_2_idx_in_text_with_entity_marker": [95, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p100", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, [E1]smooth muscle actin[/E1], [E2]smooth muscle myosin heavy chain[/E2], calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "smooth muscle actin", "entity_1_idx": [[165, 184]], "entity_1_idx_in_text_with_entity_marker": [169, 188], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle myosin heavy chain", "entity_2_idx": [[186, 218]], "entity_2_idx_in_text_with_entity_marker": [199, 231], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p101", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin [E1]CD34[/E1], type IV collagen, smooth muscle actin, [E2]smooth muscle myosin heavy chain[/E2], calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD34", "entity_1_idx": [[141, 145]], "entity_1_idx_in_text_with_entity_marker": [145, 149], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle myosin heavy chain", "entity_2_idx": [[186, 218]], "entity_2_idx_in_text_with_entity_marker": [199, 231], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p102", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, [E2]smooth muscle myosin heavy chain[/E2], calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [77, 79]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle myosin heavy chain", "entity_2_idx": [[186, 218]], "entity_2_idx_in_text_with_entity_marker": [199, 231], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p103", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, [E2]smooth muscle myosin heavy chain[/E2], calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [70, 71]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle myosin heavy chain", "entity_2_idx": [[186, 218]], "entity_2_idx_in_text_with_entity_marker": [199, 231], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p104", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, [E1]smooth muscle myosin heavy chain[/E1], [E2]calponin[/E2], and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "smooth muscle myosin heavy chain", "entity_1_idx": [[186, 218]], "entity_1_idx_in_text_with_entity_marker": [190, 222], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calponin", "entity_2_idx": [[220, 228]], "entity_2_idx_in_text_with_entity_marker": [233, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p105", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins ([E1]CKs[/E1]) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, [E2]smooth muscle myosin heavy chain[/E2], calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CKs", "entity_1_idx": [[52, 55]], "entity_1_idx_in_text_with_entity_marker": [56, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle myosin heavy chain", "entity_2_idx": [[186, 218]], "entity_2_idx_in_text_with_entity_marker": [199, 231], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p106", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, [E2]smooth muscle myosin heavy chain[/E2], calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [66, 68]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "smooth muscle myosin heavy chain", "entity_2_idx": [[186, 218]], "entity_2_idx_in_text_with_entity_marker": [199, 231], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p107", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, [E2]smooth muscle myosin heavy chain[/E2], calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [60, 62]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "smooth muscle myosin heavy chain", "entity_2_idx": [[186, 218]], "entity_2_idx_in_text_with_entity_marker": [199, 231], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p108", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin [E1]CD34[/E1], type IV collagen, [E2]smooth muscle actin[/E2], smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD34", "entity_1_idx": [[141, 145]], "entity_1_idx_in_text_with_entity_marker": [145, 149], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle actin", "entity_2_idx": [[165, 184]], "entity_2_idx_in_text_with_entity_marker": [178, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p109", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, [E2]smooth muscle actin[/E2], smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [77, 79]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle actin", "entity_2_idx": [[165, 184]], "entity_2_idx_in_text_with_entity_marker": [178, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d64.s0_BioInfer.d64.s0.p0", "text": "An atomic model of actin filaments cross-linked by fimbrin and its implications for bundle assembly and function.", "text_with_entity_marker": "An atomic model of [E1]actin[/E1] filaments cross-linked by [E2]fimbrin[/E2] and its implications for bundle assembly and function.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[19, 24]], "entity_1_idx_in_text_with_entity_marker": [23, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[51, 58]], "entity_2_idx_in_text_with_entity_marker": [64, 71], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p10", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, [E1]actin-binding protein[/E1] cofilin, [E2]profilin[/E2] and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin-binding protein", "entity_1_idx": [[189, 210]], "entity_1_idx_in_text_with_entity_marker": [193, 214], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "profilin", "entity_2_idx": [[220, 228]], "entity_2_idx_in_text_with_entity_marker": [233, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p11", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as [E1]embryonic alpha-tubulin[/E1], embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, [E2]actin-binding protein[/E2] cofilin, profilin and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "embryonic alpha-tubulin", "entity_1_idx": [[45, 68]], "entity_1_idx_in_text_with_entity_marker": [49, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin-binding protein", "entity_2_idx": [[189, 210]], "entity_2_idx_in_text_with_entity_marker": [202, 223], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p12", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, [E1]hnRNP[/E1], protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, [E2]actin-binding protein[/E2] cofilin, profilin and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hnRNP", "entity_1_idx": [[94, 99]], "entity_1_idx_in_text_with_entity_marker": [98, 103], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin-binding protein", "entity_2_idx": [[189, 210]], "entity_2_idx_in_text_with_entity_marker": [202, 223], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p13", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, [E1]embryonic beta-tubulin[/E1], hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, [E2]actin-binding protein[/E2] cofilin, profilin and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "embryonic beta-tubulin", "entity_1_idx": [[70, 92]], "entity_1_idx_in_text_with_entity_marker": [74, 96], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin-binding protein", "entity_2_idx": [[189, 210]], "entity_2_idx_in_text_with_entity_marker": [202, 223], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p14", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, [E1]actin-binding protein[/E1] [E2]cofilin[/E2], profilin and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin-binding protein", "entity_1_idx": [[189, 210]], "entity_1_idx_in_text_with_entity_marker": [193, 214], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cofilin", "entity_2_idx": [[211, 218]], "entity_2_idx_in_text_with_entity_marker": [224, 231], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p15", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase ([E1]PIMT[/E1]), ferritin heavy chain, type IV collagen, [E2]actin-binding protein[/E2] cofilin, profilin and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PIMT", "entity_1_idx": [[142, 146]], "entity_1_idx_in_text_with_entity_marker": [146, 150], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "actin-binding protein", "entity_2_idx": [[189, 210]], "entity_2_idx_in_text_with_entity_marker": [202, 223], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p16", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, [E1]protein L-isoaspartyl methyltransferase[/E1] (PIMT), ferritin heavy chain, type IV collagen, [E2]actin-binding protein[/E2] cofilin, profilin and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "protein L-isoaspartyl methyltransferase", "entity_1_idx": [[101, 140]], "entity_1_idx_in_text_with_entity_marker": [105, 144], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "actin-binding protein", "entity_2_idx": [[189, 210]], "entity_2_idx_in_text_with_entity_marker": [202, 223], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p17", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, [E1]type IV collagen[/E1], actin-binding protein cofilin, [E2]profilin[/E2] and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "type IV collagen", "entity_1_idx": [[171, 187]], "entity_1_idx_in_text_with_entity_marker": [175, 191], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[220, 228]], "entity_2_idx_in_text_with_entity_marker": [233, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p18", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as [E1]embryonic alpha-tubulin[/E1], embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, [E2]type IV collagen[/E2], actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "embryonic alpha-tubulin", "entity_1_idx": [[45, 68]], "entity_1_idx_in_text_with_entity_marker": [49, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "type IV collagen", "entity_2_idx": [[171, 187]], "entity_2_idx_in_text_with_entity_marker": [184, 200], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p19", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, [E1]hnRNP[/E1], protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, [E2]type IV collagen[/E2], actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hnRNP", "entity_1_idx": [[94, 99]], "entity_1_idx_in_text_with_entity_marker": [98, 103], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "type IV collagen", "entity_2_idx": [[171, 187]], "entity_2_idx_in_text_with_entity_marker": [184, 200], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d144.s0_BioInfer.d144.s0.p0", "text": "Coexpression of the A8R and A23R genes in Escherichia coli was required for in vitro activity.", "text_with_entity_marker": "Coexpression of the [E1]A8R[/E1] and [E2]A23R[/E2] genes in Escherichia coli was required for in vitro activity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "A8R", "entity_1_idx": [[20, 23]], "entity_1_idx_in_text_with_entity_marker": [24, 27], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "A23R", "entity_2_idx": [[28, 32]], "entity_2_idx_in_text_with_entity_marker": [41, 45], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d144.s1_BioInfer.d144.s1.p0", "text": "Expression of the A8R and A23R genes occurred between 1 and 5 h after vaccinia virus infection and was not prevented by an inhibitor of DNA replication, consistent with a role for VITF-3 in specifically regulating intermediate transcription in vivo.", "text_with_entity_marker": "Expression of the A8R and [E1]A23R[/E1] genes occurred between 1 and 5 h after vaccinia virus infection and was not prevented by an inhibitor of DNA replication, consistent with a role for [E2]VITF-3[/E2] in specifically regulating intermediate transcription in vivo.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "A23R", "entity_1_idx": [[26, 30]], "entity_1_idx_in_text_with_entity_marker": [30, 34], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "VITF-3", "entity_2_idx": [[180, 186]], "entity_2_idx_in_text_with_entity_marker": [193, 199], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d144.s1_BioInfer.d144.s1.p1", "text": "Expression of the A8R and A23R genes occurred between 1 and 5 h after vaccinia virus infection and was not prevented by an inhibitor of DNA replication, consistent with a role for VITF-3 in specifically regulating intermediate transcription in vivo.", "text_with_entity_marker": "Expression of the [E1]A8R[/E1] and [E2]A23R[/E2] genes occurred between 1 and 5 h after vaccinia virus infection and was not prevented by an inhibitor of DNA replication, consistent with a role for VITF-3 in specifically regulating intermediate transcription in vivo.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "A8R", "entity_1_idx": [[18, 21]], "entity_1_idx_in_text_with_entity_marker": [22, 25], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "A23R", "entity_2_idx": [[26, 30]], "entity_2_idx_in_text_with_entity_marker": [39, 43], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d144.s1_BioInfer.d144.s1.p2", "text": "Expression of the A8R and A23R genes occurred between 1 and 5 h after vaccinia virus infection and was not prevented by an inhibitor of DNA replication, consistent with a role for VITF-3 in specifically regulating intermediate transcription in vivo.", "text_with_entity_marker": "Expression of the [E1]A8R[/E1] and A23R genes occurred between 1 and 5 h after vaccinia virus infection and was not prevented by an inhibitor of DNA replication, consistent with a role for [E2]VITF-3[/E2] in specifically regulating intermediate transcription in vivo.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "A8R", "entity_1_idx": [[18, 21]], "entity_1_idx_in_text_with_entity_marker": [22, 25], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "VITF-3", "entity_2_idx": [[180, 186]], "entity_2_idx_in_text_with_entity_marker": [193, 199], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d144.s2_BioInfer.d144.s2.p0", "text": "We found that the 34- and 45-kDa polypeptides encoded by vaccinia virus ORFs A8R and A23R, respectively, were necessary to reconstitute transcription of a template with an intermediate stage promoter.", "text_with_entity_marker": "We found that the 34- and 45-kDa polypeptides encoded by vaccinia virus ORFs [E1]A8R[/E1] and [E2]A23R[/E2], respectively, were necessary to reconstitute transcription of a template with an intermediate stage promoter.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "A8R", "entity_1_idx": [[77, 80]], "entity_1_idx_in_text_with_entity_marker": [81, 84], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "A23R", "entity_2_idx": [[85, 89]], "entity_2_idx_in_text_with_entity_marker": [98, 102], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d462.s0_BioInfer.d462.s0.p0", "text": "One mutation, sac6-69, is in the gene encoding fimbrin, another actin-binding protein, which was expected because null mutations in SAC6 and CAP2 are known to be synthetic-lethal.", "text_with_entity_marker": "One mutation, sac6-69, is in the gene encoding fimbrin, another [E1]actin-binding protein[/E1], which was expected because null mutations in SAC6 and [E2]CAP2[/E2] are known to be synthetic-lethal.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin-binding protein", "entity_1_idx": [[64, 85]], "entity_1_idx_in_text_with_entity_marker": [68, 89], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "CAP2", "entity_2_idx": [[141, 145]], "entity_2_idx_in_text_with_entity_marker": [154, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d462.s0_BioInfer.d462.s0.p1", "text": "One mutation, sac6-69, is in the gene encoding fimbrin, another actin-binding protein, which was expected because null mutations in SAC6 and CAP2 are known to be synthetic-lethal.", "text_with_entity_marker": "One mutation, sac6-69, is in the gene encoding [E1]fimbrin[/E1], another [E2]actin-binding protein[/E2], which was expected because null mutations in SAC6 and CAP2 are known to be synthetic-lethal.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "fimbrin", "entity_1_idx": [[47, 54]], "entity_1_idx_in_text_with_entity_marker": [51, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[64, 85]], "entity_2_idx_in_text_with_entity_marker": [77, 98], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d462.s0_BioInfer.d462.s0.p2", "text": "One mutation, sac6-69, is in the gene encoding fimbrin, another actin-binding protein, which was expected because null mutations in SAC6 and CAP2 are known to be synthetic-lethal.", "text_with_entity_marker": "One mutation, [E1]sac6-69[/E1], is in the gene encoding fimbrin, another [E2]actin-binding protein[/E2], which was expected because null mutations in SAC6 and CAP2 are known to be synthetic-lethal.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "sac6-69", "entity_1_idx": [[14, 21]], "entity_1_idx_in_text_with_entity_marker": [18, 25], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin-binding protein", "entity_2_idx": [[64, 85]], "entity_2_idx_in_text_with_entity_marker": [77, 98], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d462.s0_BioInfer.d462.s0.p3", "text": "One mutation, sac6-69, is in the gene encoding fimbrin, another actin-binding protein, which was expected because null mutations in SAC6 and CAP2 are known to be synthetic-lethal.", "text_with_entity_marker": "One mutation, sac6-69, is in the gene encoding fimbrin, another [E1]actin-binding protein[/E1], which was expected because null mutations in [E2]SAC6[/E2] and CAP2 are known to be synthetic-lethal.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin-binding protein", "entity_1_idx": [[64, 85]], "entity_1_idx_in_text_with_entity_marker": [68, 89], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "SAC6", "entity_2_idx": [[132, 136]], "entity_2_idx_in_text_with_entity_marker": [145, 149], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d462.s0_BioInfer.d462.s0.p4", "text": "One mutation, sac6-69, is in the gene encoding fimbrin, another actin-binding protein, which was expected because null mutations in SAC6 and CAP2 are known to be synthetic-lethal.", "text_with_entity_marker": "One mutation, sac6-69, is in the gene encoding [E1]fimbrin[/E1], another actin-binding protein, which was expected because null mutations in SAC6 and [E2]CAP2[/E2] are known to be synthetic-lethal.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fimbrin", "entity_1_idx": [[47, 54]], "entity_1_idx_in_text_with_entity_marker": [51, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CAP2", "entity_2_idx": [[141, 145]], "entity_2_idx_in_text_with_entity_marker": [154, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d462.s0_BioInfer.d462.s0.p5", "text": "One mutation, sac6-69, is in the gene encoding fimbrin, another actin-binding protein, which was expected because null mutations in SAC6 and CAP2 are known to be synthetic-lethal.", "text_with_entity_marker": "One mutation, [E1]sac6-69[/E1], is in the gene encoding fimbrin, another actin-binding protein, which was expected because null mutations in SAC6 and [E2]CAP2[/E2] are known to be synthetic-lethal.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "sac6-69", "entity_1_idx": [[14, 21]], "entity_1_idx_in_text_with_entity_marker": [18, 25], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CAP2", "entity_2_idx": [[141, 145]], "entity_2_idx_in_text_with_entity_marker": [154, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d462.s0_BioInfer.d462.s0.p6", "text": "One mutation, sac6-69, is in the gene encoding fimbrin, another actin-binding protein, which was expected because null mutations in SAC6 and CAP2 are known to be synthetic-lethal.", "text_with_entity_marker": "One mutation, sac6-69, is in the gene encoding fimbrin, another actin-binding protein, which was expected because null mutations in [E1]SAC6[/E1] and [E2]CAP2[/E2] are known to be synthetic-lethal.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SAC6", "entity_1_idx": [[132, 136]], "entity_1_idx_in_text_with_entity_marker": [136, 140], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CAP2", "entity_2_idx": [[141, 145]], "entity_2_idx_in_text_with_entity_marker": [154, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d462.s0_BioInfer.d462.s0.p7", "text": "One mutation, sac6-69, is in the gene encoding fimbrin, another actin-binding protein, which was expected because null mutations in SAC6 and CAP2 are known to be synthetic-lethal.", "text_with_entity_marker": "One mutation, [E1]sac6-69[/E1], is in the gene encoding [E2]fimbrin[/E2], another actin-binding protein, which was expected because null mutations in SAC6 and CAP2 are known to be synthetic-lethal.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "sac6-69", "entity_1_idx": [[14, 21]], "entity_1_idx_in_text_with_entity_marker": [18, 25], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fimbrin", "entity_2_idx": [[47, 54]], "entity_2_idx_in_text_with_entity_marker": [60, 67], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d462.s0_BioInfer.d462.s0.p8", "text": "One mutation, sac6-69, is in the gene encoding fimbrin, another actin-binding protein, which was expected because null mutations in SAC6 and CAP2 are known to be synthetic-lethal.", "text_with_entity_marker": "One mutation, sac6-69, is in the gene encoding [E1]fimbrin[/E1], another actin-binding protein, which was expected because null mutations in [E2]SAC6[/E2] and CAP2 are known to be synthetic-lethal.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fimbrin", "entity_1_idx": [[47, 54]], "entity_1_idx_in_text_with_entity_marker": [51, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SAC6", "entity_2_idx": [[132, 136]], "entity_2_idx_in_text_with_entity_marker": [145, 149], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d462.s0_BioInfer.d462.s0.p9", "text": "One mutation, sac6-69, is in the gene encoding fimbrin, another actin-binding protein, which was expected because null mutations in SAC6 and CAP2 are known to be synthetic-lethal.", "text_with_entity_marker": "One mutation, [E1]sac6-69[/E1], is in the gene encoding fimbrin, another actin-binding protein, which was expected because null mutations in [E2]SAC6[/E2] and CAP2 are known to be synthetic-lethal.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "sac6-69", "entity_1_idx": [[14, 21]], "entity_1_idx_in_text_with_entity_marker": [18, 25], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SAC6", "entity_2_idx": [[132, 136]], "entity_2_idx_in_text_with_entity_marker": [145, 149], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p30", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein ([E1]P[/E1]), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, [E2]L[/E2]: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[62, 63]], "entity_1_idx_in_text_with_entity_marker": [66, 67], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[301, 302]], "entity_2_idx_in_text_with_entity_marker": [314, 315], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p31", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid ([E1]N[/E1]), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, [E2]L[/E2]: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[42, 43]], "entity_1_idx_in_text_with_entity_marker": [46, 47], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[301, 302]], "entity_2_idx_in_text_with_entity_marker": [314, 315], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p32", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion ([E1]F[/E1]), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, [E2]L[/E2]: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "F", "entity_1_idx": [[86, 87]], "entity_1_idx_in_text_with_entity_marker": [90, 91], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[301, 302]], "entity_2_idx_in_text_with_entity_marker": [314, 315], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p33", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of [E1]nucleocapsid[/E1] (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, [E2]L[/E2]: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid", "entity_1_idx": [[28, 40], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [32, 44], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[301, 302]], "entity_2_idx_in_text_with_entity_marker": [314, 315], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p34", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), [E1]matrix[/E1] (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, [E2]L[/E2]: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "matrix", "entity_1_idx": [[66, 72], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [70, 76], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[301, 302]], "entity_2_idx_in_text_with_entity_marker": [314, 315], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p35", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), [E1]phosphoprotein[/E1] (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, [E2]L[/E2]: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[46, 60], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [50, 64], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[301, 302]], "entity_2_idx_in_text_with_entity_marker": [314, 315], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p36", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and [E1]large protein[/E1] (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, [E2]L[/E2]: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "large protein", "entity_1_idx": [[94, 107]], "entity_1_idx_in_text_with_entity_marker": [98, 111], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[301, 302]], "entity_2_idx_in_text_with_entity_marker": [314, 315], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p37", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix ([E1]M[/E1]), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, [E2]L[/E2]: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[74, 75]], "entity_1_idx_in_text_with_entity_marker": [78, 79], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[301, 302]], "entity_2_idx_in_text_with_entity_marker": [314, 315], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p38", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position [E1]N[/E1]: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, [E2]L[/E2]: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[245, 246]], "entity_1_idx_in_text_with_entity_marker": [249, 250], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "L", "entity_2_idx": [[301, 302]], "entity_2_idx_in_text_with_entity_marker": [314, 315], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p39", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein ([E1]L[/E1]) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, [E2]M[/E2]: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "L", "entity_1_idx": [[109, 110]], "entity_1_idx_in_text_with_entity_marker": [113, 114], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "M", "entity_2_idx": [[273, 274]], "entity_2_idx_in_text_with_entity_marker": [286, 287], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d767.s0_BioInfer.d767.s0.p0", "text": "To determine whether alpha 1-adrenergic stimulation produced similar effects on the turnover of myofibrillar proteins, rates of synthesis and degradation were estimated for a myofibrillar-enriched protein fraction and for myosin heavy chain and actin.", "text_with_entity_marker": "To determine whether alpha 1-adrenergic stimulation produced similar effects on the turnover of myofibrillar proteins, rates of synthesis and degradation were estimated for a myofibrillar-enriched protein fraction and for [E1]myosin heavy chain[/E1] and [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[222, 240]], "entity_1_idx_in_text_with_entity_marker": [226, 244], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[245, 250]], "entity_2_idx_in_text_with_entity_marker": [258, 263], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d646.s0_BioInfer.d646.s0.p0", "text": "The most significant finding was the re-expression of E-cadherin, alpha-catenin, and beta-catenin, and increased down-regulation of gamma-catenin, in metastatic lesions.", "text_with_entity_marker": "The most significant finding was the re-expression of E-cadherin, [E1]alpha-catenin[/E1], and beta-catenin, and increased down-regulation of [E2]gamma-catenin[/E2], in metastatic lesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[66, 79]], "entity_1_idx_in_text_with_entity_marker": [70, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[132, 145]], "entity_2_idx_in_text_with_entity_marker": [145, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d646.s0_BioInfer.d646.s0.p1", "text": "The most significant finding was the re-expression of E-cadherin, alpha-catenin, and beta-catenin, and increased down-regulation of gamma-catenin, in metastatic lesions.", "text_with_entity_marker": "The most significant finding was the re-expression of E-cadherin, alpha-catenin, and [E1]beta-catenin[/E1], and increased down-regulation of [E2]gamma-catenin[/E2], in metastatic lesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[85, 97]], "entity_1_idx_in_text_with_entity_marker": [89, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[132, 145]], "entity_2_idx_in_text_with_entity_marker": [145, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d646.s0_BioInfer.d646.s0.p2", "text": "The most significant finding was the re-expression of E-cadherin, alpha-catenin, and beta-catenin, and increased down-regulation of gamma-catenin, in metastatic lesions.", "text_with_entity_marker": "The most significant finding was the re-expression of [E1]E-cadherin[/E1], alpha-catenin, and beta-catenin, and increased down-regulation of [E2]gamma-catenin[/E2], in metastatic lesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[54, 64]], "entity_1_idx_in_text_with_entity_marker": [58, 68], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[132, 145]], "entity_2_idx_in_text_with_entity_marker": [145, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d646.s0_BioInfer.d646.s0.p3", "text": "The most significant finding was the re-expression of E-cadherin, alpha-catenin, and beta-catenin, and increased down-regulation of gamma-catenin, in metastatic lesions.", "text_with_entity_marker": "The most significant finding was the re-expression of E-cadherin, [E1]alpha-catenin[/E1], and [E2]beta-catenin[/E2], and increased down-regulation of gamma-catenin, in metastatic lesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[66, 79]], "entity_1_idx_in_text_with_entity_marker": [70, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[85, 97]], "entity_2_idx_in_text_with_entity_marker": [98, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d646.s0_BioInfer.d646.s0.p4", "text": "The most significant finding was the re-expression of E-cadherin, alpha-catenin, and beta-catenin, and increased down-regulation of gamma-catenin, in metastatic lesions.", "text_with_entity_marker": "The most significant finding was the re-expression of [E1]E-cadherin[/E1], [E2]alpha-catenin[/E2], and beta-catenin, and increased down-regulation of gamma-catenin, in metastatic lesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[54, 64]], "entity_1_idx_in_text_with_entity_marker": [58, 68], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[66, 79]], "entity_2_idx_in_text_with_entity_marker": [79, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d646.s0_BioInfer.d646.s0.p5", "text": "The most significant finding was the re-expression of E-cadherin, alpha-catenin, and beta-catenin, and increased down-regulation of gamma-catenin, in metastatic lesions.", "text_with_entity_marker": "The most significant finding was the re-expression of [E1]E-cadherin[/E1], alpha-catenin, and [E2]beta-catenin[/E2], and increased down-regulation of gamma-catenin, in metastatic lesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[54, 64]], "entity_1_idx_in_text_with_entity_marker": [58, 68], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[85, 97]], "entity_2_idx_in_text_with_entity_marker": [98, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d384.s0_BioInfer.d384.s0.p0", "text": "In three of the cell lines with CTNNB1 mutations, complexes of beta-catenin with alpha-catenin and APC were detectable.", "text_with_entity_marker": "In three of the cell lines with CTNNB1 mutations, complexes of beta-catenin with [E1]alpha-catenin[/E1] and [E2]APC[/E2] were detectable.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[81, 94]], "entity_1_idx_in_text_with_entity_marker": [85, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "APC", "entity_2_idx": [[99, 102]], "entity_2_idx_in_text_with_entity_marker": [112, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d384.s0_BioInfer.d384.s0.p1", "text": "In three of the cell lines with CTNNB1 mutations, complexes of beta-catenin with alpha-catenin and APC were detectable.", "text_with_entity_marker": "In three of the cell lines with CTNNB1 mutations, complexes of [E1]beta-catenin[/E1] with alpha-catenin and [E2]APC[/E2] were detectable.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[63, 75]], "entity_1_idx_in_text_with_entity_marker": [67, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "APC", "entity_2_idx": [[99, 102]], "entity_2_idx_in_text_with_entity_marker": [112, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d384.s0_BioInfer.d384.s0.p2", "text": "In three of the cell lines with CTNNB1 mutations, complexes of beta-catenin with alpha-catenin and APC were detectable.", "text_with_entity_marker": "In three of the cell lines with [E1]CTNNB1[/E1] mutations, complexes of beta-catenin with alpha-catenin and [E2]APC[/E2] were detectable.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CTNNB1", "entity_1_idx": [[32, 38]], "entity_1_idx_in_text_with_entity_marker": [36, 42], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "APC", "entity_2_idx": [[99, 102]], "entity_2_idx_in_text_with_entity_marker": [112, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d384.s0_BioInfer.d384.s0.p3", "text": "In three of the cell lines with CTNNB1 mutations, complexes of beta-catenin with alpha-catenin and APC were detectable.", "text_with_entity_marker": "In three of the cell lines with CTNNB1 mutations, complexes of [E1]beta-catenin[/E1] with [E2]alpha-catenin[/E2] and APC were detectable.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[63, 75]], "entity_1_idx_in_text_with_entity_marker": [67, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[81, 94]], "entity_2_idx_in_text_with_entity_marker": [94, 107], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d384.s0_BioInfer.d384.s0.p4", "text": "In three of the cell lines with CTNNB1 mutations, complexes of beta-catenin with alpha-catenin and APC were detectable.", "text_with_entity_marker": "In three of the cell lines with [E1]CTNNB1[/E1] mutations, complexes of beta-catenin with [E2]alpha-catenin[/E2] and APC were detectable.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CTNNB1", "entity_1_idx": [[32, 38]], "entity_1_idx_in_text_with_entity_marker": [36, 42], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[81, 94]], "entity_2_idx_in_text_with_entity_marker": [94, 107], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d384.s0_BioInfer.d384.s0.p5", "text": "In three of the cell lines with CTNNB1 mutations, complexes of beta-catenin with alpha-catenin and APC were detectable.", "text_with_entity_marker": "In three of the cell lines with [E1]CTNNB1[/E1] mutations, complexes of [E2]beta-catenin[/E2] with alpha-catenin and APC were detectable.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CTNNB1", "entity_1_idx": [[32, 38]], "entity_1_idx_in_text_with_entity_marker": [36, 42], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[63, 75]], "entity_2_idx_in_text_with_entity_marker": [76, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d78.s1_BioInfer.d78.s1.p5", "text": "Immunofluorescence microscopy revealed that two actin-binding proteins of low molecular weight with different functional activity, ADF and cofilin, are transported into nuclei of cultured myogenic cells to form rod structures there together with actin, when the cells were incubated in medium containing dimethylsulfoxide.", "text_with_entity_marker": "Immunofluorescence microscopy revealed that two [E1]actin-binding proteins[/E1] of low molecular weight with different functional activity, ADF and cofilin, are transported into nuclei of cultured myogenic cells to form rod structures there together with [E2]actin[/E2], when the cells were incubated in medium containing dimethylsulfoxide.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin-binding proteins", "entity_1_idx": [[48, 70]], "entity_1_idx_in_text_with_entity_marker": [52, 74], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[246, 251]], "entity_2_idx_in_text_with_entity_marker": [259, 264], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d78.s2_BioInfer.d78.s2.p0", "text": "In most cases, ADF and cofilin colocalized in the same nuclear actin rods, but ADF appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.", "text_with_entity_marker": "In most cases, [E1]ADF[/E1] and cofilin colocalized in the same nuclear actin rods, but ADF appeared to predominate in mononucleated cells, while [E2]cofilin[/E2] was present in multinucleated myotubes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ADF", "entity_1_idx": [[15, 18]], "entity_1_idx_in_text_with_entity_marker": [19, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[137, 144]], "entity_2_idx_in_text_with_entity_marker": [150, 157], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d78.s2_BioInfer.d78.s2.p1", "text": "In most cases, ADF and cofilin colocalized in the same nuclear actin rods, but ADF appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.", "text_with_entity_marker": "In most cases, ADF and cofilin colocalized in the same nuclear actin rods, but [E1]ADF[/E1] appeared to predominate in mononucleated cells, while [E2]cofilin[/E2] was present in multinucleated myotubes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ADF", "entity_1_idx": [[79, 82]], "entity_1_idx_in_text_with_entity_marker": [83, 86], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cofilin", "entity_2_idx": [[137, 144]], "entity_2_idx_in_text_with_entity_marker": [150, 157], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d78.s2_BioInfer.d78.s2.p2", "text": "In most cases, ADF and cofilin colocalized in the same nuclear actin rods, but ADF appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.", "text_with_entity_marker": "In most cases, ADF and cofilin colocalized in the same nuclear [E1]actin[/E1] rods, but ADF appeared to predominate in mononucleated cells, while [E2]cofilin[/E2] was present in multinucleated myotubes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[63, 68]], "entity_1_idx_in_text_with_entity_marker": [67, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[137, 144]], "entity_2_idx_in_text_with_entity_marker": [150, 157], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d78.s2_BioInfer.d78.s2.p3", "text": "In most cases, ADF and cofilin colocalized in the same nuclear actin rods, but ADF appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.", "text_with_entity_marker": "In most cases, ADF and [E1]cofilin[/E1] colocalized in the same nuclear actin rods, but ADF appeared to predominate in mononucleated cells, while [E2]cofilin[/E2] was present in multinucleated myotubes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[23, 30]], "entity_1_idx_in_text_with_entity_marker": [27, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[137, 144]], "entity_2_idx_in_text_with_entity_marker": [150, 157], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d78.s2_BioInfer.d78.s2.p4", "text": "In most cases, ADF and cofilin colocalized in the same nuclear actin rods, but ADF appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.", "text_with_entity_marker": "In most cases, [E1]ADF[/E1] and cofilin colocalized in the same nuclear actin rods, but [E2]ADF[/E2] appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ADF", "entity_1_idx": [[15, 18]], "entity_1_idx_in_text_with_entity_marker": [19, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ADF", "entity_2_idx": [[79, 82]], "entity_2_idx_in_text_with_entity_marker": [92, 95], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d78.s2_BioInfer.d78.s2.p5", "text": "In most cases, ADF and cofilin colocalized in the same nuclear actin rods, but ADF appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.", "text_with_entity_marker": "In most cases, [E1]ADF[/E1] and cofilin colocalized in the same nuclear [E2]actin[/E2] rods, but ADF appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "ADF", "entity_1_idx": [[15, 18]], "entity_1_idx_in_text_with_entity_marker": [19, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[63, 68]], "entity_2_idx_in_text_with_entity_marker": [76, 81], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d78.s2_BioInfer.d78.s2.p6", "text": "In most cases, ADF and cofilin colocalized in the same nuclear actin rods, but ADF appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.", "text_with_entity_marker": "In most cases, [E1]ADF[/E1] and [E2]cofilin[/E2] colocalized in the same nuclear actin rods, but ADF appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "ADF", "entity_1_idx": [[15, 18]], "entity_1_idx_in_text_with_entity_marker": [19, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[23, 30]], "entity_2_idx_in_text_with_entity_marker": [36, 43], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d78.s2_BioInfer.d78.s2.p7", "text": "In most cases, ADF and cofilin colocalized in the same nuclear actin rods, but ADF appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.", "text_with_entity_marker": "In most cases, ADF and cofilin colocalized in the same nuclear [E1]actin[/E1] rods, but [E2]ADF[/E2] appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[63, 68]], "entity_1_idx_in_text_with_entity_marker": [67, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ADF", "entity_2_idx": [[79, 82]], "entity_2_idx_in_text_with_entity_marker": [92, 95], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d78.s2_BioInfer.d78.s2.p8", "text": "In most cases, ADF and cofilin colocalized in the same nuclear actin rods, but ADF appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.", "text_with_entity_marker": "In most cases, ADF and [E1]cofilin[/E1] colocalized in the same nuclear actin rods, but [E2]ADF[/E2] appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[23, 30]], "entity_1_idx_in_text_with_entity_marker": [27, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ADF", "entity_2_idx": [[79, 82]], "entity_2_idx_in_text_with_entity_marker": [92, 95], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d615.s0_BioInfer.d615.s0.p0", "text": "The gene for the human CREB binding protein, the transcriptional coactivator CBP, is included in the RT1 cosmid, and mutations in CBP have recently been identified in nondeleted RTS patients.", "text_with_entity_marker": "The gene for the human CREB binding protein, the transcriptional coactivator [E1]CBP[/E1], is included in the RT1 cosmid, and mutations in [E2]CBP[/E2] have recently been identified in nondeleted RTS patients.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CBP", "entity_1_idx": [[77, 80]], "entity_1_idx_in_text_with_entity_marker": [81, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[130, 133]], "entity_2_idx_in_text_with_entity_marker": [143, 146], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d615.s0_BioInfer.d615.s0.p1", "text": "The gene for the human CREB binding protein, the transcriptional coactivator CBP, is included in the RT1 cosmid, and mutations in CBP have recently been identified in nondeleted RTS patients.", "text_with_entity_marker": "The gene for the human [E1]CREB binding protein[/E1], the transcriptional coactivator [E2]CBP[/E2], is included in the RT1 cosmid, and mutations in CBP have recently been identified in nondeleted RTS patients.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CREB binding protein", "entity_1_idx": [[23, 43]], "entity_1_idx_in_text_with_entity_marker": [27, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[77, 80]], "entity_2_idx_in_text_with_entity_marker": [90, 93], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d615.s0_BioInfer.d615.s0.p2", "text": "The gene for the human CREB binding protein, the transcriptional coactivator CBP, is included in the RT1 cosmid, and mutations in CBP have recently been identified in nondeleted RTS patients.", "text_with_entity_marker": "The gene for the human [E1]CREB binding protein[/E1], the transcriptional coactivator CBP, is included in the RT1 cosmid, and mutations in [E2]CBP[/E2] have recently been identified in nondeleted RTS patients.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CREB binding protein", "entity_1_idx": [[23, 43]], "entity_1_idx_in_text_with_entity_marker": [27, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[130, 133]], "entity_2_idx_in_text_with_entity_marker": [143, 146], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p0", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three [E1]histone[/E1] H3 variants and [E2]histone[/E2] H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[306, 313]], "entity_1_idx_in_text_with_entity_marker": [310, 317], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[330, 337]], "entity_2_idx_in_text_with_entity_marker": [343, 350], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p1", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: [E1]histone[/E1] H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and [E2]histone[/E2] H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[158, 165]], "entity_1_idx_in_text_with_entity_marker": [162, 169], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[330, 337]], "entity_2_idx_in_text_with_entity_marker": [343, 350], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p2", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, [E1]histone[/E1] H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and [E2]histone[/E2] H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[218, 225]], "entity_1_idx_in_text_with_entity_marker": [222, 229], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[330, 337]], "entity_2_idx_in_text_with_entity_marker": [343, 350], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p3", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, [E1]histone[/E1] H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and [E2]histone[/E2] H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[203, 210]], "entity_1_idx_in_text_with_entity_marker": [207, 214], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[330, 337]], "entity_2_idx_in_text_with_entity_marker": [343, 350], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p4", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four [E1]histone[/E1] H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and [E2]histone[/E2] H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[178, 185]], "entity_1_idx_in_text_with_entity_marker": [182, 189], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[330, 337]], "entity_2_idx_in_text_with_entity_marker": [343, 350], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p5", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, [E1]histone[/E1] H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and [E2]histone[/E2] H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[257, 264]], "entity_1_idx_in_text_with_entity_marker": [261, 268], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[330, 337]], "entity_2_idx_in_text_with_entity_marker": [343, 350], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p6", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, [E1]histone[/E1] H2B, three histone H3 variants and [E2]histone[/E2] H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[287, 294]], "entity_1_idx_in_text_with_entity_marker": [291, 298], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[330, 337]], "entity_2_idx_in_text_with_entity_marker": [343, 350], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p7", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, [E1]histone[/E1] H2A.Z, histone H2B, three histone H3 variants and [E2]histone[/E2] H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[272, 279]], "entity_1_idx_in_text_with_entity_marker": [276, 283], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[330, 337]], "entity_2_idx_in_text_with_entity_marker": [343, 350], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p8", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone [E1]H3[/E1] variants and [E2]histone[/E2] H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[314, 316]], "entity_1_idx_in_text_with_entity_marker": [318, 320], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[330, 337]], "entity_2_idx_in_text_with_entity_marker": [343, 350], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p9", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone [E1]H2B[/E1], three histone H3 variants and [E2]histone[/E2] H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2B", "entity_1_idx": [[295, 298]], "entity_1_idx_in_text_with_entity_marker": [299, 302], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[330, 337]], "entity_2_idx_in_text_with_entity_marker": [343, 350], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p150", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified [E1]histones[/E1] were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone [E2]H3[/E2] variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[100, 108]], "entity_1_idx_in_text_with_entity_marker": [104, 112], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "H3", "entity_2_idx": [[314, 316]], "entity_2_idx_in_text_with_entity_marker": [327, 329], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p151", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone [E1]H2A.Z[/E1], histone H2B, three histone [E2]H3[/E2] variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.Z", "entity_1_idx": [[280, 285]], "entity_1_idx_in_text_with_entity_marker": [284, 289], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[314, 316]], "entity_2_idx_in_text_with_entity_marker": [327, 329], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p152", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone [E1]H2A.X[/E1], histone H2A.Z, histone H2B, three histone [E2]H3[/E2] variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.X", "entity_1_idx": [[265, 270]], "entity_1_idx_in_text_with_entity_marker": [269, 274], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[314, 316]], "entity_2_idx_in_text_with_entity_marker": [327, 329], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p153", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone [E1]H2A.2[/E1], histone H2A.X, histone H2A.Z, histone H2B, three histone [E2]H3[/E2] variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.2", "entity_1_idx": [[250, 255]], "entity_1_idx_in_text_with_entity_marker": [254, 259], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[314, 316]], "entity_2_idx_in_text_with_entity_marker": [327, 329], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p154", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone [E1]H2A.2[/E1], oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone [E2]H3[/E2] variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.2", "entity_1_idx": [[226, 231]], "entity_1_idx_in_text_with_entity_marker": [230, 235], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[314, 316]], "entity_2_idx_in_text_with_entity_marker": [327, 329], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p155", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone [E1]H2B[/E1], three histone H3 variants and histone [E2]H4[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2B", "entity_1_idx": [[295, 298]], "entity_1_idx_in_text_with_entity_marker": [299, 302], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[338, 340]], "entity_2_idx_in_text_with_entity_marker": [351, 353], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p156", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized [E1]histone[/E1] H2A.2, histone H2A.X, histone H2A.Z, histone [E2]H2B[/E2], three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[242, 249]], "entity_1_idx_in_text_with_entity_marker": [246, 253], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2B", "entity_2_idx": [[295, 298]], "entity_2_idx_in_text_with_entity_marker": [308, 311], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p157", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone [E1]H2A.1[/E1], histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone [E2]H2B[/E2], three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.1", "entity_1_idx": [[211, 216]], "entity_1_idx_in_text_with_entity_marker": [215, 220], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2B", "entity_2_idx": [[295, 298]], "entity_2_idx_in_text_with_entity_marker": [308, 311], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p158", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone [E1]H1[/E1] subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone [E2]H2B[/E2], three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H1", "entity_1_idx": [[186, 188]], "entity_1_idx_in_text_with_entity_marker": [190, 192], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2B", "entity_2_idx": [[295, 298]], "entity_2_idx_in_text_with_entity_marker": [308, 311], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p159", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone [E1]H1(0)[/E1], four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone [E2]H2B[/E2], three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H1(0)", "entity_1_idx": [[166, 171]], "entity_1_idx_in_text_with_entity_marker": [170, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2B", "entity_2_idx": [[295, 298]], "entity_2_idx_in_text_with_entity_marker": [308, 311], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p190", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified [E1]histones[/E1] were identified by HPLC and gel electrophoresis: histone H1(0), four histone [E2]H1[/E2] subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[100, 108]], "entity_1_idx_in_text_with_entity_marker": [104, 112], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "H1", "entity_2_idx": [[186, 188]], "entity_2_idx_in_text_with_entity_marker": [199, 201], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p191", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone [E1]H1[/E1] subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone [E2]H2A.Z[/E2], histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H1", "entity_1_idx": [[186, 188]], "entity_1_idx_in_text_with_entity_marker": [190, 192], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A.Z", "entity_2_idx": [[280, 285]], "entity_2_idx_in_text_with_entity_marker": [293, 298], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p192", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone [E1]H1[/E1] subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone [E2]H2A.X[/E2], histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H1", "entity_1_idx": [[186, 188]], "entity_1_idx_in_text_with_entity_marker": [190, 192], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A.X", "entity_2_idx": [[265, 270]], "entity_2_idx_in_text_with_entity_marker": [278, 283], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p193", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone [E1]H1[/E1] subfractions, histone H2A.1, histone H2A.2, oxidized histone [E2]H2A.2[/E2], histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H1", "entity_1_idx": [[186, 188]], "entity_1_idx_in_text_with_entity_marker": [190, 192], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A.2", "entity_2_idx": [[250, 255]], "entity_2_idx_in_text_with_entity_marker": [263, 268], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p194", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone [E1]H1[/E1] subfractions, histone H2A.1, histone [E2]H2A.2[/E2], oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H1", "entity_1_idx": [[186, 188]], "entity_1_idx_in_text_with_entity_marker": [190, 192], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A.2", "entity_2_idx": [[226, 231]], "entity_2_idx_in_text_with_entity_marker": [239, 244], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p195", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified [E1]histones[/E1] were identified by HPLC and gel electrophoresis: histone [E2]H1(0)[/E2], four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[100, 108]], "entity_1_idx_in_text_with_entity_marker": [104, 112], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "H1(0)", "entity_2_idx": [[166, 171]], "entity_2_idx_in_text_with_entity_marker": [179, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p196", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone [E1]H1(0)[/E1], four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone [E2]H2A.Z[/E2], histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H1(0)", "entity_1_idx": [[166, 171]], "entity_1_idx_in_text_with_entity_marker": [170, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A.Z", "entity_2_idx": [[280, 285]], "entity_2_idx_in_text_with_entity_marker": [293, 298], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p197", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone [E1]H1(0)[/E1], four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone [E2]H2A.X[/E2], histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H1(0)", "entity_1_idx": [[166, 171]], "entity_1_idx_in_text_with_entity_marker": [170, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A.X", "entity_2_idx": [[265, 270]], "entity_2_idx_in_text_with_entity_marker": [278, 283], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p198", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone [E1]H1(0)[/E1], four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone [E2]H2A.2[/E2], histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H1(0)", "entity_1_idx": [[166, 171]], "entity_1_idx_in_text_with_entity_marker": [170, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A.2", "entity_2_idx": [[250, 255]], "entity_2_idx_in_text_with_entity_marker": [263, 268], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p199", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone [E1]H1(0)[/E1], four histone H1 subfractions, histone H2A.1, histone [E2]H2A.2[/E2], oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H1(0)", "entity_1_idx": [[166, 171]], "entity_1_idx_in_text_with_entity_marker": [170, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A.2", "entity_2_idx": [[226, 231]], "entity_2_idx_in_text_with_entity_marker": [239, 244], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p200", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified [E1]histones[/E1] were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone [E2]H2A.Z[/E2], histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[100, 108]], "entity_1_idx_in_text_with_entity_marker": [104, 112], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "H2A.Z", "entity_2_idx": [[280, 285]], "entity_2_idx_in_text_with_entity_marker": [293, 298], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p201", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified [E1]histones[/E1] were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone [E2]H2A.X[/E2], histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[100, 108]], "entity_1_idx_in_text_with_entity_marker": [104, 112], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "H2A.X", "entity_2_idx": [[265, 270]], "entity_2_idx_in_text_with_entity_marker": [278, 283], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p202", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified [E1]histones[/E1] were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone [E2]H2A.2[/E2], histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[100, 108]], "entity_1_idx_in_text_with_entity_marker": [104, 112], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "H2A.2", "entity_2_idx": [[250, 255]], "entity_2_idx_in_text_with_entity_marker": [263, 268], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p203", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified [E1]histones[/E1] were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone [E2]H2A.2[/E2], oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[100, 108]], "entity_1_idx_in_text_with_entity_marker": [104, 112], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "H2A.2", "entity_2_idx": [[226, 231]], "entity_2_idx_in_text_with_entity_marker": [239, 244], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p204", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone [E1]H2A.X[/E1], histone [E2]H2A.Z[/E2], histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.X", "entity_1_idx": [[265, 270]], "entity_1_idx_in_text_with_entity_marker": [269, 274], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A.Z", "entity_2_idx": [[280, 285]], "entity_2_idx_in_text_with_entity_marker": [293, 298], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p205", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone [E1]H2A.2[/E1], histone H2A.X, histone [E2]H2A.Z[/E2], histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.2", "entity_1_idx": [[250, 255]], "entity_1_idx_in_text_with_entity_marker": [254, 259], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A.Z", "entity_2_idx": [[280, 285]], "entity_2_idx_in_text_with_entity_marker": [293, 298], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p206", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone [E1]H2A.2[/E1], oxidized histone H2A.2, histone H2A.X, histone [E2]H2A.Z[/E2], histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.2", "entity_1_idx": [[226, 231]], "entity_1_idx_in_text_with_entity_marker": [230, 235], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A.Z", "entity_2_idx": [[280, 285]], "entity_2_idx_in_text_with_entity_marker": [293, 298], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p207", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone [E1]H2A.2[/E1], histone [E2]H2A.X[/E2], histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.2", "entity_1_idx": [[250, 255]], "entity_1_idx_in_text_with_entity_marker": [254, 259], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A.X", "entity_2_idx": [[265, 270]], "entity_2_idx_in_text_with_entity_marker": [278, 283], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p208", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone [E1]H2A.2[/E1], oxidized histone H2A.2, histone [E2]H2A.X[/E2], histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.2", "entity_1_idx": [[226, 231]], "entity_1_idx_in_text_with_entity_marker": [230, 235], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A.X", "entity_2_idx": [[265, 270]], "entity_2_idx_in_text_with_entity_marker": [278, 283], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p209", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone [E1]H2A.2[/E1], oxidized histone [E2]H2A.2[/E2], histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.2", "entity_1_idx": [[226, 231]], "entity_1_idx_in_text_with_entity_marker": [230, 235], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A.2", "entity_2_idx": [[250, 255]], "entity_2_idx_in_text_with_entity_marker": [263, 268], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d510.s0_BioInfer.d510.s0.p0", "text": "Recruitment of a myosin heavy chain kinase to actin-rich protrusions in Dictyostelium.", "text_with_entity_marker": "Recruitment of a [E1]myosin heavy chain kinase[/E1] to [E2]actin[/E2]-rich protrusions in Dictyostelium.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "myosin heavy chain kinase", "entity_1_idx": [[17, 42]], "entity_1_idx_in_text_with_entity_marker": [21, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[46, 51]], "entity_2_idx_in_text_with_entity_marker": [59, 64], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d729.s0_BioInfer.d729.s0.p0", "text": "The two proteins were found to differ in their interaction with actin, like destrin and cofilin isolated from porcine brain.", "text_with_entity_marker": "The two proteins were found to differ in their interaction with actin, like [E1]destrin[/E1] and [E2]cofilin[/E2] isolated from porcine brain.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "destrin", "entity_1_idx": [[76, 83]], "entity_1_idx_in_text_with_entity_marker": [80, 87], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[88, 95]], "entity_2_idx_in_text_with_entity_marker": [101, 108], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d729.s0_BioInfer.d729.s0.p1", "text": "The two proteins were found to differ in their interaction with actin, like destrin and cofilin isolated from porcine brain.", "text_with_entity_marker": "The two proteins were found to differ in their interaction with [E1]actin[/E1], like destrin and [E2]cofilin[/E2] isolated from porcine brain.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[64, 69]], "entity_1_idx_in_text_with_entity_marker": [68, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[88, 95]], "entity_2_idx_in_text_with_entity_marker": [101, 108], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d729.s0_BioInfer.d729.s0.p2", "text": "The two proteins were found to differ in their interaction with actin, like destrin and cofilin isolated from porcine brain.", "text_with_entity_marker": "The two proteins were found to differ in their interaction with [E1]actin[/E1], like [E2]destrin[/E2] and cofilin isolated from porcine brain.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[64, 69]], "entity_1_idx_in_text_with_entity_marker": [68, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "destrin", "entity_2_idx": [[76, 83]], "entity_2_idx_in_text_with_entity_marker": [89, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p50", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that [E1]histone[/E1] H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/[E2]p300[/E2], and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[72, 79]], "entity_1_idx_in_text_with_entity_marker": [76, 83], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p300", "entity_2_idx": [[184, 188]], "entity_2_idx_in_text_with_entity_marker": [197, 201], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p51", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/[E1]waf1[/E1] promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/[E2]waf1[/E2] in HTLV-1-infected cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "waf1", "entity_1_idx": [[143, 147]], "entity_1_idx_in_text_with_entity_marker": [147, 151], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "waf1", "entity_2_idx": [[276, 280]], "entity_2_idx_in_text_with_entity_marker": [289, 293], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p52", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/[E1]waf1[/E1] promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of [E2]p21[/E2]/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "waf1", "entity_1_idx": [[143, 147]], "entity_1_idx_in_text_with_entity_marker": [147, 151], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "p21", "entity_2_idx": [[272, 275]], "entity_2_idx_in_text_with_entity_marker": [285, 288], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p53", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not [E1]histone[/E1] H3, was acetylated from the endogenous p21/[E2]waf1[/E2] promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[92, 99]], "entity_1_idx_in_text_with_entity_marker": [96, 103], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "waf1", "entity_2_idx": [[143, 147]], "entity_2_idx_in_text_with_entity_marker": [156, 160], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p54", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/[E1]waf1[/E1] promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with [E2]E2A[/E2] in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "waf1", "entity_1_idx": [[143, 147]], "entity_1_idx_in_text_with_entity_marker": [147, 151], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "E2A", "entity_2_idx": [[248, 251]], "entity_2_idx_in_text_with_entity_marker": [261, 264], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p55", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that [E1]histone[/E1] H4, and not histone H3, was acetylated from the endogenous p21/[E2]waf1[/E2] promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[72, 79]], "entity_1_idx_in_text_with_entity_marker": [76, 83], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "waf1", "entity_2_idx": [[143, 147]], "entity_2_idx_in_text_with_entity_marker": [156, 160], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p56", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of [E1]p21[/E1]/[E2]waf1[/E2] in HTLV-1-infected cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p21", "entity_1_idx": [[272, 275]], "entity_1_idx_in_text_with_entity_marker": [276, 279], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "waf1", "entity_2_idx": [[276, 280]], "entity_2_idx_in_text_with_entity_marker": [289, 293], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p57", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not [E1]histone[/E1] H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/[E2]waf1[/E2] in HTLV-1-infected cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[92, 99]], "entity_1_idx_in_text_with_entity_marker": [96, 103], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "waf1", "entity_2_idx": [[276, 280]], "entity_2_idx_in_text_with_entity_marker": [289, 293], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p58", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with [E1]E2A[/E1] in up-regulation of p21/[E2]waf1[/E2] in HTLV-1-infected cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E2A", "entity_1_idx": [[248, 251]], "entity_1_idx_in_text_with_entity_marker": [252, 255], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "waf1", "entity_2_idx": [[276, 280]], "entity_2_idx_in_text_with_entity_marker": [289, 293], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p59", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that [E1]histone[/E1] H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/[E2]waf1[/E2] in HTLV-1-infected cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[72, 79]], "entity_1_idx_in_text_with_entity_marker": [76, 83], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "waf1", "entity_2_idx": [[276, 280]], "entity_2_idx_in_text_with_entity_marker": [289, 293], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p90", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-[E1]4a[/E1]-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein [E2]P[/E2] and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4a", "entity_1_idx": [[38, 40]], "entity_1_idx_in_text_with_entity_marker": [42, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "P", "entity_2_idx": [[172, 173]], "entity_2_idx_in_text_with_entity_marker": [185, 186], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p91", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-[E1]4a[/E1]-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; [E2]M[/E2] is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4a", "entity_1_idx": [[38, 40]], "entity_1_idx_in_text_with_entity_marker": [42, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "M", "entity_2_idx": [[232, 233]], "entity_2_idx_in_text_with_entity_marker": [245, 246], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p92", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-[E1]4a[/E1]-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed [E2]transcriptase[/E2] gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4a", "entity_1_idx": [[38, 40]], "entity_1_idx_in_text_with_entity_marker": [42, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "transcriptase", "entity_2_idx": [[330, 343]], "entity_2_idx_in_text_with_entity_marker": [343, 356], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p93", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-[E1]4a[/E1]-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed [E2]glycoprotein[/E2] gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4a", "entity_1_idx": [[38, 40]], "entity_1_idx_in_text_with_entity_marker": [42, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "glycoprotein", "entity_2_idx": [[289, 301]], "entity_2_idx_in_text_with_entity_marker": [302, 314], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p94", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-[E1]4a[/E1]-4b-M-G-L-5', where N is the [E2]nucleocapsid protein[/E2] gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4a", "entity_1_idx": [[38, 40]], "entity_1_idx_in_text_with_entity_marker": [42, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "nucleocapsid protein", "entity_2_idx": [[69, 89]], "entity_2_idx_in_text_with_entity_marker": [82, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p95", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-[E1]4a[/E1]-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed [E2]phosphoprotein[/E2] P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4a", "entity_1_idx": [[38, 40]], "entity_1_idx_in_text_with_entity_marker": [42, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "phosphoprotein", "entity_2_idx": [[157, 171]], "entity_2_idx_in_text_with_entity_marker": [170, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p96", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-[E1]4a[/E1]-4b-M-G-L-5', where N is the nucleocapsid protein gene; [E2]4a[/E2] and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4a", "entity_1_idx": [[38, 40]], "entity_1_idx_in_text_with_entity_marker": [42, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "4a", "entity_2_idx": [[96, 98]], "entity_2_idx_in_text_with_entity_marker": [109, 111], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p97", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-[E1]4a[/E1]-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed [E2]matrix protein[/E2] gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4a", "entity_1_idx": [[38, 40]], "entity_1_idx_in_text_with_entity_marker": [42, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "matrix protein", "entity_2_idx": [[250, 264]], "entity_2_idx_in_text_with_entity_marker": [263, 277], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p98", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; [E1]G[/E1] is the proposed glycoprotein gene; and [E2]L[/E2] is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "G", "entity_1_idx": [[271, 272]], "entity_1_idx_in_text_with_entity_marker": [275, 276], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[312, 313]], "entity_2_idx_in_text_with_entity_marker": [325, 326], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p99", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where [E1]N[/E1] is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; [E2]G[/E2] is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[60, 61]], "entity_1_idx_in_text_with_entity_marker": [64, 65], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "G", "entity_2_idx": [[271, 272]], "entity_2_idx_in_text_with_entity_marker": [284, 285], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d72.s0_BioInfer.d72.s0.p0", "text": "RAD51, RAD52, RAD57, and RAD59 were required for efficient gap repair using either chromosomal or plasmid donors.", "text_with_entity_marker": "RAD51, [E1]RAD52[/E1], RAD57, and [E2]RAD59[/E2] were required for efficient gap repair using either chromosomal or plasmid donors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[7, 12]], "entity_1_idx_in_text_with_entity_marker": [11, 16], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD59", "entity_2_idx": [[25, 30]], "entity_2_idx_in_text_with_entity_marker": [38, 43], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d72.s0_BioInfer.d72.s0.p1", "text": "RAD51, RAD52, RAD57, and RAD59 were required for efficient gap repair using either chromosomal or plasmid donors.", "text_with_entity_marker": "RAD51, RAD52, [E1]RAD57[/E1], and [E2]RAD59[/E2] were required for efficient gap repair using either chromosomal or plasmid donors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD57", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD59", "entity_2_idx": [[25, 30]], "entity_2_idx_in_text_with_entity_marker": [38, 43], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d72.s0_BioInfer.d72.s0.p2", "text": "RAD51, RAD52, RAD57, and RAD59 were required for efficient gap repair using either chromosomal or plasmid donors.", "text_with_entity_marker": "[E1]RAD51[/E1], RAD52, RAD57, and [E2]RAD59[/E2] were required for efficient gap repair using either chromosomal or plasmid donors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD59", "entity_2_idx": [[25, 30]], "entity_2_idx_in_text_with_entity_marker": [38, 43], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d72.s0_BioInfer.d72.s0.p3", "text": "RAD51, RAD52, RAD57, and RAD59 were required for efficient gap repair using either chromosomal or plasmid donors.", "text_with_entity_marker": "RAD51, [E1]RAD52[/E1], [E2]RAD57[/E2], and RAD59 were required for efficient gap repair using either chromosomal or plasmid donors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[7, 12]], "entity_1_idx_in_text_with_entity_marker": [11, 16], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD57", "entity_2_idx": [[14, 19]], "entity_2_idx_in_text_with_entity_marker": [27, 32], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d72.s0_BioInfer.d72.s0.p4", "text": "RAD51, RAD52, RAD57, and RAD59 were required for efficient gap repair using either chromosomal or plasmid donors.", "text_with_entity_marker": "[E1]RAD51[/E1], [E2]RAD52[/E2], RAD57, and RAD59 were required for efficient gap repair using either chromosomal or plasmid donors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[7, 12]], "entity_2_idx_in_text_with_entity_marker": [20, 25], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d72.s0_BioInfer.d72.s0.p5", "text": "RAD51, RAD52, RAD57, and RAD59 were required for efficient gap repair using either chromosomal or plasmid donors.", "text_with_entity_marker": "[E1]RAD51[/E1], RAD52, [E2]RAD57[/E2], and RAD59 were required for efficient gap repair using either chromosomal or plasmid donors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD57", "entity_2_idx": [[14, 19]], "entity_2_idx_in_text_with_entity_marker": [27, 32], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p30", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like [E1]actin[/E1]-regulatory domains, but no specific actin structure regulated by CDC42Hs-[E2]WASp[/E2] has been identified.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[91, 96]], "entity_1_idx_in_text_with_entity_marker": [95, 100], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "WASp", "entity_2_idx": [[170, 174]], "entity_2_idx_in_text_with_entity_marker": [183, 187], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p31", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific [E1]actin[/E1] structure regulated by CDC42Hs-[E2]WASp[/E2] has been identified.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[133, 138]], "entity_1_idx_in_text_with_entity_marker": [137, 142], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "WASp", "entity_2_idx": [[170, 174]], "entity_2_idx_in_text_with_entity_marker": [183, 187], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p32", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "WASp contains a binding motif for the [E1]Rho GTPase[/E1] CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-[E2]WASp[/E2] has been identified.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rho GTPase", "entity_1_idx": [[38, 48]], "entity_1_idx_in_text_with_entity_marker": [42, 52], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "WASp", "entity_2_idx": [[170, 174]], "entity_2_idx_in_text_with_entity_marker": [183, 187], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p33", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like [E1]actin[/E1]-regulatory domains, but no specific [E2]actin[/E2] structure regulated by CDC42Hs-WASp has been identified.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[91, 96]], "entity_1_idx_in_text_with_entity_marker": [95, 100], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[133, 138]], "entity_2_idx_in_text_with_entity_marker": [146, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p34", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "WASp contains a binding motif for the [E1]Rho GTPase[/E1] CDC42Hs as well as verprolin/cofilin-like [E2]actin[/E2]-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rho GTPase", "entity_1_idx": [[38, 48]], "entity_1_idx_in_text_with_entity_marker": [42, 52], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[91, 96]], "entity_2_idx_in_text_with_entity_marker": [104, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p35", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "WASp contains a binding motif for the [E1]Rho GTPase[/E1] CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific [E2]actin[/E2] structure regulated by CDC42Hs-WASp has been identified.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rho GTPase", "entity_1_idx": [[38, 48]], "entity_1_idx_in_text_with_entity_marker": [42, 52], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[133, 138]], "entity_2_idx_in_text_with_entity_marker": [146, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s0_BioInfer.d113.s0.p10", "text": "Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.", "text_with_entity_marker": "Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the [E1]EGFR[/E1] tyrosine kinase, whereas dissociation of [E2]alpha-catenin[/E2] from E-cadherin was not.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "EGFR", "entity_1_idx": [[130, 134]], "entity_1_idx_in_text_with_entity_marker": [134, 138], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[176, 189]], "entity_2_idx_in_text_with_entity_marker": [189, 202], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s0_BioInfer.d113.s0.p11", "text": "Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.", "text_with_entity_marker": "Both tyrosine phosphorylation and association of [E1]beta-catenin[/E1] with EGFR were inhibited by tyrphostin, a specific inhibitor of the [E2]EGFR[/E2] tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[49, 61]], "entity_1_idx_in_text_with_entity_marker": [53, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "EGFR", "entity_2_idx": [[130, 134]], "entity_2_idx_in_text_with_entity_marker": [143, 147], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s0_BioInfer.d113.s0.p12", "text": "Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.", "text_with_entity_marker": "Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR [E1]tyrosine kinase[/E1], whereas dissociation of [E2]alpha-catenin[/E2] from E-cadherin was not.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tyrosine kinase", "entity_1_idx": [[135, 150]], "entity_1_idx_in_text_with_entity_marker": [139, 154], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "alpha-catenin", "entity_2_idx": [[176, 189]], "entity_2_idx_in_text_with_entity_marker": [189, 202], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s0_BioInfer.d113.s0.p13", "text": "Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.", "text_with_entity_marker": "Both tyrosine phosphorylation and association of [E1]beta-catenin[/E1] with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR [E2]tyrosine kinase[/E2], whereas dissociation of alpha-catenin from E-cadherin was not.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[49, 61]], "entity_1_idx_in_text_with_entity_marker": [53, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "tyrosine kinase", "entity_2_idx": [[135, 150]], "entity_2_idx_in_text_with_entity_marker": [148, 163], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s0_BioInfer.d113.s0.p14", "text": "Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.", "text_with_entity_marker": "Both tyrosine phosphorylation and association of [E1]beta-catenin[/E1] with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of [E2]alpha-catenin[/E2] from E-cadherin was not.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[49, 61]], "entity_1_idx_in_text_with_entity_marker": [53, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[176, 189]], "entity_2_idx_in_text_with_entity_marker": [189, 202], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s1_BioInfer.d113.s1.p0", "text": "The results suggest that tyrosine phosphorylation of beta-catenin is achieved by EGFR upon tryptic digestion of cells and concurrent with but independent of dissociation of alpha-catenin from E-cadherin.", "text_with_entity_marker": "The results suggest that tyrosine phosphorylation of [E1]beta-catenin[/E1] is achieved by EGFR upon tryptic digestion of cells and concurrent with but independent of dissociation of [E2]alpha-catenin[/E2] from E-cadherin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[53, 65]], "entity_1_idx_in_text_with_entity_marker": [57, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[173, 186]], "entity_2_idx_in_text_with_entity_marker": [186, 199], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s1_BioInfer.d113.s1.p1", "text": "The results suggest that tyrosine phosphorylation of beta-catenin is achieved by EGFR upon tryptic digestion of cells and concurrent with but independent of dissociation of alpha-catenin from E-cadherin.", "text_with_entity_marker": "The results suggest that tyrosine phosphorylation of beta-catenin is achieved by [E1]EGFR[/E1] upon tryptic digestion of cells and concurrent with but independent of dissociation of [E2]alpha-catenin[/E2] from E-cadherin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "EGFR", "entity_1_idx": [[81, 85]], "entity_1_idx_in_text_with_entity_marker": [85, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[173, 186]], "entity_2_idx_in_text_with_entity_marker": [186, 199], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s1_BioInfer.d113.s1.p2", "text": "The results suggest that tyrosine phosphorylation of beta-catenin is achieved by EGFR upon tryptic digestion of cells and concurrent with but independent of dissociation of alpha-catenin from E-cadherin.", "text_with_entity_marker": "The results suggest that tyrosine phosphorylation of beta-catenin is achieved by EGFR upon tryptic digestion of cells and concurrent with but independent of dissociation of [E1]alpha-catenin[/E1] from [E2]E-cadherin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[173, 186]], "entity_1_idx_in_text_with_entity_marker": [177, 190], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[192, 202]], "entity_2_idx_in_text_with_entity_marker": [205, 215], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s1_BioInfer.d113.s1.p3", "text": "The results suggest that tyrosine phosphorylation of beta-catenin is achieved by EGFR upon tryptic digestion of cells and concurrent with but independent of dissociation of alpha-catenin from E-cadherin.", "text_with_entity_marker": "The results suggest that tyrosine phosphorylation of [E1]beta-catenin[/E1] is achieved by [E2]EGFR[/E2] upon tryptic digestion of cells and concurrent with but independent of dissociation of alpha-catenin from E-cadherin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[53, 65]], "entity_1_idx_in_text_with_entity_marker": [57, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "EGFR", "entity_2_idx": [[81, 85]], "entity_2_idx_in_text_with_entity_marker": [94, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d113.s1_BioInfer.d113.s1.p4", "text": "The results suggest that tyrosine phosphorylation of beta-catenin is achieved by EGFR upon tryptic digestion of cells and concurrent with but independent of dissociation of alpha-catenin from E-cadherin.", "text_with_entity_marker": "The results suggest that tyrosine phosphorylation of [E1]beta-catenin[/E1] is achieved by EGFR upon tryptic digestion of cells and concurrent with but independent of dissociation of alpha-catenin from [E2]E-cadherin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[53, 65]], "entity_1_idx_in_text_with_entity_marker": [57, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[192, 202]], "entity_2_idx_in_text_with_entity_marker": [205, 215], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d475.s0_BioInfer.d475.s0.p0", "text": "Our results showed that cell morphology, cell adhesion pattern, actin organization, and distribution of integrin subunits, talin, vinculin, and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the collagens.", "text_with_entity_marker": "Our results showed that cell morphology, cell adhesion pattern, actin organization, and distribution of [E1]integrin[/E1] subunits, talin, [E2]vinculin[/E2], and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the collagens.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "integrin", "entity_1_idx": [[104, 112]], "entity_1_idx_in_text_with_entity_marker": [108, 116], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[130, 138]], "entity_2_idx_in_text_with_entity_marker": [143, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d475.s0_BioInfer.d475.s0.p1", "text": "Our results showed that cell morphology, cell adhesion pattern, actin organization, and distribution of integrin subunits, talin, vinculin, and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the collagens.", "text_with_entity_marker": "Our results showed that cell morphology, cell adhesion pattern, actin organization, and distribution of [E1]integrin[/E1] subunits, [E2]talin[/E2], vinculin, and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the collagens.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "integrin", "entity_1_idx": [[104, 112]], "entity_1_idx_in_text_with_entity_marker": [108, 116], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[123, 128]], "entity_2_idx_in_text_with_entity_marker": [136, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d475.s0_BioInfer.d475.s0.p2", "text": "Our results showed that cell morphology, cell adhesion pattern, actin organization, and distribution of integrin subunits, talin, vinculin, and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the collagens.", "text_with_entity_marker": "Our results showed that cell morphology, cell adhesion pattern, actin organization, and distribution of [E1]integrin[/E1] subunits, talin, vinculin, and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the [E2]collagens[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "integrin", "entity_1_idx": [[104, 112]], "entity_1_idx_in_text_with_entity_marker": [108, 116], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "collagens", "entity_2_idx": [[236, 245]], "entity_2_idx_in_text_with_entity_marker": [249, 258], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d475.s0_BioInfer.d475.s0.p3", "text": "Our results showed that cell morphology, cell adhesion pattern, actin organization, and distribution of integrin subunits, talin, vinculin, and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the collagens.", "text_with_entity_marker": "Our results showed that cell morphology, cell adhesion pattern, [E1]actin[/E1] organization, and distribution of [E2]integrin[/E2] subunits, talin, vinculin, and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the collagens.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[64, 69]], "entity_1_idx_in_text_with_entity_marker": [68, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "integrin", "entity_2_idx": [[104, 112]], "entity_2_idx_in_text_with_entity_marker": [117, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d475.s0_BioInfer.d475.s0.p4", "text": "Our results showed that cell morphology, cell adhesion pattern, actin organization, and distribution of integrin subunits, talin, vinculin, and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the collagens.", "text_with_entity_marker": "Our results showed that cell morphology, cell adhesion pattern, actin organization, and distribution of integrin subunits, [E1]talin[/E1], [E2]vinculin[/E2], and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the collagens.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[123, 128]], "entity_1_idx_in_text_with_entity_marker": [127, 132], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[130, 138]], "entity_2_idx_in_text_with_entity_marker": [143, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d475.s0_BioInfer.d475.s0.p5", "text": "Our results showed that cell morphology, cell adhesion pattern, actin organization, and distribution of integrin subunits, talin, vinculin, and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the collagens.", "text_with_entity_marker": "Our results showed that cell morphology, cell adhesion pattern, actin organization, and distribution of integrin subunits, talin, [E1]vinculin[/E1], and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the [E2]collagens[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "vinculin", "entity_1_idx": [[130, 138]], "entity_1_idx_in_text_with_entity_marker": [134, 142], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "collagens", "entity_2_idx": [[236, 245]], "entity_2_idx_in_text_with_entity_marker": [249, 258], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d475.s0_BioInfer.d475.s0.p6", "text": "Our results showed that cell morphology, cell adhesion pattern, actin organization, and distribution of integrin subunits, talin, vinculin, and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the collagens.", "text_with_entity_marker": "Our results showed that cell morphology, cell adhesion pattern, [E1]actin[/E1] organization, and distribution of integrin subunits, talin, [E2]vinculin[/E2], and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the collagens.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[64, 69]], "entity_1_idx_in_text_with_entity_marker": [68, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[130, 138]], "entity_2_idx_in_text_with_entity_marker": [143, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d475.s0_BioInfer.d475.s0.p7", "text": "Our results showed that cell morphology, cell adhesion pattern, actin organization, and distribution of integrin subunits, talin, vinculin, and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the collagens.", "text_with_entity_marker": "Our results showed that cell morphology, cell adhesion pattern, actin organization, and distribution of integrin subunits, [E1]talin[/E1], vinculin, and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the [E2]collagens[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[123, 128]], "entity_1_idx_in_text_with_entity_marker": [127, 132], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "collagens", "entity_2_idx": [[236, 245]], "entity_2_idx_in_text_with_entity_marker": [249, 258], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d475.s0_BioInfer.d475.s0.p8", "text": "Our results showed that cell morphology, cell adhesion pattern, actin organization, and distribution of integrin subunits, talin, vinculin, and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the collagens.", "text_with_entity_marker": "Our results showed that cell morphology, cell adhesion pattern, [E1]actin[/E1] organization, and distribution of integrin subunits, [E2]talin[/E2], vinculin, and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the collagens.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[64, 69]], "entity_1_idx_in_text_with_entity_marker": [68, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[123, 128]], "entity_2_idx_in_text_with_entity_marker": [136, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d475.s0_BioInfer.d475.s0.p9", "text": "Our results showed that cell morphology, cell adhesion pattern, actin organization, and distribution of integrin subunits, talin, vinculin, and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the collagens.", "text_with_entity_marker": "Our results showed that cell morphology, cell adhesion pattern, [E1]actin[/E1] organization, and distribution of integrin subunits, talin, vinculin, and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the [E2]collagens[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[64, 69]], "entity_1_idx_in_text_with_entity_marker": [68, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "collagens", "entity_2_idx": [[236, 245]], "entity_2_idx_in_text_with_entity_marker": [249, 258], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p40", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of [E1]E-cadherin[/E1], alpha-catenin, and beta-catenin; and the heat shock proteins of [E2]HSP27[/E2] and HSP70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[274, 284]], "entity_1_idx_in_text_with_entity_marker": [278, 288], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "HSP27", "entity_2_idx": [[350, 355]], "entity_2_idx_in_text_with_entity_marker": [363, 368], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p41", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, [E1]alpha-catenin[/E1], and beta-catenin; and the heat shock proteins of [E2]HSP27[/E2] and HSP70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[286, 299]], "entity_1_idx_in_text_with_entity_marker": [290, 303], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "HSP27", "entity_2_idx": [[350, 355]], "entity_2_idx_in_text_with_entity_marker": [363, 368], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p42", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, [E1]p27KIP1[/E1], and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of [E2]HSP27[/E2] and HSP70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p27KIP1", "entity_1_idx": [[219, 226]], "entity_1_idx_in_text_with_entity_marker": [223, 230], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "HSP27", "entity_2_idx": [[350, 355]], "entity_2_idx_in_text_with_entity_marker": [363, 368], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p43", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, [E1]Rb[/E1], p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of [E2]HSP27[/E2] and HSP70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rb", "entity_1_idx": [[206, 208]], "entity_1_idx_in_text_with_entity_marker": [210, 212], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "HSP27", "entity_2_idx": [[350, 355]], "entity_2_idx_in_text_with_entity_marker": [363, 368], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p44", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of [E1]HSP27[/E1] and [E2]HSP70[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HSP27", "entity_1_idx": [[350, 355]], "entity_1_idx_in_text_with_entity_marker": [354, 359], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HSP70", "entity_2_idx": [[360, 365]], "entity_2_idx_in_text_with_entity_marker": [373, 378], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p45", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of [E1]E-cadherin[/E1], [E2]alpha-catenin[/E2], and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[274, 284]], "entity_1_idx_in_text_with_entity_marker": [278, 288], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[286, 299]], "entity_2_idx_in_text_with_entity_marker": [299, 312], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p46", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, [E1]p27KIP1[/E1], and PCNA; the cell-cell adhesion molecules of [E2]E-cadherin[/E2], alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p27KIP1", "entity_1_idx": [[219, 226]], "entity_1_idx_in_text_with_entity_marker": [223, 230], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[274, 284]], "entity_2_idx_in_text_with_entity_marker": [287, 297], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p47", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, [E1]Rb[/E1], p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of [E2]E-cadherin[/E2], alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rb", "entity_1_idx": [[206, 208]], "entity_1_idx_in_text_with_entity_marker": [210, 212], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[274, 284]], "entity_2_idx_in_text_with_entity_marker": [287, 297], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p48", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of [E1]E-cadherin[/E1], alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and [E2]HSP70[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[274, 284]], "entity_1_idx_in_text_with_entity_marker": [278, 288], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "HSP70", "entity_2_idx": [[360, 365]], "entity_2_idx_in_text_with_entity_marker": [373, 378], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p49", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, [E1]p27KIP1[/E1], and PCNA; the cell-cell adhesion molecules of E-cadherin, [E2]alpha-catenin[/E2], and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p27KIP1", "entity_1_idx": [[219, 226]], "entity_1_idx_in_text_with_entity_marker": [223, 230], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[286, 299]], "entity_2_idx_in_text_with_entity_marker": [299, 312], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p10", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins [E1]FADD[/E1]/[E2]MORT1[/E2], TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[46, 50]], "entity_1_idx_in_text_with_entity_marker": [50, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MORT1", "entity_2_idx": [[51, 56]], "entity_2_idx_in_text_with_entity_marker": [64, 69], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p11", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins [E1]FADD[/E1]/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 ([E2]TRAIL-R1[/E2] and TRAIL-R2) are controversial.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "FADD", "entity_1_idx": [[46, 50]], "entity_1_idx_in_text_with_entity_marker": [50, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL-R1", "entity_2_idx": [[191, 199]], "entity_2_idx_in_text_with_entity_marker": [204, 212], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p12", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins [E1]FADD[/E1]/MORT1, TRADD, and RIP and the apoptosis-initiating [E2]caspases[/E2]-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[46, 50]], "entity_1_idx_in_text_with_entity_marker": [50, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "caspases", "entity_2_idx": [[102, 110], [117, 120]], "entity_2_idx_in_text_with_entity_marker": [115, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p13", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins [E1]FADD[/E1]/MORT1, TRADD, and RIP and the apoptosis-initiating [E2]caspases-8[/E2] and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[46, 50]], "entity_1_idx_in_text_with_entity_marker": [50, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "caspases-8", "entity_2_idx": [[102, 112]], "entity_2_idx_in_text_with_entity_marker": [115, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p14", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins [E1]FADD[/E1]/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing [E2]TRAIL receptors[/E2] 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "FADD", "entity_1_idx": [[46, 50]], "entity_1_idx_in_text_with_entity_marker": [50, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL receptors", "entity_2_idx": [[166, 181], [188, 189]], "entity_2_idx_in_text_with_entity_marker": [179, 194], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p15", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins [E1]FADD[/E1]/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing [E2]TRAIL receptors 1[/E2] and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "FADD", "entity_1_idx": [[46, 50]], "entity_1_idx_in_text_with_entity_marker": [50, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL receptors 1", "entity_2_idx": [[166, 183]], "entity_2_idx_in_text_with_entity_marker": [179, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p16", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins [E1]FADD[/E1]/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and [E2]TRAIL-R2[/E2]) are controversial.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "FADD", "entity_1_idx": [[46, 50]], "entity_1_idx_in_text_with_entity_marker": [50, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL-R2", "entity_2_idx": [[204, 212]], "entity_2_idx_in_text_with_entity_marker": [217, 225], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p17", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/[E1]MORT1[/E1], [E2]TRADD[/E2], and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MORT1", "entity_1_idx": [[51, 56]], "entity_1_idx_in_text_with_entity_marker": [55, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[58, 63]], "entity_2_idx_in_text_with_entity_marker": [71, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p18", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/MORT1, [E1]TRADD[/E1], and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 ([E2]TRAIL-R1[/E2] and TRAIL-R2) are controversial.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TRADD", "entity_1_idx": [[58, 63]], "entity_1_idx_in_text_with_entity_marker": [62, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAIL-R1", "entity_2_idx": [[191, 199]], "entity_2_idx_in_text_with_entity_marker": [204, 212], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d634.s0_BioInfer.d634.s0.p19", "text": "The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "text_with_entity_marker": "The involvement of the death adaptor proteins FADD/MORT1, [E1]TRADD[/E1], and RIP and the apoptosis-initiating [E2]caspases[/E2]-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRADD", "entity_1_idx": [[58, 63]], "entity_1_idx_in_text_with_entity_marker": [62, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "caspases", "entity_2_idx": [[102, 110], [117, 120]], "entity_2_idx_in_text_with_entity_marker": [115, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d373.s0_BioInfer.d373.s0.p0", "text": "In this actin clustering, profilin, a monomeric actin-binding protein that has been suggested to be involved in actin polymerization, was shown to be essential.", "text_with_entity_marker": "In this actin clustering, [E1]profilin[/E1], a monomeric actin-binding protein that has been suggested to be involved in [E2]actin[/E2] polymerization, was shown to be essential.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[26, 34]], "entity_1_idx_in_text_with_entity_marker": [30, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[112, 117]], "entity_2_idx_in_text_with_entity_marker": [125, 130], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d373.s0_BioInfer.d373.s0.p1", "text": "In this actin clustering, profilin, a monomeric actin-binding protein that has been suggested to be involved in actin polymerization, was shown to be essential.", "text_with_entity_marker": "In this [E1]actin[/E1] clustering, [E2]profilin[/E2], a monomeric actin-binding protein that has been suggested to be involved in actin polymerization, was shown to be essential.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[8, 13]], "entity_1_idx_in_text_with_entity_marker": [12, 17], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[26, 34]], "entity_2_idx_in_text_with_entity_marker": [39, 47], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d373.s0_BioInfer.d373.s0.p2", "text": "In this actin clustering, profilin, a monomeric actin-binding protein that has been suggested to be involved in actin polymerization, was shown to be essential.", "text_with_entity_marker": "In this actin clustering, [E1]profilin[/E1], a monomeric [E2]actin-binding protein[/E2] that has been suggested to be involved in actin polymerization, was shown to be essential.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[26, 34]], "entity_1_idx_in_text_with_entity_marker": [30, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[48, 69]], "entity_2_idx_in_text_with_entity_marker": [61, 82], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d373.s0_BioInfer.d373.s0.p3", "text": "In this actin clustering, profilin, a monomeric actin-binding protein that has been suggested to be involved in actin polymerization, was shown to be essential.", "text_with_entity_marker": "In this [E1]actin[/E1] clustering, profilin, a monomeric actin-binding protein that has been suggested to be involved in [E2]actin[/E2] polymerization, was shown to be essential.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[8, 13]], "entity_1_idx_in_text_with_entity_marker": [12, 17], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[112, 117]], "entity_2_idx_in_text_with_entity_marker": [125, 130], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d373.s0_BioInfer.d373.s0.p4", "text": "In this actin clustering, profilin, a monomeric actin-binding protein that has been suggested to be involved in actin polymerization, was shown to be essential.", "text_with_entity_marker": "In this actin clustering, profilin, a monomeric [E1]actin-binding protein[/E1] that has been suggested to be involved in [E2]actin[/E2] polymerization, was shown to be essential.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin-binding protein", "entity_1_idx": [[48, 69]], "entity_1_idx_in_text_with_entity_marker": [52, 73], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[112, 117]], "entity_2_idx_in_text_with_entity_marker": [125, 130], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d373.s0_BioInfer.d373.s0.p5", "text": "In this actin clustering, profilin, a monomeric actin-binding protein that has been suggested to be involved in actin polymerization, was shown to be essential.", "text_with_entity_marker": "In this [E1]actin[/E1] clustering, profilin, a monomeric [E2]actin-binding protein[/E2] that has been suggested to be involved in actin polymerization, was shown to be essential.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[8, 13]], "entity_1_idx_in_text_with_entity_marker": [12, 17], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[48, 69]], "entity_2_idx_in_text_with_entity_marker": [61, 82], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d90.s0_BioInfer.d90.s0.p0", "text": "BACKGROUND AND OBJECTIVES: Reduced expressions of cell adhesion molecules (E-cadherin, alpha-catenin, and beta-catenin) has been reported to be associated with tumor metastasis.", "text_with_entity_marker": "BACKGROUND AND OBJECTIVES: Reduced expressions of cell adhesion molecules ([E1]E-cadherin[/E1], alpha-catenin, and [E2]beta-catenin[/E2]) has been reported to be associated with tumor metastasis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[75, 85]], "entity_1_idx_in_text_with_entity_marker": [79, 89], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[106, 118]], "entity_2_idx_in_text_with_entity_marker": [119, 131], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d90.s0_BioInfer.d90.s0.p1", "text": "BACKGROUND AND OBJECTIVES: Reduced expressions of cell adhesion molecules (E-cadherin, alpha-catenin, and beta-catenin) has been reported to be associated with tumor metastasis.", "text_with_entity_marker": "BACKGROUND AND OBJECTIVES: Reduced expressions of cell adhesion molecules ([E1]E-cadherin[/E1], [E2]alpha-catenin[/E2], and beta-catenin) has been reported to be associated with tumor metastasis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[75, 85]], "entity_1_idx_in_text_with_entity_marker": [79, 89], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[87, 100]], "entity_2_idx_in_text_with_entity_marker": [100, 113], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d90.s0_BioInfer.d90.s0.p2", "text": "BACKGROUND AND OBJECTIVES: Reduced expressions of cell adhesion molecules (E-cadherin, alpha-catenin, and beta-catenin) has been reported to be associated with tumor metastasis.", "text_with_entity_marker": "BACKGROUND AND OBJECTIVES: Reduced expressions of cell adhesion molecules (E-cadherin, [E1]alpha-catenin[/E1], and [E2]beta-catenin[/E2]) has been reported to be associated with tumor metastasis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[87, 100]], "entity_1_idx_in_text_with_entity_marker": [91, 104], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[106, 118]], "entity_2_idx_in_text_with_entity_marker": [119, 131], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d90.s1_BioInfer.d90.s1.p0", "text": "In this study, we evaluated the prognostic significance of E-cadherin, alpha-catenin, and beta-catenin expressions in the metastatic foci of patients with colorectal carcinoma.", "text_with_entity_marker": "In this study, we evaluated the prognostic significance of [E1]E-cadherin[/E1], alpha-catenin, and [E2]beta-catenin[/E2] expressions in the metastatic foci of patients with colorectal carcinoma.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[59, 69]], "entity_1_idx_in_text_with_entity_marker": [63, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[90, 102]], "entity_2_idx_in_text_with_entity_marker": [103, 115], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d90.s1_BioInfer.d90.s1.p1", "text": "In this study, we evaluated the prognostic significance of E-cadherin, alpha-catenin, and beta-catenin expressions in the metastatic foci of patients with colorectal carcinoma.", "text_with_entity_marker": "In this study, we evaluated the prognostic significance of [E1]E-cadherin[/E1], [E2]alpha-catenin[/E2], and beta-catenin expressions in the metastatic foci of patients with colorectal carcinoma.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[59, 69]], "entity_1_idx_in_text_with_entity_marker": [63, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[71, 84]], "entity_2_idx_in_text_with_entity_marker": [84, 97], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d90.s1_BioInfer.d90.s1.p2", "text": "In this study, we evaluated the prognostic significance of E-cadherin, alpha-catenin, and beta-catenin expressions in the metastatic foci of patients with colorectal carcinoma.", "text_with_entity_marker": "In this study, we evaluated the prognostic significance of E-cadherin, [E1]alpha-catenin[/E1], and [E2]beta-catenin[/E2] expressions in the metastatic foci of patients with colorectal carcinoma.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[71, 84]], "entity_1_idx_in_text_with_entity_marker": [75, 88], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[90, 102]], "entity_2_idx_in_text_with_entity_marker": [103, 115], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d90.s2_BioInfer.d90.s2.p0", "text": "RESULTS: Reduced normal expression of E-cadherin, alpha-catenin, and beta-catenin in comparison with normal epithelium was detected in 78 primary tumors, respectively.", "text_with_entity_marker": "RESULTS: Reduced normal expression of [E1]E-cadherin[/E1], alpha-catenin, and [E2]beta-catenin[/E2] in comparison with normal epithelium was detected in 78 primary tumors, respectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[38, 48]], "entity_1_idx_in_text_with_entity_marker": [42, 52], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[69, 81]], "entity_2_idx_in_text_with_entity_marker": [82, 94], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d90.s2_BioInfer.d90.s2.p1", "text": "RESULTS: Reduced normal expression of E-cadherin, alpha-catenin, and beta-catenin in comparison with normal epithelium was detected in 78 primary tumors, respectively.", "text_with_entity_marker": "RESULTS: Reduced normal expression of [E1]E-cadherin[/E1], [E2]alpha-catenin[/E2], and beta-catenin in comparison with normal epithelium was detected in 78 primary tumors, respectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[38, 48]], "entity_1_idx_in_text_with_entity_marker": [42, 52], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[50, 63]], "entity_2_idx_in_text_with_entity_marker": [63, 76], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d90.s2_BioInfer.d90.s2.p2", "text": "RESULTS: Reduced normal expression of E-cadherin, alpha-catenin, and beta-catenin in comparison with normal epithelium was detected in 78 primary tumors, respectively.", "text_with_entity_marker": "RESULTS: Reduced normal expression of E-cadherin, [E1]alpha-catenin[/E1], and [E2]beta-catenin[/E2] in comparison with normal epithelium was detected in 78 primary tumors, respectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[50, 63]], "entity_1_idx_in_text_with_entity_marker": [54, 67], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[69, 81]], "entity_2_idx_in_text_with_entity_marker": [82, 94], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d675.s0_BioInfer.d675.s0.p0", "text": "The proteins encoded by MRS5 and MRS11, which display 35%, sequence identity are both located in the mitochondrial intermembrane space.", "text_with_entity_marker": "The proteins encoded by [E1]MRS5[/E1] and [E2]MRS11[/E2], which display 35%, sequence identity are both located in the mitochondrial intermembrane space.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MRS5", "entity_1_idx": [[24, 28]], "entity_1_idx_in_text_with_entity_marker": [28, 32], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MRS11", "entity_2_idx": [[33, 38]], "entity_2_idx_in_text_with_entity_marker": [46, 51], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d512.s0_BioInfer.d512.s0.p0", "text": "Reduced E-cadherin, alpha-catenin, beta-catenin and plakoglobin expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).", "text_with_entity_marker": "Reduced E-cadherin, [E1]alpha-catenin[/E1], beta-catenin and [E2]plakoglobin[/E2] expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[20, 33]], "entity_1_idx_in_text_with_entity_marker": [24, 37], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[52, 63]], "entity_2_idx_in_text_with_entity_marker": [65, 76], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d512.s0_BioInfer.d512.s0.p1", "text": "Reduced E-cadherin, alpha-catenin, beta-catenin and plakoglobin expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).", "text_with_entity_marker": "Reduced E-cadherin, alpha-catenin, [E1]beta-catenin[/E1] and [E2]plakoglobin[/E2] expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[35, 47]], "entity_1_idx_in_text_with_entity_marker": [39, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[52, 63]], "entity_2_idx_in_text_with_entity_marker": [65, 76], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d512.s0_BioInfer.d512.s0.p2", "text": "Reduced E-cadherin, alpha-catenin, beta-catenin and plakoglobin expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).", "text_with_entity_marker": "Reduced [E1]E-cadherin[/E1], alpha-catenin, beta-catenin and [E2]plakoglobin[/E2] expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[8, 18]], "entity_1_idx_in_text_with_entity_marker": [12, 22], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[52, 63]], "entity_2_idx_in_text_with_entity_marker": [65, 76], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d512.s0_BioInfer.d512.s0.p3", "text": "Reduced E-cadherin, alpha-catenin, beta-catenin and plakoglobin expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).", "text_with_entity_marker": "Reduced E-cadherin, [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2] and plakoglobin expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[20, 33]], "entity_1_idx_in_text_with_entity_marker": [24, 37], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[35, 47]], "entity_2_idx_in_text_with_entity_marker": [48, 60], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d512.s0_BioInfer.d512.s0.p4", "text": "Reduced E-cadherin, alpha-catenin, beta-catenin and plakoglobin expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).", "text_with_entity_marker": "Reduced [E1]E-cadherin[/E1], [E2]alpha-catenin[/E2], beta-catenin and plakoglobin expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[8, 18]], "entity_1_idx_in_text_with_entity_marker": [12, 22], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[20, 33]], "entity_2_idx_in_text_with_entity_marker": [33, 46], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d512.s0_BioInfer.d512.s0.p5", "text": "Reduced E-cadherin, alpha-catenin, beta-catenin and plakoglobin expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).", "text_with_entity_marker": "Reduced [E1]E-cadherin[/E1], alpha-catenin, [E2]beta-catenin[/E2] and plakoglobin expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[8, 18]], "entity_1_idx_in_text_with_entity_marker": [12, 22], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[35, 47]], "entity_2_idx_in_text_with_entity_marker": [48, 60], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p25", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, [E1]TNFR-1[/E1], TRAIL, FADD, TRADD, RIP, [E2]FAF[/E2], FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNFR-1", "entity_1_idx": [[152, 158]], "entity_1_idx_in_text_with_entity_marker": [156, 162], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAF", "entity_2_idx": [[185, 188]], "entity_2_idx_in_text_with_entity_marker": [198, 201], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p26", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for [E1]Fas[/E1], Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, [E2]FAF[/E2], FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas", "entity_1_idx": [[135, 138]], "entity_1_idx_in_text_with_entity_marker": [139, 142], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAF", "entity_2_idx": [[185, 188]], "entity_2_idx_in_text_with_entity_marker": [198, 201], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p27", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, [E1]TRADD[/E1], RIP, FAF, [E2]FAP[/E2], and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRADD", "entity_1_idx": [[173, 178]], "entity_1_idx_in_text_with_entity_marker": [177, 182], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAP", "entity_2_idx": [[190, 193]], "entity_2_idx_in_text_with_entity_marker": [203, 206], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p28", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, [E1]RIP[/E1], FAF, [E2]FAP[/E2], and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RIP", "entity_1_idx": [[180, 183]], "entity_1_idx_in_text_with_entity_marker": [184, 187], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAP", "entity_2_idx": [[190, 193]], "entity_2_idx_in_text_with_entity_marker": [203, 206], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p29", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, [E1]FAP[/E1], and [E2]caspase-8[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FAP", "entity_1_idx": [[190, 193]], "entity_1_idx_in_text_with_entity_marker": [194, 197], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "caspase-8", "entity_2_idx": [[199, 208]], "entity_2_idx_in_text_with_entity_marker": [212, 221], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p30", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, [E1]FADD[/E1], TRADD, RIP, FAF, [E2]FAP[/E2], and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[167, 171]], "entity_1_idx_in_text_with_entity_marker": [171, 175], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAP", "entity_2_idx": [[190, 193]], "entity_2_idx_in_text_with_entity_marker": [203, 206], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p31", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, [E1]Fas ligand[/E1], TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, [E2]FAP[/E2], and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas ligand", "entity_1_idx": [[140, 150]], "entity_1_idx_in_text_with_entity_marker": [144, 154], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAP", "entity_2_idx": [[190, 193]], "entity_2_idx_in_text_with_entity_marker": [203, 206], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p32", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, [E1]TNFR-1[/E1], TRAIL, FADD, TRADD, RIP, FAF, [E2]FAP[/E2], and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNFR-1", "entity_1_idx": [[152, 158]], "entity_1_idx_in_text_with_entity_marker": [156, 162], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAP", "entity_2_idx": [[190, 193]], "entity_2_idx_in_text_with_entity_marker": [203, 206], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p33", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for [E1]Fas[/E1], Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, [E2]FAP[/E2], and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas", "entity_1_idx": [[135, 138]], "entity_1_idx_in_text_with_entity_marker": [139, 142], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAP", "entity_2_idx": [[190, 193]], "entity_2_idx_in_text_with_entity_marker": [203, 206], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p34", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, [E1]TRADD[/E1], [E2]RIP[/E2], FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRADD", "entity_1_idx": [[173, 178]], "entity_1_idx_in_text_with_entity_marker": [177, 182], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RIP", "entity_2_idx": [[180, 183]], "entity_2_idx_in_text_with_entity_marker": [193, 196], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p35", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, [E1]TRADD[/E1], RIP, FAF, FAP, and [E2]caspase-8[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRADD", "entity_1_idx": [[173, 178]], "entity_1_idx_in_text_with_entity_marker": [177, 182], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "caspase-8", "entity_2_idx": [[199, 208]], "entity_2_idx_in_text_with_entity_marker": [212, 221], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p36", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, [E1]FADD[/E1], [E2]TRADD[/E2], RIP, FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[167, 171]], "entity_1_idx_in_text_with_entity_marker": [171, 175], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRADD", "entity_2_idx": [[173, 178]], "entity_2_idx_in_text_with_entity_marker": [186, 191], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p37", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, [E1]Fas ligand[/E1], TNFR-1, TRAIL, FADD, [E2]TRADD[/E2], RIP, FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas ligand", "entity_1_idx": [[140, 150]], "entity_1_idx_in_text_with_entity_marker": [144, 154], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRADD", "entity_2_idx": [[173, 178]], "entity_2_idx_in_text_with_entity_marker": [186, 191], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p38", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, [E1]TNFR-1[/E1], TRAIL, FADD, [E2]TRADD[/E2], RIP, FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNFR-1", "entity_1_idx": [[152, 158]], "entity_1_idx_in_text_with_entity_marker": [156, 162], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRADD", "entity_2_idx": [[173, 178]], "entity_2_idx_in_text_with_entity_marker": [186, 191], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p39", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for [E1]Fas[/E1], Fas ligand, TNFR-1, TRAIL, FADD, [E2]TRADD[/E2], RIP, FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas", "entity_1_idx": [[135, 138]], "entity_1_idx_in_text_with_entity_marker": [139, 142], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRADD", "entity_2_idx": [[173, 178]], "entity_2_idx_in_text_with_entity_marker": [186, 191], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p40", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, [E1]RIP[/E1], FAF, FAP, and [E2]caspase-8[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RIP", "entity_1_idx": [[180, 183]], "entity_1_idx_in_text_with_entity_marker": [184, 187], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "caspase-8", "entity_2_idx": [[199, 208]], "entity_2_idx_in_text_with_entity_marker": [212, 221], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p41", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, [E1]FADD[/E1], TRADD, [E2]RIP[/E2], FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[167, 171]], "entity_1_idx_in_text_with_entity_marker": [171, 175], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RIP", "entity_2_idx": [[180, 183]], "entity_2_idx_in_text_with_entity_marker": [193, 196], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p42", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, [E1]Fas ligand[/E1], TNFR-1, TRAIL, FADD, TRADD, [E2]RIP[/E2], FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas ligand", "entity_1_idx": [[140, 150]], "entity_1_idx_in_text_with_entity_marker": [144, 154], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RIP", "entity_2_idx": [[180, 183]], "entity_2_idx_in_text_with_entity_marker": [193, 196], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p43", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, [E1]TNFR-1[/E1], TRAIL, FADD, TRADD, [E2]RIP[/E2], FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNFR-1", "entity_1_idx": [[152, 158]], "entity_1_idx_in_text_with_entity_marker": [156, 162], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RIP", "entity_2_idx": [[180, 183]], "entity_2_idx_in_text_with_entity_marker": [193, 196], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p44", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for [E1]Fas[/E1], Fas ligand, TNFR-1, TRAIL, FADD, TRADD, [E2]RIP[/E2], FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas", "entity_1_idx": [[135, 138]], "entity_1_idx_in_text_with_entity_marker": [139, 142], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RIP", "entity_2_idx": [[180, 183]], "entity_2_idx_in_text_with_entity_marker": [193, 196], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p60", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, [E1]histones[/E1] H2A, H2B, H3, and H4, are rapidly acetylated; [E2]histone[/E2] H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[33, 41]], "entity_1_idx_in_text_with_entity_marker": [37, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[88, 95]], "entity_2_idx_in_text_with_entity_marker": [101, 108], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p61", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; [E1]histone[/E1] [E2]H4[/E2] shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[88, 95]], "entity_1_idx_in_text_with_entity_marker": [92, 99], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[96, 98]], "entity_2_idx_in_text_with_entity_marker": [109, 111], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p62", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and [E1]H4[/E1], are rapidly acetylated; [E2]histone[/E2] H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[60, 62]], "entity_1_idx_in_text_with_entity_marker": [64, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[88, 95]], "entity_2_idx_in_text_with_entity_marker": [101, 108], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p63", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; [E1]histone[/E1] H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone [E2]H3[/E2] has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[88, 95]], "entity_1_idx_in_text_with_entity_marker": [92, 99], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[253, 255]], "entity_2_idx_in_text_with_entity_marker": [266, 268], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p64", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; [E1]histone[/E1] H4 shows five subfractions, analogous to the five subfractions of mammalian histone [E2]H4[/E2] (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[88, 95]], "entity_1_idx_in_text_with_entity_marker": [92, 99], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[180, 182]], "entity_2_idx_in_text_with_entity_marker": [193, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p65", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones [E1]H2A[/E1], H2B, H3, and H4, are rapidly acetylated; [E2]histone[/E2] H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A", "entity_1_idx": [[42, 45]], "entity_1_idx_in_text_with_entity_marker": [46, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[88, 95]], "entity_2_idx_in_text_with_entity_marker": [101, 108], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p66", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, [E1]H3[/E1], and H4, are rapidly acetylated; [E2]histone[/E2] H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[52, 54]], "entity_1_idx_in_text_with_entity_marker": [56, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[88, 95]], "entity_2_idx_in_text_with_entity_marker": [101, 108], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p67", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, [E1]H2B[/E1], H3, and H4, are rapidly acetylated; [E2]histone[/E2] H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2B", "entity_1_idx": [[47, 50]], "entity_1_idx_in_text_with_entity_marker": [51, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[88, 95]], "entity_2_idx_in_text_with_entity_marker": [101, 108], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p68", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; [E1]histone[/E1] H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones [E2]H2A[/E2] and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[88, 95]], "entity_1_idx_in_text_with_entity_marker": [92, 99], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2A", "entity_2_idx": [[396, 399]], "entity_2_idx_in_text_with_entity_marker": [409, 412], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p69", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; [E1]histone[/E1] H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone [E2]H3[/E2]; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[88, 95]], "entity_1_idx_in_text_with_entity_marker": [92, 99], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[383, 385]], "entity_2_idx_in_text_with_entity_marker": [396, 398], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p0", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/[E1]MORT-1[/E1], RIP) and [E2]TRAF[/E2] domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MORT-1", "entity_1_idx": [[73, 79]], "entity_1_idx_in_text_with_entity_marker": [77, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAF", "entity_2_idx": [[90, 94]], "entity_2_idx_in_text_with_entity_marker": [103, 107], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p1", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, [E1]FADD[/E1]/MORT-1, RIP) and [E2]TRAF[/E2] domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[68, 72]], "entity_1_idx_in_text_with_entity_marker": [72, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAF", "entity_2_idx": [[90, 94]], "entity_2_idx_in_text_with_entity_marker": [103, 107], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p2", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and [E1]TRAF[/E1] domain-containing proteins (TRAF-1, [E2]TRAF-2[/E2], TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRAF", "entity_1_idx": [[90, 94]], "entity_1_idx_in_text_with_entity_marker": [94, 98], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRAF-2", "entity_2_idx": [[131, 137]], "entity_2_idx_in_text_with_entity_marker": [144, 150], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p3", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and [E1]TRAF[/E1] domain-containing proteins ([E2]TRAF-1[/E2], TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRAF", "entity_1_idx": [[90, 94]], "entity_1_idx_in_text_with_entity_marker": [94, 98], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRAF-1", "entity_2_idx": [[123, 129]], "entity_2_idx_in_text_with_entity_marker": [136, 142], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p4", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and [E1]TRAF[/E1] domain-containing proteins (TRAF-1, TRAF-2, [E2]TRAF-3[/E2]) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRAF", "entity_1_idx": [[90, 94]], "entity_1_idx_in_text_with_entity_marker": [94, 98], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRAF-3", "entity_2_idx": [[139, 145]], "entity_2_idx_in_text_with_entity_marker": [152, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p5", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain ([E1]TNF-RI[/E1], Fas, TRADD, FADD/MORT-1, RIP) and [E2]TRAF[/E2] domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNF-RI", "entity_1_idx": [[48, 54]], "entity_1_idx_in_text_with_entity_marker": [52, 58], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRAF", "entity_2_idx": [[90, 94]], "entity_2_idx_in_text_with_entity_marker": [103, 107], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p6", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, Fas, [E1]TRADD[/E1], FADD/MORT-1, RIP) and [E2]TRAF[/E2] domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRADD", "entity_1_idx": [[61, 66]], "entity_1_idx_in_text_with_entity_marker": [65, 70], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRAF", "entity_2_idx": [[90, 94]], "entity_2_idx_in_text_with_entity_marker": [103, 107], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p7", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, [E1]Fas[/E1], TRADD, FADD/MORT-1, RIP) and [E2]TRAF[/E2] domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas", "entity_1_idx": [[56, 59]], "entity_1_idx_in_text_with_entity_marker": [60, 63], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRAF", "entity_2_idx": [[90, 94]], "entity_2_idx_in_text_with_entity_marker": [103, 107], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p8", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, [E1]RIP[/E1]) and [E2]TRAF[/E2] domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RIP", "entity_1_idx": [[81, 84]], "entity_1_idx_in_text_with_entity_marker": [85, 88], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRAF", "entity_2_idx": [[90, 94]], "entity_2_idx_in_text_with_entity_marker": [103, 107], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p9", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, [E1]FADD[/E1]/[E2]MORT-1[/E2], RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[68, 72]], "entity_1_idx_in_text_with_entity_marker": [72, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MORT-1", "entity_2_idx": [[73, 79]], "entity_2_idx_in_text_with_entity_marker": [86, 92], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p20", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain ([E1]TNF-RI[/E1], Fas, TRADD, [E2]FADD[/E2]/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNF-RI", "entity_1_idx": [[48, 54]], "entity_1_idx_in_text_with_entity_marker": [52, 58], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FADD", "entity_2_idx": [[68, 72]], "entity_2_idx_in_text_with_entity_marker": [81, 85], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p21", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, Fas, [E1]TRADD[/E1], [E2]FADD[/E2]/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRADD", "entity_1_idx": [[61, 66]], "entity_1_idx_in_text_with_entity_marker": [65, 70], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FADD", "entity_2_idx": [[68, 72]], "entity_2_idx_in_text_with_entity_marker": [81, 85], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p22", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, [E1]Fas[/E1], TRADD, [E2]FADD[/E2]/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas", "entity_1_idx": [[56, 59]], "entity_1_idx_in_text_with_entity_marker": [60, 63], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FADD", "entity_2_idx": [[68, 72]], "entity_2_idx_in_text_with_entity_marker": [81, 85], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p23", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, [E1]FADD[/E1]/MORT-1, [E2]RIP[/E2]) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[68, 72]], "entity_1_idx_in_text_with_entity_marker": [72, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP", "entity_2_idx": [[81, 84]], "entity_2_idx_in_text_with_entity_marker": [94, 97], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p24", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins ([E1]TRAF-1[/E1], [E2]TRAF-2[/E2], TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRAF-1", "entity_1_idx": [[123, 129]], "entity_1_idx_in_text_with_entity_marker": [127, 133], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRAF-2", "entity_2_idx": [[131, 137]], "entity_2_idx_in_text_with_entity_marker": [144, 150], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p25", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, [E1]TRAF-2[/E1], [E2]TRAF-3[/E2]) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRAF-2", "entity_1_idx": [[131, 137]], "entity_1_idx_in_text_with_entity_marker": [135, 141], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRAF-3", "entity_2_idx": [[139, 145]], "entity_2_idx_in_text_with_entity_marker": [152, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p26", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain ([E1]TNF-RI[/E1], Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, [E2]TRAF-2[/E2], TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNF-RI", "entity_1_idx": [[48, 54]], "entity_1_idx_in_text_with_entity_marker": [52, 58], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRAF-2", "entity_2_idx": [[131, 137]], "entity_2_idx_in_text_with_entity_marker": [144, 150], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p27", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, Fas, [E1]TRADD[/E1], FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, [E2]TRAF-2[/E2], TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRADD", "entity_1_idx": [[61, 66]], "entity_1_idx_in_text_with_entity_marker": [65, 70], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRAF-2", "entity_2_idx": [[131, 137]], "entity_2_idx_in_text_with_entity_marker": [144, 150], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p28", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, [E1]Fas[/E1], TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, [E2]TRAF-2[/E2], TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas", "entity_1_idx": [[56, 59]], "entity_1_idx_in_text_with_entity_marker": [60, 63], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRAF-2", "entity_2_idx": [[131, 137]], "entity_2_idx_in_text_with_entity_marker": [144, 150], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p29", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, [E1]RIP[/E1]) and TRAF domain-containing proteins (TRAF-1, [E2]TRAF-2[/E2], TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RIP", "entity_1_idx": [[81, 84]], "entity_1_idx_in_text_with_entity_marker": [85, 88], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRAF-2", "entity_2_idx": [[131, 137]], "entity_2_idx_in_text_with_entity_marker": [144, 150], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p40", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain ([E1]TNF-RI[/E1], [E2]Fas[/E2], TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNF-RI", "entity_1_idx": [[48, 54]], "entity_1_idx_in_text_with_entity_marker": [52, 58], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Fas", "entity_2_idx": [[56, 59]], "entity_2_idx_in_text_with_entity_marker": [69, 72], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p41", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain ([E1]TNF-RI[/E1], Fas, TRADD, FADD/MORT-1, [E2]RIP[/E2]) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNF-RI", "entity_1_idx": [[48, 54]], "entity_1_idx_in_text_with_entity_marker": [52, 58], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RIP", "entity_2_idx": [[81, 84]], "entity_2_idx_in_text_with_entity_marker": [94, 97], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p42", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, [E1]Fas[/E1], [E2]TRADD[/E2], FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas", "entity_1_idx": [[56, 59]], "entity_1_idx_in_text_with_entity_marker": [60, 63], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRADD", "entity_2_idx": [[61, 66]], "entity_2_idx_in_text_with_entity_marker": [74, 79], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p43", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, Fas, [E1]TRADD[/E1], FADD/MORT-1, [E2]RIP[/E2]) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRADD", "entity_1_idx": [[61, 66]], "entity_1_idx_in_text_with_entity_marker": [65, 70], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RIP", "entity_2_idx": [[81, 84]], "entity_2_idx_in_text_with_entity_marker": [94, 97], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d390.s0_BioInfer.d390.s0.p44", "text": "Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "text_with_entity_marker": "Isolation and characterization of death domain (TNF-RI, [E1]Fas[/E1], TRADD, FADD/MORT-1, [E2]RIP[/E2]) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas", "entity_1_idx": [[56, 59]], "entity_1_idx_in_text_with_entity_marker": [60, 63], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RIP", "entity_2_idx": [[81, 84]], "entity_2_idx_in_text_with_entity_marker": [94, 97], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d350.s0_BioInfer.d350.s0.p0", "text": "In order to help explain the apparent beneficial effects of cyclin D1 over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the cyclin dependent kinase inhibitor p27, which blocks the activating effects of cyclin D1.", "text_with_entity_marker": "In order to help explain the apparent beneficial effects of cyclin D1 over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the [E1]cyclin dependent kinase inhibitor[/E1] p27, which blocks the activating effects of [E2]cyclin D1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin dependent kinase inhibitor", "entity_1_idx": [[178, 211]], "entity_1_idx_in_text_with_entity_marker": [182, 215], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cyclin D1", "entity_2_idx": [[256, 265]], "entity_2_idx_in_text_with_entity_marker": [269, 278], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d350.s0_BioInfer.d350.s0.p1", "text": "In order to help explain the apparent beneficial effects of cyclin D1 over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the cyclin dependent kinase inhibitor p27, which blocks the activating effects of cyclin D1.", "text_with_entity_marker": "In order to help explain the apparent beneficial effects of [E1]cyclin D1[/E1] over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the [E2]cyclin dependent kinase inhibitor[/E2] p27, which blocks the activating effects of cyclin D1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin D1", "entity_1_idx": [[60, 69]], "entity_1_idx_in_text_with_entity_marker": [64, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cyclin dependent kinase inhibitor", "entity_2_idx": [[178, 211]], "entity_2_idx_in_text_with_entity_marker": [191, 224], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d350.s0_BioInfer.d350.s0.p2", "text": "In order to help explain the apparent beneficial effects of cyclin D1 over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the cyclin dependent kinase inhibitor p27, which blocks the activating effects of cyclin D1.", "text_with_entity_marker": "In order to help explain the apparent beneficial effects of cyclin D1 over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the [E1]cyclin dependent kinase inhibitor[/E1] [E2]p27[/E2], which blocks the activating effects of cyclin D1.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin dependent kinase inhibitor", "entity_1_idx": [[178, 211]], "entity_1_idx_in_text_with_entity_marker": [182, 215], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p27", "entity_2_idx": [[212, 215]], "entity_2_idx_in_text_with_entity_marker": [225, 228], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d350.s0_BioInfer.d350.s0.p3", "text": "In order to help explain the apparent beneficial effects of cyclin D1 over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the cyclin dependent kinase inhibitor p27, which blocks the activating effects of cyclin D1.", "text_with_entity_marker": "In order to help explain the apparent beneficial effects of [E1]cyclin D1[/E1] over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the cyclin dependent kinase inhibitor p27, which blocks the activating effects of [E2]cyclin D1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin D1", "entity_1_idx": [[60, 69]], "entity_1_idx_in_text_with_entity_marker": [64, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cyclin D1", "entity_2_idx": [[256, 265]], "entity_2_idx_in_text_with_entity_marker": [269, 278], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d350.s0_BioInfer.d350.s0.p4", "text": "In order to help explain the apparent beneficial effects of cyclin D1 over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the cyclin dependent kinase inhibitor p27, which blocks the activating effects of cyclin D1.", "text_with_entity_marker": "In order to help explain the apparent beneficial effects of cyclin D1 over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the cyclin dependent kinase inhibitor [E1]p27[/E1], which blocks the activating effects of [E2]cyclin D1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p27", "entity_1_idx": [[212, 215]], "entity_1_idx_in_text_with_entity_marker": [216, 219], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin D1", "entity_2_idx": [[256, 265]], "entity_2_idx_in_text_with_entity_marker": [269, 278], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d350.s0_BioInfer.d350.s0.p5", "text": "In order to help explain the apparent beneficial effects of cyclin D1 over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the cyclin dependent kinase inhibitor p27, which blocks the activating effects of cyclin D1.", "text_with_entity_marker": "In order to help explain the apparent beneficial effects of [E1]cyclin D1[/E1] over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the cyclin dependent kinase inhibitor [E2]p27[/E2], which blocks the activating effects of cyclin D1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin D1", "entity_1_idx": [[60, 69]], "entity_1_idx_in_text_with_entity_marker": [64, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p27", "entity_2_idx": [[212, 215]], "entity_2_idx_in_text_with_entity_marker": [225, 228], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s0_BioInfer.d388.s0.p0", "text": "In vivo importance of actin nucleotide exchange catalyzed by profilin.", "text_with_entity_marker": "In vivo importance of [E1]actin[/E1] nucleotide exchange catalyzed by [E2]profilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[22, 27]], "entity_1_idx_in_text_with_entity_marker": [26, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[61, 69]], "entity_2_idx_in_text_with_entity_marker": [74, 82], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s1_BioInfer.d388.s1.p0", "text": "act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.", "text_with_entity_marker": "[E1]act1-157[/E1], an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of [E2]pfy1-4[/E2], a profilin mutant defective in actin binding.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "act1-157", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "pfy1-4", "entity_2_idx": [[169, 175]], "entity_2_idx_in_text_with_entity_marker": [182, 188], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s1_BioInfer.d388.s1.p1", "text": "act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.", "text_with_entity_marker": "act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of [E1]pfy1-4[/E1], a [E2]profilin[/E2] mutant defective in actin binding.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "pfy1-4", "entity_1_idx": [[169, 175]], "entity_1_idx_in_text_with_entity_marker": [173, 179], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[179, 187]], "entity_2_idx_in_text_with_entity_marker": [192, 200], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s1_BioInfer.d388.s1.p2", "text": "act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.", "text_with_entity_marker": "act1-157, an [E1]actin[/E1] mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of [E2]pfy1-4[/E2], a profilin mutant defective in actin binding.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[13, 18]], "entity_1_idx_in_text_with_entity_marker": [17, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "pfy1-4", "entity_2_idx": [[169, 175]], "entity_2_idx_in_text_with_entity_marker": [182, 188], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s1_BioInfer.d388.s1.p3", "text": "act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.", "text_with_entity_marker": "act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in [E1]actin[/E1] organization, cell growth, and fluid-phase endocytosis of [E2]pfy1-4[/E2], a profilin mutant defective in actin binding.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[105, 110]], "entity_1_idx_in_text_with_entity_marker": [109, 114], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "pfy1-4", "entity_2_idx": [[169, 175]], "entity_2_idx_in_text_with_entity_marker": [182, 188], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s1_BioInfer.d388.s1.p4", "text": "act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.", "text_with_entity_marker": "act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of [E1]pfy1-4[/E1], a profilin mutant defective in [E2]actin[/E2] binding.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "pfy1-4", "entity_1_idx": [[169, 175]], "entity_1_idx_in_text_with_entity_marker": [173, 179], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[208, 213]], "entity_2_idx_in_text_with_entity_marker": [221, 226], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s1_BioInfer.d388.s1.p5", "text": "act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.", "text_with_entity_marker": "[E1]act1-157[/E1], an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a [E2]profilin[/E2] mutant defective in actin binding.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "act1-157", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[179, 187]], "entity_2_idx_in_text_with_entity_marker": [192, 200], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s1_BioInfer.d388.s1.p6", "text": "act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.", "text_with_entity_marker": "[E1]act1-157[/E1], an [E2]actin[/E2] mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "act1-157", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[13, 18]], "entity_2_idx_in_text_with_entity_marker": [26, 31], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s1_BioInfer.d388.s1.p7", "text": "act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.", "text_with_entity_marker": "[E1]act1-157[/E1], an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in [E2]actin[/E2] organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "act1-157", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[105, 110]], "entity_2_idx_in_text_with_entity_marker": [118, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s1_BioInfer.d388.s1.p8", "text": "act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.", "text_with_entity_marker": "[E1]act1-157[/E1], an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in [E2]actin[/E2] binding.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "act1-157", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[208, 213]], "entity_2_idx_in_text_with_entity_marker": [221, 226], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s2_BioInfer.d388.s2.p4", "text": "The actin monomer-binding protein, profilin, influences the dynamics of actin filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on actin, and promoting barbed-end assembly.", "text_with_entity_marker": "The actin monomer-binding protein, [E1]profilin[/E1], influences the dynamics of actin filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on [E2]actin[/E2], and promoting barbed-end assembly.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[35, 43]], "entity_1_idx_in_text_with_entity_marker": [39, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[157, 162]], "entity_2_idx_in_text_with_entity_marker": [170, 175], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s2_BioInfer.d388.s2.p5", "text": "The actin monomer-binding protein, profilin, influences the dynamics of actin filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on actin, and promoting barbed-end assembly.", "text_with_entity_marker": "The actin monomer-binding protein, [E1]profilin[/E1], influences the dynamics of [E2]actin[/E2] filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on actin, and promoting barbed-end assembly.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[35, 43]], "entity_1_idx_in_text_with_entity_marker": [39, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[72, 77]], "entity_2_idx_in_text_with_entity_marker": [85, 90], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s3_BioInfer.d388.s3.p0", "text": "To study profilin function, we extensively mutagenized the Saccharomyces cerevisiae profilin gene (PFY1) and examined the consequences of specific point mutations on growth and actin organization.", "text_with_entity_marker": "To study [E1]profilin[/E1] function, we extensively mutagenized the Saccharomyces cerevisiae profilin gene (PFY1) and examined the consequences of specific point mutations on growth and [E2]actin[/E2] organization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[177, 182]], "entity_2_idx_in_text_with_entity_marker": [190, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s3_BioInfer.d388.s3.p1", "text": "To study profilin function, we extensively mutagenized the Saccharomyces cerevisiae profilin gene (PFY1) and examined the consequences of specific point mutations on growth and actin organization.", "text_with_entity_marker": "To study profilin function, we extensively mutagenized the Saccharomyces cerevisiae [E1]profilin[/E1] gene (PFY1) and examined the consequences of specific point mutations on growth and [E2]actin[/E2] organization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[84, 92]], "entity_1_idx_in_text_with_entity_marker": [88, 96], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[177, 182]], "entity_2_idx_in_text_with_entity_marker": [190, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s3_BioInfer.d388.s3.p2", "text": "To study profilin function, we extensively mutagenized the Saccharomyces cerevisiae profilin gene (PFY1) and examined the consequences of specific point mutations on growth and actin organization.", "text_with_entity_marker": "To study profilin function, we extensively mutagenized the Saccharomyces cerevisiae profilin gene ([E1]PFY1[/E1]) and examined the consequences of specific point mutations on growth and [E2]actin[/E2] organization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PFY1", "entity_1_idx": [[99, 103]], "entity_1_idx_in_text_with_entity_marker": [103, 107], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "actin", "entity_2_idx": [[177, 182]], "entity_2_idx_in_text_with_entity_marker": [190, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s3_BioInfer.d388.s3.p3", "text": "To study profilin function, we extensively mutagenized the Saccharomyces cerevisiae profilin gene (PFY1) and examined the consequences of specific point mutations on growth and actin organization.", "text_with_entity_marker": "To study [E1]profilin[/E1] function, we extensively mutagenized the Saccharomyces cerevisiae [E2]profilin[/E2] gene (PFY1) and examined the consequences of specific point mutations on growth and actin organization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[84, 92]], "entity_2_idx_in_text_with_entity_marker": [97, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s3_BioInfer.d388.s3.p4", "text": "To study profilin function, we extensively mutagenized the Saccharomyces cerevisiae profilin gene (PFY1) and examined the consequences of specific point mutations on growth and actin organization.", "text_with_entity_marker": "To study [E1]profilin[/E1] function, we extensively mutagenized the Saccharomyces cerevisiae profilin gene ([E2]PFY1[/E2]) and examined the consequences of specific point mutations on growth and actin organization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PFY1", "entity_2_idx": [[99, 103]], "entity_2_idx_in_text_with_entity_marker": [112, 116], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d388.s3_BioInfer.d388.s3.p5", "text": "To study profilin function, we extensively mutagenized the Saccharomyces cerevisiae profilin gene (PFY1) and examined the consequences of specific point mutations on growth and actin organization.", "text_with_entity_marker": "To study profilin function, we extensively mutagenized the Saccharomyces cerevisiae [E1]profilin[/E1] gene ([E2]PFY1[/E2]) and examined the consequences of specific point mutations on growth and actin organization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[84, 92]], "entity_1_idx_in_text_with_entity_marker": [88, 96], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PFY1", "entity_2_idx": [[99, 103]], "entity_2_idx_in_text_with_entity_marker": [112, 116], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p10", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, [E1]BUD8[/E1] and [E2]DFG16[/E2], mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BUD8", "entity_1_idx": [[293, 297]], "entity_1_idx_in_text_with_entity_marker": [297, 301], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG16", "entity_2_idx": [[302, 307]], "entity_2_idx_in_text_with_entity_marker": [315, 320], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p11", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, [E1]DFG9[/E1], DFG10, [E2]BUD8[/E2] and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DFG9", "entity_1_idx": [[280, 284]], "entity_1_idx_in_text_with_entity_marker": [284, 288], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BUD8", "entity_2_idx": [[293, 297]], "entity_2_idx_in_text_with_entity_marker": [306, 310], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p12", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, [E1]SPA2[/E1], BNI1, DFG5, DFG9, DFG10, [E2]BUD8[/E2] and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SPA2", "entity_1_idx": [[262, 266]], "entity_1_idx_in_text_with_entity_marker": [266, 270], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BUD8", "entity_2_idx": [[293, 297]], "entity_2_idx_in_text_with_entity_marker": [306, 310], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p13", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, [E1]SRV2[/E1], TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, [E2]BUD8[/E2] and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SRV2", "entity_1_idx": [[250, 254]], "entity_1_idx_in_text_with_entity_marker": [254, 258], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BUD8", "entity_2_idx": [[293, 297]], "entity_2_idx_in_text_with_entity_marker": [306, 310], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p14", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, [E1]DFG5[/E1], DFG9, DFG10, [E2]BUD8[/E2] and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DFG5", "entity_1_idx": [[274, 278]], "entity_1_idx_in_text_with_entity_marker": [278, 282], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BUD8", "entity_2_idx": [[293, 297]], "entity_2_idx_in_text_with_entity_marker": [306, 310], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p15", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, [E1]CDC39[/E1], STE12, [E2]TEC1[/E2], WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDC39", "entity_1_idx": [[205, 210]], "entity_1_idx_in_text_with_entity_marker": [209, 214], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TEC1", "entity_2_idx": [[219, 223]], "entity_2_idx_in_text_with_entity_marker": [232, 236], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p16", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, [E1]TEC1[/E1], WHI3, [E2]NAB1[/E2], DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TEC1", "entity_1_idx": [[219, 223]], "entity_1_idx_in_text_with_entity_marker": [223, 227], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "NAB1", "entity_2_idx": [[231, 235]], "entity_2_idx_in_text_with_entity_marker": [244, 248], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p17", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, [E1]STE12[/E1], [E2]TEC1[/E2], WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "STE12", "entity_1_idx": [[212, 217]], "entity_1_idx_in_text_with_entity_marker": [216, 221], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TEC1", "entity_2_idx": [[219, 223]], "entity_2_idx_in_text_with_entity_marker": [232, 236], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p18", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, [E1]TEC1[/E1], WHI3, NAB1, DBR1, [E2]CDC55[/E2], SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TEC1", "entity_1_idx": [[219, 223]], "entity_1_idx_in_text_with_entity_marker": [223, 227], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CDC55", "entity_2_idx": [[243, 248]], "entity_2_idx_in_text_with_entity_marker": [256, 261], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p19", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, [E1]TEC1[/E1], [E2]WHI3[/E2], NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TEC1", "entity_1_idx": [[219, 223]], "entity_1_idx_in_text_with_entity_marker": [223, 227], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "WHI3", "entity_2_idx": [[225, 229]], "entity_2_idx_in_text_with_entity_marker": [238, 242], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p20", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, [E1]TEC1[/E1], WHI3, NAB1, DBR1, CDC55, SRV2, [E2]TPM1[/E2], SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TEC1", "entity_1_idx": [[219, 223]], "entity_1_idx_in_text_with_entity_marker": [223, 227], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TPM1", "entity_2_idx": [[256, 260]], "entity_2_idx_in_text_with_entity_marker": [269, 273], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p21", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, [E1]TEC1[/E1], WHI3, NAB1, [E2]DBR1[/E2], CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TEC1", "entity_1_idx": [[219, 223]], "entity_1_idx_in_text_with_entity_marker": [223, 227], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DBR1", "entity_2_idx": [[237, 241]], "entity_2_idx_in_text_with_entity_marker": [250, 254], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p22", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, [E1]TEC1[/E1], WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, [E2]BNI1[/E2], DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TEC1", "entity_1_idx": [[219, 223]], "entity_1_idx_in_text_with_entity_marker": [223, 227], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BNI1", "entity_2_idx": [[268, 272]], "entity_2_idx_in_text_with_entity_marker": [281, 285], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p23", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, [E1]TEC1[/E1], WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, [E2]DFG10[/E2], BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TEC1", "entity_1_idx": [[219, 223]], "entity_1_idx_in_text_with_entity_marker": [223, 227], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG10", "entity_2_idx": [[286, 291]], "entity_2_idx_in_text_with_entity_marker": [299, 304], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p24", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, [E1]TEC1[/E1], WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and [E2]DFG16[/E2], mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TEC1", "entity_1_idx": [[219, 223]], "entity_1_idx_in_text_with_entity_marker": [223, 227], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG16", "entity_2_idx": [[302, 307]], "entity_2_idx_in_text_with_entity_marker": [315, 320], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p25", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, [E1]TEC1[/E1], WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, [E2]DFG9[/E2], DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TEC1", "entity_1_idx": [[219, 223]], "entity_1_idx_in_text_with_entity_marker": [223, 227], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG9", "entity_2_idx": [[280, 284]], "entity_2_idx_in_text_with_entity_marker": [293, 297], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p26", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, [E1]TEC1[/E1], WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, [E2]SPA2[/E2], BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TEC1", "entity_1_idx": [[219, 223]], "entity_1_idx_in_text_with_entity_marker": [223, 227], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SPA2", "entity_2_idx": [[262, 266]], "entity_2_idx_in_text_with_entity_marker": [275, 279], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p27", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, [E1]TEC1[/E1], WHI3, NAB1, DBR1, CDC55, [E2]SRV2[/E2], TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TEC1", "entity_1_idx": [[219, 223]], "entity_1_idx_in_text_with_entity_marker": [223, 227], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SRV2", "entity_2_idx": [[250, 254]], "entity_2_idx_in_text_with_entity_marker": [263, 267], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p28", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, [E1]TEC1[/E1], WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, [E2]DFG5[/E2], DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TEC1", "entity_1_idx": [[219, 223]], "entity_1_idx_in_text_with_entity_marker": [223, 227], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG5", "entity_2_idx": [[274, 278]], "entity_2_idx_in_text_with_entity_marker": [287, 291], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p29", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, [E1]CDC39[/E1], STE12, TEC1, WHI3, [E2]NAB1[/E2], DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDC39", "entity_1_idx": [[205, 210]], "entity_1_idx_in_text_with_entity_marker": [209, 214], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "NAB1", "entity_2_idx": [[231, 235]], "entity_2_idx_in_text_with_entity_marker": [244, 248], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d297.s0_BioInfer.d297.s0.p0", "text": "Immunoprecipitation of alpha-catenin was increased in response to both doses of CdCl2, while the immunoprecipitation of beta-catenin was little changed by either cadmium dose.", "text_with_entity_marker": "Immunoprecipitation of [E1]alpha-catenin[/E1] was increased in response to both doses of CdCl2, while the immunoprecipitation of [E2]beta-catenin[/E2] was little changed by either cadmium dose.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[23, 36]], "entity_1_idx_in_text_with_entity_marker": [27, 40], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[120, 132]], "entity_2_idx_in_text_with_entity_marker": [133, 145], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d725.s0_BioInfer.d725.s0.p0", "text": "The structure of Ykt6pN differed entirely from that of syntaxin and resembled the overall fold of the actin regulatory protein, profilin.", "text_with_entity_marker": "The structure of Ykt6pN differed entirely from that of [E1]syntaxin[/E1] and resembled the overall fold of the [E2]actin[/E2] regulatory protein, profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "syntaxin", "entity_1_idx": [[55, 63]], "entity_1_idx_in_text_with_entity_marker": [59, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[102, 107]], "entity_2_idx_in_text_with_entity_marker": [115, 120], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d725.s0_BioInfer.d725.s0.p1", "text": "The structure of Ykt6pN differed entirely from that of syntaxin and resembled the overall fold of the actin regulatory protein, profilin.", "text_with_entity_marker": "The structure of [E1]Ykt6pN[/E1] differed entirely from that of [E2]syntaxin[/E2] and resembled the overall fold of the actin regulatory protein, profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Ykt6pN", "entity_1_idx": [[17, 23]], "entity_1_idx_in_text_with_entity_marker": [21, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "syntaxin", "entity_2_idx": [[55, 63]], "entity_2_idx_in_text_with_entity_marker": [68, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d725.s0_BioInfer.d725.s0.p2", "text": "The structure of Ykt6pN differed entirely from that of syntaxin and resembled the overall fold of the actin regulatory protein, profilin.", "text_with_entity_marker": "The structure of Ykt6pN differed entirely from that of [E1]syntaxin[/E1] and resembled the overall fold of the actin regulatory protein, [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "syntaxin", "entity_1_idx": [[55, 63]], "entity_1_idx_in_text_with_entity_marker": [59, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[128, 136]], "entity_2_idx_in_text_with_entity_marker": [141, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d725.s0_BioInfer.d725.s0.p3", "text": "The structure of Ykt6pN differed entirely from that of syntaxin and resembled the overall fold of the actin regulatory protein, profilin.", "text_with_entity_marker": "The structure of [E1]Ykt6pN[/E1] differed entirely from that of syntaxin and resembled the overall fold of the [E2]actin[/E2] regulatory protein, profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Ykt6pN", "entity_1_idx": [[17, 23]], "entity_1_idx_in_text_with_entity_marker": [21, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[102, 107]], "entity_2_idx_in_text_with_entity_marker": [115, 120], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d725.s0_BioInfer.d725.s0.p4", "text": "The structure of Ykt6pN differed entirely from that of syntaxin and resembled the overall fold of the actin regulatory protein, profilin.", "text_with_entity_marker": "The structure of Ykt6pN differed entirely from that of syntaxin and resembled the overall fold of the [E1]actin[/E1] regulatory protein, [E2]profilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[102, 107]], "entity_1_idx_in_text_with_entity_marker": [106, 111], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[128, 136]], "entity_2_idx_in_text_with_entity_marker": [141, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d725.s0_BioInfer.d725.s0.p5", "text": "The structure of Ykt6pN differed entirely from that of syntaxin and resembled the overall fold of the actin regulatory protein, profilin.", "text_with_entity_marker": "The structure of [E1]Ykt6pN[/E1] differed entirely from that of syntaxin and resembled the overall fold of the actin regulatory protein, [E2]profilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Ykt6pN", "entity_1_idx": [[17, 23]], "entity_1_idx_in_text_with_entity_marker": [21, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[128, 136]], "entity_2_idx_in_text_with_entity_marker": [141, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d546.s0_BioInfer.d546.s0.p0", "text": "Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.", "text_with_entity_marker": "Specific antibodies to myosin heavy chain isoforms ([E1]SM1[/E1], SM2, SMemb), caldesmon, and [E2]alpha-smooth muscle actin[/E2] and cDNAs for SMemb were used.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SM1", "entity_1_idx": [[52, 55]], "entity_1_idx_in_text_with_entity_marker": [56, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-smooth muscle actin", "entity_2_idx": [[85, 110]], "entity_2_idx_in_text_with_entity_marker": [98, 123], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d546.s0_BioInfer.d546.s0.p1", "text": "Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.", "text_with_entity_marker": "Specific antibodies to myosin heavy chain isoforms ([E1]SM1[/E1], SM2, SMemb), [E2]caldesmon[/E2], and alpha-smooth muscle actin and cDNAs for SMemb were used.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SM1", "entity_1_idx": [[52, 55]], "entity_1_idx_in_text_with_entity_marker": [56, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "caldesmon", "entity_2_idx": [[70, 79]], "entity_2_idx_in_text_with_entity_marker": [83, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d546.s0_BioInfer.d546.s0.p2", "text": "Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.", "text_with_entity_marker": "Specific antibodies to myosin heavy chain isoforms ([E1]SM1[/E1], [E2]SM2[/E2], SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SM1", "entity_1_idx": [[52, 55]], "entity_1_idx_in_text_with_entity_marker": [56, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SM2", "entity_2_idx": [[57, 60]], "entity_2_idx_in_text_with_entity_marker": [70, 73], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d546.s0_BioInfer.d546.s0.p3", "text": "Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.", "text_with_entity_marker": "Specific antibodies to myosin heavy chain isoforms ([E1]SM1[/E1], SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for [E2]SMemb[/E2] were used.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SM1", "entity_1_idx": [[52, 55]], "entity_1_idx_in_text_with_entity_marker": [56, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SMemb", "entity_2_idx": [[125, 130]], "entity_2_idx_in_text_with_entity_marker": [138, 143], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d546.s0_BioInfer.d546.s0.p4", "text": "Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.", "text_with_entity_marker": "Specific antibodies to myosin heavy chain isoforms ([E1]SM1[/E1], SM2, [E2]SMemb[/E2]), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SM1", "entity_1_idx": [[52, 55]], "entity_1_idx_in_text_with_entity_marker": [56, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SMemb", "entity_2_idx": [[62, 67]], "entity_2_idx_in_text_with_entity_marker": [75, 80], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d546.s0_BioInfer.d546.s0.p5", "text": "Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.", "text_with_entity_marker": "Specific antibodies to [E1]myosin heavy chain[/E1] isoforms ([E2]SM1[/E2], SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "myosin heavy chain", "entity_1_idx": [[23, 41]], "entity_1_idx_in_text_with_entity_marker": [27, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SM1", "entity_2_idx": [[52, 55]], "entity_2_idx_in_text_with_entity_marker": [65, 68], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d546.s0_BioInfer.d546.s0.p6", "text": "Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.", "text_with_entity_marker": "Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), [E1]caldesmon[/E1], and [E2]alpha-smooth muscle actin[/E2] and cDNAs for SMemb were used.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "caldesmon", "entity_1_idx": [[70, 79]], "entity_1_idx_in_text_with_entity_marker": [74, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-smooth muscle actin", "entity_2_idx": [[85, 110]], "entity_2_idx_in_text_with_entity_marker": [98, 123], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d546.s0_BioInfer.d546.s0.p7", "text": "Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.", "text_with_entity_marker": "Specific antibodies to myosin heavy chain isoforms (SM1, [E1]SM2[/E1], SMemb), caldesmon, and [E2]alpha-smooth muscle actin[/E2] and cDNAs for SMemb were used.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SM2", "entity_1_idx": [[57, 60]], "entity_1_idx_in_text_with_entity_marker": [61, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-smooth muscle actin", "entity_2_idx": [[85, 110]], "entity_2_idx_in_text_with_entity_marker": [98, 123], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d546.s0_BioInfer.d546.s0.p8", "text": "Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.", "text_with_entity_marker": "Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and [E1]alpha-smooth muscle actin[/E1] and cDNAs for [E2]SMemb[/E2] were used.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[85, 110]], "entity_1_idx_in_text_with_entity_marker": [89, 114], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SMemb", "entity_2_idx": [[125, 130]], "entity_2_idx_in_text_with_entity_marker": [138, 143], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d546.s0_BioInfer.d546.s0.p9", "text": "Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.", "text_with_entity_marker": "Specific antibodies to myosin heavy chain isoforms (SM1, SM2, [E1]SMemb[/E1]), caldesmon, and [E2]alpha-smooth muscle actin[/E2] and cDNAs for SMemb were used.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SMemb", "entity_1_idx": [[62, 67]], "entity_1_idx_in_text_with_entity_marker": [66, 71], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-smooth muscle actin", "entity_2_idx": [[85, 110]], "entity_2_idx_in_text_with_entity_marker": [98, 123], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d546.s0_BioInfer.d546.s0.p10", "text": "Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.", "text_with_entity_marker": "Specific antibodies to [E1]myosin heavy chain[/E1] isoforms (SM1, SM2, SMemb), caldesmon, and [E2]alpha-smooth muscle actin[/E2] and cDNAs for SMemb were used.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[23, 41]], "entity_1_idx_in_text_with_entity_marker": [27, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-smooth muscle actin", "entity_2_idx": [[85, 110]], "entity_2_idx_in_text_with_entity_marker": [98, 123], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d546.s0_BioInfer.d546.s0.p11", "text": "Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.", "text_with_entity_marker": "Specific antibodies to myosin heavy chain isoforms (SM1, [E1]SM2[/E1], SMemb), [E2]caldesmon[/E2], and alpha-smooth muscle actin and cDNAs for SMemb were used.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SM2", "entity_1_idx": [[57, 60]], "entity_1_idx_in_text_with_entity_marker": [61, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "caldesmon", "entity_2_idx": [[70, 79]], "entity_2_idx_in_text_with_entity_marker": [83, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d546.s0_BioInfer.d546.s0.p12", "text": "Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.", "text_with_entity_marker": "Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), [E1]caldesmon[/E1], and alpha-smooth muscle actin and cDNAs for [E2]SMemb[/E2] were used.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "caldesmon", "entity_1_idx": [[70, 79]], "entity_1_idx_in_text_with_entity_marker": [74, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SMemb", "entity_2_idx": [[125, 130]], "entity_2_idx_in_text_with_entity_marker": [138, 143], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d546.s0_BioInfer.d546.s0.p13", "text": "Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.", "text_with_entity_marker": "Specific antibodies to myosin heavy chain isoforms (SM1, SM2, [E1]SMemb[/E1]), [E2]caldesmon[/E2], and alpha-smooth muscle actin and cDNAs for SMemb were used.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SMemb", "entity_1_idx": [[62, 67]], "entity_1_idx_in_text_with_entity_marker": [66, 71], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "caldesmon", "entity_2_idx": [[70, 79]], "entity_2_idx_in_text_with_entity_marker": [83, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d546.s0_BioInfer.d546.s0.p14", "text": "Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.", "text_with_entity_marker": "Specific antibodies to [E1]myosin heavy chain[/E1] isoforms (SM1, SM2, SMemb), [E2]caldesmon[/E2], and alpha-smooth muscle actin and cDNAs for SMemb were used.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[23, 41]], "entity_1_idx_in_text_with_entity_marker": [27, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "caldesmon", "entity_2_idx": [[70, 79]], "entity_2_idx_in_text_with_entity_marker": [83, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d546.s0_BioInfer.d546.s0.p15", "text": "Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.", "text_with_entity_marker": "Specific antibodies to myosin heavy chain isoforms (SM1, [E1]SM2[/E1], SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for [E2]SMemb[/E2] were used.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SM2", "entity_1_idx": [[57, 60]], "entity_1_idx_in_text_with_entity_marker": [61, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SMemb", "entity_2_idx": [[125, 130]], "entity_2_idx_in_text_with_entity_marker": [138, 143], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d546.s0_BioInfer.d546.s0.p16", "text": "Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.", "text_with_entity_marker": "Specific antibodies to myosin heavy chain isoforms (SM1, [E1]SM2[/E1], [E2]SMemb[/E2]), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SM2", "entity_1_idx": [[57, 60]], "entity_1_idx_in_text_with_entity_marker": [61, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SMemb", "entity_2_idx": [[62, 67]], "entity_2_idx_in_text_with_entity_marker": [75, 80], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d546.s0_BioInfer.d546.s0.p17", "text": "Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.", "text_with_entity_marker": "Specific antibodies to [E1]myosin heavy chain[/E1] isoforms (SM1, [E2]SM2[/E2], SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "myosin heavy chain", "entity_1_idx": [[23, 41]], "entity_1_idx_in_text_with_entity_marker": [27, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SM2", "entity_2_idx": [[57, 60]], "entity_2_idx_in_text_with_entity_marker": [70, 73], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d546.s0_BioInfer.d546.s0.p18", "text": "Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.", "text_with_entity_marker": "Specific antibodies to myosin heavy chain isoforms (SM1, SM2, [E1]SMemb[/E1]), caldesmon, and alpha-smooth muscle actin and cDNAs for [E2]SMemb[/E2] were used.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SMemb", "entity_1_idx": [[62, 67]], "entity_1_idx_in_text_with_entity_marker": [66, 71], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SMemb", "entity_2_idx": [[125, 130]], "entity_2_idx_in_text_with_entity_marker": [138, 143], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d546.s0_BioInfer.d546.s0.p19", "text": "Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.", "text_with_entity_marker": "Specific antibodies to [E1]myosin heavy chain[/E1] isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for [E2]SMemb[/E2] were used.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[23, 41]], "entity_1_idx_in_text_with_entity_marker": [27, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SMemb", "entity_2_idx": [[125, 130]], "entity_2_idx_in_text_with_entity_marker": [138, 143], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d546.s0_BioInfer.d546.s0.p20", "text": "Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.", "text_with_entity_marker": "Specific antibodies to [E1]myosin heavy chain[/E1] isoforms (SM1, SM2, [E2]SMemb[/E2]), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "myosin heavy chain", "entity_1_idx": [[23, 41]], "entity_1_idx_in_text_with_entity_marker": [27, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SMemb", "entity_2_idx": [[62, 67]], "entity_2_idx_in_text_with_entity_marker": [75, 80], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d235.s0_BioInfer.d235.s0.p0", "text": "Gravin is not likely to be a nonerythroid spectrin, talin, myosin, or actin-binding protein based on the lack of reactivity of antigravin with these polypeptides in immunoblots.", "text_with_entity_marker": "Gravin is not likely to be a [E1]nonerythroid spectrin[/E1], talin, [E2]myosin[/E2], or actin-binding protein based on the lack of reactivity of antigravin with these polypeptides in immunoblots.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nonerythroid spectrin", "entity_1_idx": [[29, 50]], "entity_1_idx_in_text_with_entity_marker": [33, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin", "entity_2_idx": [[59, 65]], "entity_2_idx_in_text_with_entity_marker": [72, 78], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d235.s0_BioInfer.d235.s0.p1", "text": "Gravin is not likely to be a nonerythroid spectrin, talin, myosin, or actin-binding protein based on the lack of reactivity of antigravin with these polypeptides in immunoblots.", "text_with_entity_marker": "[E1]Gravin[/E1] is not likely to be a [E2]nonerythroid spectrin[/E2], talin, myosin, or actin-binding protein based on the lack of reactivity of antigravin with these polypeptides in immunoblots.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Gravin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nonerythroid spectrin", "entity_2_idx": [[29, 50]], "entity_2_idx_in_text_with_entity_marker": [42, 63], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d235.s0_BioInfer.d235.s0.p2", "text": "Gravin is not likely to be a nonerythroid spectrin, talin, myosin, or actin-binding protein based on the lack of reactivity of antigravin with these polypeptides in immunoblots.", "text_with_entity_marker": "Gravin is not likely to be a [E1]nonerythroid spectrin[/E1], [E2]talin[/E2], myosin, or actin-binding protein based on the lack of reactivity of antigravin with these polypeptides in immunoblots.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nonerythroid spectrin", "entity_1_idx": [[29, 50]], "entity_1_idx_in_text_with_entity_marker": [33, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[52, 57]], "entity_2_idx_in_text_with_entity_marker": [65, 70], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d235.s0_BioInfer.d235.s0.p3", "text": "Gravin is not likely to be a nonerythroid spectrin, talin, myosin, or actin-binding protein based on the lack of reactivity of antigravin with these polypeptides in immunoblots.", "text_with_entity_marker": "Gravin is not likely to be a [E1]nonerythroid spectrin[/E1], talin, myosin, or [E2]actin-binding protein[/E2] based on the lack of reactivity of antigravin with these polypeptides in immunoblots.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nonerythroid spectrin", "entity_1_idx": [[29, 50]], "entity_1_idx_in_text_with_entity_marker": [33, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[70, 91]], "entity_2_idx_in_text_with_entity_marker": [83, 104], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d235.s0_BioInfer.d235.s0.p4", "text": "Gravin is not likely to be a nonerythroid spectrin, talin, myosin, or actin-binding protein based on the lack of reactivity of antigravin with these polypeptides in immunoblots.", "text_with_entity_marker": "Gravin is not likely to be a [E1]nonerythroid spectrin[/E1], talin, myosin, or actin-binding protein based on the lack of reactivity of [E2]antigravin[/E2] with these polypeptides in immunoblots.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "nonerythroid spectrin", "entity_1_idx": [[29, 50]], "entity_1_idx_in_text_with_entity_marker": [33, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "antigravin", "entity_2_idx": [[127, 137]], "entity_2_idx_in_text_with_entity_marker": [140, 150], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d235.s0_BioInfer.d235.s0.p5", "text": "Gravin is not likely to be a nonerythroid spectrin, talin, myosin, or actin-binding protein based on the lack of reactivity of antigravin with these polypeptides in immunoblots.", "text_with_entity_marker": "[E1]Gravin[/E1] is not likely to be a nonerythroid spectrin, talin, [E2]myosin[/E2], or actin-binding protein based on the lack of reactivity of antigravin with these polypeptides in immunoblots.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Gravin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin", "entity_2_idx": [[59, 65]], "entity_2_idx_in_text_with_entity_marker": [72, 78], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d235.s0_BioInfer.d235.s0.p6", "text": "Gravin is not likely to be a nonerythroid spectrin, talin, myosin, or actin-binding protein based on the lack of reactivity of antigravin with these polypeptides in immunoblots.", "text_with_entity_marker": "Gravin is not likely to be a nonerythroid spectrin, [E1]talin[/E1], [E2]myosin[/E2], or actin-binding protein based on the lack of reactivity of antigravin with these polypeptides in immunoblots.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[52, 57]], "entity_1_idx_in_text_with_entity_marker": [56, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin", "entity_2_idx": [[59, 65]], "entity_2_idx_in_text_with_entity_marker": [72, 78], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d235.s0_BioInfer.d235.s0.p7", "text": "Gravin is not likely to be a nonerythroid spectrin, talin, myosin, or actin-binding protein based on the lack of reactivity of antigravin with these polypeptides in immunoblots.", "text_with_entity_marker": "Gravin is not likely to be a nonerythroid spectrin, talin, [E1]myosin[/E1], or [E2]actin-binding protein[/E2] based on the lack of reactivity of antigravin with these polypeptides in immunoblots.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin", "entity_1_idx": [[59, 65]], "entity_1_idx_in_text_with_entity_marker": [63, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[70, 91]], "entity_2_idx_in_text_with_entity_marker": [83, 104], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d235.s0_BioInfer.d235.s0.p8", "text": "Gravin is not likely to be a nonerythroid spectrin, talin, myosin, or actin-binding protein based on the lack of reactivity of antigravin with these polypeptides in immunoblots.", "text_with_entity_marker": "Gravin is not likely to be a nonerythroid spectrin, talin, [E1]myosin[/E1], or actin-binding protein based on the lack of reactivity of [E2]antigravin[/E2] with these polypeptides in immunoblots.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "myosin", "entity_1_idx": [[59, 65]], "entity_1_idx_in_text_with_entity_marker": [63, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "antigravin", "entity_2_idx": [[127, 137]], "entity_2_idx_in_text_with_entity_marker": [140, 150], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d235.s0_BioInfer.d235.s0.p9", "text": "Gravin is not likely to be a nonerythroid spectrin, talin, myosin, or actin-binding protein based on the lack of reactivity of antigravin with these polypeptides in immunoblots.", "text_with_entity_marker": "[E1]Gravin[/E1] is not likely to be a nonerythroid spectrin, [E2]talin[/E2], myosin, or actin-binding protein based on the lack of reactivity of antigravin with these polypeptides in immunoblots.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Gravin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[52, 57]], "entity_2_idx_in_text_with_entity_marker": [65, 70], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d235.s0_BioInfer.d235.s0.p10", "text": "Gravin is not likely to be a nonerythroid spectrin, talin, myosin, or actin-binding protein based on the lack of reactivity of antigravin with these polypeptides in immunoblots.", "text_with_entity_marker": "[E1]Gravin[/E1] is not likely to be a nonerythroid spectrin, talin, myosin, or [E2]actin-binding protein[/E2] based on the lack of reactivity of antigravin with these polypeptides in immunoblots.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Gravin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[70, 91]], "entity_2_idx_in_text_with_entity_marker": [83, 104], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d235.s0_BioInfer.d235.s0.p11", "text": "Gravin is not likely to be a nonerythroid spectrin, talin, myosin, or actin-binding protein based on the lack of reactivity of antigravin with these polypeptides in immunoblots.", "text_with_entity_marker": "[E1]Gravin[/E1] is not likely to be a nonerythroid spectrin, talin, myosin, or actin-binding protein based on the lack of reactivity of [E2]antigravin[/E2] with these polypeptides in immunoblots.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Gravin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "antigravin", "entity_2_idx": [[127, 137]], "entity_2_idx_in_text_with_entity_marker": [140, 150], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d235.s0_BioInfer.d235.s0.p12", "text": "Gravin is not likely to be a nonerythroid spectrin, talin, myosin, or actin-binding protein based on the lack of reactivity of antigravin with these polypeptides in immunoblots.", "text_with_entity_marker": "Gravin is not likely to be a nonerythroid spectrin, [E1]talin[/E1], myosin, or [E2]actin-binding protein[/E2] based on the lack of reactivity of antigravin with these polypeptides in immunoblots.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[52, 57]], "entity_1_idx_in_text_with_entity_marker": [56, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[70, 91]], "entity_2_idx_in_text_with_entity_marker": [83, 104], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d235.s0_BioInfer.d235.s0.p13", "text": "Gravin is not likely to be a nonerythroid spectrin, talin, myosin, or actin-binding protein based on the lack of reactivity of antigravin with these polypeptides in immunoblots.", "text_with_entity_marker": "Gravin is not likely to be a nonerythroid spectrin, [E1]talin[/E1], myosin, or actin-binding protein based on the lack of reactivity of [E2]antigravin[/E2] with these polypeptides in immunoblots.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[52, 57]], "entity_1_idx_in_text_with_entity_marker": [56, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "antigravin", "entity_2_idx": [[127, 137]], "entity_2_idx_in_text_with_entity_marker": [140, 150], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d235.s0_BioInfer.d235.s0.p14", "text": "Gravin is not likely to be a nonerythroid spectrin, talin, myosin, or actin-binding protein based on the lack of reactivity of antigravin with these polypeptides in immunoblots.", "text_with_entity_marker": "Gravin is not likely to be a nonerythroid spectrin, talin, myosin, or [E1]actin-binding protein[/E1] based on the lack of reactivity of [E2]antigravin[/E2] with these polypeptides in immunoblots.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin-binding protein", "entity_1_idx": [[70, 91]], "entity_1_idx_in_text_with_entity_marker": [74, 95], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "antigravin", "entity_2_idx": [[127, 137]], "entity_2_idx_in_text_with_entity_marker": [140, 150], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d602.s0_BioInfer.d602.s0.p0", "text": "The C-terminal region of ORC3 was, however, necessary to bring ORC4 and ORC5 into the core complex.", "text_with_entity_marker": "The C-terminal region of ORC3 was, however, necessary to bring [E1]ORC4[/E1] and [E2]ORC5[/E2] into the core complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "ORC4", "entity_1_idx": [[63, 67]], "entity_1_idx_in_text_with_entity_marker": [67, 71], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ORC5", "entity_2_idx": [[72, 76]], "entity_2_idx_in_text_with_entity_marker": [85, 89], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d602.s0_BioInfer.d602.s0.p1", "text": "The C-terminal region of ORC3 was, however, necessary to bring ORC4 and ORC5 into the core complex.", "text_with_entity_marker": "The C-terminal region of [E1]ORC3[/E1] was, however, necessary to bring [E2]ORC4[/E2] and ORC5 into the core complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "ORC3", "entity_1_idx": [[25, 29]], "entity_1_idx_in_text_with_entity_marker": [29, 33], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ORC4", "entity_2_idx": [[63, 67]], "entity_2_idx_in_text_with_entity_marker": [76, 80], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d602.s0_BioInfer.d602.s0.p2", "text": "The C-terminal region of ORC3 was, however, necessary to bring ORC4 and ORC5 into the core complex.", "text_with_entity_marker": "The C-terminal region of [E1]ORC3[/E1] was, however, necessary to bring ORC4 and [E2]ORC5[/E2] into the core complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "ORC3", "entity_1_idx": [[25, 29]], "entity_1_idx_in_text_with_entity_marker": [29, 33], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ORC5", "entity_2_idx": [[72, 76]], "entity_2_idx_in_text_with_entity_marker": [85, 89], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d473.s0_BioInfer.d473.s0.p0", "text": "Our data, which suggest that pollen profilin can regulate actin-based cytoskeletal protein assembly and protein kinase or phosphatase activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.", "text_with_entity_marker": "Our data, which suggest that pollen [E1]profilin[/E1] can regulate [E2]actin[/E2]-based cytoskeletal protein assembly and protein kinase or phosphatase activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[36, 44]], "entity_1_idx_in_text_with_entity_marker": [40, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[58, 63]], "entity_2_idx_in_text_with_entity_marker": [71, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d473.s0_BioInfer.d473.s0.p1", "text": "Our data, which suggest that pollen profilin can regulate actin-based cytoskeletal protein assembly and protein kinase or phosphatase activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.", "text_with_entity_marker": "Our data, which suggest that pollen profilin can regulate [E1]actin[/E1]-based cytoskeletal protein assembly and protein kinase or phosphatase activity, indicate a possible role for the involvement of [E2]profilin[/E2] in signaling pathways that may regulate pollen tube growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[58, 63]], "entity_1_idx_in_text_with_entity_marker": [62, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[192, 200]], "entity_2_idx_in_text_with_entity_marker": [205, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d473.s0_BioInfer.d473.s0.p2", "text": "Our data, which suggest that pollen profilin can regulate actin-based cytoskeletal protein assembly and protein kinase or phosphatase activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.", "text_with_entity_marker": "Our data, which suggest that pollen profilin can regulate [E1]actin[/E1]-based cytoskeletal protein assembly and [E2]protein kinase[/E2] or phosphatase activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[58, 63]], "entity_1_idx_in_text_with_entity_marker": [62, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "protein kinase", "entity_2_idx": [[104, 118]], "entity_2_idx_in_text_with_entity_marker": [117, 131], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d473.s0_BioInfer.d473.s0.p3", "text": "Our data, which suggest that pollen profilin can regulate actin-based cytoskeletal protein assembly and protein kinase or phosphatase activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.", "text_with_entity_marker": "Our data, which suggest that pollen profilin can regulate [E1]actin[/E1]-based cytoskeletal protein assembly and [E2]protein[/E2] kinase or phosphatase activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[58, 63]], "entity_1_idx_in_text_with_entity_marker": [62, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "protein", "entity_2_idx": [[104, 111], [122, 133]], "entity_2_idx_in_text_with_entity_marker": [117, 124], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d473.s0_BioInfer.d473.s0.p4", "text": "Our data, which suggest that pollen profilin can regulate actin-based cytoskeletal protein assembly and protein kinase or phosphatase activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.", "text_with_entity_marker": "Our data, which suggest that pollen [E1]profilin[/E1] can regulate actin-based cytoskeletal protein assembly and protein kinase or phosphatase activity, indicate a possible role for the involvement of [E2]profilin[/E2] in signaling pathways that may regulate pollen tube growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[36, 44]], "entity_1_idx_in_text_with_entity_marker": [40, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[192, 200]], "entity_2_idx_in_text_with_entity_marker": [205, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d473.s0_BioInfer.d473.s0.p5", "text": "Our data, which suggest that pollen profilin can regulate actin-based cytoskeletal protein assembly and protein kinase or phosphatase activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.", "text_with_entity_marker": "Our data, which suggest that pollen [E1]profilin[/E1] can regulate actin-based cytoskeletal protein assembly and [E2]protein kinase[/E2] or phosphatase activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[36, 44]], "entity_1_idx_in_text_with_entity_marker": [40, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "protein kinase", "entity_2_idx": [[104, 118]], "entity_2_idx_in_text_with_entity_marker": [117, 131], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d473.s0_BioInfer.d473.s0.p6", "text": "Our data, which suggest that pollen profilin can regulate actin-based cytoskeletal protein assembly and protein kinase or phosphatase activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.", "text_with_entity_marker": "Our data, which suggest that pollen [E1]profilin[/E1] can regulate actin-based cytoskeletal protein assembly and [E2]protein[/E2] kinase or phosphatase activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[36, 44]], "entity_1_idx_in_text_with_entity_marker": [40, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "protein", "entity_2_idx": [[104, 111], [122, 133]], "entity_2_idx_in_text_with_entity_marker": [117, 124], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d473.s0_BioInfer.d473.s0.p7", "text": "Our data, which suggest that pollen profilin can regulate actin-based cytoskeletal protein assembly and protein kinase or phosphatase activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.", "text_with_entity_marker": "Our data, which suggest that pollen profilin can regulate actin-based cytoskeletal protein assembly and [E1]protein kinase[/E1] or phosphatase activity, indicate a possible role for the involvement of [E2]profilin[/E2] in signaling pathways that may regulate pollen tube growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "protein kinase", "entity_1_idx": [[104, 118]], "entity_1_idx_in_text_with_entity_marker": [108, 122], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "profilin", "entity_2_idx": [[192, 200]], "entity_2_idx_in_text_with_entity_marker": [205, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d473.s0_BioInfer.d473.s0.p8", "text": "Our data, which suggest that pollen profilin can regulate actin-based cytoskeletal protein assembly and protein kinase or phosphatase activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.", "text_with_entity_marker": "Our data, which suggest that pollen profilin can regulate actin-based cytoskeletal protein assembly and [E1]protein[/E1] kinase or phosphatase activity, indicate a possible role for the involvement of [E2]profilin[/E2] in signaling pathways that may regulate pollen tube growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "protein", "entity_1_idx": [[104, 111], [122, 133]], "entity_1_idx_in_text_with_entity_marker": [108, 115], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "profilin", "entity_2_idx": [[192, 200]], "entity_2_idx_in_text_with_entity_marker": [205, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d473.s0_BioInfer.d473.s0.p9", "text": "Our data, which suggest that pollen profilin can regulate actin-based cytoskeletal protein assembly and protein kinase or phosphatase activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.", "text_with_entity_marker": "Our data, which suggest that pollen profilin can regulate actin-based cytoskeletal protein assembly and [E1-E2]protein[/E1] kinase[/E2] or phosphatase activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "protein", "entity_1_idx": [[104, 111], [122, 133]], "entity_1_idx_in_text_with_entity_marker": [111, 118], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "protein[/E1] kinase", "entity_2_idx": [[104, 118]], "entity_2_idx_in_text_with_entity_marker": [111, 130], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p10", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein ([E1]P[/E1]) and matrix (M) proteins of MV and the H, F, [E2]NP[/E2] and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[112, 113]], "entity_1_idx_in_text_with_entity_marker": [116, 117], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[159, 161], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [172, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p11", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein ([E1]NP[/E1]), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, [E2]NP[/E2] and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP", "entity_1_idx": [[91, 93]], "entity_1_idx_in_text_with_entity_marker": [95, 97], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[159, 161], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [172, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p12", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix ([E1]M[/E1]) proteins of MV and the H, F, [E2]NP[/E2] and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[127, 128]], "entity_1_idx_in_text_with_entity_marker": [131, 132], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[159, 161], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [172, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p13", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), [E1]fusion[/E1] ([E2]F[/E2]), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion", "entity_1_idx": [[57, 63], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [61, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F", "entity_2_idx": [[65, 66]], "entity_2_idx_in_text_with_entity_marker": [78, 79], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p14", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion ([E1]F[/E1]), nucleocapsid protein (NP), phosphoprotein (P) and [E2]matrix[/E2] (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "F", "entity_1_idx": [[65, 66]], "entity_1_idx_in_text_with_entity_marker": [69, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix", "entity_2_idx": [[119, 125], [130, 138]], "entity_2_idx_in_text_with_entity_marker": [132, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p15", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the [E1]haemagglutinin[/E1] (H), fusion ([E2]F[/E2]), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "haemagglutinin", "entity_1_idx": [[37, 51], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [41, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F", "entity_2_idx": [[65, 66]], "entity_2_idx_in_text_with_entity_marker": [78, 79], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p16", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion ([E1]F[/E1]), [E2]nucleocapsid protein[/E2] (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "F", "entity_1_idx": [[65, 66]], "entity_1_idx_in_text_with_entity_marker": [69, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid protein", "entity_2_idx": [[69, 89], [130, 138]], "entity_2_idx_in_text_with_entity_marker": [82, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p17", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion ([E1]F[/E1]), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the [E2]H[/E2], F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "F", "entity_1_idx": [[65, 66]], "entity_1_idx_in_text_with_entity_marker": [69, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[153, 154], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [166, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p18", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion ([E1]F[/E1]), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and [E2]P proteins[/E2] of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "F", "entity_1_idx": [[65, 66]], "entity_1_idx_in_text_with_entity_marker": [69, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P proteins", "entity_2_idx": [[166, 176]], "entity_2_idx_in_text_with_entity_marker": [179, 189], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p19", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion ([E1]F[/E1]), nucleocapsid protein (NP), [E2]phosphoprotein[/E2] (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "F", "entity_1_idx": [[65, 66]], "entity_1_idx_in_text_with_entity_marker": [69, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[96, 110], [130, 138]], "entity_2_idx_in_text_with_entity_marker": [109, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p90", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein ([E1]NP[/E1]), phosphoprotein (P) and matrix ([E2]M[/E2]) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP", "entity_1_idx": [[91, 93]], "entity_1_idx_in_text_with_entity_marker": [95, 97], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[127, 128]], "entity_2_idx_in_text_with_entity_marker": [140, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d781.s0_BioInfer.d781.s0.p0", "text": "Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of talin and myosin to the supernatant.", "text_with_entity_marker": "Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein ([E1]ABP[/E1]) but lost greater than 80% of talin and [E2]myosin[/E2] to the supernatant.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ABP", "entity_1_idx": [[122, 125]], "entity_1_idx_in_text_with_entity_marker": [126, 129], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin", "entity_2_idx": [[166, 172]], "entity_2_idx_in_text_with_entity_marker": [179, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d781.s0_BioInfer.d781.s0.p1", "text": "Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of talin and myosin to the supernatant.", "text_with_entity_marker": "Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their [E1]actin-binding protein[/E1] (ABP) but lost greater than 80% of talin and [E2]myosin[/E2] to the supernatant.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin-binding protein", "entity_1_idx": [[99, 120]], "entity_1_idx_in_text_with_entity_marker": [103, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin", "entity_2_idx": [[166, 172]], "entity_2_idx_in_text_with_entity_marker": [179, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d781.s0_BioInfer.d781.s0.p2", "text": "Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of talin and myosin to the supernatant.", "text_with_entity_marker": "Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of [E1]talin[/E1] and [E2]myosin[/E2] to the supernatant.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[156, 161]], "entity_1_idx_in_text_with_entity_marker": [160, 165], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin", "entity_2_idx": [[166, 172]], "entity_2_idx_in_text_with_entity_marker": [179, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d781.s0_BioInfer.d781.s0.p3", "text": "Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of talin and myosin to the supernatant.", "text_with_entity_marker": "Under all conditions, platelets retained 40-50% of their total [E1]actin[/E1] and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of talin and [E2]myosin[/E2] to the supernatant.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[63, 68]], "entity_1_idx_in_text_with_entity_marker": [67, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin", "entity_2_idx": [[166, 172]], "entity_2_idx_in_text_with_entity_marker": [179, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d781.s0_BioInfer.d781.s0.p4", "text": "Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of talin and myosin to the supernatant.", "text_with_entity_marker": "Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their [E1]actin-binding protein[/E1] ([E2]ABP[/E2]) but lost greater than 80% of talin and myosin to the supernatant.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin-binding protein", "entity_1_idx": [[99, 120]], "entity_1_idx_in_text_with_entity_marker": [103, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ABP", "entity_2_idx": [[122, 125]], "entity_2_idx_in_text_with_entity_marker": [135, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d781.s0_BioInfer.d781.s0.p5", "text": "Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of talin and myosin to the supernatant.", "text_with_entity_marker": "Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein ([E1]ABP[/E1]) but lost greater than 80% of [E2]talin[/E2] and myosin to the supernatant.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ABP", "entity_1_idx": [[122, 125]], "entity_1_idx_in_text_with_entity_marker": [126, 129], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[156, 161]], "entity_2_idx_in_text_with_entity_marker": [169, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d781.s0_BioInfer.d781.s0.p6", "text": "Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of talin and myosin to the supernatant.", "text_with_entity_marker": "Under all conditions, platelets retained 40-50% of their total [E1]actin[/E1] and greater than 70% of their actin-binding protein ([E2]ABP[/E2]) but lost greater than 80% of talin and myosin to the supernatant.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[63, 68]], "entity_1_idx_in_text_with_entity_marker": [67, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "ABP", "entity_2_idx": [[122, 125]], "entity_2_idx_in_text_with_entity_marker": [135, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d781.s0_BioInfer.d781.s0.p7", "text": "Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of talin and myosin to the supernatant.", "text_with_entity_marker": "Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their [E1]actin-binding protein[/E1] (ABP) but lost greater than 80% of [E2]talin[/E2] and myosin to the supernatant.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin-binding protein", "entity_1_idx": [[99, 120]], "entity_1_idx_in_text_with_entity_marker": [103, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[156, 161]], "entity_2_idx_in_text_with_entity_marker": [169, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d781.s0_BioInfer.d781.s0.p8", "text": "Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of talin and myosin to the supernatant.", "text_with_entity_marker": "Under all conditions, platelets retained 40-50% of their total [E1]actin[/E1] and greater than 70% of their [E2]actin-binding protein[/E2] (ABP) but lost greater than 80% of talin and myosin to the supernatant.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[63, 68]], "entity_1_idx_in_text_with_entity_marker": [67, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin-binding protein", "entity_2_idx": [[99, 120]], "entity_2_idx_in_text_with_entity_marker": [112, 133], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d781.s0_BioInfer.d781.s0.p9", "text": "Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of talin and myosin to the supernatant.", "text_with_entity_marker": "Under all conditions, platelets retained 40-50% of their total [E1]actin[/E1] and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of [E2]talin[/E2] and myosin to the supernatant.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[63, 68]], "entity_1_idx_in_text_with_entity_marker": [67, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[156, 161]], "entity_2_idx_in_text_with_entity_marker": [169, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p20", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, [E1]myosin heavy chain[/E1], calmodulin, calponin, calcium vector protein, [E2]creatine kinase[/E2], muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[124, 142]], "entity_1_idx_in_text_with_entity_marker": [128, 146], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "creatine kinase", "entity_2_idx": [[190, 205]], "entity_2_idx_in_text_with_entity_marker": [203, 218], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p21", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, [E1]myosin regulatory light chain[/E1], myosin light chain kinase, myosin heavy chain, [E2]calmodulin[/E2], calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin regulatory light chain", "entity_1_idx": [[66, 95]], "entity_1_idx_in_text_with_entity_marker": [70, 99], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calmodulin", "entity_2_idx": [[144, 154]], "entity_2_idx_in_text_with_entity_marker": [157, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p22", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, [E1]myosin light chain kinase[/E1], myosin heavy chain, [E2]calmodulin[/E2], calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin light chain kinase", "entity_1_idx": [[97, 122]], "entity_1_idx_in_text_with_entity_marker": [101, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calmodulin", "entity_2_idx": [[144, 154]], "entity_2_idx_in_text_with_entity_marker": [157, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p23", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, [E1]tropomyosin[/E1], troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, [E2]calmodulin[/E2], calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tropomyosin", "entity_1_idx": [[41, 52]], "entity_1_idx_in_text_with_entity_marker": [45, 56], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calmodulin", "entity_2_idx": [[144, 154]], "entity_2_idx_in_text_with_entity_marker": [157, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p24", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, [E1]troponin I[/E1], myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, [E2]calmodulin[/E2], calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "troponin I", "entity_1_idx": [[54, 64]], "entity_1_idx_in_text_with_entity_marker": [58, 68], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calmodulin", "entity_2_idx": [[144, 154]], "entity_2_idx_in_text_with_entity_marker": [157, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p25", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included [E1]actin[/E1], tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, [E2]calmodulin[/E2], calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[34, 39]], "entity_1_idx_in_text_with_entity_marker": [38, 43], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calmodulin", "entity_2_idx": [[144, 154]], "entity_2_idx_in_text_with_entity_marker": [157, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p26", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, [E1]calmodulin[/E1], calponin, calcium vector protein, creatine kinase, [E2]muscle LIM[/E2] protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "calmodulin", "entity_1_idx": [[144, 154]], "entity_1_idx_in_text_with_entity_marker": [148, 158], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "muscle LIM", "entity_2_idx": [[207, 217]], "entity_2_idx_in_text_with_entity_marker": [220, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p27", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, [E1]calmodulin[/E1], [E2]calponin[/E2], calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "calmodulin", "entity_1_idx": [[144, 154]], "entity_1_idx_in_text_with_entity_marker": [148, 158], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calponin", "entity_2_idx": [[156, 164]], "entity_2_idx_in_text_with_entity_marker": [169, 177], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p28", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, [E1]calmodulin[/E1], calponin, calcium vector protein, creatine kinase, muscle LIM protein, and [E2]SH3-binding glutamate-rich protein[/E2], suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "calmodulin", "entity_1_idx": [[144, 154]], "entity_1_idx_in_text_with_entity_marker": [148, 158], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SH3-binding glutamate-rich protein", "entity_2_idx": [[231, 265]], "entity_2_idx_in_text_with_entity_marker": [244, 278], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p29", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, [E1]calmodulin[/E1], calponin, calcium vector protein, [E2]creatine kinase[/E2], muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "calmodulin", "entity_1_idx": [[144, 154]], "entity_1_idx_in_text_with_entity_marker": [148, 158], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "creatine kinase", "entity_2_idx": [[190, 205]], "entity_2_idx_in_text_with_entity_marker": [203, 218], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d656.s0_BioInfer.d656.s0.p0", "text": "The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, [E1]beta-catenin[/E1], and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[188, 200]], "entity_1_idx_in_text_with_entity_marker": [192, 204], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[206, 217]], "entity_2_idx_in_text_with_entity_marker": [219, 230], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d656.s0_BioInfer.d656.s0.p1", "text": "The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], and plakoglobin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[173, 186]], "entity_1_idx_in_text_with_entity_marker": [177, 190], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[188, 200]], "entity_2_idx_in_text_with_entity_marker": [201, 213], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d656.s0_BioInfer.d656.s0.p2", "text": "The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing [E1]E-cadherin[/E1] and its cytoplasmic cofactors alpha-catenin, [E2]beta-catenin[/E2], and plakoglobin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[132, 142]], "entity_1_idx_in_text_with_entity_marker": [136, 146], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[188, 200]], "entity_2_idx_in_text_with_entity_marker": [201, 213], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d656.s0_BioInfer.d656.s0.p3", "text": "The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The [E1]p120cas[/E1] gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, [E2]beta-catenin[/E2], and plakoglobin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p120cas", "entity_1_idx": [[4, 11]], "entity_1_idx_in_text_with_entity_marker": [8, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[188, 200]], "entity_2_idx_in_text_with_entity_marker": [201, 213], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d656.s0_BioInfer.d656.s0.p4", "text": "The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The p120cas gene encodes a [E1]protein tyrosine kinase[/E1] substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, [E2]beta-catenin[/E2], and plakoglobin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "protein tyrosine kinase", "entity_1_idx": [[27, 50]], "entity_1_idx_in_text_with_entity_marker": [31, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[188, 200]], "entity_2_idx_in_text_with_entity_marker": [201, 213], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d656.s0_BioInfer.d656.s0.p5", "text": "The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors [E1]alpha-catenin[/E1], beta-catenin, and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[173, 186]], "entity_1_idx_in_text_with_entity_marker": [177, 190], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[206, 217]], "entity_2_idx_in_text_with_entity_marker": [219, 230], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d656.s0_BioInfer.d656.s0.p6", "text": "The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing [E1]E-cadherin[/E1] and its cytoplasmic cofactors alpha-catenin, beta-catenin, and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[132, 142]], "entity_1_idx_in_text_with_entity_marker": [136, 146], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[206, 217]], "entity_2_idx_in_text_with_entity_marker": [219, 230], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d656.s0_BioInfer.d656.s0.p7", "text": "The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The [E1]p120cas[/E1] gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p120cas", "entity_1_idx": [[4, 11]], "entity_1_idx_in_text_with_entity_marker": [8, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[206, 217]], "entity_2_idx_in_text_with_entity_marker": [219, 230], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d656.s0_BioInfer.d656.s0.p8", "text": "The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The p120cas gene encodes a [E1]protein tyrosine kinase[/E1] substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "protein tyrosine kinase", "entity_1_idx": [[27, 50]], "entity_1_idx_in_text_with_entity_marker": [31, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[206, 217]], "entity_2_idx_in_text_with_entity_marker": [219, 230], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d656.s0_BioInfer.d656.s0.p9", "text": "The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing [E1]E-cadherin[/E1] and its cytoplasmic cofactors [E2]alpha-catenin[/E2], beta-catenin, and plakoglobin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[132, 142]], "entity_1_idx_in_text_with_entity_marker": [136, 146], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[173, 186]], "entity_2_idx_in_text_with_entity_marker": [186, 199], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d656.s0_BioInfer.d656.s0.p10", "text": "The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The [E1]p120cas[/E1] gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors [E2]alpha-catenin[/E2], beta-catenin, and plakoglobin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p120cas", "entity_1_idx": [[4, 11]], "entity_1_idx_in_text_with_entity_marker": [8, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[173, 186]], "entity_2_idx_in_text_with_entity_marker": [186, 199], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d656.s0_BioInfer.d656.s0.p11", "text": "The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The p120cas gene encodes a [E1]protein tyrosine kinase[/E1] substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors [E2]alpha-catenin[/E2], beta-catenin, and plakoglobin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "protein tyrosine kinase", "entity_1_idx": [[27, 50]], "entity_1_idx_in_text_with_entity_marker": [31, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[173, 186]], "entity_2_idx_in_text_with_entity_marker": [186, 199], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d656.s0_BioInfer.d656.s0.p12", "text": "The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The [E1]p120cas[/E1] gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing [E2]E-cadherin[/E2] and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p120cas", "entity_1_idx": [[4, 11]], "entity_1_idx_in_text_with_entity_marker": [8, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[132, 142]], "entity_2_idx_in_text_with_entity_marker": [145, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d656.s0_BioInfer.d656.s0.p13", "text": "The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The p120cas gene encodes a [E1]protein tyrosine kinase[/E1] substrate that associates with the cell-cell adhesion protein complex containing [E2]E-cadherin[/E2] and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "protein tyrosine kinase", "entity_1_idx": [[27, 50]], "entity_1_idx_in_text_with_entity_marker": [31, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[132, 142]], "entity_2_idx_in_text_with_entity_marker": [145, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d656.s0_BioInfer.d656.s0.p14", "text": "The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The [E1]p120cas[/E1] gene encodes a [E2]protein tyrosine kinase[/E2] substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p120cas", "entity_1_idx": [[4, 11]], "entity_1_idx_in_text_with_entity_marker": [8, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "protein tyrosine kinase", "entity_2_idx": [[27, 50]], "entity_2_idx_in_text_with_entity_marker": [40, 63], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p30", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, [E1]profilins Ia[/E1]/b and II, [E2]myosins[/E2] IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins Ia", "entity_1_idx": [[67, 79]], "entity_1_idx_in_text_with_entity_marker": [71, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosins", "entity_2_idx": [[90, 97], [109, 111]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p31", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, [E1-E2]profilins I[/E1]a[/E2]/b and II, myosins IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins I", "entity_1_idx": [[67, 78], [80, 81]], "entity_1_idx_in_text_with_entity_marker": [74, 85], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilins I[/E1]a", "entity_2_idx": [[67, 79]], "entity_2_idx_in_text_with_entity_marker": [74, 91], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p32", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, [E1]profilins Ia[/E1]/b and II, [E2]myosins IB[/E2], IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins Ia", "entity_1_idx": [[67, 79]], "entity_1_idx_in_text_with_entity_marker": [71, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosins IB", "entity_2_idx": [[90, 100]], "entity_2_idx_in_text_with_entity_marker": [103, 113], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p33", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, [E1]profilins Ia[/E1]/b and II, myosins IB, IC and II, and [E2]calmodulin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins Ia", "entity_1_idx": [[67, 79]], "entity_1_idx_in_text_with_entity_marker": [71, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calmodulin", "entity_2_idx": [[117, 127]], "entity_2_idx_in_text_with_entity_marker": [130, 140], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p34", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and 18S rRNA, [E1]actin I[/E1], profilins Ia/b and II, [E2]myosins[/E2] IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin I", "entity_1_idx": [[58, 65]], "entity_1_idx_in_text_with_entity_marker": [62, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosins", "entity_2_idx": [[90, 97], [102, 104]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p35", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, [E1]profilins[/E1] Ia/b and II, [E2]myosins[/E2] IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[67, 76], [86, 88]], "entity_1_idx_in_text_with_entity_marker": [71, 80], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosins", "entity_2_idx": [[90, 97], [102, 104]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p36", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, [E1-E2]myosins[/E1-E2] IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosins", "entity_1_idx": [[90, 97], [109, 111]], "entity_1_idx_in_text_with_entity_marker": [97, 104], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosins", "entity_2_idx": [[90, 97], [102, 104]], "entity_2_idx_in_text_with_entity_marker": [97, 104], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p37", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, [E1]profilins I[/E1]a/b and II, [E2]myosins[/E2] IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins I", "entity_1_idx": [[67, 78], [80, 81]], "entity_1_idx_in_text_with_entity_marker": [71, 82], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosins", "entity_2_idx": [[90, 97], [102, 104]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p38", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, [E1-E2]myosins[/E1] IB[/E2], IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosins", "entity_1_idx": [[90, 97], [102, 104]], "entity_1_idx_in_text_with_entity_marker": [97, 104], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosins[/E1] IB", "entity_2_idx": [[90, 100]], "entity_2_idx_in_text_with_entity_marker": [97, 112], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p39", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, [E1]myosins[/E1] IB, IC and II, and [E2]calmodulin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosins", "entity_1_idx": [[90, 97], [102, 104]], "entity_1_idx_in_text_with_entity_marker": [94, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calmodulin", "entity_2_idx": [[117, 127]], "entity_2_idx_in_text_with_entity_marker": [130, 140], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d37.s0_BioInfer.d37.s0.p0", "text": "All of the experimental data were quantitatively accounted for on the basis of a 1:1 complex between profilin and monomeric actin with a Kr between 4 and 9 microM, the same value obtained previously in the absence of MgCl2.", "text_with_entity_marker": "All of the experimental data were quantitatively accounted for on the basis of a 1:1 complex between [E1]profilin[/E1] and monomeric [E2]actin[/E2] with a Kr between 4 and 9 microM, the same value obtained previously in the absence of MgCl2.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[101, 109]], "entity_1_idx_in_text_with_entity_marker": [105, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[124, 129]], "entity_2_idx_in_text_with_entity_marker": [137, 142], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d37.s1_BioInfer.d37.s1.p0", "text": "The interaction of Acanthamoeba actin and Acanthamoeba profilin was evaluated as a function of ionic conditions.", "text_with_entity_marker": "The interaction of Acanthamoeba [E1]actin[/E1] and Acanthamoeba [E2]profilin[/E2] was evaluated as a function of ionic conditions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[32, 37]], "entity_1_idx_in_text_with_entity_marker": [36, 41], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[55, 63]], "entity_2_idx_in_text_with_entity_marker": [68, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d252.s0_BioInfer.d252.s0.p10", "text": "Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.", "text_with_entity_marker": "Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and [E1]Arp2[/E1]/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by [E2]Arp[/E2]2/3 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Arp2", "entity_1_idx": [[105, 109]], "entity_1_idx_in_text_with_entity_marker": [109, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp", "entity_2_idx": [[224, 227], [229, 230]], "entity_2_idx_in_text_with_entity_marker": [237, 240], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d252.s0_BioInfer.d252.s0.p11", "text": "Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.", "text_with_entity_marker": "Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and [E1]Arp2[/E1]/3 complex and mimics the C-terminal domain of [E2]WASp[/E2] family proteins in catalyzing filament barbed end branching by Arp2/3 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Arp2", "entity_1_idx": [[105, 109]], "entity_1_idx_in_text_with_entity_marker": [109, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "WASp", "entity_2_idx": [[156, 160]], "entity_2_idx_in_text_with_entity_marker": [169, 173], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d252.s0_BioInfer.d252.s0.p12", "text": "Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.", "text_with_entity_marker": "Here we show that the N-terminal domain of [E1]ActA[/E1] binds one actin monomer, in a profilin-like fashion, and [E2]Arp2[/E2]/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "ActA", "entity_1_idx": [[43, 47]], "entity_1_idx_in_text_with_entity_marker": [47, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp2", "entity_2_idx": [[105, 109]], "entity_2_idx_in_text_with_entity_marker": [118, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d252.s0_BioInfer.d252.s0.p13", "text": "Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.", "text_with_entity_marker": "Here we show that the N-terminal domain of ActA binds one [E1]actin[/E1] monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by [E2]Arp2[/E2]/3 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[58, 63]], "entity_1_idx_in_text_with_entity_marker": [62, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp2", "entity_2_idx": [[224, 228]], "entity_2_idx_in_text_with_entity_marker": [237, 241], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d252.s0_BioInfer.d252.s0.p14", "text": "Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.", "text_with_entity_marker": "Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and [E1]Arp[/E1]2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by [E2]Arp2[/E2]/3 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Arp", "entity_1_idx": [[105, 108], [110, 111]], "entity_1_idx_in_text_with_entity_marker": [109, 112], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp2", "entity_2_idx": [[224, 228]], "entity_2_idx_in_text_with_entity_marker": [237, 241], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d252.s0_BioInfer.d252.s0.p15", "text": "Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.", "text_with_entity_marker": "Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by [E1-E2]Arp[/E1]2[/E2]/3 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arp", "entity_1_idx": [[224, 227], [229, 230]], "entity_1_idx_in_text_with_entity_marker": [231, 234], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp[/E1]2", "entity_2_idx": [[224, 228]], "entity_2_idx_in_text_with_entity_marker": [231, 240], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d252.s0_BioInfer.d252.s0.p16", "text": "Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.", "text_with_entity_marker": "Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of [E1]WASp[/E1] family proteins in catalyzing filament barbed end branching by [E2]Arp2[/E2]/3 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "WASp", "entity_1_idx": [[156, 160]], "entity_1_idx_in_text_with_entity_marker": [160, 164], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp2", "entity_2_idx": [[224, 228]], "entity_2_idx_in_text_with_entity_marker": [237, 241], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d252.s0_BioInfer.d252.s0.p17", "text": "Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.", "text_with_entity_marker": "Here we show that the N-terminal domain of [E1]ActA[/E1] binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by [E2]Arp2[/E2]/3 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ActA", "entity_1_idx": [[43, 47]], "entity_1_idx_in_text_with_entity_marker": [47, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp2", "entity_2_idx": [[224, 228]], "entity_2_idx_in_text_with_entity_marker": [237, 241], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d252.s0_BioInfer.d252.s0.p18", "text": "Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.", "text_with_entity_marker": "Here we show that the N-terminal domain of ActA binds one [E1]actin[/E1] monomer, in a profilin-like fashion, and [E2]Arp[/E2]2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[58, 63]], "entity_1_idx_in_text_with_entity_marker": [62, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp", "entity_2_idx": [[105, 108], [110, 111]], "entity_2_idx_in_text_with_entity_marker": [118, 121], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d252.s0_BioInfer.d252.s0.p19", "text": "Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.", "text_with_entity_marker": "Here we show that the N-terminal domain of ActA binds one [E1]actin[/E1] monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by [E2]Arp[/E2]2/3 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[58, 63]], "entity_1_idx_in_text_with_entity_marker": [62, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp", "entity_2_idx": [[224, 227], [229, 230]], "entity_2_idx_in_text_with_entity_marker": [237, 240], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d685.s0_BioInfer.d685.s0.p0", "text": "The resulting beta-catenin product is unable to bind alpha-catenin that is responsible for actin filament binding and organization.", "text_with_entity_marker": "The resulting [E1]beta-catenin[/E1] product is unable to bind [E2]alpha-catenin[/E2] that is responsible for actin filament binding and organization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[14, 26]], "entity_1_idx_in_text_with_entity_marker": [18, 30], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[53, 66]], "entity_2_idx_in_text_with_entity_marker": [66, 79], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d685.s0_BioInfer.d685.s0.p1", "text": "The resulting beta-catenin product is unable to bind alpha-catenin that is responsible for actin filament binding and organization.", "text_with_entity_marker": "The resulting [E1]beta-catenin[/E1] product is unable to bind alpha-catenin that is responsible for [E2]actin[/E2] filament binding and organization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[14, 26]], "entity_1_idx_in_text_with_entity_marker": [18, 30], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[91, 96]], "entity_2_idx_in_text_with_entity_marker": [104, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d685.s0_BioInfer.d685.s0.p2", "text": "The resulting beta-catenin product is unable to bind alpha-catenin that is responsible for actin filament binding and organization.", "text_with_entity_marker": "The resulting beta-catenin product is unable to bind [E1]alpha-catenin[/E1] that is responsible for [E2]actin[/E2] filament binding and organization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[53, 66]], "entity_1_idx_in_text_with_entity_marker": [57, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[91, 96]], "entity_2_idx_in_text_with_entity_marker": [104, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d414.s0_BioInfer.d414.s0.p0", "text": "MC159 and E8 inhibited both TNFR-1- and CD-95-induced apoptosis as well as killing mediated by overexpression of the downstream adaptors TRADD and FADD.", "text_with_entity_marker": "MC159 and E8 inhibited both [E1]TNFR-1[/E1]- and CD-95-induced apoptosis as well as killing mediated by overexpression of the downstream adaptors TRADD and [E2]FADD[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNFR-1", "entity_1_idx": [[28, 34]], "entity_1_idx_in_text_with_entity_marker": [32, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[147, 151]], "entity_2_idx_in_text_with_entity_marker": [160, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d414.s0_BioInfer.d414.s0.p1", "text": "MC159 and E8 inhibited both TNFR-1- and CD-95-induced apoptosis as well as killing mediated by overexpression of the downstream adaptors TRADD and FADD.", "text_with_entity_marker": "MC159 and E8 inhibited both [E1]TNFR-1[/E1]- and [E2]CD-95[/E2]-induced apoptosis as well as killing mediated by overexpression of the downstream adaptors TRADD and FADD.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNFR-1", "entity_1_idx": [[28, 34]], "entity_1_idx_in_text_with_entity_marker": [32, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD-95", "entity_2_idx": [[40, 45]], "entity_2_idx_in_text_with_entity_marker": [53, 58], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d414.s0_BioInfer.d414.s0.p2", "text": "MC159 and E8 inhibited both TNFR-1- and CD-95-induced apoptosis as well as killing mediated by overexpression of the downstream adaptors TRADD and FADD.", "text_with_entity_marker": "MC159 and E8 inhibited both [E1]TNFR-1[/E1]- and CD-95-induced apoptosis as well as killing mediated by overexpression of the downstream adaptors [E2]TRADD[/E2] and FADD.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNFR-1", "entity_1_idx": [[28, 34]], "entity_1_idx_in_text_with_entity_marker": [32, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[137, 142]], "entity_2_idx_in_text_with_entity_marker": [150, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d414.s0_BioInfer.d414.s0.p3", "text": "MC159 and E8 inhibited both TNFR-1- and CD-95-induced apoptosis as well as killing mediated by overexpression of the downstream adaptors TRADD and FADD.", "text_with_entity_marker": "[E1]MC159[/E1] and E8 inhibited both [E2]TNFR-1[/E2]- and CD-95-induced apoptosis as well as killing mediated by overexpression of the downstream adaptors TRADD and FADD.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MC159", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNFR-1", "entity_2_idx": [[28, 34]], "entity_2_idx_in_text_with_entity_marker": [41, 47], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d414.s0_BioInfer.d414.s0.p4", "text": "MC159 and E8 inhibited both TNFR-1- and CD-95-induced apoptosis as well as killing mediated by overexpression of the downstream adaptors TRADD and FADD.", "text_with_entity_marker": "MC159 and [E1]E8[/E1] inhibited both [E2]TNFR-1[/E2]- and CD-95-induced apoptosis as well as killing mediated by overexpression of the downstream adaptors TRADD and FADD.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E8", "entity_1_idx": [[10, 12]], "entity_1_idx_in_text_with_entity_marker": [14, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNFR-1", "entity_2_idx": [[28, 34]], "entity_2_idx_in_text_with_entity_marker": [41, 47], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d414.s0_BioInfer.d414.s0.p5", "text": "MC159 and E8 inhibited both TNFR-1- and CD-95-induced apoptosis as well as killing mediated by overexpression of the downstream adaptors TRADD and FADD.", "text_with_entity_marker": "MC159 and E8 inhibited both TNFR-1- and [E1]CD-95[/E1]-induced apoptosis as well as killing mediated by overexpression of the downstream adaptors TRADD and [E2]FADD[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD-95", "entity_1_idx": [[40, 45]], "entity_1_idx_in_text_with_entity_marker": [44, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[147, 151]], "entity_2_idx_in_text_with_entity_marker": [160, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d414.s0_BioInfer.d414.s0.p6", "text": "MC159 and E8 inhibited both TNFR-1- and CD-95-induced apoptosis as well as killing mediated by overexpression of the downstream adaptors TRADD and FADD.", "text_with_entity_marker": "MC159 and E8 inhibited both TNFR-1- and CD-95-induced apoptosis as well as killing mediated by overexpression of the downstream adaptors [E1]TRADD[/E1] and [E2]FADD[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRADD", "entity_1_idx": [[137, 142]], "entity_1_idx_in_text_with_entity_marker": [141, 146], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[147, 151]], "entity_2_idx_in_text_with_entity_marker": [160, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d414.s0_BioInfer.d414.s0.p7", "text": "MC159 and E8 inhibited both TNFR-1- and CD-95-induced apoptosis as well as killing mediated by overexpression of the downstream adaptors TRADD and FADD.", "text_with_entity_marker": "[E1]MC159[/E1] and E8 inhibited both TNFR-1- and CD-95-induced apoptosis as well as killing mediated by overexpression of the downstream adaptors TRADD and [E2]FADD[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MC159", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[147, 151]], "entity_2_idx_in_text_with_entity_marker": [160, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d414.s0_BioInfer.d414.s0.p8", "text": "MC159 and E8 inhibited both TNFR-1- and CD-95-induced apoptosis as well as killing mediated by overexpression of the downstream adaptors TRADD and FADD.", "text_with_entity_marker": "MC159 and [E1]E8[/E1] inhibited both TNFR-1- and CD-95-induced apoptosis as well as killing mediated by overexpression of the downstream adaptors TRADD and [E2]FADD[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E8", "entity_1_idx": [[10, 12]], "entity_1_idx_in_text_with_entity_marker": [14, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[147, 151]], "entity_2_idx_in_text_with_entity_marker": [160, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d414.s0_BioInfer.d414.s0.p9", "text": "MC159 and E8 inhibited both TNFR-1- and CD-95-induced apoptosis as well as killing mediated by overexpression of the downstream adaptors TRADD and FADD.", "text_with_entity_marker": "MC159 and E8 inhibited both TNFR-1- and [E1]CD-95[/E1]-induced apoptosis as well as killing mediated by overexpression of the downstream adaptors [E2]TRADD[/E2] and FADD.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD-95", "entity_1_idx": [[40, 45]], "entity_1_idx_in_text_with_entity_marker": [44, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[137, 142]], "entity_2_idx_in_text_with_entity_marker": [150, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d414.s0_BioInfer.d414.s0.p10", "text": "MC159 and E8 inhibited both TNFR-1- and CD-95-induced apoptosis as well as killing mediated by overexpression of the downstream adaptors TRADD and FADD.", "text_with_entity_marker": "[E1]MC159[/E1] and E8 inhibited both TNFR-1- and [E2]CD-95[/E2]-induced apoptosis as well as killing mediated by overexpression of the downstream adaptors TRADD and FADD.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MC159", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD-95", "entity_2_idx": [[40, 45]], "entity_2_idx_in_text_with_entity_marker": [53, 58], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d414.s0_BioInfer.d414.s0.p11", "text": "MC159 and E8 inhibited both TNFR-1- and CD-95-induced apoptosis as well as killing mediated by overexpression of the downstream adaptors TRADD and FADD.", "text_with_entity_marker": "MC159 and [E1]E8[/E1] inhibited both TNFR-1- and [E2]CD-95[/E2]-induced apoptosis as well as killing mediated by overexpression of the downstream adaptors TRADD and FADD.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E8", "entity_1_idx": [[10, 12]], "entity_1_idx_in_text_with_entity_marker": [14, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD-95", "entity_2_idx": [[40, 45]], "entity_2_idx_in_text_with_entity_marker": [53, 58], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d414.s0_BioInfer.d414.s0.p12", "text": "MC159 and E8 inhibited both TNFR-1- and CD-95-induced apoptosis as well as killing mediated by overexpression of the downstream adaptors TRADD and FADD.", "text_with_entity_marker": "[E1]MC159[/E1] and E8 inhibited both TNFR-1- and CD-95-induced apoptosis as well as killing mediated by overexpression of the downstream adaptors [E2]TRADD[/E2] and FADD.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MC159", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[137, 142]], "entity_2_idx_in_text_with_entity_marker": [150, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d414.s0_BioInfer.d414.s0.p13", "text": "MC159 and E8 inhibited both TNFR-1- and CD-95-induced apoptosis as well as killing mediated by overexpression of the downstream adaptors TRADD and FADD.", "text_with_entity_marker": "MC159 and [E1]E8[/E1] inhibited both TNFR-1- and CD-95-induced apoptosis as well as killing mediated by overexpression of the downstream adaptors [E2]TRADD[/E2] and FADD.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E8", "entity_1_idx": [[10, 12]], "entity_1_idx_in_text_with_entity_marker": [14, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[137, 142]], "entity_2_idx_in_text_with_entity_marker": [150, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d414.s0_BioInfer.d414.s0.p14", "text": "MC159 and E8 inhibited both TNFR-1- and CD-95-induced apoptosis as well as killing mediated by overexpression of the downstream adaptors TRADD and FADD.", "text_with_entity_marker": "[E1]MC159[/E1] and [E2]E8[/E2] inhibited both TNFR-1- and CD-95-induced apoptosis as well as killing mediated by overexpression of the downstream adaptors TRADD and FADD.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MC159", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E8", "entity_2_idx": [[10, 12]], "entity_2_idx_in_text_with_entity_marker": [23, 25], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d670.s0_BioInfer.d670.s0.p0", "text": "The products of the yeast mismatch repair genes MSH2 and MSH3 participate in the inhibition of genetic recombination between homeologous (divergent) DNA sequences.", "text_with_entity_marker": "The products of the yeast mismatch repair genes [E1]MSH2[/E1] and [E2]MSH3[/E2] participate in the inhibition of genetic recombination between homeologous (divergent) DNA sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[48, 52]], "entity_1_idx_in_text_with_entity_marker": [52, 56], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH3", "entity_2_idx": [[57, 61]], "entity_2_idx_in_text_with_entity_marker": [70, 74], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d670.s1_BioInfer.d670.s1.p0", "text": "These results suggest that MSH2 and MSH3 can function differentially to control homeologous exchanges.", "text_with_entity_marker": "These results suggest that [E1]MSH2[/E1] and [E2]MSH3[/E2] can function differentially to control homeologous exchanges.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[27, 31]], "entity_1_idx_in_text_with_entity_marker": [31, 35], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH3", "entity_2_idx": [[36, 40]], "entity_2_idx_in_text_with_entity_marker": [49, 53], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p20", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones [E1]H3[/E1] and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone [E2]H4[/E2] and p53 substrates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[82, 84]], "entity_1_idx_in_text_with_entity_marker": [86, 88], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[206, 208]], "entity_2_idx_in_text_with_entity_marker": [219, 221], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p21", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative PCAF substrates, [E1]histones[/E1] H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone [E2]H4[/E2] and p53 substrates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[73, 81]], "entity_1_idx_in_text_with_entity_marker": [77, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[206, 208]], "entity_2_idx_in_text_with_entity_marker": [219, 221], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p22", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the [E1]histone[/E1] [E2]H4[/E2] and p53 substrates.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[198, 205]], "entity_1_idx_in_text_with_entity_marker": [202, 209], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[206, 208]], "entity_2_idx_in_text_with_entity_marker": [219, 221], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p23", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone [E1]H4[/E1] and [E2]p53[/E2] substrates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[206, 208]], "entity_1_idx_in_text_with_entity_marker": [210, 212], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[213, 216]], "entity_2_idx_in_text_with_entity_marker": [226, 229], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p24", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and [E1]H4[/E1] and the transcription factor p53, and have determined that [E2]histone[/E2] H3 is significantly preferred over the histone H4 and p53 substrates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[89, 91]], "entity_1_idx_in_text_with_entity_marker": [93, 95], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[151, 158]], "entity_2_idx_in_text_with_entity_marker": [164, 171], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p25", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative [E1]PCAF[/E1] substrates, histones H3 and H4 and the transcription factor p53, and have determined that [E2]histone[/E2] H3 is significantly preferred over the histone H4 and p53 substrates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PCAF", "entity_1_idx": [[56, 60]], "entity_1_idx_in_text_with_entity_marker": [60, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[151, 158]], "entity_2_idx_in_text_with_entity_marker": [164, 171], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p26", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones [E1]H3[/E1] and H4 and the transcription factor p53, and have determined that [E2]histone[/E2] H3 is significantly preferred over the histone H4 and p53 substrates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[82, 84]], "entity_1_idx_in_text_with_entity_marker": [86, 88], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[151, 158]], "entity_2_idx_in_text_with_entity_marker": [164, 171], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p27", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative PCAF substrates, [E1]histones[/E1] H3 and H4 and the transcription factor p53, and have determined that [E2]histone[/E2] H3 is significantly preferred over the histone H4 and p53 substrates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[73, 81]], "entity_1_idx_in_text_with_entity_marker": [77, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[151, 158]], "entity_2_idx_in_text_with_entity_marker": [164, 171], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p28", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that [E1]histone[/E1] H3 is significantly preferred over the [E2]histone[/E2] H4 and p53 substrates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[151, 158]], "entity_1_idx_in_text_with_entity_marker": [155, 162], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[198, 205]], "entity_2_idx_in_text_with_entity_marker": [211, 218], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d210.s0_BioInfer.d210.s0.p29", "text": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.", "text_with_entity_marker": "Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that [E1]histone[/E1] H3 is significantly preferred over the histone H4 and [E2]p53[/E2] substrates.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[151, 158]], "entity_1_idx_in_text_with_entity_marker": [155, 162], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p53", "entity_2_idx": [[213, 216]], "entity_2_idx_in_text_with_entity_marker": [226, 229], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d787.s0_BioInfer.d787.s0.p0", "text": "Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.", "text_with_entity_marker": "Using ITP (a substrate for myosin II [E1]ATPase[/E1]) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [[E2]MHCK[/E2]]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ATPase", "entity_1_idx": [[37, 43]], "entity_1_idx_in_text_with_entity_marker": [41, 47], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "MHCK", "entity_2_idx": [[111, 115]], "entity_2_idx_in_text_with_entity_marker": [124, 128], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d787.s0_BioInfer.d787.s0.p1", "text": "Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.", "text_with_entity_marker": "Using ITP (a substrate for [E1]myosin II[/E1] ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [[E2]MHCK[/E2]]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin II", "entity_1_idx": [[27, 36]], "entity_1_idx_in_text_with_entity_marker": [31, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MHCK", "entity_2_idx": [[111, 115]], "entity_2_idx_in_text_with_entity_marker": [124, 128], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d787.s0_BioInfer.d787.s0.p2", "text": "Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.", "text_with_entity_marker": "Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [[E1]MHCK[/E1]]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that [E2]MHCK[/E2] was localized at the foci.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MHCK", "entity_1_idx": [[111, 115]], "entity_1_idx_in_text_with_entity_marker": [115, 119], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MHCK", "entity_2_idx": [[254, 258]], "entity_2_idx_in_text_with_entity_marker": [267, 271], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d787.s0_BioInfer.d787.s0.p3", "text": "Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.", "text_with_entity_marker": "Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for [E1]myosin II heavy-chain kinase[/E1] [[E2]MHCK[/E2]]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin II heavy-chain kinase", "entity_1_idx": [[81, 109]], "entity_1_idx_in_text_with_entity_marker": [85, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MHCK", "entity_2_idx": [[111, 115]], "entity_2_idx_in_text_with_entity_marker": [124, 128], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d787.s0_BioInfer.d787.s0.p4", "text": "Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.", "text_with_entity_marker": "Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [[E1]MHCK[/E1]]), we demonstrated that phosphorylation of [E2]myosin heavy chains[/E2] occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MHCK", "entity_1_idx": [[111, 115]], "entity_1_idx_in_text_with_entity_marker": [115, 119], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chains", "entity_2_idx": [[159, 178]], "entity_2_idx_in_text_with_entity_marker": [172, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d787.s0_BioInfer.d787.s0.p5", "text": "Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.", "text_with_entity_marker": "Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [[E1]MHCK[/E1]]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the [E2]actin[/E2] network, a result that suggests that MHCK was localized at the foci.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MHCK", "entity_1_idx": [[111, 115]], "entity_1_idx_in_text_with_entity_marker": [115, 119], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[211, 216]], "entity_2_idx_in_text_with_entity_marker": [224, 229], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d787.s0_BioInfer.d787.s0.p6", "text": "Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.", "text_with_entity_marker": "Using ITP (a substrate for [E1]myosin II[/E1] [E2]ATPase[/E2]) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "myosin II", "entity_1_idx": [[27, 36]], "entity_1_idx_in_text_with_entity_marker": [31, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ATPase", "entity_2_idx": [[37, 43]], "entity_2_idx_in_text_with_entity_marker": [50, 56], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d787.s0_BioInfer.d787.s0.p7", "text": "Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.", "text_with_entity_marker": "Using ITP (a substrate for myosin II [E1]ATPase[/E1]) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that [E2]MHCK[/E2] was localized at the foci.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ATPase", "entity_1_idx": [[37, 43]], "entity_1_idx_in_text_with_entity_marker": [41, 47], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "MHCK", "entity_2_idx": [[254, 258]], "entity_2_idx_in_text_with_entity_marker": [267, 271], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d787.s0_BioInfer.d787.s0.p8", "text": "Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.", "text_with_entity_marker": "Using ITP (a substrate for myosin II [E1]ATPase[/E1]) and/or ATP gamma S (a substrate for [E2]myosin II heavy-chain kinase[/E2] [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ATPase", "entity_1_idx": [[37, 43]], "entity_1_idx_in_text_with_entity_marker": [41, 47], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "myosin II heavy-chain kinase", "entity_2_idx": [[81, 109]], "entity_2_idx_in_text_with_entity_marker": [94, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d787.s0_BioInfer.d787.s0.p9", "text": "Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.", "text_with_entity_marker": "Using ITP (a substrate for myosin II [E1]ATPase[/E1]) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of [E2]myosin heavy chains[/E2] occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ATPase", "entity_1_idx": [[37, 43]], "entity_1_idx_in_text_with_entity_marker": [41, 47], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "myosin heavy chains", "entity_2_idx": [[159, 178]], "entity_2_idx_in_text_with_entity_marker": [172, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d787.s0_BioInfer.d787.s0.p10", "text": "Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.", "text_with_entity_marker": "Using ITP (a substrate for myosin II [E1]ATPase[/E1]) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the [E2]actin[/E2] network, a result that suggests that MHCK was localized at the foci.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ATPase", "entity_1_idx": [[37, 43]], "entity_1_idx_in_text_with_entity_marker": [41, 47], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[211, 216]], "entity_2_idx_in_text_with_entity_marker": [224, 229], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d787.s0_BioInfer.d787.s0.p11", "text": "Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.", "text_with_entity_marker": "Using ITP (a substrate for [E1]myosin II[/E1] ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that [E2]MHCK[/E2] was localized at the foci.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin II", "entity_1_idx": [[27, 36]], "entity_1_idx_in_text_with_entity_marker": [31, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MHCK", "entity_2_idx": [[254, 258]], "entity_2_idx_in_text_with_entity_marker": [267, 271], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d787.s0_BioInfer.d787.s0.p12", "text": "Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.", "text_with_entity_marker": "Using ITP (a substrate for [E1]myosin II[/E1] ATPase) and/or ATP gamma S (a substrate for [E2]myosin II heavy-chain kinase[/E2] [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin II", "entity_1_idx": [[27, 36]], "entity_1_idx_in_text_with_entity_marker": [31, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin II heavy-chain kinase", "entity_2_idx": [[81, 109]], "entity_2_idx_in_text_with_entity_marker": [94, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d787.s0_BioInfer.d787.s0.p13", "text": "Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.", "text_with_entity_marker": "Using ITP (a substrate for [E1]myosin II[/E1] ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of [E2]myosin heavy chains[/E2] occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin II", "entity_1_idx": [[27, 36]], "entity_1_idx_in_text_with_entity_marker": [31, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chains", "entity_2_idx": [[159, 178]], "entity_2_idx_in_text_with_entity_marker": [172, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d787.s0_BioInfer.d787.s0.p14", "text": "Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.", "text_with_entity_marker": "Using ITP (a substrate for [E1]myosin II[/E1] ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the [E2]actin[/E2] network, a result that suggests that MHCK was localized at the foci.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin II", "entity_1_idx": [[27, 36]], "entity_1_idx_in_text_with_entity_marker": [31, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[211, 216]], "entity_2_idx_in_text_with_entity_marker": [224, 229], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d787.s0_BioInfer.d787.s0.p15", "text": "Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.", "text_with_entity_marker": "Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for [E1]myosin II heavy-chain kinase[/E1] [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that [E2]MHCK[/E2] was localized at the foci.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin II heavy-chain kinase", "entity_1_idx": [[81, 109]], "entity_1_idx_in_text_with_entity_marker": [85, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MHCK", "entity_2_idx": [[254, 258]], "entity_2_idx_in_text_with_entity_marker": [267, 271], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d787.s0_BioInfer.d787.s0.p16", "text": "Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.", "text_with_entity_marker": "Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of [E1]myosin heavy chains[/E1] occurred at the foci within the actin network, a result that suggests that [E2]MHCK[/E2] was localized at the foci.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chains", "entity_1_idx": [[159, 178]], "entity_1_idx_in_text_with_entity_marker": [163, 182], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MHCK", "entity_2_idx": [[254, 258]], "entity_2_idx_in_text_with_entity_marker": [267, 271], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d787.s0_BioInfer.d787.s0.p17", "text": "Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.", "text_with_entity_marker": "Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the [E1]actin[/E1] network, a result that suggests that [E2]MHCK[/E2] was localized at the foci.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[211, 216]], "entity_1_idx_in_text_with_entity_marker": [215, 220], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MHCK", "entity_2_idx": [[254, 258]], "entity_2_idx_in_text_with_entity_marker": [267, 271], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d787.s0_BioInfer.d787.s0.p18", "text": "Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.", "text_with_entity_marker": "Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for [E1]myosin II heavy-chain kinase[/E1] [MHCK]), we demonstrated that phosphorylation of [E2]myosin heavy chains[/E2] occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin II heavy-chain kinase", "entity_1_idx": [[81, 109]], "entity_1_idx_in_text_with_entity_marker": [85, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chains", "entity_2_idx": [[159, 178]], "entity_2_idx_in_text_with_entity_marker": [172, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d787.s0_BioInfer.d787.s0.p19", "text": "Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.", "text_with_entity_marker": "Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for [E1]myosin II heavy-chain kinase[/E1] [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the [E2]actin[/E2] network, a result that suggests that MHCK was localized at the foci.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin II heavy-chain kinase", "entity_1_idx": [[81, 109]], "entity_1_idx_in_text_with_entity_marker": [85, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[211, 216]], "entity_2_idx_in_text_with_entity_marker": [224, 229], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d787.s0_BioInfer.d787.s0.p20", "text": "Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.", "text_with_entity_marker": "Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of [E1]myosin heavy chains[/E1] occurred at the foci within the [E2]actin[/E2] network, a result that suggests that MHCK was localized at the foci.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chains", "entity_1_idx": [[159, 178]], "entity_1_idx_in_text_with_entity_marker": [163, 182], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[211, 216]], "entity_2_idx_in_text_with_entity_marker": [224, 229], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p30", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, [E1]vinculin[/E1] and [E2]alpha-actinin[/E2] appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "vinculin", "entity_1_idx": [[124, 132]], "entity_1_idx_in_text_with_entity_marker": [128, 136], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-actinin", "entity_2_idx": [[137, 150]], "entity_2_idx_in_text_with_entity_marker": [150, 163], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p31", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, [E1]cadherins[/E1], alpha-catenin, beta-catenin, plakoglobin, vinculin and [E2]alpha-actinin[/E2] appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cadherins", "entity_1_idx": [[71, 80]], "entity_1_idx_in_text_with_entity_marker": [75, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-actinin", "entity_2_idx": [[137, 150]], "entity_2_idx_in_text_with_entity_marker": [150, 163], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p32", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, [E1]integrins[/E1], cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and [E2]alpha-actinin[/E2] appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "integrins", "entity_1_idx": [[60, 69]], "entity_1_idx_in_text_with_entity_marker": [64, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-actinin", "entity_2_idx": [[137, 150]], "entity_2_idx_in_text_with_entity_marker": [150, 163], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p33", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, integrins, [E1]cadherins[/E1], alpha-catenin, beta-catenin, plakoglobin, [E2]vinculin[/E2] and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cadherins", "entity_1_idx": [[71, 80]], "entity_1_idx_in_text_with_entity_marker": [75, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[124, 132]], "entity_2_idx_in_text_with_entity_marker": [137, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p34", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, [E1]integrins[/E1], cadherins, alpha-catenin, beta-catenin, plakoglobin, [E2]vinculin[/E2] and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "integrins", "entity_1_idx": [[60, 69]], "entity_1_idx_in_text_with_entity_marker": [64, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[124, 132]], "entity_2_idx_in_text_with_entity_marker": [137, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d833.s0_BioInfer.d833.s0.p35", "text": "Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "text_with_entity_marker": "Within 1 hour of raising the concentration of calcium ions, [E1]integrins[/E1], [E2]cadherins[/E2], alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "integrins", "entity_1_idx": [[60, 69]], "entity_1_idx_in_text_with_entity_marker": [64, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherins", "entity_2_idx": [[71, 80]], "entity_2_idx_in_text_with_entity_marker": [84, 93], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d689.s0_BioInfer.d689.s0.p0", "text": "The Saccharomyces cerevisiae RAD51 and RAD54 genes are both required for the occurrence of homologous recombination and for the repair of double-stranded DNA breaks.", "text_with_entity_marker": "The Saccharomyces cerevisiae [E1]RAD51[/E1] and [E2]RAD54[/E2] genes are both required for the occurrence of homologous recombination and for the repair of double-stranded DNA breaks.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[29, 34]], "entity_1_idx_in_text_with_entity_marker": [33, 38], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD54", "entity_2_idx": [[39, 44]], "entity_2_idx_in_text_with_entity_marker": [52, 57], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s1_BioInfer.d214.s1.p0", "text": "Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, cofilin, and profilin.", "text_with_entity_marker": "Our data strongly support the view that the mobile form of [E1]actin[/E1] in slow transport is soluble and that a substantial amount of this actin may travel as a complex with [E2]actin depolymerizing factor[/E2], cofilin, and profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[59, 64]], "entity_1_idx_in_text_with_entity_marker": [63, 68], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin depolymerizing factor", "entity_2_idx": [[167, 194]], "entity_2_idx_in_text_with_entity_marker": [180, 207], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s1_BioInfer.d214.s1.p1", "text": "Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, cofilin, and profilin.", "text_with_entity_marker": "Our data strongly support the view that the mobile form of [E1]actin[/E1] in slow transport is soluble and that a substantial amount of this [E2]actin[/E2] may travel as a complex with actin depolymerizing factor, cofilin, and profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[59, 64]], "entity_1_idx_in_text_with_entity_marker": [63, 68], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[132, 137]], "entity_2_idx_in_text_with_entity_marker": [145, 150], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s1_BioInfer.d214.s1.p2", "text": "Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, cofilin, and profilin.", "text_with_entity_marker": "Our data strongly support the view that the mobile form of [E1]actin[/E1] in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, [E2]cofilin[/E2], and profilin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[59, 64]], "entity_1_idx_in_text_with_entity_marker": [63, 68], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cofilin", "entity_2_idx": [[196, 203]], "entity_2_idx_in_text_with_entity_marker": [209, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s1_BioInfer.d214.s1.p3", "text": "Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, cofilin, and profilin.", "text_with_entity_marker": "Our data strongly support the view that the mobile form of [E1]actin[/E1] in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, cofilin, and [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[59, 64]], "entity_1_idx_in_text_with_entity_marker": [63, 68], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[209, 217]], "entity_2_idx_in_text_with_entity_marker": [222, 230], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s1_BioInfer.d214.s1.p4", "text": "Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, cofilin, and profilin.", "text_with_entity_marker": "Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this [E1]actin[/E1] may travel as a complex with [E2]actin depolymerizing factor[/E2], cofilin, and profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[132, 137]], "entity_1_idx_in_text_with_entity_marker": [136, 141], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin depolymerizing factor", "entity_2_idx": [[167, 194]], "entity_2_idx_in_text_with_entity_marker": [180, 207], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s1_BioInfer.d214.s1.p5", "text": "Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, cofilin, and profilin.", "text_with_entity_marker": "Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with [E1]actin depolymerizing factor[/E1], [E2]cofilin[/E2], and profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin depolymerizing factor", "entity_1_idx": [[167, 194]], "entity_1_idx_in_text_with_entity_marker": [171, 198], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[196, 203]], "entity_2_idx_in_text_with_entity_marker": [209, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s1_BioInfer.d214.s1.p6", "text": "Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, cofilin, and profilin.", "text_with_entity_marker": "Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with [E1]actin depolymerizing factor[/E1], cofilin, and [E2]profilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin depolymerizing factor", "entity_1_idx": [[167, 194]], "entity_1_idx_in_text_with_entity_marker": [171, 198], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[209, 217]], "entity_2_idx_in_text_with_entity_marker": [222, 230], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s1_BioInfer.d214.s1.p7", "text": "Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, cofilin, and profilin.", "text_with_entity_marker": "Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this [E1]actin[/E1] may travel as a complex with actin depolymerizing factor, [E2]cofilin[/E2], and profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[132, 137]], "entity_1_idx_in_text_with_entity_marker": [136, 141], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[196, 203]], "entity_2_idx_in_text_with_entity_marker": [209, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s1_BioInfer.d214.s1.p8", "text": "Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, cofilin, and profilin.", "text_with_entity_marker": "Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this [E1]actin[/E1] may travel as a complex with actin depolymerizing factor, cofilin, and [E2]profilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[132, 137]], "entity_1_idx_in_text_with_entity_marker": [136, 141], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[209, 217]], "entity_2_idx_in_text_with_entity_marker": [222, 230], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s1_BioInfer.d214.s1.p9", "text": "Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, cofilin, and profilin.", "text_with_entity_marker": "Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, [E1]cofilin[/E1], and [E2]profilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[196, 203]], "entity_1_idx_in_text_with_entity_marker": [200, 207], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[209, 217]], "entity_2_idx_in_text_with_entity_marker": [222, 230], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d285.s0_BioInfer.d285.s0.p0", "text": "Immediately after synthesis, E-cadherin, beta-catenin, and plakoglobin cosedimented as complexes.", "text_with_entity_marker": "Immediately after synthesis, E-cadherin, [E1]beta-catenin[/E1], and [E2]plakoglobin[/E2] cosedimented as complexes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[41, 53]], "entity_1_idx_in_text_with_entity_marker": [45, 57], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[59, 70]], "entity_2_idx_in_text_with_entity_marker": [72, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d285.s0_BioInfer.d285.s0.p1", "text": "Immediately after synthesis, E-cadherin, beta-catenin, and plakoglobin cosedimented as complexes.", "text_with_entity_marker": "Immediately after synthesis, [E1]E-cadherin[/E1], [E2]beta-catenin[/E2], and plakoglobin cosedimented as complexes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[29, 39]], "entity_1_idx_in_text_with_entity_marker": [33, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[41, 53]], "entity_2_idx_in_text_with_entity_marker": [54, 66], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d285.s0_BioInfer.d285.s0.p2", "text": "Immediately after synthesis, E-cadherin, beta-catenin, and plakoglobin cosedimented as complexes.", "text_with_entity_marker": "Immediately after synthesis, [E1]E-cadherin[/E1], beta-catenin, and [E2]plakoglobin[/E2] cosedimented as complexes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[29, 39]], "entity_1_idx_in_text_with_entity_marker": [33, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[59, 70]], "entity_2_idx_in_text_with_entity_marker": [72, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d285.s1_BioInfer.d285.s1.p0", "text": "alpha-Catenin was not associated with these complexes after synthesis, but a subpopulation of alpha-catenin joined the complex at a time coincident with the arrival of E-cadherin at the plasma membrane.", "text_with_entity_marker": "alpha-Catenin was not associated with these complexes after synthesis, but a subpopulation of [E1]alpha-catenin[/E1] joined the complex at a time coincident with the arrival of [E2]E-cadherin[/E2] at the plasma membrane.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[94, 107]], "entity_1_idx_in_text_with_entity_marker": [98, 111], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[168, 178]], "entity_2_idx_in_text_with_entity_marker": [181, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d285.s1_BioInfer.d285.s1.p1", "text": "alpha-Catenin was not associated with these complexes after synthesis, but a subpopulation of alpha-catenin joined the complex at a time coincident with the arrival of E-cadherin at the plasma membrane.", "text_with_entity_marker": "[E1]alpha-Catenin[/E1] was not associated with these complexes after synthesis, but a subpopulation of alpha-catenin joined the complex at a time coincident with the arrival of [E2]E-cadherin[/E2] at the plasma membrane.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-Catenin", "entity_1_idx": [[0, 13]], "entity_1_idx_in_text_with_entity_marker": [4, 17], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[168, 178]], "entity_2_idx_in_text_with_entity_marker": [181, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d285.s1_BioInfer.d285.s1.p2", "text": "alpha-Catenin was not associated with these complexes after synthesis, but a subpopulation of alpha-catenin joined the complex at a time coincident with the arrival of E-cadherin at the plasma membrane.", "text_with_entity_marker": "[E1]alpha-Catenin[/E1] was not associated with these complexes after synthesis, but a subpopulation of [E2]alpha-catenin[/E2] joined the complex at a time coincident with the arrival of E-cadherin at the plasma membrane.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-Catenin", "entity_1_idx": [[0, 13]], "entity_1_idx_in_text_with_entity_marker": [4, 17], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[94, 107]], "entity_2_idx_in_text_with_entity_marker": [107, 120], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d523.s0_BioInfer.d523.s0.p0", "text": "RIPc, one of the cleavage products, enhanced interaction between TRADD and FADD/MORT1 and increased cells' sensitivity to TNF.", "text_with_entity_marker": "RIPc, one of the cleavage products, enhanced interaction between TRADD and [E1]FADD[/E1]/MORT1 and increased cells' sensitivity to [E2]TNF[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[75, 79]], "entity_1_idx_in_text_with_entity_marker": [79, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNF", "entity_2_idx": [[122, 125]], "entity_2_idx_in_text_with_entity_marker": [135, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d523.s0_BioInfer.d523.s0.p1", "text": "RIPc, one of the cleavage products, enhanced interaction between TRADD and FADD/MORT1 and increased cells' sensitivity to TNF.", "text_with_entity_marker": "[E1]RIPc[/E1], one of the cleavage products, enhanced interaction between TRADD and FADD/MORT1 and increased cells' sensitivity to [E2]TNF[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RIPc", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNF", "entity_2_idx": [[122, 125]], "entity_2_idx_in_text_with_entity_marker": [135, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d523.s0_BioInfer.d523.s0.p2", "text": "RIPc, one of the cleavage products, enhanced interaction between TRADD and FADD/MORT1 and increased cells' sensitivity to TNF.", "text_with_entity_marker": "RIPc, one of the cleavage products, enhanced interaction between TRADD and FADD/[E1]MORT1[/E1] and increased cells' sensitivity to [E2]TNF[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MORT1", "entity_1_idx": [[80, 85]], "entity_1_idx_in_text_with_entity_marker": [84, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNF", "entity_2_idx": [[122, 125]], "entity_2_idx_in_text_with_entity_marker": [135, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d523.s0_BioInfer.d523.s0.p3", "text": "RIPc, one of the cleavage products, enhanced interaction between TRADD and FADD/MORT1 and increased cells' sensitivity to TNF.", "text_with_entity_marker": "RIPc, one of the cleavage products, enhanced interaction between [E1]TRADD[/E1] and FADD/MORT1 and increased cells' sensitivity to [E2]TNF[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRADD", "entity_1_idx": [[65, 70]], "entity_1_idx_in_text_with_entity_marker": [69, 74], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNF", "entity_2_idx": [[122, 125]], "entity_2_idx_in_text_with_entity_marker": [135, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d523.s0_BioInfer.d523.s0.p4", "text": "RIPc, one of the cleavage products, enhanced interaction between TRADD and FADD/MORT1 and increased cells' sensitivity to TNF.", "text_with_entity_marker": "[E1]RIPc[/E1], one of the cleavage products, enhanced interaction between TRADD and [E2]FADD[/E2]/MORT1 and increased cells' sensitivity to TNF.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RIPc", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[75, 79]], "entity_2_idx_in_text_with_entity_marker": [88, 92], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d523.s0_BioInfer.d523.s0.p5", "text": "RIPc, one of the cleavage products, enhanced interaction between TRADD and FADD/MORT1 and increased cells' sensitivity to TNF.", "text_with_entity_marker": "RIPc, one of the cleavage products, enhanced interaction between TRADD and [E1]FADD[/E1]/[E2]MORT1[/E2] and increased cells' sensitivity to TNF.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[75, 79]], "entity_1_idx_in_text_with_entity_marker": [79, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MORT1", "entity_2_idx": [[80, 85]], "entity_2_idx_in_text_with_entity_marker": [93, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d523.s0_BioInfer.d523.s0.p6", "text": "RIPc, one of the cleavage products, enhanced interaction between TRADD and FADD/MORT1 and increased cells' sensitivity to TNF.", "text_with_entity_marker": "RIPc, one of the cleavage products, enhanced interaction between [E1]TRADD[/E1] and [E2]FADD[/E2]/MORT1 and increased cells' sensitivity to TNF.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TRADD", "entity_1_idx": [[65, 70]], "entity_1_idx_in_text_with_entity_marker": [69, 74], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[75, 79]], "entity_2_idx_in_text_with_entity_marker": [88, 92], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d523.s0_BioInfer.d523.s0.p7", "text": "RIPc, one of the cleavage products, enhanced interaction between TRADD and FADD/MORT1 and increased cells' sensitivity to TNF.", "text_with_entity_marker": "[E1]RIPc[/E1], one of the cleavage products, enhanced interaction between TRADD and FADD/[E2]MORT1[/E2] and increased cells' sensitivity to TNF.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RIPc", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MORT1", "entity_2_idx": [[80, 85]], "entity_2_idx_in_text_with_entity_marker": [93, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d523.s0_BioInfer.d523.s0.p8", "text": "RIPc, one of the cleavage products, enhanced interaction between TRADD and FADD/MORT1 and increased cells' sensitivity to TNF.", "text_with_entity_marker": "[E1]RIPc[/E1], one of the cleavage products, enhanced interaction between [E2]TRADD[/E2] and FADD/MORT1 and increased cells' sensitivity to TNF.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RIPc", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[65, 70]], "entity_2_idx_in_text_with_entity_marker": [78, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d523.s0_BioInfer.d523.s0.p9", "text": "RIPc, one of the cleavage products, enhanced interaction between TRADD and FADD/MORT1 and increased cells' sensitivity to TNF.", "text_with_entity_marker": "RIPc, one of the cleavage products, enhanced interaction between [E1]TRADD[/E1] and FADD/[E2]MORT1[/E2] and increased cells' sensitivity to TNF.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TRADD", "entity_1_idx": [[65, 70]], "entity_1_idx_in_text_with_entity_marker": [69, 74], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MORT1", "entity_2_idx": [[80, 85]], "entity_2_idx_in_text_with_entity_marker": [93, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d370.s0_BioInfer.d370.s0.p0", "text": "In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-cadherin, alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-cadherin, alpha-catenin, [E1]beta-catenin[/E1], and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[296, 308]], "entity_1_idx_in_text_with_entity_marker": [300, 312], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[314, 325]], "entity_2_idx_in_text_with_entity_marker": [327, 338], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d370.s0_BioInfer.d370.s0.p1", "text": "In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-cadherin, alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-cadherin, [E1]alpha-catenin[/E1], beta-catenin, and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[281, 294]], "entity_1_idx_in_text_with_entity_marker": [285, 298], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[314, 325]], "entity_2_idx_in_text_with_entity_marker": [327, 338], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d370.s0_BioInfer.d370.s0.p2", "text": "In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-cadherin, alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: [E1]vascular endothelial[/E1] (VE)-cadherin, alpha-catenin, beta-catenin, and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vascular endothelial", "entity_1_idx": [[245, 265], [271, 279]], "entity_1_idx_in_text_with_entity_marker": [249, 269], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[314, 325]], "entity_2_idx_in_text_with_entity_marker": [327, 338], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d370.s0_BioInfer.d370.s0.p3", "text": "In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-cadherin, alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "In the present paper, using indirect immunofluorescence, we found that PMN adhesion to [E1]tumor necrosis factor[/E1]-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-cadherin, alpha-catenin, beta-catenin, and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tumor necrosis factor", "entity_1_idx": [[87, 108]], "entity_1_idx_in_text_with_entity_marker": [91, 112], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[314, 325]], "entity_2_idx_in_text_with_entity_marker": [327, 338], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d370.s0_BioInfer.d370.s0.p4", "text": "In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-cadherin, alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-cadherin, [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], and plakoglobin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[281, 294]], "entity_1_idx_in_text_with_entity_marker": [285, 298], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[296, 308]], "entity_2_idx_in_text_with_entity_marker": [309, 321], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d370.s0_BioInfer.d370.s0.p5", "text": "In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-cadherin, alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: [E1]vascular endothelial[/E1] (VE)-cadherin, alpha-catenin, [E2]beta-catenin[/E2], and plakoglobin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vascular endothelial", "entity_1_idx": [[245, 265], [271, 279]], "entity_1_idx_in_text_with_entity_marker": [249, 269], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[296, 308]], "entity_2_idx_in_text_with_entity_marker": [309, 321], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d370.s0_BioInfer.d370.s0.p6", "text": "In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-cadherin, alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "In the present paper, using indirect immunofluorescence, we found that PMN adhesion to [E1]tumor necrosis factor[/E1]-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-cadherin, alpha-catenin, [E2]beta-catenin[/E2], and plakoglobin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tumor necrosis factor", "entity_1_idx": [[87, 108]], "entity_1_idx_in_text_with_entity_marker": [91, 112], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[296, 308]], "entity_2_idx_in_text_with_entity_marker": [309, 321], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d370.s0_BioInfer.d370.s0.p7", "text": "In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-cadherin, alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: [E1]vascular endothelial[/E1] (VE)-cadherin, [E2]alpha-catenin[/E2], beta-catenin, and plakoglobin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vascular endothelial", "entity_1_idx": [[245, 265], [271, 279]], "entity_1_idx_in_text_with_entity_marker": [249, 269], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[281, 294]], "entity_2_idx_in_text_with_entity_marker": [294, 307], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d370.s0_BioInfer.d370.s0.p8", "text": "In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-cadherin, alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "In the present paper, using indirect immunofluorescence, we found that PMN adhesion to [E1]tumor necrosis factor[/E1]-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-cadherin, [E2]alpha-catenin[/E2], beta-catenin, and plakoglobin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tumor necrosis factor", "entity_1_idx": [[87, 108]], "entity_1_idx_in_text_with_entity_marker": [91, 112], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[281, 294]], "entity_2_idx_in_text_with_entity_marker": [294, 307], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d370.s0_BioInfer.d370.s0.p9", "text": "In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-cadherin, alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "In the present paper, using indirect immunofluorescence, we found that PMN adhesion to [E1]tumor necrosis factor[/E1]-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: [E2]vascular endothelial[/E2] (VE)-cadherin, alpha-catenin, beta-catenin, and plakoglobin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tumor necrosis factor", "entity_1_idx": [[87, 108]], "entity_1_idx_in_text_with_entity_marker": [91, 112], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vascular endothelial", "entity_2_idx": [[245, 265], [271, 279]], "entity_2_idx_in_text_with_entity_marker": [258, 278], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p10", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the [E1]cyclin-dependent kinase inhibitor[/E1] [E2]p27[/E2], enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[127, 160]], "entity_1_idx_in_text_with_entity_marker": [131, 164], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p27", "entity_2_idx": [[161, 164]], "entity_2_idx_in_text_with_entity_marker": [174, 177], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p11", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor [E1]p27[/E1], enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to [E2]cyclin E[/E2]/CDK2 (but not to cyclin D3/CDK4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p27", "entity_1_idx": [[161, 164]], "entity_1_idx_in_text_with_entity_marker": [165, 168], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E", "entity_2_idx": [[272, 280]], "entity_2_idx_in_text_with_entity_marker": [285, 293], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p12", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor [E1]p27[/E1], enhanced association of p27 with cyclin E/[E2]CDK2[/E2] complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p27", "entity_1_idx": [[161, 164]], "entity_1_idx_in_text_with_entity_marker": [165, 168], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CDK2", "entity_2_idx": [[208, 212]], "entity_2_idx_in_text_with_entity_marker": [221, 225], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p13", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor [E1]p27[/E1], enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to [E2]cyclin D3[/E2]/CDK4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p27", "entity_1_idx": [[161, 164]], "entity_1_idx_in_text_with_entity_marker": [165, 168], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin D3", "entity_2_idx": [[298, 307]], "entity_2_idx_in_text_with_entity_marker": [311, 320], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p14", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor [E1]p27[/E1], enhanced association of p27 with [E2]cyclin E[/E2]/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p27", "entity_1_idx": [[161, 164]], "entity_1_idx_in_text_with_entity_marker": [165, 168], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E", "entity_2_idx": [[199, 207]], "entity_2_idx_in_text_with_entity_marker": [212, 220], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p15", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor [E1]p27[/E1], enhanced association of [E2]p27[/E2] with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p27", "entity_1_idx": [[161, 164]], "entity_1_idx_in_text_with_entity_marker": [165, 168], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p27", "entity_2_idx": [[190, 193]], "entity_2_idx_in_text_with_entity_marker": [203, 206], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p16", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor [E1]p27[/E1], enhanced association of p27 with cyclin E/CDK2 complexes and suppression of [E2]kinase[/E2] activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p27", "entity_1_idx": [[161, 164]], "entity_1_idx_in_text_with_entity_marker": [165, 168], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "kinase", "entity_2_idx": [[242, 248]], "entity_2_idx_in_text_with_entity_marker": [255, 261], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p17", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the [E1]cyclin-dependent kinase inhibitor[/E1] p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/[E2]CDK2[/E2] (but not to cyclin D3/CDK4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[127, 160]], "entity_1_idx_in_text_with_entity_marker": [131, 164], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "CDK2", "entity_2_idx": [[281, 285]], "entity_2_idx_in_text_with_entity_marker": [294, 298], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p18", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to [E1]cyclin E[/E1]/[E2]CDK2[/E2] (but not to cyclin D3/CDK4).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin E", "entity_1_idx": [[272, 280]], "entity_1_idx_in_text_with_entity_marker": [276, 284], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CDK2", "entity_2_idx": [[281, 285]], "entity_2_idx_in_text_with_entity_marker": [294, 298], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p19", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/[E1]CDK2[/E1] complexes and suppression of kinase activity associated to cyclin E/[E2]CDK2[/E2] (but not to cyclin D3/CDK4).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDK2", "entity_1_idx": [[208, 212]], "entity_1_idx_in_text_with_entity_marker": [212, 216], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CDK2", "entity_2_idx": [[281, 285]], "entity_2_idx_in_text_with_entity_marker": [294, 298], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d159.s0_BioInfer.d159.s0.p0", "text": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "text_with_entity_marker": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein ([E1]L[/E1]), phosphoprotein (P), and nucleocapsid protein ([E2]NP[/E2]), alone or together, for the expression of biologically active proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "L", "entity_1_idx": [[96, 97]], "entity_1_idx_in_text_with_entity_marker": [100, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[146, 148]], "entity_2_idx_in_text_with_entity_marker": [159, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d159.s0_BioInfer.d159.s0.p1", "text": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "text_with_entity_marker": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein ([E1]L[/E1]), phosphoprotein (P), and [E2]nucleocapsid protein[/E2] (NP), alone or together, for the expression of biologically active proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "L", "entity_1_idx": [[96, 97]], "entity_1_idx_in_text_with_entity_marker": [100, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid protein", "entity_2_idx": [[124, 144]], "entity_2_idx_in_text_with_entity_marker": [137, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d159.s0_BioInfer.d159.s0.p2", "text": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "text_with_entity_marker": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the [E1]large protein[/E1] ([E2]L[/E2]), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "large protein", "entity_1_idx": [[81, 94]], "entity_1_idx_in_text_with_entity_marker": [85, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "L", "entity_2_idx": [[96, 97]], "entity_2_idx_in_text_with_entity_marker": [109, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d159.s0_BioInfer.d159.s0.p3", "text": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "text_with_entity_marker": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein ([E1]L[/E1]), phosphoprotein ([E2]P[/E2]), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "L", "entity_1_idx": [[96, 97]], "entity_1_idx_in_text_with_entity_marker": [100, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[116, 117]], "entity_2_idx_in_text_with_entity_marker": [129, 130], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d159.s0_BioInfer.d159.s0.p4", "text": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "text_with_entity_marker": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein ([E1]L[/E1]), [E2]phosphoprotein[/E2] (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "L", "entity_1_idx": [[96, 97]], "entity_1_idx_in_text_with_entity_marker": [100, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[100, 114]], "entity_2_idx_in_text_with_entity_marker": [113, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d159.s0_BioInfer.d159.s0.p5", "text": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "text_with_entity_marker": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and [E1]nucleocapsid protein[/E1] ([E2]NP[/E2]), alone or together, for the expression of biologically active proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[124, 144]], "entity_1_idx_in_text_with_entity_marker": [128, 148], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[146, 148]], "entity_2_idx_in_text_with_entity_marker": [159, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d159.s0_BioInfer.d159.s0.p6", "text": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "text_with_entity_marker": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the [E1]large protein[/E1] (L), phosphoprotein (P), and nucleocapsid protein ([E2]NP[/E2]), alone or together, for the expression of biologically active proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "large protein", "entity_1_idx": [[81, 94]], "entity_1_idx_in_text_with_entity_marker": [85, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[146, 148]], "entity_2_idx_in_text_with_entity_marker": [159, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d159.s0_BioInfer.d159.s0.p7", "text": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "text_with_entity_marker": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein ([E1]P[/E1]), and nucleocapsid protein ([E2]NP[/E2]), alone or together, for the expression of biologically active proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[116, 117]], "entity_1_idx_in_text_with_entity_marker": [120, 121], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[146, 148]], "entity_2_idx_in_text_with_entity_marker": [159, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d159.s0_BioInfer.d159.s0.p8", "text": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "text_with_entity_marker": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), [E1]phosphoprotein[/E1] (P), and nucleocapsid protein ([E2]NP[/E2]), alone or together, for the expression of biologically active proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[100, 114]], "entity_1_idx_in_text_with_entity_marker": [104, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[146, 148]], "entity_2_idx_in_text_with_entity_marker": [159, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d159.s0_BioInfer.d159.s0.p9", "text": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "text_with_entity_marker": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the [E1]large protein[/E1] (L), phosphoprotein (P), and [E2]nucleocapsid protein[/E2] (NP), alone or together, for the expression of biologically active proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "large protein", "entity_1_idx": [[81, 94]], "entity_1_idx_in_text_with_entity_marker": [85, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid protein", "entity_2_idx": [[124, 144]], "entity_2_idx_in_text_with_entity_marker": [137, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d159.s0_BioInfer.d159.s0.p10", "text": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "text_with_entity_marker": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein ([E1]P[/E1]), and [E2]nucleocapsid protein[/E2] (NP), alone or together, for the expression of biologically active proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[116, 117]], "entity_1_idx_in_text_with_entity_marker": [120, 121], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid protein", "entity_2_idx": [[124, 144]], "entity_2_idx_in_text_with_entity_marker": [137, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d159.s0_BioInfer.d159.s0.p11", "text": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "text_with_entity_marker": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), [E1]phosphoprotein[/E1] (P), and [E2]nucleocapsid protein[/E2] (NP), alone or together, for the expression of biologically active proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[100, 114]], "entity_1_idx_in_text_with_entity_marker": [104, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid protein", "entity_2_idx": [[124, 144]], "entity_2_idx_in_text_with_entity_marker": [137, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d159.s0_BioInfer.d159.s0.p12", "text": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "text_with_entity_marker": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the [E1]large protein[/E1] (L), phosphoprotein ([E2]P[/E2]), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "large protein", "entity_1_idx": [[81, 94]], "entity_1_idx_in_text_with_entity_marker": [85, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[116, 117]], "entity_2_idx_in_text_with_entity_marker": [129, 130], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d159.s0_BioInfer.d159.s0.p13", "text": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "text_with_entity_marker": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the [E1]large protein[/E1] (L), [E2]phosphoprotein[/E2] (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "large protein", "entity_1_idx": [[81, 94]], "entity_1_idx_in_text_with_entity_marker": [85, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[100, 114]], "entity_2_idx_in_text_with_entity_marker": [113, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d159.s0_BioInfer.d159.s0.p14", "text": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "text_with_entity_marker": "CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), [E1]phosphoprotein[/E1] ([E2]P[/E2]), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[100, 114]], "entity_1_idx_in_text_with_entity_marker": [104, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[116, 117]], "entity_2_idx_in_text_with_entity_marker": [129, 130], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d738.s0_BioInfer.d738.s0.p0", "text": "This cadherin-catenin complex plays an indispensable role in construction of ordered multicellular structures such as polarized epithelium.", "text_with_entity_marker": "This [E1]cadherin[/E1]-[E2]catenin[/E2] complex plays an indispensable role in construction of ordered multicellular structures such as polarized epithelium.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cadherin", "entity_1_idx": [[5, 13]], "entity_1_idx_in_text_with_entity_marker": [9, 17], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "catenin", "entity_2_idx": [[14, 21]], "entity_2_idx_in_text_with_entity_marker": [27, 34], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d738.s1_BioInfer.d738.s1.p0", "text": "beta-catenin and plakoglobin possibly play more regulatory roles, as it was shown that their tyrosine phosphorylation correlated with modified cadherin activities.", "text_with_entity_marker": "beta-catenin and [E1]plakoglobin[/E1] possibly play more regulatory roles, as it was shown that their tyrosine phosphorylation correlated with modified [E2]cadherin[/E2] activities.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "plakoglobin", "entity_1_idx": [[17, 28]], "entity_1_idx_in_text_with_entity_marker": [21, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherin", "entity_2_idx": [[143, 151]], "entity_2_idx_in_text_with_entity_marker": [156, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d738.s1_BioInfer.d738.s1.p1", "text": "beta-catenin and plakoglobin possibly play more regulatory roles, as it was shown that their tyrosine phosphorylation correlated with modified cadherin activities.", "text_with_entity_marker": "[E1]beta-catenin[/E1] and plakoglobin possibly play more regulatory roles, as it was shown that their tyrosine phosphorylation correlated with modified [E2]cadherin[/E2] activities.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherin", "entity_2_idx": [[143, 151]], "entity_2_idx_in_text_with_entity_marker": [156, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d738.s1_BioInfer.d738.s1.p2", "text": "beta-catenin and plakoglobin possibly play more regulatory roles, as it was shown that their tyrosine phosphorylation correlated with modified cadherin activities.", "text_with_entity_marker": "[E1]beta-catenin[/E1] and [E2]plakoglobin[/E2] possibly play more regulatory roles, as it was shown that their tyrosine phosphorylation correlated with modified cadherin activities.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[17, 28]], "entity_2_idx_in_text_with_entity_marker": [30, 41], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d102.s0_BioInfer.d102.s0.p0", "text": "Birch pollen profilin and actin can be copurified as a complex, and purified recombinant birch profilin can be used as an affinity matrix to obtain birch pollen actin.", "text_with_entity_marker": "Birch pollen profilin and [E1]actin[/E1] can be copurified as a complex, and purified recombinant birch profilin can be used as an affinity matrix to obtain birch [E2]pollen actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[26, 31]], "entity_1_idx_in_text_with_entity_marker": [30, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "pollen actin", "entity_2_idx": [[154, 166]], "entity_2_idx_in_text_with_entity_marker": [167, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d102.s0_BioInfer.d102.s0.p1", "text": "Birch pollen profilin and actin can be copurified as a complex, and purified recombinant birch profilin can be used as an affinity matrix to obtain birch pollen actin.", "text_with_entity_marker": "Birch pollen profilin and [E1]actin[/E1] can be copurified as a complex, and purified recombinant birch [E2]profilin[/E2] can be used as an affinity matrix to obtain birch pollen actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[26, 31]], "entity_1_idx_in_text_with_entity_marker": [30, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[95, 103]], "entity_2_idx_in_text_with_entity_marker": [108, 116], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d102.s0_BioInfer.d102.s0.p2", "text": "Birch pollen profilin and actin can be copurified as a complex, and purified recombinant birch profilin can be used as an affinity matrix to obtain birch pollen actin.", "text_with_entity_marker": "Birch [E1]pollen profilin[/E1] and [E2]actin[/E2] can be copurified as a complex, and purified recombinant birch profilin can be used as an affinity matrix to obtain birch pollen actin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "pollen profilin", "entity_1_idx": [[6, 21]], "entity_1_idx_in_text_with_entity_marker": [10, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[26, 31]], "entity_2_idx_in_text_with_entity_marker": [39, 44], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d102.s0_BioInfer.d102.s0.p3", "text": "Birch pollen profilin and actin can be copurified as a complex, and purified recombinant birch profilin can be used as an affinity matrix to obtain birch pollen actin.", "text_with_entity_marker": "Birch pollen profilin and actin can be copurified as a complex, and purified recombinant birch [E1]profilin[/E1] can be used as an affinity matrix to obtain birch [E2]pollen actin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[95, 103]], "entity_1_idx_in_text_with_entity_marker": [99, 107], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "pollen actin", "entity_2_idx": [[154, 166]], "entity_2_idx_in_text_with_entity_marker": [167, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d102.s0_BioInfer.d102.s0.p4", "text": "Birch pollen profilin and actin can be copurified as a complex, and purified recombinant birch profilin can be used as an affinity matrix to obtain birch pollen actin.", "text_with_entity_marker": "Birch [E1]pollen profilin[/E1] and actin can be copurified as a complex, and purified recombinant birch profilin can be used as an affinity matrix to obtain birch [E2]pollen actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "pollen profilin", "entity_1_idx": [[6, 21]], "entity_1_idx_in_text_with_entity_marker": [10, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "pollen actin", "entity_2_idx": [[154, 166]], "entity_2_idx_in_text_with_entity_marker": [167, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d102.s0_BioInfer.d102.s0.p5", "text": "Birch pollen profilin and actin can be copurified as a complex, and purified recombinant birch profilin can be used as an affinity matrix to obtain birch pollen actin.", "text_with_entity_marker": "Birch [E1]pollen profilin[/E1] and actin can be copurified as a complex, and purified recombinant birch [E2]profilin[/E2] can be used as an affinity matrix to obtain birch pollen actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "pollen profilin", "entity_1_idx": [[6, 21]], "entity_1_idx_in_text_with_entity_marker": [10, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[95, 103]], "entity_2_idx_in_text_with_entity_marker": [108, 116], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d102.s1_BioInfer.d102.s1.p0", "text": "In this study, profilin is identified as an actin-binding protein in higher plants which is present in monocot and dicot angiosperms.", "text_with_entity_marker": "In this study, [E1]profilin[/E1] is identified as an [E2]actin-binding protein[/E2] in higher plants which is present in monocot and dicot angiosperms.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[15, 23]], "entity_1_idx_in_text_with_entity_marker": [19, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[44, 65]], "entity_2_idx_in_text_with_entity_marker": [57, 78], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d102.s2_BioInfer.d102.s2.p0", "text": "The binding of 125I-labeled recombinant birch pollen profilin to plant and animal actins can be blocked by profilin-specific antibodies that react with different epitopes of birch profilin.", "text_with_entity_marker": "The binding of 125I-labeled recombinant birch pollen profilin to plant and animal actins can be blocked by [E1]profilin[/E1]-specific antibodies that react with different epitopes of birch [E2]profilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[107, 115]], "entity_1_idx_in_text_with_entity_marker": [111, 119], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[180, 188]], "entity_2_idx_in_text_with_entity_marker": [193, 201], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d102.s2_BioInfer.d102.s2.p1", "text": "The binding of 125I-labeled recombinant birch pollen profilin to plant and animal actins can be blocked by profilin-specific antibodies that react with different epitopes of birch profilin.", "text_with_entity_marker": "The binding of 125I-labeled recombinant birch pollen profilin to plant and animal [E1]actins[/E1] can be blocked by [E2]profilin[/E2]-specific antibodies that react with different epitopes of birch profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actins", "entity_1_idx": [[82, 88]], "entity_1_idx_in_text_with_entity_marker": [86, 92], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[107, 115]], "entity_2_idx_in_text_with_entity_marker": [120, 128], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d102.s2_BioInfer.d102.s2.p2", "text": "The binding of 125I-labeled recombinant birch pollen profilin to plant and animal actins can be blocked by profilin-specific antibodies that react with different epitopes of birch profilin.", "text_with_entity_marker": "The binding of 125I-labeled recombinant birch pollen [E1]profilin[/E1] to plant and animal actins can be blocked by [E2]profilin[/E2]-specific antibodies that react with different epitopes of birch profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[53, 61]], "entity_1_idx_in_text_with_entity_marker": [57, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[107, 115]], "entity_2_idx_in_text_with_entity_marker": [120, 128], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d102.s2_BioInfer.d102.s2.p3", "text": "The binding of 125I-labeled recombinant birch pollen profilin to plant and animal actins can be blocked by profilin-specific antibodies that react with different epitopes of birch profilin.", "text_with_entity_marker": "The binding of 125I-labeled recombinant birch pollen profilin to plant and animal [E1]actins[/E1] can be blocked by profilin-specific antibodies that react with different epitopes of birch [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actins", "entity_1_idx": [[82, 88]], "entity_1_idx_in_text_with_entity_marker": [86, 92], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[180, 188]], "entity_2_idx_in_text_with_entity_marker": [193, 201], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d102.s2_BioInfer.d102.s2.p4", "text": "The binding of 125I-labeled recombinant birch pollen profilin to plant and animal actins can be blocked by profilin-specific antibodies that react with different epitopes of birch profilin.", "text_with_entity_marker": "The binding of 125I-labeled recombinant birch pollen [E1]profilin[/E1] to plant and animal actins can be blocked by profilin-specific antibodies that react with different epitopes of birch [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[53, 61]], "entity_1_idx_in_text_with_entity_marker": [57, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[180, 188]], "entity_2_idx_in_text_with_entity_marker": [193, 201], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d102.s2_BioInfer.d102.s2.p5", "text": "The binding of 125I-labeled recombinant birch pollen profilin to plant and animal actins can be blocked by profilin-specific antibodies that react with different epitopes of birch profilin.", "text_with_entity_marker": "The binding of 125I-labeled recombinant birch pollen [E1]profilin[/E1] to plant and animal [E2]actins[/E2] can be blocked by profilin-specific antibodies that react with different epitopes of birch profilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[53, 61]], "entity_1_idx_in_text_with_entity_marker": [57, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actins", "entity_2_idx": [[82, 88]], "entity_2_idx_in_text_with_entity_marker": [95, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d207.s0_BioInfer.d207.s0.p0", "text": "Features studied were actin, microtubules, vinculin, and talin, using immunofluorescence, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and immunoblotting; permeability of the cell sheet; wound healing; and phagocytic capacity.", "text_with_entity_marker": "Features studied were [E1]actin[/E1], microtubules, vinculin, and [E2]talin[/E2], using immunofluorescence, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and immunoblotting; permeability of the cell sheet; wound healing; and phagocytic capacity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[22, 27]], "entity_1_idx_in_text_with_entity_marker": [26, 31], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[57, 62]], "entity_2_idx_in_text_with_entity_marker": [70, 75], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d207.s0_BioInfer.d207.s0.p1", "text": "Features studied were actin, microtubules, vinculin, and talin, using immunofluorescence, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and immunoblotting; permeability of the cell sheet; wound healing; and phagocytic capacity.", "text_with_entity_marker": "Features studied were actin, microtubules, [E1]vinculin[/E1], and [E2]talin[/E2], using immunofluorescence, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and immunoblotting; permeability of the cell sheet; wound healing; and phagocytic capacity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[43, 51]], "entity_1_idx_in_text_with_entity_marker": [47, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[57, 62]], "entity_2_idx_in_text_with_entity_marker": [70, 75], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d207.s0_BioInfer.d207.s0.p2", "text": "Features studied were actin, microtubules, vinculin, and talin, using immunofluorescence, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and immunoblotting; permeability of the cell sheet; wound healing; and phagocytic capacity.", "text_with_entity_marker": "Features studied were [E1]actin[/E1], microtubules, [E2]vinculin[/E2], and talin, using immunofluorescence, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and immunoblotting; permeability of the cell sheet; wound healing; and phagocytic capacity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[22, 27]], "entity_1_idx_in_text_with_entity_marker": [26, 31], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[43, 51]], "entity_2_idx_in_text_with_entity_marker": [56, 64], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d254.s0_BioInfer.d254.s0.p0", "text": "Here, we show that the x-ray sensitivity of rad55 and rad57 mutant strains is suppressible by overexpression of RAD51 or RAD52.", "text_with_entity_marker": "Here, we show that the x-ray sensitivity of rad55 and [E1]rad57[/E1] mutant strains is suppressible by overexpression of [E2]RAD51[/E2] or RAD52.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "rad57", "entity_1_idx": [[54, 59]], "entity_1_idx_in_text_with_entity_marker": [58, 63], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD51", "entity_2_idx": [[112, 117]], "entity_2_idx_in_text_with_entity_marker": [125, 130], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d254.s0_BioInfer.d254.s0.p1", "text": "Here, we show that the x-ray sensitivity of rad55 and rad57 mutant strains is suppressible by overexpression of RAD51 or RAD52.", "text_with_entity_marker": "Here, we show that the x-ray sensitivity of [E1]rad55[/E1] and [E2]rad57[/E2] mutant strains is suppressible by overexpression of RAD51 or RAD52.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "rad55", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "rad57", "entity_2_idx": [[54, 59]], "entity_2_idx_in_text_with_entity_marker": [67, 72], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d254.s0_BioInfer.d254.s0.p2", "text": "Here, we show that the x-ray sensitivity of rad55 and rad57 mutant strains is suppressible by overexpression of RAD51 or RAD52.", "text_with_entity_marker": "Here, we show that the x-ray sensitivity of rad55 and [E1]rad57[/E1] mutant strains is suppressible by overexpression of RAD51 or [E2]RAD52[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "rad57", "entity_1_idx": [[54, 59]], "entity_1_idx_in_text_with_entity_marker": [58, 63], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD52", "entity_2_idx": [[121, 126]], "entity_2_idx_in_text_with_entity_marker": [134, 139], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d254.s0_BioInfer.d254.s0.p3", "text": "Here, we show that the x-ray sensitivity of rad55 and rad57 mutant strains is suppressible by overexpression of RAD51 or RAD52.", "text_with_entity_marker": "Here, we show that the x-ray sensitivity of [E1]rad55[/E1] and rad57 mutant strains is suppressible by overexpression of [E2]RAD51[/E2] or RAD52.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "rad55", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD51", "entity_2_idx": [[112, 117]], "entity_2_idx_in_text_with_entity_marker": [125, 130], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d254.s0_BioInfer.d254.s0.p4", "text": "Here, we show that the x-ray sensitivity of rad55 and rad57 mutant strains is suppressible by overexpression of RAD51 or RAD52.", "text_with_entity_marker": "Here, we show that the x-ray sensitivity of rad55 and rad57 mutant strains is suppressible by overexpression of [E1]RAD51[/E1] or [E2]RAD52[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[112, 117]], "entity_1_idx_in_text_with_entity_marker": [116, 121], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD52", "entity_2_idx": [[121, 126]], "entity_2_idx_in_text_with_entity_marker": [134, 139], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d254.s0_BioInfer.d254.s0.p5", "text": "Here, we show that the x-ray sensitivity of rad55 and rad57 mutant strains is suppressible by overexpression of RAD51 or RAD52.", "text_with_entity_marker": "Here, we show that the x-ray sensitivity of [E1]rad55[/E1] and rad57 mutant strains is suppressible by overexpression of RAD51 or [E2]RAD52[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "rad55", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD52", "entity_2_idx": [[121, 126]], "entity_2_idx_in_text_with_entity_marker": [134, 139], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p0", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, [E1]TRADD[/E1], FADD and [E2]RAIDD[/E2] - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TRADD", "entity_1_idx": [[131, 136]], "entity_1_idx_in_text_with_entity_marker": [135, 140], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAIDD", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p1", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The tumor necrosis factor receptor 1 ([E1]TNFR1[/E1]) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, [E2]TRADD[/E2], FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TNFR1", "entity_1_idx": [[38, 43]], "entity_1_idx_in_text_with_entity_marker": [42, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[131, 136]], "entity_2_idx_in_text_with_entity_marker": [144, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p2", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The tumor necrosis factor receptor 1 (TNFR1) and the [E1]Fas[/E1] receptor recruit complexes formed by the interactions between RIP kinase, [E2]TRADD[/E2], FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Fas", "entity_1_idx": [[53, 56]], "entity_1_idx_in_text_with_entity_marker": [57, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[131, 136]], "entity_2_idx_in_text_with_entity_marker": [144, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p3", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The [E1]tumor necrosis factor receptor 1[/E1] (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, [E2]TRADD[/E2], FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "tumor necrosis factor receptor 1", "entity_1_idx": [[4, 36]], "entity_1_idx_in_text_with_entity_marker": [8, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[131, 136]], "entity_2_idx_in_text_with_entity_marker": [144, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p4", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between [E1]RIP kinase[/E1], [E2]TRADD[/E2], FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RIP kinase", "entity_1_idx": [[119, 129]], "entity_1_idx_in_text_with_entity_marker": [123, 133], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[131, 136]], "entity_2_idx_in_text_with_entity_marker": [144, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p5", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, [E1]TRADD[/E1], [E2]FADD[/E2] and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TRADD", "entity_1_idx": [[131, 136]], "entity_1_idx_in_text_with_entity_marker": [135, 140], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[138, 142]], "entity_2_idx_in_text_with_entity_marker": [151, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p6", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The tumor necrosis factor receptor 1 ([E1]TNFR1[/E1]) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and [E2]RAIDD[/E2] - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TNFR1", "entity_1_idx": [[38, 43]], "entity_1_idx_in_text_with_entity_marker": [42, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAIDD", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p7", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The tumor necrosis factor receptor 1 (TNFR1) and the [E1]Fas[/E1] receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and [E2]RAIDD[/E2] - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Fas", "entity_1_idx": [[53, 56]], "entity_1_idx_in_text_with_entity_marker": [57, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAIDD", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p8", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The [E1]tumor necrosis factor receptor 1[/E1] (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and [E2]RAIDD[/E2] - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "tumor necrosis factor receptor 1", "entity_1_idx": [[4, 36]], "entity_1_idx_in_text_with_entity_marker": [8, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAIDD", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p9", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between [E1]RIP kinase[/E1], TRADD, FADD and [E2]RAIDD[/E2] - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RIP kinase", "entity_1_idx": [[119, 129]], "entity_1_idx_in_text_with_entity_marker": [123, 133], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAIDD", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p10", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, [E1]FADD[/E1] and [E2]RAIDD[/E2] - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "FADD", "entity_1_idx": [[138, 142]], "entity_1_idx_in_text_with_entity_marker": [142, 146], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAIDD", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p11", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The tumor necrosis factor receptor 1 ([E1]TNFR1[/E1]) and the [E2]Fas[/E2] receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNFR1", "entity_1_idx": [[38, 43]], "entity_1_idx_in_text_with_entity_marker": [42, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Fas", "entity_2_idx": [[53, 56]], "entity_2_idx_in_text_with_entity_marker": [66, 69], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p12", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The [E1]tumor necrosis factor receptor 1[/E1] ([E2]TNFR1[/E2]) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tumor necrosis factor receptor 1", "entity_1_idx": [[4, 36]], "entity_1_idx_in_text_with_entity_marker": [8, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNFR1", "entity_2_idx": [[38, 43]], "entity_2_idx_in_text_with_entity_marker": [51, 56], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p13", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The tumor necrosis factor receptor 1 ([E1]TNFR1[/E1]) and the Fas receptor recruit complexes formed by the interactions between [E2]RIP kinase[/E2], TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TNFR1", "entity_1_idx": [[38, 43]], "entity_1_idx_in_text_with_entity_marker": [42, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP kinase", "entity_2_idx": [[119, 129]], "entity_2_idx_in_text_with_entity_marker": [132, 142], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p14", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The tumor necrosis factor receptor 1 ([E1]TNFR1[/E1]) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, [E2]FADD[/E2] and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TNFR1", "entity_1_idx": [[38, 43]], "entity_1_idx_in_text_with_entity_marker": [42, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[138, 142]], "entity_2_idx_in_text_with_entity_marker": [151, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p15", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The [E1]tumor necrosis factor receptor 1[/E1] (TNFR1) and the [E2]Fas[/E2] receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tumor necrosis factor receptor 1", "entity_1_idx": [[4, 36]], "entity_1_idx_in_text_with_entity_marker": [8, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Fas", "entity_2_idx": [[53, 56]], "entity_2_idx_in_text_with_entity_marker": [66, 69], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p16", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The tumor necrosis factor receptor 1 (TNFR1) and the [E1]Fas[/E1] receptor recruit complexes formed by the interactions between [E2]RIP kinase[/E2], TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Fas", "entity_1_idx": [[53, 56]], "entity_1_idx_in_text_with_entity_marker": [57, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP kinase", "entity_2_idx": [[119, 129]], "entity_2_idx_in_text_with_entity_marker": [132, 142], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p17", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The tumor necrosis factor receptor 1 (TNFR1) and the [E1]Fas[/E1] receptor recruit complexes formed by the interactions between RIP kinase, TRADD, [E2]FADD[/E2] and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Fas", "entity_1_idx": [[53, 56]], "entity_1_idx_in_text_with_entity_marker": [57, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[138, 142]], "entity_2_idx_in_text_with_entity_marker": [151, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p18", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The [E1]tumor necrosis factor receptor 1[/E1] (TNFR1) and the Fas receptor recruit complexes formed by the interactions between [E2]RIP kinase[/E2], TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "tumor necrosis factor receptor 1", "entity_1_idx": [[4, 36]], "entity_1_idx_in_text_with_entity_marker": [8, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP kinase", "entity_2_idx": [[119, 129]], "entity_2_idx_in_text_with_entity_marker": [132, 142], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p19", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The [E1]tumor necrosis factor receptor 1[/E1] (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, [E2]FADD[/E2] and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "tumor necrosis factor receptor 1", "entity_1_idx": [[4, 36]], "entity_1_idx_in_text_with_entity_marker": [8, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[138, 142]], "entity_2_idx_in_text_with_entity_marker": [151, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p20", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between [E1]RIP kinase[/E1], TRADD, [E2]FADD[/E2] and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RIP kinase", "entity_1_idx": [[119, 129]], "entity_1_idx_in_text_with_entity_marker": [123, 133], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[138, 142]], "entity_2_idx_in_text_with_entity_marker": [151, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d326.s0_BioInfer.d326.s0.p0", "text": "In contrast, EC located immediately behind the migrating front retained junctional VE-cadherin, alpha-catenin, and beta-catenin while plakoglobin was absent from these sites.", "text_with_entity_marker": "In contrast, EC located immediately behind the migrating front retained junctional VE-cadherin, [E1]alpha-catenin[/E1], and beta-catenin while [E2]plakoglobin[/E2] was absent from these sites.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[96, 109]], "entity_1_idx_in_text_with_entity_marker": [100, 113], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[134, 145]], "entity_2_idx_in_text_with_entity_marker": [147, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d326.s0_BioInfer.d326.s0.p1", "text": "In contrast, EC located immediately behind the migrating front retained junctional VE-cadherin, alpha-catenin, and beta-catenin while plakoglobin was absent from these sites.", "text_with_entity_marker": "In contrast, EC located immediately behind the migrating front retained junctional VE-cadherin, alpha-catenin, and [E1]beta-catenin[/E1] while [E2]plakoglobin[/E2] was absent from these sites.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[115, 127]], "entity_1_idx_in_text_with_entity_marker": [119, 131], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[134, 145]], "entity_2_idx_in_text_with_entity_marker": [147, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d326.s0_BioInfer.d326.s0.p2", "text": "In contrast, EC located immediately behind the migrating front retained junctional VE-cadherin, alpha-catenin, and beta-catenin while plakoglobin was absent from these sites.", "text_with_entity_marker": "In contrast, EC located immediately behind the migrating front retained junctional [E1]VE-cadherin[/E1], alpha-catenin, and beta-catenin while [E2]plakoglobin[/E2] was absent from these sites.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "VE-cadherin", "entity_1_idx": [[83, 94]], "entity_1_idx_in_text_with_entity_marker": [87, 98], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[134, 145]], "entity_2_idx_in_text_with_entity_marker": [147, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d326.s0_BioInfer.d326.s0.p3", "text": "In contrast, EC located immediately behind the migrating front retained junctional VE-cadherin, alpha-catenin, and beta-catenin while plakoglobin was absent from these sites.", "text_with_entity_marker": "In contrast, EC located immediately behind the migrating front retained junctional VE-cadherin, [E1]alpha-catenin[/E1], and [E2]beta-catenin[/E2] while plakoglobin was absent from these sites.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[96, 109]], "entity_1_idx_in_text_with_entity_marker": [100, 113], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[115, 127]], "entity_2_idx_in_text_with_entity_marker": [128, 140], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d326.s0_BioInfer.d326.s0.p4", "text": "In contrast, EC located immediately behind the migrating front retained junctional VE-cadherin, alpha-catenin, and beta-catenin while plakoglobin was absent from these sites.", "text_with_entity_marker": "In contrast, EC located immediately behind the migrating front retained junctional [E1]VE-cadherin[/E1], [E2]alpha-catenin[/E2], and beta-catenin while plakoglobin was absent from these sites.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "VE-cadherin", "entity_1_idx": [[83, 94]], "entity_1_idx_in_text_with_entity_marker": [87, 98], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[96, 109]], "entity_2_idx_in_text_with_entity_marker": [109, 122], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d326.s0_BioInfer.d326.s0.p5", "text": "In contrast, EC located immediately behind the migrating front retained junctional VE-cadherin, alpha-catenin, and beta-catenin while plakoglobin was absent from these sites.", "text_with_entity_marker": "In contrast, EC located immediately behind the migrating front retained junctional [E1]VE-cadherin[/E1], alpha-catenin, and [E2]beta-catenin[/E2] while plakoglobin was absent from these sites.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "VE-cadherin", "entity_1_idx": [[83, 94]], "entity_1_idx_in_text_with_entity_marker": [87, 98], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[115, 127]], "entity_2_idx_in_text_with_entity_marker": [128, 140], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s0_BioInfer.d379.s0.p10", "text": "In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.", "text_with_entity_marker": "In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of [E1]msh2[/E1], msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and [E2]MSH6[/E2] proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "msh2", "entity_1_idx": [[202, 206]], "entity_1_idx_in_text_with_entity_marker": [206, 210], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH6", "entity_2_idx": [[316, 320]], "entity_2_idx_in_text_with_entity_marker": [329, 333], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s0_BioInfer.d379.s0.p11", "text": "In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.", "text_with_entity_marker": "In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and [E1]msh6[/E1] mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and [E2]MSH6[/E2] proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "msh6", "entity_1_idx": [[218, 222]], "entity_1_idx_in_text_with_entity_marker": [222, 226], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH6", "entity_2_idx": [[316, 320]], "entity_2_idx_in_text_with_entity_marker": [329, 333], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s0_BioInfer.d379.s0.p12", "text": "In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.", "text_with_entity_marker": "In this study the role of [E1]MSH2[/E1], MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and [E2]MSH6[/E2] proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[26, 30]], "entity_1_idx_in_text_with_entity_marker": [30, 34], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH6", "entity_2_idx": [[316, 320]], "entity_2_idx_in_text_with_entity_marker": [329, 333], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s0_BioInfer.d379.s0.p13", "text": "In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.", "text_with_entity_marker": "In this study the role of MSH2, MSH3, and [E1]MSH6[/E1] in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and [E2]MSH6[/E2] proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH6", "entity_1_idx": [[42, 46]], "entity_1_idx_in_text_with_entity_marker": [46, 50], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH6", "entity_2_idx": [[316, 320]], "entity_2_idx_in_text_with_entity_marker": [329, 333], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s0_BioInfer.d379.s0.p14", "text": "In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.", "text_with_entity_marker": "In this study the role of MSH2, [E1]MSH3[/E1], and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and [E2]MSH6[/E2] proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH3", "entity_1_idx": [[32, 36]], "entity_1_idx_in_text_with_entity_marker": [36, 40], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH6", "entity_2_idx": [[316, 320]], "entity_2_idx_in_text_with_entity_marker": [329, 333], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s0_BioInfer.d379.s0.p15", "text": "In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.", "text_with_entity_marker": "In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, [E1]msh3[/E1], and msh6 mutations and by studying the physical interaction between the MSH2 protein and the [E2]MSH3[/E2] and MSH6 proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "msh3", "entity_1_idx": [[208, 212]], "entity_1_idx_in_text_with_entity_marker": [212, 216], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH3", "entity_2_idx": [[307, 311]], "entity_2_idx_in_text_with_entity_marker": [320, 324], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s0_BioInfer.d379.s0.p16", "text": "In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.", "text_with_entity_marker": "In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of [E1]msh2[/E1], msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the [E2]MSH3[/E2] and MSH6 proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "msh2", "entity_1_idx": [[202, 206]], "entity_1_idx_in_text_with_entity_marker": [206, 210], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH3", "entity_2_idx": [[307, 311]], "entity_2_idx_in_text_with_entity_marker": [320, 324], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s0_BioInfer.d379.s0.p17", "text": "In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.", "text_with_entity_marker": "In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and [E1]msh6[/E1] mutations and by studying the physical interaction between the MSH2 protein and the [E2]MSH3[/E2] and MSH6 proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "msh6", "entity_1_idx": [[218, 222]], "entity_1_idx_in_text_with_entity_marker": [222, 226], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH3", "entity_2_idx": [[307, 311]], "entity_2_idx_in_text_with_entity_marker": [320, 324], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s0_BioInfer.d379.s0.p18", "text": "In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.", "text_with_entity_marker": "In this study the role of [E1]MSH2[/E1], MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the [E2]MSH3[/E2] and MSH6 proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[26, 30]], "entity_1_idx_in_text_with_entity_marker": [30, 34], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH3", "entity_2_idx": [[307, 311]], "entity_2_idx_in_text_with_entity_marker": [320, 324], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s0_BioInfer.d379.s0.p19", "text": "In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.", "text_with_entity_marker": "In this study the role of MSH2, MSH3, and [E1]MSH6[/E1] in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the [E2]MSH3[/E2] and MSH6 proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH6", "entity_1_idx": [[42, 46]], "entity_1_idx_in_text_with_entity_marker": [46, 50], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH3", "entity_2_idx": [[307, 311]], "entity_2_idx_in_text_with_entity_marker": [320, 324], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d501.s0_BioInfer.d501.s0.p0", "text": "PS1 fragments form complexes with E-cadherin, beta-catenin, and alpha-catenin, all components of adherens junctions.", "text_with_entity_marker": "[E1]PS1[/E1] fragments form complexes with E-cadherin, [E2]beta-catenin[/E2], and alpha-catenin, all components of adherens junctions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PS1", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[46, 58]], "entity_2_idx_in_text_with_entity_marker": [59, 71], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d501.s0_BioInfer.d501.s0.p1", "text": "PS1 fragments form complexes with E-cadherin, beta-catenin, and alpha-catenin, all components of adherens junctions.", "text_with_entity_marker": "[E1]PS1[/E1] fragments form complexes with [E2]E-cadherin[/E2], beta-catenin, and alpha-catenin, all components of adherens junctions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PS1", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[34, 44]], "entity_2_idx_in_text_with_entity_marker": [47, 57], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d501.s0_BioInfer.d501.s0.p2", "text": "PS1 fragments form complexes with E-cadherin, beta-catenin, and alpha-catenin, all components of adherens junctions.", "text_with_entity_marker": "[E1]PS1[/E1] fragments form complexes with E-cadherin, beta-catenin, and [E2]alpha-catenin[/E2], all components of adherens junctions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PS1", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[64, 77]], "entity_2_idx_in_text_with_entity_marker": [77, 90], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d501.s0_BioInfer.d501.s0.p3", "text": "PS1 fragments form complexes with E-cadherin, beta-catenin, and alpha-catenin, all components of adherens junctions.", "text_with_entity_marker": "PS1 fragments form complexes with [E1]E-cadherin[/E1], [E2]beta-catenin[/E2], and alpha-catenin, all components of adherens junctions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[34, 44]], "entity_1_idx_in_text_with_entity_marker": [38, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[46, 58]], "entity_2_idx_in_text_with_entity_marker": [59, 71], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d501.s0_BioInfer.d501.s0.p4", "text": "PS1 fragments form complexes with E-cadherin, beta-catenin, and alpha-catenin, all components of adherens junctions.", "text_with_entity_marker": "PS1 fragments form complexes with E-cadherin, [E1]beta-catenin[/E1], and [E2]alpha-catenin[/E2], all components of adherens junctions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[46, 58]], "entity_1_idx_in_text_with_entity_marker": [50, 62], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[64, 77]], "entity_2_idx_in_text_with_entity_marker": [77, 90], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d501.s0_BioInfer.d501.s0.p5", "text": "PS1 fragments form complexes with E-cadherin, beta-catenin, and alpha-catenin, all components of adherens junctions.", "text_with_entity_marker": "PS1 fragments form complexes with [E1]E-cadherin[/E1], beta-catenin, and [E2]alpha-catenin[/E2], all components of adherens junctions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[34, 44]], "entity_1_idx_in_text_with_entity_marker": [38, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[64, 77]], "entity_2_idx_in_text_with_entity_marker": [77, 90], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p30", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the [E1]fusion[/E1] (F), phosphoprotein (P), [E2]H[/E2], nucleocapsid (N) and matrix (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion", "entity_1_idx": [[120, 126], [187, 195]], "entity_1_idx_in_text_with_entity_marker": [124, 130], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[152, 153], [187, 195]], "entity_2_idx_in_text_with_entity_marker": [165, 166], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p31", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), [E1]H[/E1], nucleocapsid (N) and [E2]matrix[/E2] (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H", "entity_1_idx": [[152, 153], [187, 195]], "entity_1_idx_in_text_with_entity_marker": [156, 157], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "matrix", "entity_2_idx": [[176, 182], [187, 195]], "entity_2_idx_in_text_with_entity_marker": [189, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p32", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), [E1]phosphoprotein[/E1] (P), [E2]H[/E2], nucleocapsid (N) and matrix (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[132, 146], [187, 195]], "entity_1_idx_in_text_with_entity_marker": [136, 150], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[152, 153], [187, 195]], "entity_2_idx_in_text_with_entity_marker": [165, 166], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p33", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the [E1]fusion[/E1] (F), phosphoprotein (P), H, nucleocapsid (N) and [E2]matrix[/E2] (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion", "entity_1_idx": [[120, 126], [187, 195]], "entity_1_idx_in_text_with_entity_marker": [124, 130], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix", "entity_2_idx": [[176, 182], [187, 195]], "entity_2_idx_in_text_with_entity_marker": [189, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p34", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the [E1]fusion[/E1] (F), [E2]phosphoprotein[/E2] (P), H, nucleocapsid (N) and matrix (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion", "entity_1_idx": [[120, 126], [187, 195]], "entity_1_idx_in_text_with_entity_marker": [124, 130], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[132, 146], [187, 195]], "entity_2_idx_in_text_with_entity_marker": [145, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p35", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), [E1]phosphoprotein[/E1] (P), H, nucleocapsid (N) and [E2]matrix[/E2] (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[132, 146], [187, 195]], "entity_1_idx_in_text_with_entity_marker": [136, 150], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix", "entity_2_idx": [[176, 182], [187, 195]], "entity_2_idx_in_text_with_entity_marker": [189, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d829.s0_BioInfer.d829.s0.p0", "text": "When a lyophilized Mf and AO mixture was incubated at 40 degrees C and 65% relative humidity, the conjugation of AO was confirmed at myosin heavy chain, actin, and tropomyosin.", "text_with_entity_marker": "When a lyophilized Mf and AO mixture was incubated at 40 degrees C and 65% relative humidity, the conjugation of AO was confirmed at myosin heavy chain, [E1]actin[/E1], and [E2]tropomyosin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[153, 158]], "entity_1_idx_in_text_with_entity_marker": [157, 162], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "tropomyosin", "entity_2_idx": [[164, 175]], "entity_2_idx_in_text_with_entity_marker": [177, 188], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d829.s0_BioInfer.d829.s0.p1", "text": "When a lyophilized Mf and AO mixture was incubated at 40 degrees C and 65% relative humidity, the conjugation of AO was confirmed at myosin heavy chain, actin, and tropomyosin.", "text_with_entity_marker": "When a lyophilized Mf and AO mixture was incubated at 40 degrees C and 65% relative humidity, the conjugation of AO was confirmed at [E1]myosin heavy chain[/E1], actin, and [E2]tropomyosin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[133, 151]], "entity_1_idx_in_text_with_entity_marker": [137, 155], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "tropomyosin", "entity_2_idx": [[164, 175]], "entity_2_idx_in_text_with_entity_marker": [177, 188], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d829.s0_BioInfer.d829.s0.p2", "text": "When a lyophilized Mf and AO mixture was incubated at 40 degrees C and 65% relative humidity, the conjugation of AO was confirmed at myosin heavy chain, actin, and tropomyosin.", "text_with_entity_marker": "When a lyophilized Mf and AO mixture was incubated at 40 degrees C and 65% relative humidity, the conjugation of AO was confirmed at [E1]myosin heavy chain[/E1], [E2]actin[/E2], and tropomyosin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[133, 151]], "entity_1_idx_in_text_with_entity_marker": [137, 155], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[153, 158]], "entity_2_idx_in_text_with_entity_marker": [166, 171], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p10", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large ([E1]L[/E1]; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural ([E2]V[/E2]; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "L", "entity_1_idx": [[170, 171]], "entity_1_idx_in_text_with_entity_marker": [174, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "V", "entity_2_idx": [[340, 341]], "entity_2_idx_in_text_with_entity_marker": [353, 354], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p11", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large ([E1]L[/E1]; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid ([E2]N[/E2]; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "L", "entity_1_idx": [[170, 171]], "entity_1_idx_in_text_with_entity_marker": [174, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[240, 241]], "entity_2_idx_in_text_with_entity_marker": [253, 254], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p12", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large ([E1]L[/E1]; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix ([E2]M[/E2]; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "L", "entity_1_idx": [[170, 171]], "entity_1_idx_in_text_with_entity_marker": [174, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[309, 310]], "entity_2_idx_in_text_with_entity_marker": [322, 323], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p13", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), [E1]fusion[/E1] ([E2]F0[/E2]; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fusion", "entity_1_idx": [[252, 258], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [256, 262], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F0", "entity_2_idx": [[260, 262]], "entity_2_idx_in_text_with_entity_marker": [273, 275], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p14", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion ([E1]F0[/E1]; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and [E2]non-structural[/E2] (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "F0", "entity_1_idx": [[260, 262]], "entity_1_idx_in_text_with_entity_marker": [264, 266], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "non-structural", "entity_2_idx": [[324, 338], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [337, 351], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p15", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion ([E1]F0[/E1]; 63 kDa), phosphoprotein (P; 49 kDa), [E2]matrix[/E2] (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "F0", "entity_1_idx": [[260, 262]], "entity_1_idx_in_text_with_entity_marker": [264, 266], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix", "entity_2_idx": [[301, 307], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [314, 320], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p16", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase ([E1]HN[/E1]; 74 kDa), nucleocapsid (N; 66 kDa), fusion ([E2]F0[/E2]; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HN", "entity_1_idx": [[213, 215]], "entity_1_idx_in_text_with_entity_marker": [217, 219], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F0", "entity_2_idx": [[260, 262]], "entity_2_idx_in_text_with_entity_marker": [273, 275], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p17", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the [E1]large[/E1] (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion ([E2]F0[/E2]; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "large", "entity_1_idx": [[163, 168], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [167, 172], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F0", "entity_2_idx": [[260, 262]], "entity_2_idx_in_text_with_entity_marker": [273, 275], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p18", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), [E1]nucleocapsid[/E1] (N; 66 kDa), fusion ([E2]F0[/E2]; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid", "entity_1_idx": [[226, 238], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [230, 242], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F0", "entity_2_idx": [[260, 262]], "entity_2_idx_in_text_with_entity_marker": [273, 275], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p19", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), [E1]haemagglutinin neuraminidase[/E1] (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion ([E2]F0[/E2]; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "haemagglutinin neuraminidase", "entity_1_idx": [[183, 211], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [187, 215], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F0", "entity_2_idx": [[260, 262]], "entity_2_idx_in_text_with_entity_marker": [273, 275], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d307.s0_BioInfer.d307.s0.p0", "text": "In Acanthamoeba actin polymerization is regulated, at least in part, by profilin, which binds to actin monomers, and by capping protein, which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.", "text_with_entity_marker": "In Acanthamoeba actin polymerization is regulated, at least in part, by profilin, which binds to [E1]actin[/E1] monomers, and by [E2]capping protein[/E2], which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[97, 102]], "entity_1_idx_in_text_with_entity_marker": [101, 106], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "capping protein", "entity_2_idx": [[120, 135]], "entity_2_idx_in_text_with_entity_marker": [133, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d307.s0_BioInfer.d307.s0.p1", "text": "In Acanthamoeba actin polymerization is regulated, at least in part, by profilin, which binds to actin monomers, and by capping protein, which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.", "text_with_entity_marker": "In Acanthamoeba actin polymerization is regulated, at least in part, by [E1]profilin[/E1], which binds to actin monomers, and by [E2]capping protein[/E2], which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[72, 80]], "entity_1_idx_in_text_with_entity_marker": [76, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "capping protein", "entity_2_idx": [[120, 135]], "entity_2_idx_in_text_with_entity_marker": [133, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d307.s0_BioInfer.d307.s0.p2", "text": "In Acanthamoeba actin polymerization is regulated, at least in part, by profilin, which binds to actin monomers, and by capping protein, which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.", "text_with_entity_marker": "In Acanthamoeba [E1]actin[/E1] polymerization is regulated, at least in part, by profilin, which binds to actin monomers, and by [E2]capping protein[/E2], which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[16, 21]], "entity_1_idx_in_text_with_entity_marker": [20, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "capping protein", "entity_2_idx": [[120, 135]], "entity_2_idx_in_text_with_entity_marker": [133, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d307.s0_BioInfer.d307.s0.p3", "text": "In Acanthamoeba actin polymerization is regulated, at least in part, by profilin, which binds to actin monomers, and by capping protein, which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.", "text_with_entity_marker": "In Acanthamoeba actin polymerization is regulated, at least in part, by [E1]profilin[/E1], which binds to [E2]actin[/E2] monomers, and by capping protein, which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[72, 80]], "entity_1_idx_in_text_with_entity_marker": [76, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[97, 102]], "entity_2_idx_in_text_with_entity_marker": [110, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d307.s0_BioInfer.d307.s0.p4", "text": "In Acanthamoeba actin polymerization is regulated, at least in part, by profilin, which binds to actin monomers, and by capping protein, which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.", "text_with_entity_marker": "In Acanthamoeba [E1]actin[/E1] polymerization is regulated, at least in part, by profilin, which binds to [E2]actin[/E2] monomers, and by capping protein, which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[16, 21]], "entity_1_idx_in_text_with_entity_marker": [20, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[97, 102]], "entity_2_idx_in_text_with_entity_marker": [110, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d307.s0_BioInfer.d307.s0.p5", "text": "In Acanthamoeba actin polymerization is regulated, at least in part, by profilin, which binds to actin monomers, and by capping protein, which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.", "text_with_entity_marker": "In Acanthamoeba [E1]actin[/E1] polymerization is regulated, at least in part, by [E2]profilin[/E2], which binds to actin monomers, and by capping protein, which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[16, 21]], "entity_1_idx_in_text_with_entity_marker": [20, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[72, 80]], "entity_2_idx_in_text_with_entity_marker": [85, 93], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s0_BioInfer.d296.s0.p0", "text": "Immunolocalization of E-cadherin (E-cad), alpha-catenin, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).", "text_with_entity_marker": "Immunolocalization of [E1]E-cadherin[/E1] (E-cad), alpha-catenin, [E2]beta-catenin[/E2], and CD44 has rarely been investigated in human cholangiocarcinoma (CC).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[22, 32]], "entity_1_idx_in_text_with_entity_marker": [26, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[57, 69]], "entity_2_idx_in_text_with_entity_marker": [70, 82], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s0_BioInfer.d296.s0.p1", "text": "Immunolocalization of E-cadherin (E-cad), alpha-catenin, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).", "text_with_entity_marker": "Immunolocalization of E-cadherin ([E1]E-cad[/E1]), alpha-catenin, [E2]beta-catenin[/E2], and CD44 has rarely been investigated in human cholangiocarcinoma (CC).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cad", "entity_1_idx": [[34, 39]], "entity_1_idx_in_text_with_entity_marker": [38, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[57, 69]], "entity_2_idx_in_text_with_entity_marker": [70, 82], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s0_BioInfer.d296.s0.p2", "text": "Immunolocalization of E-cadherin (E-cad), alpha-catenin, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).", "text_with_entity_marker": "Immunolocalization of E-cadherin (E-cad), [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], and CD44 has rarely been investigated in human cholangiocarcinoma (CC).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[42, 55]], "entity_1_idx_in_text_with_entity_marker": [46, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[57, 69]], "entity_2_idx_in_text_with_entity_marker": [70, 82], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s0_BioInfer.d296.s0.p3", "text": "Immunolocalization of E-cadherin (E-cad), alpha-catenin, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).", "text_with_entity_marker": "Immunolocalization of E-cadherin (E-cad), alpha-catenin, [E1]beta-catenin[/E1], and [E2]CD44[/E2] has rarely been investigated in human cholangiocarcinoma (CC).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[57, 69]], "entity_1_idx_in_text_with_entity_marker": [61, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CD44", "entity_2_idx": [[75, 79]], "entity_2_idx_in_text_with_entity_marker": [88, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s0_BioInfer.d296.s0.p4", "text": "Immunolocalization of E-cadherin (E-cad), alpha-catenin, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).", "text_with_entity_marker": "Immunolocalization of [E1]E-cadherin[/E1] ([E2]E-cad[/E2]), alpha-catenin, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[22, 32]], "entity_1_idx_in_text_with_entity_marker": [26, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cad", "entity_2_idx": [[34, 39]], "entity_2_idx_in_text_with_entity_marker": [47, 52], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s0_BioInfer.d296.s0.p5", "text": "Immunolocalization of E-cadherin (E-cad), alpha-catenin, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).", "text_with_entity_marker": "Immunolocalization of [E1]E-cadherin[/E1] (E-cad), [E2]alpha-catenin[/E2], beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[22, 32]], "entity_1_idx_in_text_with_entity_marker": [26, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[42, 55]], "entity_2_idx_in_text_with_entity_marker": [55, 68], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s0_BioInfer.d296.s0.p6", "text": "Immunolocalization of E-cadherin (E-cad), alpha-catenin, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).", "text_with_entity_marker": "Immunolocalization of [E1]E-cadherin[/E1] (E-cad), alpha-catenin, beta-catenin, and [E2]CD44[/E2] has rarely been investigated in human cholangiocarcinoma (CC).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[22, 32]], "entity_1_idx_in_text_with_entity_marker": [26, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD44", "entity_2_idx": [[75, 79]], "entity_2_idx_in_text_with_entity_marker": [88, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s0_BioInfer.d296.s0.p7", "text": "Immunolocalization of E-cadherin (E-cad), alpha-catenin, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).", "text_with_entity_marker": "Immunolocalization of E-cadherin ([E1]E-cad[/E1]), [E2]alpha-catenin[/E2], beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cad", "entity_1_idx": [[34, 39]], "entity_1_idx_in_text_with_entity_marker": [38, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[42, 55]], "entity_2_idx_in_text_with_entity_marker": [55, 68], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s0_BioInfer.d296.s0.p8", "text": "Immunolocalization of E-cadherin (E-cad), alpha-catenin, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).", "text_with_entity_marker": "Immunolocalization of E-cadherin ([E1]E-cad[/E1]), alpha-catenin, beta-catenin, and [E2]CD44[/E2] has rarely been investigated in human cholangiocarcinoma (CC).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cad", "entity_1_idx": [[34, 39]], "entity_1_idx_in_text_with_entity_marker": [38, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD44", "entity_2_idx": [[75, 79]], "entity_2_idx_in_text_with_entity_marker": [88, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s0_BioInfer.d296.s0.p9", "text": "Immunolocalization of E-cadherin (E-cad), alpha-catenin, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).", "text_with_entity_marker": "Immunolocalization of E-cadherin (E-cad), [E1]alpha-catenin[/E1], beta-catenin, and [E2]CD44[/E2] has rarely been investigated in human cholangiocarcinoma (CC).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[42, 55]], "entity_1_idx_in_text_with_entity_marker": [46, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CD44", "entity_2_idx": [[75, 79]], "entity_2_idx_in_text_with_entity_marker": [88, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s2_BioInfer.d296.s2.p17", "text": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "text_with_entity_marker": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, [E1]CD44v7-8[/E1], and [E2]CD44v10[/E2], were expressed at the cell membrane of normal intrahepatic bile ducts.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD44v7-8", "entity_1_idx": [[88, 96]], "entity_1_idx_in_text_with_entity_marker": [92, 100], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD44v10", "entity_2_idx": [[102, 109]], "entity_2_idx_in_text_with_entity_marker": [115, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s2_BioInfer.d296.s2.p18", "text": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "text_with_entity_marker": "In normal livers, [E1]E-cad[/E1], alpha-catenin and beta-catenin, but not CD44s, CD44v5, [E2]CD44v6[/E2], CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cad", "entity_1_idx": [[18, 23]], "entity_1_idx_in_text_with_entity_marker": [22, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD44v6", "entity_2_idx": [[80, 86]], "entity_2_idx_in_text_with_entity_marker": [93, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s2_BioInfer.d296.s2.p19", "text": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "text_with_entity_marker": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, [E1]CD44v5[/E1], [E2]CD44v6[/E2], CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD44v5", "entity_1_idx": [[72, 78]], "entity_1_idx_in_text_with_entity_marker": [76, 82], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD44v6", "entity_2_idx": [[80, 86]], "entity_2_idx_in_text_with_entity_marker": [93, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s2_BioInfer.d296.s2.p20", "text": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "text_with_entity_marker": "In normal livers, E-cad, [E1]alpha-catenin[/E1] and beta-catenin, but not CD44s, CD44v5, [E2]CD44v6[/E2], CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[25, 38]], "entity_1_idx_in_text_with_entity_marker": [29, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD44v6", "entity_2_idx": [[80, 86]], "entity_2_idx_in_text_with_entity_marker": [93, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s2_BioInfer.d296.s2.p21", "text": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "text_with_entity_marker": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, [E1]CD44v6[/E1], [E2]CD44v7-8[/E2], and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD44v6", "entity_1_idx": [[80, 86]], "entity_1_idx_in_text_with_entity_marker": [84, 90], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD44v7-8", "entity_2_idx": [[88, 96]], "entity_2_idx_in_text_with_entity_marker": [101, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s2_BioInfer.d296.s2.p22", "text": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "text_with_entity_marker": "In normal livers, [E1]E-cad[/E1], alpha-catenin and beta-catenin, but not CD44s, [E2]CD44v5[/E2], CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cad", "entity_1_idx": [[18, 23]], "entity_1_idx_in_text_with_entity_marker": [22, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD44v5", "entity_2_idx": [[72, 78]], "entity_2_idx_in_text_with_entity_marker": [85, 91], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s2_BioInfer.d296.s2.p23", "text": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "text_with_entity_marker": "In normal livers, [E1]E-cad[/E1], [E2]alpha-catenin[/E2] and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cad", "entity_1_idx": [[18, 23]], "entity_1_idx_in_text_with_entity_marker": [22, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[25, 38]], "entity_2_idx_in_text_with_entity_marker": [38, 51], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s2_BioInfer.d296.s2.p24", "text": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "text_with_entity_marker": "In normal livers, [E1]E-cad[/E1], alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, [E2]CD44v7-8[/E2], and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cad", "entity_1_idx": [[18, 23]], "entity_1_idx_in_text_with_entity_marker": [22, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD44v7-8", "entity_2_idx": [[88, 96]], "entity_2_idx_in_text_with_entity_marker": [101, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s2_BioInfer.d296.s2.p25", "text": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "text_with_entity_marker": "In normal livers, E-cad, [E1]alpha-catenin[/E1] and beta-catenin, but not CD44s, [E2]CD44v5[/E2], CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[25, 38]], "entity_1_idx_in_text_with_entity_marker": [29, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD44v5", "entity_2_idx": [[72, 78]], "entity_2_idx_in_text_with_entity_marker": [85, 91], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s2_BioInfer.d296.s2.p26", "text": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "text_with_entity_marker": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, [E1]CD44v5[/E1], CD44v6, [E2]CD44v7-8[/E2], and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD44v5", "entity_1_idx": [[72, 78]], "entity_1_idx_in_text_with_entity_marker": [76, 82], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD44v7-8", "entity_2_idx": [[88, 96]], "entity_2_idx_in_text_with_entity_marker": [101, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s3_BioInfer.d296.s3.p19", "text": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "text_with_entity_marker": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or [E1]c-erbB2[/E1] expression, except for beta-catenin, the down-regulation of which was associated with [E2]c-erbB2[/E2] down-regulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "c-erbB2", "entity_1_idx": [[214, 221]], "entity_1_idx_in_text_with_entity_marker": [218, 225], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "c-erbB2", "entity_2_idx": [[308, 315]], "entity_2_idx_in_text_with_entity_marker": [321, 328], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s3_BioInfer.d296.s3.p20", "text": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "text_with_entity_marker": "We found that the down-regulation of E-cad, [E1]alpha-catenin[/E1], and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or [E2]c-erbB2[/E2] expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[44, 57]], "entity_1_idx_in_text_with_entity_marker": [48, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "c-erbB2", "entity_2_idx": [[214, 221]], "entity_2_idx_in_text_with_entity_marker": [227, 234], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s3_BioInfer.d296.s3.p21", "text": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "text_with_entity_marker": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, [E1]Ki-67[/E1] labeling, or [E2]c-erbB2[/E2] expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Ki-67", "entity_1_idx": [[195, 200]], "entity_1_idx_in_text_with_entity_marker": [199, 204], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "c-erbB2", "entity_2_idx": [[214, 221]], "entity_2_idx_in_text_with_entity_marker": [227, 234], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s3_BioInfer.d296.s3.p22", "text": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "text_with_entity_marker": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, [E1]p53[/E1] expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with [E2]c-erbB2[/E2] down-regulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p53", "entity_1_idx": [[179, 182]], "entity_1_idx_in_text_with_entity_marker": [183, 186], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "c-erbB2", "entity_2_idx": [[308, 315]], "entity_2_idx_in_text_with_entity_marker": [321, 328], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s3_BioInfer.d296.s3.p23", "text": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "text_with_entity_marker": "We found that the down-regulation of E-cad, [E1]alpha-catenin[/E1], and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, [E2]p53[/E2] expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[44, 57]], "entity_1_idx_in_text_with_entity_marker": [48, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[179, 182]], "entity_2_idx_in_text_with_entity_marker": [192, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s3_BioInfer.d296.s3.p24", "text": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "text_with_entity_marker": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, [E1]p53[/E1] expression, [E2]Ki-67[/E2] labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p53", "entity_1_idx": [[179, 182]], "entity_1_idx_in_text_with_entity_marker": [183, 186], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Ki-67", "entity_2_idx": [[195, 200]], "entity_2_idx_in_text_with_entity_marker": [208, 213], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s3_BioInfer.d296.s3.p25", "text": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "text_with_entity_marker": "We found that the down-regulation of E-cad, [E1]alpha-catenin[/E1], and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with [E2]c-erbB2[/E2] down-regulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[44, 57]], "entity_1_idx_in_text_with_entity_marker": [48, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "c-erbB2", "entity_2_idx": [[308, 315]], "entity_2_idx_in_text_with_entity_marker": [321, 328], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s3_BioInfer.d296.s3.p26", "text": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "text_with_entity_marker": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, [E1]Ki-67[/E1] labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with [E2]c-erbB2[/E2] down-regulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Ki-67", "entity_1_idx": [[195, 200]], "entity_1_idx_in_text_with_entity_marker": [199, 204], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "c-erbB2", "entity_2_idx": [[308, 315]], "entity_2_idx_in_text_with_entity_marker": [321, 328], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s3_BioInfer.d296.s3.p27", "text": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "text_with_entity_marker": "We found that the down-regulation of E-cad, [E1]alpha-catenin[/E1], and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, [E2]Ki-67[/E2] labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[44, 57]], "entity_1_idx_in_text_with_entity_marker": [48, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Ki-67", "entity_2_idx": [[195, 200]], "entity_2_idx_in_text_with_entity_marker": [208, 213], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d554.s0_BioInfer.d554.s0.p0", "text": "Study of mutated yeast profilins and profilins from Acanthamoeba suggests that the ability of profilin to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind actin.", "text_with_entity_marker": "Study of mutated yeast profilins and profilins from Acanthamoeba suggests that the ability of [E1]profilin[/E1] to suppress [E2]cap-[/E2] cells is dependent upon a property other than, or in addition to, its ability to bind actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[94, 102]], "entity_1_idx_in_text_with_entity_marker": [98, 106], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cap-", "entity_2_idx": [[115, 119]], "entity_2_idx_in_text_with_entity_marker": [128, 132], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d554.s0_BioInfer.d554.s0.p1", "text": "Study of mutated yeast profilins and profilins from Acanthamoeba suggests that the ability of profilin to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind actin.", "text_with_entity_marker": "Study of mutated yeast profilins and profilins from Acanthamoeba suggests that the ability of profilin to suppress [E1]cap-[/E1] cells is dependent upon a property other than, or in addition to, its ability to bind [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cap-", "entity_1_idx": [[115, 119]], "entity_1_idx_in_text_with_entity_marker": [119, 123], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "actin", "entity_2_idx": [[206, 211]], "entity_2_idx_in_text_with_entity_marker": [219, 224], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d554.s0_BioInfer.d554.s0.p2", "text": "Study of mutated yeast profilins and profilins from Acanthamoeba suggests that the ability of profilin to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind actin.", "text_with_entity_marker": "Study of mutated yeast [E1]profilins[/E1] and profilins from Acanthamoeba suggests that the ability of profilin to suppress [E2]cap-[/E2] cells is dependent upon a property other than, or in addition to, its ability to bind actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[23, 32]], "entity_1_idx_in_text_with_entity_marker": [27, 36], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cap-", "entity_2_idx": [[115, 119]], "entity_2_idx_in_text_with_entity_marker": [128, 132], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d554.s0_BioInfer.d554.s0.p3", "text": "Study of mutated yeast profilins and profilins from Acanthamoeba suggests that the ability of profilin to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind actin.", "text_with_entity_marker": "Study of mutated yeast profilins and [E1]profilins[/E1] from Acanthamoeba suggests that the ability of profilin to suppress [E2]cap-[/E2] cells is dependent upon a property other than, or in addition to, its ability to bind actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[37, 46]], "entity_1_idx_in_text_with_entity_marker": [41, 50], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cap-", "entity_2_idx": [[115, 119]], "entity_2_idx_in_text_with_entity_marker": [128, 132], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d554.s0_BioInfer.d554.s0.p4", "text": "Study of mutated yeast profilins and profilins from Acanthamoeba suggests that the ability of profilin to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind actin.", "text_with_entity_marker": "Study of mutated yeast profilins and profilins from Acanthamoeba suggests that the ability of [E1]profilin[/E1] to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind [E2]actin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[94, 102]], "entity_1_idx_in_text_with_entity_marker": [98, 106], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[206, 211]], "entity_2_idx_in_text_with_entity_marker": [219, 224], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d554.s0_BioInfer.d554.s0.p5", "text": "Study of mutated yeast profilins and profilins from Acanthamoeba suggests that the ability of profilin to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind actin.", "text_with_entity_marker": "Study of mutated yeast [E1]profilins[/E1] and profilins from Acanthamoeba suggests that the ability of [E2]profilin[/E2] to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[23, 32]], "entity_1_idx_in_text_with_entity_marker": [27, 36], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[94, 102]], "entity_2_idx_in_text_with_entity_marker": [107, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d554.s0_BioInfer.d554.s0.p6", "text": "Study of mutated yeast profilins and profilins from Acanthamoeba suggests that the ability of profilin to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind actin.", "text_with_entity_marker": "Study of mutated yeast profilins and [E1]profilins[/E1] from Acanthamoeba suggests that the ability of [E2]profilin[/E2] to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[37, 46]], "entity_1_idx_in_text_with_entity_marker": [41, 50], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[94, 102]], "entity_2_idx_in_text_with_entity_marker": [107, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d554.s0_BioInfer.d554.s0.p7", "text": "Study of mutated yeast profilins and profilins from Acanthamoeba suggests that the ability of profilin to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind actin.", "text_with_entity_marker": "Study of mutated yeast [E1]profilins[/E1] and profilins from Acanthamoeba suggests that the ability of profilin to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[23, 32]], "entity_1_idx_in_text_with_entity_marker": [27, 36], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[206, 211]], "entity_2_idx_in_text_with_entity_marker": [219, 224], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d554.s0_BioInfer.d554.s0.p8", "text": "Study of mutated yeast profilins and profilins from Acanthamoeba suggests that the ability of profilin to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind actin.", "text_with_entity_marker": "Study of mutated yeast profilins and [E1]profilins[/E1] from Acanthamoeba suggests that the ability of profilin to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[37, 46]], "entity_1_idx_in_text_with_entity_marker": [41, 50], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[206, 211]], "entity_2_idx_in_text_with_entity_marker": [219, 224], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d554.s0_BioInfer.d554.s0.p9", "text": "Study of mutated yeast profilins and profilins from Acanthamoeba suggests that the ability of profilin to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind actin.", "text_with_entity_marker": "Study of mutated yeast [E1]profilins[/E1] and [E2]profilins[/E2] from Acanthamoeba suggests that the ability of profilin to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[23, 32]], "entity_1_idx_in_text_with_entity_marker": [27, 36], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilins", "entity_2_idx": [[37, 46]], "entity_2_idx_in_text_with_entity_marker": [50, 59], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d51.s0_BioInfer.d51.s0.p0", "text": "MSH2 plays a fundamental role in mispair recognition whereas MSH3 and MSH6 appear to modify the specificity of this recognition.", "text_with_entity_marker": "[E1]MSH2[/E1] plays a fundamental role in mispair recognition whereas MSH3 and [E2]MSH6[/E2] appear to modify the specificity of this recognition.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH6", "entity_2_idx": [[70, 74]], "entity_2_idx_in_text_with_entity_marker": [83, 87], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d51.s0_BioInfer.d51.s0.p1", "text": "MSH2 plays a fundamental role in mispair recognition whereas MSH3 and MSH6 appear to modify the specificity of this recognition.", "text_with_entity_marker": "[E1]MSH2[/E1] plays a fundamental role in mispair recognition whereas [E2]MSH3[/E2] and MSH6 appear to modify the specificity of this recognition.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH3", "entity_2_idx": [[61, 65]], "entity_2_idx_in_text_with_entity_marker": [74, 78], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d51.s0_BioInfer.d51.s0.p2", "text": "MSH2 plays a fundamental role in mispair recognition whereas MSH3 and MSH6 appear to modify the specificity of this recognition.", "text_with_entity_marker": "MSH2 plays a fundamental role in mispair recognition whereas [E1]MSH3[/E1] and [E2]MSH6[/E2] appear to modify the specificity of this recognition.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH3", "entity_1_idx": [[61, 65]], "entity_1_idx_in_text_with_entity_marker": [65, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH6", "entity_2_idx": [[70, 74]], "entity_2_idx_in_text_with_entity_marker": [83, 87], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p10", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae [E1]RAD14[/E1] was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, [E2]RAD3[/E2], RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD14", "entity_1_idx": [[25, 30]], "entity_1_idx_in_text_with_entity_marker": [29, 34], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD3", "entity_2_idx": [[146, 150]], "entity_2_idx_in_text_with_entity_marker": [159, 163], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p11", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae [E1]RAD14[/E1] was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, [E2]RAD10[/E2], RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD14", "entity_1_idx": [[25, 30]], "entity_1_idx_in_text_with_entity_marker": [29, 34], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD10", "entity_2_idx": [[152, 157]], "entity_2_idx_in_text_with_entity_marker": [165, 170], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p12", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae [E1]RAD14[/E1] was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and [E2]RAD1[/E2], RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD14", "entity_1_idx": [[25, 30]], "entity_1_idx_in_text_with_entity_marker": [29, 34], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD1", "entity_2_idx": [[134, 138]], "entity_2_idx_in_text_with_entity_marker": [147, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p13", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae [E1]RAD14[/E1] was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, [E2]RAD2[/E2], RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD14", "entity_1_idx": [[25, 30]], "entity_1_idx_in_text_with_entity_marker": [29, 34], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD2", "entity_2_idx": [[140, 144]], "entity_2_idx_in_text_with_entity_marker": [153, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p14", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae [E1]RAD14[/E1] was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, [E2]RAD14[/E2], and RAD25 subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD14", "entity_1_idx": [[25, 30]], "entity_1_idx_in_text_with_entity_marker": [29, 34], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD14", "entity_2_idx": [[159, 164]], "entity_2_idx_in_text_with_entity_marker": [172, 177], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p15", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between [E1]MSH2[/E1] and RAD1, RAD2, RAD3, RAD10, RAD14, and [E2]RAD25[/E2] subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MSH2", "entity_1_idx": [[125, 129]], "entity_1_idx_in_text_with_entity_marker": [129, 133], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD25", "entity_2_idx": [[170, 175]], "entity_2_idx_in_text_with_entity_marker": [183, 188], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p16", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between [E1]MSH2[/E1] and RAD1, RAD2, [E2]RAD3[/E2], RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MSH2", "entity_1_idx": [[125, 129]], "entity_1_idx_in_text_with_entity_marker": [129, 133], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD3", "entity_2_idx": [[146, 150]], "entity_2_idx_in_text_with_entity_marker": [159, 163], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p17", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between [E1]MSH2[/E1] and RAD1, RAD2, RAD3, [E2]RAD10[/E2], RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MSH2", "entity_1_idx": [[125, 129]], "entity_1_idx_in_text_with_entity_marker": [129, 133], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD10", "entity_2_idx": [[152, 157]], "entity_2_idx_in_text_with_entity_marker": [165, 170], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p18", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between [E1]MSH2[/E1] and [E2]RAD1[/E2], RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MSH2", "entity_1_idx": [[125, 129]], "entity_1_idx_in_text_with_entity_marker": [129, 133], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD1", "entity_2_idx": [[134, 138]], "entity_2_idx_in_text_with_entity_marker": [147, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d527.s0_BioInfer.d527.s0.p19", "text": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between MSH2 and RAD1, RAD2, RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "text_with_entity_marker": "Saccharomyces cerevisiae RAD14 was identified in a two-hybrid screen using MSH2 as \"bait,\" and pairwise interactions between [E1]MSH2[/E1] and RAD1, [E2]RAD2[/E2], RAD3, RAD10, RAD14, and RAD25 subsequently were demonstrated by two-hybrid analysis.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "MSH2", "entity_1_idx": [[125, 129]], "entity_1_idx_in_text_with_entity_marker": [129, 133], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD2", "entity_2_idx": [[140, 144]], "entity_2_idx_in_text_with_entity_marker": [153, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d636.s0_BioInfer.d636.s0.p0", "text": "The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: actin, villin, fimbrin and brush border myosin-I.", "text_with_entity_marker": "The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: [E1]actin[/E1], villin, fimbrin and [E2]brush border myosin-I[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[89, 94]], "entity_1_idx_in_text_with_entity_marker": [93, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "brush border myosin-I", "entity_2_idx": [[116, 137]], "entity_2_idx_in_text_with_entity_marker": [129, 150], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d636.s0_BioInfer.d636.s0.p1", "text": "The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: actin, villin, fimbrin and brush border myosin-I.", "text_with_entity_marker": "The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: [E1]actin[/E1], [E2]villin[/E2], fimbrin and brush border myosin-I.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[89, 94]], "entity_1_idx_in_text_with_entity_marker": [93, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "villin", "entity_2_idx": [[96, 102]], "entity_2_idx_in_text_with_entity_marker": [109, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d636.s0_BioInfer.d636.s0.p2", "text": "The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: actin, villin, fimbrin and brush border myosin-I.", "text_with_entity_marker": "The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: [E1]actin[/E1], villin, [E2]fimbrin[/E2] and brush border myosin-I.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[89, 94]], "entity_1_idx_in_text_with_entity_marker": [93, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[104, 111]], "entity_2_idx_in_text_with_entity_marker": [117, 124], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d636.s0_BioInfer.d636.s0.p3", "text": "The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: actin, villin, fimbrin and brush border myosin-I.", "text_with_entity_marker": "The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: actin, [E1]villin[/E1], fimbrin and [E2]brush border myosin-I[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "villin", "entity_1_idx": [[96, 102]], "entity_1_idx_in_text_with_entity_marker": [100, 106], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "brush border myosin-I", "entity_2_idx": [[116, 137]], "entity_2_idx_in_text_with_entity_marker": [129, 150], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d636.s0_BioInfer.d636.s0.p4", "text": "The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: actin, villin, fimbrin and brush border myosin-I.", "text_with_entity_marker": "The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: actin, villin, [E1]fimbrin[/E1] and [E2]brush border myosin-I[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "fimbrin", "entity_1_idx": [[104, 111]], "entity_1_idx_in_text_with_entity_marker": [108, 115], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "brush border myosin-I", "entity_2_idx": [[116, 137]], "entity_2_idx_in_text_with_entity_marker": [129, 150], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d636.s0_BioInfer.d636.s0.p5", "text": "The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: actin, villin, fimbrin and brush border myosin-I.", "text_with_entity_marker": "The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: actin, [E1]villin[/E1], [E2]fimbrin[/E2] and brush border myosin-I.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "villin", "entity_1_idx": [[96, 102]], "entity_1_idx_in_text_with_entity_marker": [100, 106], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[104, 111]], "entity_2_idx_in_text_with_entity_marker": [117, 124], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d788.s0_BioInfer.d788.s0.p0", "text": "Using the known three-dimensional structure of the homologous actin-binding domain of fimbrin, these results have enabled us to determine the likely orientation of the utrophin actin-binding domain with respect to the actin filament.", "text_with_entity_marker": "Using the known three-dimensional structure of the homologous actin-binding domain of [E1]fimbrin[/E1], these results have enabled us to determine the likely orientation of the [E2]utrophin[/E2] actin-binding domain with respect to the actin filament.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "fimbrin", "entity_1_idx": [[86, 93]], "entity_1_idx_in_text_with_entity_marker": [90, 97], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "utrophin", "entity_2_idx": [[168, 176]], "entity_2_idx_in_text_with_entity_marker": [181, 189], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d788.s0_BioInfer.d788.s0.p1", "text": "Using the known three-dimensional structure of the homologous actin-binding domain of fimbrin, these results have enabled us to determine the likely orientation of the utrophin actin-binding domain with respect to the actin filament.", "text_with_entity_marker": "Using the known three-dimensional structure of the homologous actin-binding domain of fimbrin, these results have enabled us to determine the likely orientation of the [E1]utrophin[/E1] actin-binding domain with respect to the [E2]actin[/E2] filament.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "utrophin", "entity_1_idx": [[168, 176]], "entity_1_idx_in_text_with_entity_marker": [172, 180], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[218, 223]], "entity_2_idx_in_text_with_entity_marker": [231, 236], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d788.s0_BioInfer.d788.s0.p2", "text": "Using the known three-dimensional structure of the homologous actin-binding domain of fimbrin, these results have enabled us to determine the likely orientation of the utrophin actin-binding domain with respect to the actin filament.", "text_with_entity_marker": "Using the known three-dimensional structure of the homologous actin-binding domain of fimbrin, these results have enabled us to determine the likely orientation of the [E1]utrophin[/E1] [E2]actin[/E2]-binding domain with respect to the actin filament.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "utrophin", "entity_1_idx": [[168, 176]], "entity_1_idx_in_text_with_entity_marker": [172, 180], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[177, 182]], "entity_2_idx_in_text_with_entity_marker": [190, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d788.s0_BioInfer.d788.s0.p3", "text": "Using the known three-dimensional structure of the homologous actin-binding domain of fimbrin, these results have enabled us to determine the likely orientation of the utrophin actin-binding domain with respect to the actin filament.", "text_with_entity_marker": "Using the known three-dimensional structure of the homologous [E1]actin[/E1]-binding domain of fimbrin, these results have enabled us to determine the likely orientation of the [E2]utrophin[/E2] actin-binding domain with respect to the actin filament.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[62, 67]], "entity_1_idx_in_text_with_entity_marker": [66, 71], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "utrophin", "entity_2_idx": [[168, 176]], "entity_2_idx_in_text_with_entity_marker": [181, 189], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d788.s0_BioInfer.d788.s0.p4", "text": "Using the known three-dimensional structure of the homologous actin-binding domain of fimbrin, these results have enabled us to determine the likely orientation of the utrophin actin-binding domain with respect to the actin filament.", "text_with_entity_marker": "Using the known three-dimensional structure of the homologous actin-binding domain of [E1]fimbrin[/E1], these results have enabled us to determine the likely orientation of the utrophin actin-binding domain with respect to the [E2]actin[/E2] filament.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fimbrin", "entity_1_idx": [[86, 93]], "entity_1_idx_in_text_with_entity_marker": [90, 97], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[218, 223]], "entity_2_idx_in_text_with_entity_marker": [231, 236], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d788.s0_BioInfer.d788.s0.p5", "text": "Using the known three-dimensional structure of the homologous actin-binding domain of fimbrin, these results have enabled us to determine the likely orientation of the utrophin actin-binding domain with respect to the actin filament.", "text_with_entity_marker": "Using the known three-dimensional structure of the homologous actin-binding domain of [E1]fimbrin[/E1], these results have enabled us to determine the likely orientation of the utrophin [E2]actin[/E2]-binding domain with respect to the actin filament.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fimbrin", "entity_1_idx": [[86, 93]], "entity_1_idx_in_text_with_entity_marker": [90, 97], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[177, 182]], "entity_2_idx_in_text_with_entity_marker": [190, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d788.s0_BioInfer.d788.s0.p6", "text": "Using the known three-dimensional structure of the homologous actin-binding domain of fimbrin, these results have enabled us to determine the likely orientation of the utrophin actin-binding domain with respect to the actin filament.", "text_with_entity_marker": "Using the known three-dimensional structure of the homologous [E1]actin[/E1]-binding domain of [E2]fimbrin[/E2], these results have enabled us to determine the likely orientation of the utrophin actin-binding domain with respect to the actin filament.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[62, 67]], "entity_1_idx_in_text_with_entity_marker": [66, 71], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[86, 93]], "entity_2_idx_in_text_with_entity_marker": [99, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d788.s0_BioInfer.d788.s0.p7", "text": "Using the known three-dimensional structure of the homologous actin-binding domain of fimbrin, these results have enabled us to determine the likely orientation of the utrophin actin-binding domain with respect to the actin filament.", "text_with_entity_marker": "Using the known three-dimensional structure of the homologous actin-binding domain of fimbrin, these results have enabled us to determine the likely orientation of the utrophin [E1]actin[/E1]-binding domain with respect to the [E2]actin[/E2] filament.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[177, 182]], "entity_1_idx_in_text_with_entity_marker": [181, 186], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[218, 223]], "entity_2_idx_in_text_with_entity_marker": [231, 236], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d788.s0_BioInfer.d788.s0.p8", "text": "Using the known three-dimensional structure of the homologous actin-binding domain of fimbrin, these results have enabled us to determine the likely orientation of the utrophin actin-binding domain with respect to the actin filament.", "text_with_entity_marker": "Using the known three-dimensional structure of the homologous [E1]actin[/E1]-binding domain of fimbrin, these results have enabled us to determine the likely orientation of the utrophin actin-binding domain with respect to the [E2]actin[/E2] filament.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[62, 67]], "entity_1_idx_in_text_with_entity_marker": [66, 71], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[218, 223]], "entity_2_idx_in_text_with_entity_marker": [231, 236], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d788.s0_BioInfer.d788.s0.p9", "text": "Using the known three-dimensional structure of the homologous actin-binding domain of fimbrin, these results have enabled us to determine the likely orientation of the utrophin actin-binding domain with respect to the actin filament.", "text_with_entity_marker": "Using the known three-dimensional structure of the homologous [E1]actin[/E1]-binding domain of fimbrin, these results have enabled us to determine the likely orientation of the utrophin [E2]actin[/E2]-binding domain with respect to the actin filament.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[62, 67]], "entity_1_idx_in_text_with_entity_marker": [66, 71], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[177, 182]], "entity_2_idx_in_text_with_entity_marker": [190, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d23.s0_BioInfer.d23.s0.p0", "text": "Addition of Acanthamoeba profilin in molar ratios to actin of about 1.1:1 and 2.3:1 retarded the initial kinetics of assembly (induced by addition of 2mM Mg+2) and reduced the fraction of actin incorporated into filaments.", "text_with_entity_marker": "Addition of Acanthamoeba [E1]profilin[/E1] in molar ratios to actin of about 1.1:1 and 2.3:1 retarded the initial kinetics of assembly (induced by addition of 2mM Mg+2) and reduced the fraction of [E2]actin[/E2] incorporated into filaments.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[25, 33]], "entity_1_idx_in_text_with_entity_marker": [29, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[188, 193]], "entity_2_idx_in_text_with_entity_marker": [201, 206], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d23.s0_BioInfer.d23.s0.p1", "text": "Addition of Acanthamoeba profilin in molar ratios to actin of about 1.1:1 and 2.3:1 retarded the initial kinetics of assembly (induced by addition of 2mM Mg+2) and reduced the fraction of actin incorporated into filaments.", "text_with_entity_marker": "Addition of Acanthamoeba [E1]profilin[/E1] in molar ratios to [E2]actin[/E2] of about 1.1:1 and 2.3:1 retarded the initial kinetics of assembly (induced by addition of 2mM Mg+2) and reduced the fraction of actin incorporated into filaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[25, 33]], "entity_1_idx_in_text_with_entity_marker": [29, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[53, 58]], "entity_2_idx_in_text_with_entity_marker": [66, 71], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d23.s0_BioInfer.d23.s0.p2", "text": "Addition of Acanthamoeba profilin in molar ratios to actin of about 1.1:1 and 2.3:1 retarded the initial kinetics of assembly (induced by addition of 2mM Mg+2) and reduced the fraction of actin incorporated into filaments.", "text_with_entity_marker": "Addition of Acanthamoeba profilin in molar ratios to [E1]actin[/E1] of about 1.1:1 and 2.3:1 retarded the initial kinetics of assembly (induced by addition of 2mM Mg+2) and reduced the fraction of [E2]actin[/E2] incorporated into filaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[53, 58]], "entity_1_idx_in_text_with_entity_marker": [57, 62], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[188, 193]], "entity_2_idx_in_text_with_entity_marker": [201, 206], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d315.s0_BioInfer.d315.s0.p0", "text": "In addition, we have demonstrated that increased gene dosage of either SIR1 or SIR4, two other factors required for silencing, suppresses the silencing defect of the rap1 mutants.", "text_with_entity_marker": "In addition, we have demonstrated that increased gene dosage of either SIR1 or [E1]SIR4[/E1], two other factors required for silencing, suppresses the silencing defect of the [E2]rap1[/E2] mutants.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "SIR4", "entity_1_idx": [[79, 83]], "entity_1_idx_in_text_with_entity_marker": [83, 87], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "rap1", "entity_2_idx": [[166, 170]], "entity_2_idx_in_text_with_entity_marker": [179, 183], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d315.s0_BioInfer.d315.s0.p1", "text": "In addition, we have demonstrated that increased gene dosage of either SIR1 or SIR4, two other factors required for silencing, suppresses the silencing defect of the rap1 mutants.", "text_with_entity_marker": "In addition, we have demonstrated that increased gene dosage of either [E1]SIR1[/E1] or [E2]SIR4[/E2], two other factors required for silencing, suppresses the silencing defect of the rap1 mutants.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SIR1", "entity_1_idx": [[71, 75]], "entity_1_idx_in_text_with_entity_marker": [75, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SIR4", "entity_2_idx": [[79, 83]], "entity_2_idx_in_text_with_entity_marker": [92, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d315.s0_BioInfer.d315.s0.p2", "text": "In addition, we have demonstrated that increased gene dosage of either SIR1 or SIR4, two other factors required for silencing, suppresses the silencing defect of the rap1 mutants.", "text_with_entity_marker": "In addition, we have demonstrated that increased gene dosage of either [E1]SIR1[/E1] or SIR4, two other factors required for silencing, suppresses the silencing defect of the [E2]rap1[/E2] mutants.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "SIR1", "entity_1_idx": [[71, 75]], "entity_1_idx_in_text_with_entity_marker": [75, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "rap1", "entity_2_idx": [[166, 170]], "entity_2_idx_in_text_with_entity_marker": [179, 183], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d143.s0_BioInfer.d143.s0.p0", "text": "Class II profilins had higher affinity for poly-l-proline and sequestered more monomeric actin than did class I profilins.", "text_with_entity_marker": "Class II profilins had higher affinity for poly-l-proline and sequestered more monomeric [E1]actin[/E1] than did [E2]class I profilins[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[89, 94]], "entity_1_idx_in_text_with_entity_marker": [93, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "class I profilins", "entity_2_idx": [[104, 121]], "entity_2_idx_in_text_with_entity_marker": [117, 134], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d143.s0_BioInfer.d143.s0.p1", "text": "Class II profilins had higher affinity for poly-l-proline and sequestered more monomeric actin than did class I profilins.", "text_with_entity_marker": "[E1]Class II profilins[/E1] had higher affinity for poly-l-proline and sequestered more monomeric actin than did [E2]class I profilins[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Class II profilins", "entity_1_idx": [[0, 18]], "entity_1_idx_in_text_with_entity_marker": [4, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "class I profilins", "entity_2_idx": [[104, 121]], "entity_2_idx_in_text_with_entity_marker": [117, 134], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d143.s0_BioInfer.d143.s0.p2", "text": "Class II profilins had higher affinity for poly-l-proline and sequestered more monomeric actin than did class I profilins.", "text_with_entity_marker": "[E1]Class II profilins[/E1] had higher affinity for poly-l-proline and sequestered more monomeric [E2]actin[/E2] than did class I profilins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Class II profilins", "entity_1_idx": [[0, 18]], "entity_1_idx_in_text_with_entity_marker": [4, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[89, 94]], "entity_2_idx_in_text_with_entity_marker": [102, 107], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d143.s1_BioInfer.d143.s1.p0", "text": "The actin-sequestering activity of both maize profilin classes was found to be dependent on the concentration of free calcium.", "text_with_entity_marker": "The [E1]actin[/E1]-sequestering activity of both maize [E2]profilin[/E2] classes was found to be dependent on the concentration of free calcium.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[4, 9]], "entity_1_idx_in_text_with_entity_marker": [8, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[46, 54]], "entity_2_idx_in_text_with_entity_marker": [59, 67], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d143.s2_BioInfer.d143.s2.p0", "text": "We propose a model in which profilin alters cellular concentrations of actin polymers in response to fluctuations in cytosolic calcium concentration.", "text_with_entity_marker": "We propose a model in which [E1]profilin[/E1] alters cellular concentrations of [E2]actin[/E2] polymers in response to fluctuations in cytosolic calcium concentration.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[28, 36]], "entity_1_idx_in_text_with_entity_marker": [32, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[71, 76]], "entity_2_idx_in_text_with_entity_marker": [84, 89], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p30", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or [E1]paxillin[/E1]-containing focal adhesions or actin stress fibers on fibronectin, whereas [E2]vinculin[/E2] (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "paxillin", "entity_1_idx": [[465, 473]], "entity_1_idx_in_text_with_entity_marker": [469, 477], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[548, 556]], "entity_2_idx_in_text_with_entity_marker": [561, 569], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p31", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to [E1]laminin[/E1], but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas [E2]vinculin[/E2] (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "laminin", "entity_1_idx": [[185, 192]], "entity_1_idx_in_text_with_entity_marker": [189, 196], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[548, 556]], "entity_2_idx_in_text_with_entity_marker": [561, 569], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p32", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a [E1]vinculin[/E1] (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas [E2]vinculin[/E2] (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[395, 403]], "entity_1_idx_in_text_with_entity_marker": [399, 407], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[548, 556]], "entity_2_idx_in_text_with_entity_marker": [561, 569], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p33", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble [E1]vinculin[/E1] or paxillin-containing focal adhesions or actin stress fibers on [E2]fibronectin[/E2], whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[453, 461]], "entity_1_idx_in_text_with_entity_marker": [457, 465], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fibronectin", "entity_2_idx": [[527, 538]], "entity_2_idx_in_text_with_entity_marker": [540, 551], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p34", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or [E1]laminin[/E1] and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble [E2]vinculin[/E2] or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "laminin", "entity_1_idx": [[67, 74]], "entity_1_idx_in_text_with_entity_marker": [71, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[453, 461]], "entity_2_idx_in_text_with_entity_marker": [466, 474], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p35", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not [E1]fibronectin[/E1] (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble [E2]vinculin[/E2] or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fibronectin", "entity_1_idx": [[202, 213]], "entity_1_idx_in_text_with_entity_marker": [206, 217], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[453, 461]], "entity_2_idx_in_text_with_entity_marker": [466, 474], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p36", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on [E1]gelatin[/E1] or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble [E2]vinculin[/E2] or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gelatin", "entity_1_idx": [[56, 63]], "entity_1_idx_in_text_with_entity_marker": [60, 67], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[453, 461]], "entity_2_idx_in_text_with_entity_marker": [466, 474], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p37", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on [E1]fibronectin[/E1] (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble [E2]vinculin[/E2] or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fibronectin", "entity_1_idx": [[142, 153]], "entity_1_idx_in_text_with_entity_marker": [146, 157], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[453, 461]], "entity_2_idx_in_text_with_entity_marker": [466, 474], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p38", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of [E1]beta1 integrin[/E1], although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble [E2]vinculin[/E2] or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta1 integrin", "entity_1_idx": [[251, 265]], "entity_1_idx_in_text_with_entity_marker": [255, 269], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[453, 461]], "entity_2_idx_in_text_with_entity_marker": [466, 474], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p39", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble [E1]vinculin[/E1] or [E2]paxillin[/E2]-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[453, 461]], "entity_1_idx_in_text_with_entity_marker": [457, 465], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "paxillin", "entity_2_idx": [[465, 473]], "entity_2_idx_in_text_with_entity_marker": [478, 486], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p40", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to [E1]laminin[/E1], but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble [E2]vinculin[/E2] or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "laminin", "entity_1_idx": [[185, 192]], "entity_1_idx_in_text_with_entity_marker": [189, 196], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[453, 461]], "entity_2_idx_in_text_with_entity_marker": [466, 474], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p41", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a [E1]vinculin[/E1] (-/-) ES cell mutant (e) were unable to assemble [E2]vinculin[/E2] or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[395, 403]], "entity_1_idx_in_text_with_entity_marker": [399, 407], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[453, 461]], "entity_2_idx_in_text_with_entity_marker": [466, 474], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p42", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or [E1]laminin[/E1] and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on [E2]fibronectin[/E2], whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "laminin", "entity_1_idx": [[67, 74]], "entity_1_idx_in_text_with_entity_marker": [71, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fibronectin", "entity_2_idx": [[527, 538]], "entity_2_idx_in_text_with_entity_marker": [540, 551], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p43", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not [E1]fibronectin[/E1] (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on [E2]fibronectin[/E2], whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fibronectin", "entity_1_idx": [[202, 213]], "entity_1_idx_in_text_with_entity_marker": [206, 217], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fibronectin", "entity_2_idx": [[527, 538]], "entity_2_idx_in_text_with_entity_marker": [540, 551], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p44", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on [E1]gelatin[/E1] or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on [E2]fibronectin[/E2], whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gelatin", "entity_1_idx": [[56, 63]], "entity_1_idx_in_text_with_entity_marker": [60, 67], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fibronectin", "entity_2_idx": [[527, 538]], "entity_2_idx_in_text_with_entity_marker": [540, 551], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p45", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on [E1]fibronectin[/E1] (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on [E2]fibronectin[/E2], whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fibronectin", "entity_1_idx": [[142, 153]], "entity_1_idx_in_text_with_entity_marker": [146, 157], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fibronectin", "entity_2_idx": [[527, 538]], "entity_2_idx_in_text_with_entity_marker": [540, 551], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p46", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of [E1]beta1 integrin[/E1], although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on [E2]fibronectin[/E2], whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta1 integrin", "entity_1_idx": [[251, 265]], "entity_1_idx_in_text_with_entity_marker": [255, 269], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fibronectin", "entity_2_idx": [[527, 538]], "entity_2_idx_in_text_with_entity_marker": [540, 551], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p47", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or [E1]paxillin[/E1]-containing focal adhesions or actin stress fibers on [E2]fibronectin[/E2], whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "paxillin", "entity_1_idx": [[465, 473]], "entity_1_idx_in_text_with_entity_marker": [469, 477], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fibronectin", "entity_2_idx": [[527, 538]], "entity_2_idx_in_text_with_entity_marker": [540, 551], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p48", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to [E1]laminin[/E1], but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on [E2]fibronectin[/E2], whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "laminin", "entity_1_idx": [[185, 192]], "entity_1_idx_in_text_with_entity_marker": [189, 196], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fibronectin", "entity_2_idx": [[527, 538]], "entity_2_idx_in_text_with_entity_marker": [540, 551], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p49", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a [E1]vinculin[/E1] (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on [E2]fibronectin[/E2], whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[395, 403]], "entity_1_idx_in_text_with_entity_marker": [399, 407], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fibronectin", "entity_2_idx": [[527, 538]], "entity_2_idx_in_text_with_entity_marker": [540, 551], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p60", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not [E1]fibronectin[/E1] (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or [E2]paxillin[/E2]-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fibronectin", "entity_1_idx": [[202, 213]], "entity_1_idx_in_text_with_entity_marker": [206, 217], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "paxillin", "entity_2_idx": [[465, 473]], "entity_2_idx_in_text_with_entity_marker": [478, 486], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p61", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to [E1]laminin[/E1], but not [E2]fibronectin[/E2] (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "laminin", "entity_1_idx": [[185, 192]], "entity_1_idx_in_text_with_entity_marker": [189, 196], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fibronectin", "entity_2_idx": [[202, 213]], "entity_2_idx_in_text_with_entity_marker": [215, 226], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p62", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not [E1]fibronectin[/E1] (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a [E2]vinculin[/E2] (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fibronectin", "entity_1_idx": [[202, 213]], "entity_1_idx_in_text_with_entity_marker": [206, 217], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[395, 403]], "entity_2_idx_in_text_with_entity_marker": [408, 416], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p63", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on [E1]gelatin[/E1] or laminin and grew as rounded colonies, although they were able to spread on [E2]fibronectin[/E2] (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gelatin", "entity_1_idx": [[56, 63]], "entity_1_idx_in_text_with_entity_marker": [60, 67], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fibronectin", "entity_2_idx": [[142, 153]], "entity_2_idx_in_text_with_entity_marker": [155, 166], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p64", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on [E1]gelatin[/E1] or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of [E2]beta1 integrin[/E2], although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gelatin", "entity_1_idx": [[56, 63]], "entity_1_idx_in_text_with_entity_marker": [60, 67], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta1 integrin", "entity_2_idx": [[251, 265]], "entity_2_idx_in_text_with_entity_marker": [264, 278], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p65", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on [E1]gelatin[/E1] or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or [E2]paxillin[/E2]-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gelatin", "entity_1_idx": [[56, 63]], "entity_1_idx_in_text_with_entity_marker": [60, 67], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "paxillin", "entity_2_idx": [[465, 473]], "entity_2_idx_in_text_with_entity_marker": [478, 486], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p66", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on [E1]gelatin[/E1] or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to [E2]laminin[/E2], but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gelatin", "entity_1_idx": [[56, 63]], "entity_1_idx_in_text_with_entity_marker": [60, 67], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "laminin", "entity_2_idx": [[185, 192]], "entity_2_idx_in_text_with_entity_marker": [198, 205], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p67", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on [E1]gelatin[/E1] or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a [E2]vinculin[/E2] (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gelatin", "entity_1_idx": [[56, 63]], "entity_1_idx_in_text_with_entity_marker": [60, 67], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[395, 403]], "entity_2_idx_in_text_with_entity_marker": [408, 416], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p68", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on [E1]fibronectin[/E1] (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of [E2]beta1 integrin[/E2], although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fibronectin", "entity_1_idx": [[142, 153]], "entity_1_idx_in_text_with_entity_marker": [146, 157], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta1 integrin", "entity_2_idx": [[251, 265]], "entity_2_idx_in_text_with_entity_marker": [264, 278], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p69", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on [E1]fibronectin[/E1] (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or [E2]paxillin[/E2]-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fibronectin", "entity_1_idx": [[142, 153]], "entity_1_idx_in_text_with_entity_marker": [146, 157], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "paxillin", "entity_2_idx": [[465, 473]], "entity_2_idx_in_text_with_entity_marker": [478, 486], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p30", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "[E1]PF4[/E1]-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-[E2]cdk2[/E2] complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PF4", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cdk2", "entity_2_idx": [[167, 171]], "entity_2_idx_in_text_with_entity_marker": [180, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p31", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of [E1]cyclin E[/E1]-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-[E2]cdk2[/E2] complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin E", "entity_1_idx": [[32, 40]], "entity_1_idx_in_text_with_entity_marker": [36, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cdk2", "entity_2_idx": [[167, 171]], "entity_2_idx_in_text_with_entity_marker": [180, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p32", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, [E1]p21[/E1](Cip1/WAF1), to the cyclin E-[E2]cdk2[/E2] complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p21", "entity_1_idx": [[135, 138]], "entity_1_idx_in_text_with_entity_marker": [139, 142], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cdk2", "entity_2_idx": [[167, 171]], "entity_2_idx_in_text_with_entity_marker": [180, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p33", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "[E1]PF4[/E1]-dependent downregulation of [E2]cyclin E[/E2]-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PF4", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E", "entity_2_idx": [[32, 40]], "entity_2_idx_in_text_with_entity_marker": [45, 53], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p34", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "[E1]PF4[/E1]-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, [E2]p21[/E2](Cip1/WAF1), to the cyclin E-cdk2 complex.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PF4", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p21", "entity_2_idx": [[135, 138]], "entity_2_idx_in_text_with_entity_marker": [148, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p35", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of [E1]cyclin E[/E1]-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, [E2]p21[/E2](Cip1/WAF1), to the cyclin E-cdk2 complex.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin E", "entity_1_idx": [[32, 40]], "entity_1_idx_in_text_with_entity_marker": [36, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p21", "entity_2_idx": [[135, 138]], "entity_2_idx_in_text_with_entity_marker": [148, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d809.s0_BioInfer.d809.s0.p0", "text": "We have characterized this actin with respect to its ability to interact with yeast profilin and tropomyosin, the only yeast actin-binding proteins so far purified and characterized.", "text_with_entity_marker": "We have characterized this [E1]actin[/E1] with respect to its ability to interact with yeast [E2]profilin[/E2] and tropomyosin, the only yeast actin-binding proteins so far purified and characterized.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[27, 32]], "entity_1_idx_in_text_with_entity_marker": [31, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[84, 92]], "entity_2_idx_in_text_with_entity_marker": [97, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d809.s0_BioInfer.d809.s0.p1", "text": "We have characterized this actin with respect to its ability to interact with yeast profilin and tropomyosin, the only yeast actin-binding proteins so far purified and characterized.", "text_with_entity_marker": "We have characterized this [E1]actin[/E1] with respect to its ability to interact with yeast profilin and tropomyosin, the only yeast [E2]actin-binding proteins[/E2] so far purified and characterized.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[27, 32]], "entity_1_idx_in_text_with_entity_marker": [31, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding proteins", "entity_2_idx": [[125, 147]], "entity_2_idx_in_text_with_entity_marker": [138, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d809.s0_BioInfer.d809.s0.p2", "text": "We have characterized this actin with respect to its ability to interact with yeast profilin and tropomyosin, the only yeast actin-binding proteins so far purified and characterized.", "text_with_entity_marker": "We have characterized this [E1]actin[/E1] with respect to its ability to interact with yeast profilin and [E2]tropomyosin[/E2], the only yeast actin-binding proteins so far purified and characterized.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[27, 32]], "entity_1_idx_in_text_with_entity_marker": [31, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "tropomyosin", "entity_2_idx": [[97, 108]], "entity_2_idx_in_text_with_entity_marker": [110, 121], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d809.s0_BioInfer.d809.s0.p3", "text": "We have characterized this actin with respect to its ability to interact with yeast profilin and tropomyosin, the only yeast actin-binding proteins so far purified and characterized.", "text_with_entity_marker": "We have characterized this actin with respect to its ability to interact with yeast [E1]profilin[/E1] and tropomyosin, the only yeast [E2]actin-binding proteins[/E2] so far purified and characterized.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[84, 92]], "entity_1_idx_in_text_with_entity_marker": [88, 96], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding proteins", "entity_2_idx": [[125, 147]], "entity_2_idx_in_text_with_entity_marker": [138, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d809.s0_BioInfer.d809.s0.p4", "text": "We have characterized this actin with respect to its ability to interact with yeast profilin and tropomyosin, the only yeast actin-binding proteins so far purified and characterized.", "text_with_entity_marker": "We have characterized this actin with respect to its ability to interact with yeast [E1]profilin[/E1] and [E2]tropomyosin[/E2], the only yeast actin-binding proteins so far purified and characterized.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[84, 92]], "entity_1_idx_in_text_with_entity_marker": [88, 96], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "tropomyosin", "entity_2_idx": [[97, 108]], "entity_2_idx_in_text_with_entity_marker": [110, 121], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d809.s0_BioInfer.d809.s0.p5", "text": "We have characterized this actin with respect to its ability to interact with yeast profilin and tropomyosin, the only yeast actin-binding proteins so far purified and characterized.", "text_with_entity_marker": "We have characterized this actin with respect to its ability to interact with yeast profilin and [E1]tropomyosin[/E1], the only yeast [E2]actin-binding proteins[/E2] so far purified and characterized.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "tropomyosin", "entity_1_idx": [[97, 108]], "entity_1_idx_in_text_with_entity_marker": [101, 112], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding proteins", "entity_2_idx": [[125, 147]], "entity_2_idx_in_text_with_entity_marker": [138, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d809.s1_BioInfer.d809.s1.p0", "text": "Yeast profilin can sequester yeast actin monomers and thereby reduce the ability of yeast actin to polymerize, whereas it has little effect on the degree of polymerization of rabbit skeletal muscle actin.", "text_with_entity_marker": "Yeast [E1]profilin[/E1] can sequester yeast [E2]actin[/E2] monomers and thereby reduce the ability of yeast actin to polymerize, whereas it has little effect on the degree of polymerization of rabbit skeletal muscle actin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[6, 14]], "entity_1_idx_in_text_with_entity_marker": [10, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[35, 40]], "entity_2_idx_in_text_with_entity_marker": [48, 53], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d809.s1_BioInfer.d809.s1.p1", "text": "Yeast profilin can sequester yeast actin monomers and thereby reduce the ability of yeast actin to polymerize, whereas it has little effect on the degree of polymerization of rabbit skeletal muscle actin.", "text_with_entity_marker": "Yeast [E1]profilin[/E1] can sequester yeast actin monomers and thereby reduce the ability of yeast [E2]actin[/E2] to polymerize, whereas it has little effect on the degree of polymerization of rabbit skeletal muscle actin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[6, 14]], "entity_1_idx_in_text_with_entity_marker": [10, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[90, 95]], "entity_2_idx_in_text_with_entity_marker": [103, 108], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d809.s1_BioInfer.d809.s1.p2", "text": "Yeast profilin can sequester yeast actin monomers and thereby reduce the ability of yeast actin to polymerize, whereas it has little effect on the degree of polymerization of rabbit skeletal muscle actin.", "text_with_entity_marker": "Yeast [E1]profilin[/E1] can sequester yeast actin monomers and thereby reduce the ability of yeast actin to polymerize, whereas it has little effect on the degree of polymerization of rabbit [E2]skeletal muscle actin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[6, 14]], "entity_1_idx_in_text_with_entity_marker": [10, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "skeletal muscle actin", "entity_2_idx": [[182, 203]], "entity_2_idx_in_text_with_entity_marker": [195, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d809.s1_BioInfer.d809.s1.p3", "text": "Yeast profilin can sequester yeast actin monomers and thereby reduce the ability of yeast actin to polymerize, whereas it has little effect on the degree of polymerization of rabbit skeletal muscle actin.", "text_with_entity_marker": "Yeast profilin can sequester yeast [E1]actin[/E1] monomers and thereby reduce the ability of yeast [E2]actin[/E2] to polymerize, whereas it has little effect on the degree of polymerization of rabbit skeletal muscle actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[35, 40]], "entity_1_idx_in_text_with_entity_marker": [39, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[90, 95]], "entity_2_idx_in_text_with_entity_marker": [103, 108], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d809.s1_BioInfer.d809.s1.p4", "text": "Yeast profilin can sequester yeast actin monomers and thereby reduce the ability of yeast actin to polymerize, whereas it has little effect on the degree of polymerization of rabbit skeletal muscle actin.", "text_with_entity_marker": "Yeast profilin can sequester yeast [E1]actin[/E1] monomers and thereby reduce the ability of yeast actin to polymerize, whereas it has little effect on the degree of polymerization of rabbit [E2]skeletal muscle actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[35, 40]], "entity_1_idx_in_text_with_entity_marker": [39, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "skeletal muscle actin", "entity_2_idx": [[182, 203]], "entity_2_idx_in_text_with_entity_marker": [195, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d809.s1_BioInfer.d809.s1.p5", "text": "Yeast profilin can sequester yeast actin monomers and thereby reduce the ability of yeast actin to polymerize, whereas it has little effect on the degree of polymerization of rabbit skeletal muscle actin.", "text_with_entity_marker": "Yeast profilin can sequester yeast actin monomers and thereby reduce the ability of yeast [E1]actin[/E1] to polymerize, whereas it has little effect on the degree of polymerization of rabbit [E2]skeletal muscle actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[90, 95]], "entity_1_idx_in_text_with_entity_marker": [94, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "skeletal muscle actin", "entity_2_idx": [[182, 203]], "entity_2_idx_in_text_with_entity_marker": [195, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d643.s0_BioInfer.d643.s0.p0", "text": "The mechanism of profilin-promoted actin polymerization has been systematically reinvestigated.", "text_with_entity_marker": "The mechanism of [E1]profilin[/E1]-promoted [E2]actin[/E2] polymerization has been systematically reinvestigated.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[17, 25]], "entity_1_idx_in_text_with_entity_marker": [21, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[35, 40]], "entity_2_idx_in_text_with_entity_marker": [48, 53], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d643.s1_BioInfer.d643.s1.p0", "text": "When measured in the absence of profilin, actin assembly curves over a 0.7-4 microM thymosin-beta4 concentration range fit a simple monomer sequestering model (1 microM K(D) for Thymosin-beta4.Actin).", "text_with_entity_marker": "When measured in the absence of profilin, actin assembly curves over a 0.7-4 microM thymosin-beta4 concentration range fit a simple monomer sequestering model (1 microM K(D) for [E1]Thymosin-beta4[/E1].[E2]Actin[/E2]).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Thymosin-beta4", "entity_1_idx": [[178, 192]], "entity_1_idx_in_text_with_entity_marker": [182, 196], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Actin", "entity_2_idx": [[193, 198]], "entity_2_idx_in_text_with_entity_marker": [206, 211], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d643.s1_BioInfer.d643.s1.p1", "text": "When measured in the absence of profilin, actin assembly curves over a 0.7-4 microM thymosin-beta4 concentration range fit a simple monomer sequestering model (1 microM K(D) for Thymosin-beta4.Actin).", "text_with_entity_marker": "When measured in the absence of profilin, [E1]actin[/E1] assembly curves over a 0.7-4 microM thymosin-beta4 concentration range fit a simple monomer sequestering model (1 microM K(D) for [E2]Thymosin-beta4[/E2].Actin).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[42, 47]], "entity_1_idx_in_text_with_entity_marker": [46, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Thymosin-beta4", "entity_2_idx": [[178, 192]], "entity_2_idx_in_text_with_entity_marker": [191, 205], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d643.s1_BioInfer.d643.s1.p2", "text": "When measured in the absence of profilin, actin assembly curves over a 0.7-4 microM thymosin-beta4 concentration range fit a simple monomer sequestering model (1 microM K(D) for Thymosin-beta4.Actin).", "text_with_entity_marker": "When measured in the absence of [E1]profilin[/E1], actin assembly curves over a 0.7-4 microM thymosin-beta4 concentration range fit a simple monomer sequestering model (1 microM K(D) for [E2]Thymosin-beta4[/E2].Actin).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[32, 40]], "entity_1_idx_in_text_with_entity_marker": [36, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Thymosin-beta4", "entity_2_idx": [[178, 192]], "entity_2_idx_in_text_with_entity_marker": [191, 205], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d643.s1_BioInfer.d643.s1.p3", "text": "When measured in the absence of profilin, actin assembly curves over a 0.7-4 microM thymosin-beta4 concentration range fit a simple monomer sequestering model (1 microM K(D) for Thymosin-beta4.Actin).", "text_with_entity_marker": "When measured in the absence of profilin, actin assembly curves over a 0.7-4 microM [E1]thymosin-beta4[/E1] concentration range fit a simple monomer sequestering model (1 microM K(D) for [E2]Thymosin-beta4[/E2].Actin).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thymosin-beta4", "entity_1_idx": [[84, 98]], "entity_1_idx_in_text_with_entity_marker": [88, 102], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Thymosin-beta4", "entity_2_idx": [[178, 192]], "entity_2_idx_in_text_with_entity_marker": [191, 205], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d643.s1_BioInfer.d643.s1.p4", "text": "When measured in the absence of profilin, actin assembly curves over a 0.7-4 microM thymosin-beta4 concentration range fit a simple monomer sequestering model (1 microM K(D) for Thymosin-beta4.Actin).", "text_with_entity_marker": "When measured in the absence of profilin, [E1]actin[/E1] assembly curves over a 0.7-4 microM thymosin-beta4 concentration range fit a simple monomer sequestering model (1 microM K(D) for Thymosin-beta4.[E2]Actin[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[42, 47]], "entity_1_idx_in_text_with_entity_marker": [46, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Actin", "entity_2_idx": [[193, 198]], "entity_2_idx_in_text_with_entity_marker": [206, 211], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d643.s1_BioInfer.d643.s1.p5", "text": "When measured in the absence of profilin, actin assembly curves over a 0.7-4 microM thymosin-beta4 concentration range fit a simple monomer sequestering model (1 microM K(D) for Thymosin-beta4.Actin).", "text_with_entity_marker": "When measured in the absence of [E1]profilin[/E1], actin assembly curves over a 0.7-4 microM thymosin-beta4 concentration range fit a simple monomer sequestering model (1 microM K(D) for Thymosin-beta4.[E2]Actin[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[32, 40]], "entity_1_idx_in_text_with_entity_marker": [36, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Actin", "entity_2_idx": [[193, 198]], "entity_2_idx_in_text_with_entity_marker": [206, 211], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d643.s1_BioInfer.d643.s1.p6", "text": "When measured in the absence of profilin, actin assembly curves over a 0.7-4 microM thymosin-beta4 concentration range fit a simple monomer sequestering model (1 microM K(D) for Thymosin-beta4.Actin).", "text_with_entity_marker": "When measured in the absence of profilin, actin assembly curves over a 0.7-4 microM [E1]thymosin-beta4[/E1] concentration range fit a simple monomer sequestering model (1 microM K(D) for Thymosin-beta4.[E2]Actin[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thymosin-beta4", "entity_1_idx": [[84, 98]], "entity_1_idx_in_text_with_entity_marker": [88, 102], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Actin", "entity_2_idx": [[193, 198]], "entity_2_idx_in_text_with_entity_marker": [206, 211], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d643.s1_BioInfer.d643.s1.p7", "text": "When measured in the absence of profilin, actin assembly curves over a 0.7-4 microM thymosin-beta4 concentration range fit a simple monomer sequestering model (1 microM K(D) for Thymosin-beta4.Actin).", "text_with_entity_marker": "When measured in the absence of [E1]profilin[/E1], [E2]actin[/E2] assembly curves over a 0.7-4 microM thymosin-beta4 concentration range fit a simple monomer sequestering model (1 microM K(D) for Thymosin-beta4.Actin).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[32, 40]], "entity_1_idx_in_text_with_entity_marker": [36, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[42, 47]], "entity_2_idx_in_text_with_entity_marker": [55, 60], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d643.s1_BioInfer.d643.s1.p8", "text": "When measured in the absence of profilin, actin assembly curves over a 0.7-4 microM thymosin-beta4 concentration range fit a simple monomer sequestering model (1 microM K(D) for Thymosin-beta4.Actin).", "text_with_entity_marker": "When measured in the absence of profilin, [E1]actin[/E1] assembly curves over a 0.7-4 microM [E2]thymosin-beta4[/E2] concentration range fit a simple monomer sequestering model (1 microM K(D) for Thymosin-beta4.Actin).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[42, 47]], "entity_1_idx_in_text_with_entity_marker": [46, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "thymosin-beta4", "entity_2_idx": [[84, 98]], "entity_2_idx_in_text_with_entity_marker": [97, 111], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d643.s1_BioInfer.d643.s1.p9", "text": "When measured in the absence of profilin, actin assembly curves over a 0.7-4 microM thymosin-beta4 concentration range fit a simple monomer sequestering model (1 microM K(D) for Thymosin-beta4.Actin).", "text_with_entity_marker": "When measured in the absence of [E1]profilin[/E1], actin assembly curves over a 0.7-4 microM [E2]thymosin-beta4[/E2] concentration range fit a simple monomer sequestering model (1 microM K(D) for Thymosin-beta4.Actin).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[32, 40]], "entity_1_idx_in_text_with_entity_marker": [36, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "thymosin-beta4", "entity_2_idx": [[84, 98]], "entity_2_idx_in_text_with_entity_marker": [97, 111], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d643.s2_BioInfer.d643.s2.p0", "text": "With solutions of actin (2 microM) and thymosin-beta4 (2 or 4 microM), the barbed-end assembly rate rose with increasing profilin concentration (0.7-2 microM).", "text_with_entity_marker": "With solutions of actin (2 microM) and [E1]thymosin-beta4[/E1] (2 or 4 microM), the barbed-end assembly rate rose with increasing [E2]profilin[/E2] concentration (0.7-2 microM).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thymosin-beta4", "entity_1_idx": [[39, 53]], "entity_1_idx_in_text_with_entity_marker": [43, 57], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[121, 129]], "entity_2_idx_in_text_with_entity_marker": [134, 142], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d643.s2_BioInfer.d643.s2.p1", "text": "With solutions of actin (2 microM) and thymosin-beta4 (2 or 4 microM), the barbed-end assembly rate rose with increasing profilin concentration (0.7-2 microM).", "text_with_entity_marker": "With solutions of [E1]actin[/E1] (2 microM) and [E2]thymosin-beta4[/E2] (2 or 4 microM), the barbed-end assembly rate rose with increasing profilin concentration (0.7-2 microM).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[18, 23]], "entity_1_idx_in_text_with_entity_marker": [22, 27], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "thymosin-beta4", "entity_2_idx": [[39, 53]], "entity_2_idx_in_text_with_entity_marker": [52, 66], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d643.s2_BioInfer.d643.s2.p2", "text": "With solutions of actin (2 microM) and thymosin-beta4 (2 or 4 microM), the barbed-end assembly rate rose with increasing profilin concentration (0.7-2 microM).", "text_with_entity_marker": "With solutions of [E1]actin[/E1] (2 microM) and thymosin-beta4 (2 or 4 microM), the barbed-end assembly rate rose with increasing [E2]profilin[/E2] concentration (0.7-2 microM).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[18, 23]], "entity_1_idx_in_text_with_entity_marker": [22, 27], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[121, 129]], "entity_2_idx_in_text_with_entity_marker": [134, 142], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d623.s0_BioInfer.d623.s0.p0", "text": "The higher affinity of vaccinia profilin for polyphosphoinositides (Kd = 0.2-8.5 microM) than for actin or poly(L-proline) and the concentration of vaccinia profilin expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia profilin binds preferentially to PIP and PIP2 in vivo.", "text_with_entity_marker": "The higher affinity of vaccinia profilin for polyphosphoinositides (Kd = 0.2-8.5 microM) than for actin or poly(L-proline) and the concentration of vaccinia [E1]profilin[/E1] expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia [E2]profilin[/E2] binds preferentially to PIP and PIP2 in vivo.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[157, 165]], "entity_1_idx_in_text_with_entity_marker": [161, 169], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[247, 255]], "entity_2_idx_in_text_with_entity_marker": [260, 268], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d623.s0_BioInfer.d623.s0.p1", "text": "The higher affinity of vaccinia profilin for polyphosphoinositides (Kd = 0.2-8.5 microM) than for actin or poly(L-proline) and the concentration of vaccinia profilin expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia profilin binds preferentially to PIP and PIP2 in vivo.", "text_with_entity_marker": "The higher affinity of vaccinia profilin for polyphosphoinositides (Kd = 0.2-8.5 microM) than for [E1]actin[/E1] or poly(L-proline) and the concentration of vaccinia profilin expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia [E2]profilin[/E2] binds preferentially to PIP and PIP2 in vivo.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[98, 103]], "entity_1_idx_in_text_with_entity_marker": [102, 107], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[247, 255]], "entity_2_idx_in_text_with_entity_marker": [260, 268], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d623.s0_BioInfer.d623.s0.p2", "text": "The higher affinity of vaccinia profilin for polyphosphoinositides (Kd = 0.2-8.5 microM) than for actin or poly(L-proline) and the concentration of vaccinia profilin expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia profilin binds preferentially to PIP and PIP2 in vivo.", "text_with_entity_marker": "The higher affinity of vaccinia [E1]profilin[/E1] for polyphosphoinositides (Kd = 0.2-8.5 microM) than for actin or poly(L-proline) and the concentration of vaccinia profilin expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia [E2]profilin[/E2] binds preferentially to PIP and PIP2 in vivo.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[32, 40]], "entity_1_idx_in_text_with_entity_marker": [36, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[247, 255]], "entity_2_idx_in_text_with_entity_marker": [260, 268], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d623.s0_BioInfer.d623.s0.p3", "text": "The higher affinity of vaccinia profilin for polyphosphoinositides (Kd = 0.2-8.5 microM) than for actin or poly(L-proline) and the concentration of vaccinia profilin expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia profilin binds preferentially to PIP and PIP2 in vivo.", "text_with_entity_marker": "The higher affinity of vaccinia profilin for polyphosphoinositides (Kd = 0.2-8.5 microM) than for [E1]actin[/E1] or poly(L-proline) and the concentration of vaccinia [E2]profilin[/E2] expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia profilin binds preferentially to PIP and PIP2 in vivo.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[98, 103]], "entity_1_idx_in_text_with_entity_marker": [102, 107], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[157, 165]], "entity_2_idx_in_text_with_entity_marker": [170, 178], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d623.s0_BioInfer.d623.s0.p4", "text": "The higher affinity of vaccinia profilin for polyphosphoinositides (Kd = 0.2-8.5 microM) than for actin or poly(L-proline) and the concentration of vaccinia profilin expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia profilin binds preferentially to PIP and PIP2 in vivo.", "text_with_entity_marker": "The higher affinity of vaccinia [E1]profilin[/E1] for polyphosphoinositides (Kd = 0.2-8.5 microM) than for actin or poly(L-proline) and the concentration of vaccinia [E2]profilin[/E2] expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia profilin binds preferentially to PIP and PIP2 in vivo.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[32, 40]], "entity_1_idx_in_text_with_entity_marker": [36, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[157, 165]], "entity_2_idx_in_text_with_entity_marker": [170, 178], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d623.s0_BioInfer.d623.s0.p5", "text": "The higher affinity of vaccinia profilin for polyphosphoinositides (Kd = 0.2-8.5 microM) than for actin or poly(L-proline) and the concentration of vaccinia profilin expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia profilin binds preferentially to PIP and PIP2 in vivo.", "text_with_entity_marker": "The higher affinity of vaccinia [E1]profilin[/E1] for polyphosphoinositides (Kd = 0.2-8.5 microM) than for [E2]actin[/E2] or poly(L-proline) and the concentration of vaccinia profilin expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia profilin binds preferentially to PIP and PIP2 in vivo.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[32, 40]], "entity_1_idx_in_text_with_entity_marker": [36, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[98, 103]], "entity_2_idx_in_text_with_entity_marker": [111, 116], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d623.s1_BioInfer.d623.s1.p0", "text": "We expressed in Escherichia coli the vaccinia virus gene for a protein similar to vertebrate profilins, purified the recombinant viral profilin, and characterized its interactions with actin and polyphosphoinositides.", "text_with_entity_marker": "We expressed in Escherichia coli the vaccinia virus gene for a protein similar to vertebrate [E1]profilins[/E1], purified the recombinant viral [E2]profilin[/E2], and characterized its interactions with actin and polyphosphoinositides.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[93, 102]], "entity_1_idx_in_text_with_entity_marker": [97, 106], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[135, 143]], "entity_2_idx_in_text_with_entity_marker": [148, 156], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d623.s1_BioInfer.d623.s1.p1", "text": "We expressed in Escherichia coli the vaccinia virus gene for a protein similar to vertebrate profilins, purified the recombinant viral profilin, and characterized its interactions with actin and polyphosphoinositides.", "text_with_entity_marker": "We expressed in Escherichia coli the vaccinia virus gene for a protein similar to vertebrate profilins, purified the recombinant viral [E1]profilin[/E1], and characterized its interactions with [E2]actin[/E2] and polyphosphoinositides.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[135, 143]], "entity_1_idx_in_text_with_entity_marker": [139, 147], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[185, 190]], "entity_2_idx_in_text_with_entity_marker": [198, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d623.s1_BioInfer.d623.s1.p2", "text": "We expressed in Escherichia coli the vaccinia virus gene for a protein similar to vertebrate profilins, purified the recombinant viral profilin, and characterized its interactions with actin and polyphosphoinositides.", "text_with_entity_marker": "We expressed in Escherichia coli the vaccinia virus gene for a protein similar to vertebrate [E1]profilins[/E1], purified the recombinant viral profilin, and characterized its interactions with [E2]actin[/E2] and polyphosphoinositides.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[93, 102]], "entity_1_idx_in_text_with_entity_marker": [97, 106], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[185, 190]], "entity_2_idx_in_text_with_entity_marker": [198, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s1_BioInfer.d140.s1.p4", "text": "In this study we have used the yeast two-hybrid system to map the domains on alpha-catenin that allow it to associate with beta-catenin/plakoglobin and with alpha-actinin.", "text_with_entity_marker": "In this study we have used the yeast two-hybrid system to map the domains on [E1]alpha-catenin[/E1] that allow it to associate with beta-catenin/plakoglobin and with [E2]alpha-actinin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[77, 90]], "entity_1_idx_in_text_with_entity_marker": [81, 94], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-actinin", "entity_2_idx": [[157, 170]], "entity_2_idx_in_text_with_entity_marker": [170, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s1_BioInfer.d140.s1.p5", "text": "In this study we have used the yeast two-hybrid system to map the domains on alpha-catenin that allow it to associate with beta-catenin/plakoglobin and with alpha-actinin.", "text_with_entity_marker": "In this study we have used the yeast two-hybrid system to map the domains on alpha-catenin that allow it to associate with [E1]beta-catenin[/E1]/plakoglobin and with [E2]alpha-actinin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[123, 135]], "entity_1_idx_in_text_with_entity_marker": [127, 139], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-actinin", "entity_2_idx": [[157, 170]], "entity_2_idx_in_text_with_entity_marker": [170, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s2_BioInfer.d140.s2.p0", "text": "beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "text_with_entity_marker": "beta-catenin or [E1]plakoglobin[/E1] is associated directly with the [E2]cadherin[/E2]; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "plakoglobin", "entity_1_idx": [[16, 27]], "entity_1_idx_in_text_with_entity_marker": [20, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherin", "entity_2_idx": [[60, 68]], "entity_2_idx_in_text_with_entity_marker": [73, 81], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s2_BioInfer.d140.s2.p1", "text": "beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "text_with_entity_marker": "[E1]beta-catenin[/E1] or plakoglobin is associated directly with the [E2]cadherin[/E2]; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherin", "entity_2_idx": [[60, 68]], "entity_2_idx_in_text_with_entity_marker": [73, 81], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s2_BioInfer.d140.s2.p2", "text": "beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "text_with_entity_marker": "beta-catenin or plakoglobin is associated directly with the [E1]cadherin[/E1]; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the [E2]cadherin[/E2]/catenin complex to the actin cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cadherin", "entity_1_idx": [[60, 68]], "entity_1_idx_in_text_with_entity_marker": [64, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherin", "entity_2_idx": [[141, 149]], "entity_2_idx_in_text_with_entity_marker": [154, 162], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s2_BioInfer.d140.s2.p3", "text": "beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "text_with_entity_marker": "beta-catenin or plakoglobin is associated directly with the [E1]cadherin[/E1]; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/[E2]catenin[/E2] complex to the actin cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cadherin", "entity_1_idx": [[60, 68]], "entity_1_idx_in_text_with_entity_marker": [64, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "catenin", "entity_2_idx": [[150, 157]], "entity_2_idx_in_text_with_entity_marker": [163, 170], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s2_BioInfer.d140.s2.p4", "text": "beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "text_with_entity_marker": "beta-catenin or plakoglobin is associated directly with the [E1]cadherin[/E1]; [E2]alpha-catenin[/E2] binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cadherin", "entity_1_idx": [[60, 68]], "entity_1_idx_in_text_with_entity_marker": [64, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[70, 83]], "entity_2_idx_in_text_with_entity_marker": [83, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s2_BioInfer.d140.s2.p5", "text": "beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "text_with_entity_marker": "beta-catenin or plakoglobin is associated directly with the [E1]cadherin[/E1]; alpha-catenin binds to beta-catenin/[E2]plakoglobin[/E2] and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cadherin", "entity_1_idx": [[60, 68]], "entity_1_idx_in_text_with_entity_marker": [64, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[106, 117]], "entity_2_idx_in_text_with_entity_marker": [119, 130], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s2_BioInfer.d140.s2.p6", "text": "beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "text_with_entity_marker": "beta-catenin or plakoglobin is associated directly with the [E1]cadherin[/E1]; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cadherin", "entity_1_idx": [[60, 68]], "entity_1_idx_in_text_with_entity_marker": [64, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[173, 178]], "entity_2_idx_in_text_with_entity_marker": [186, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s2_BioInfer.d140.s2.p7", "text": "beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "text_with_entity_marker": "beta-catenin or plakoglobin is associated directly with the [E1]cadherin[/E1]; alpha-catenin binds to [E2]beta-catenin[/E2]/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cadherin", "entity_1_idx": [[60, 68]], "entity_1_idx_in_text_with_entity_marker": [64, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[93, 105]], "entity_2_idx_in_text_with_entity_marker": [106, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d601.s0_BioInfer.d601.s0.p0", "text": "The C-terminal of TRADD comprises the \"death domain\" that is responsible for association of TNFR1 and other death domain-containing proteins such as FADD and RIP.", "text_with_entity_marker": "The C-terminal of [E1]TRADD[/E1] comprises the \"death domain\" that is responsible for association of TNFR1 and other death domain-containing proteins such as [E2]FADD[/E2] and RIP.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRADD", "entity_1_idx": [[18, 23]], "entity_1_idx_in_text_with_entity_marker": [22, 27], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FADD", "entity_2_idx": [[149, 153]], "entity_2_idx_in_text_with_entity_marker": [162, 166], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d601.s0_BioInfer.d601.s0.p1", "text": "The C-terminal of TRADD comprises the \"death domain\" that is responsible for association of TNFR1 and other death domain-containing proteins such as FADD and RIP.", "text_with_entity_marker": "The C-terminal of [E1]TRADD[/E1] comprises the \"death domain\" that is responsible for association of [E2]TNFR1[/E2] and other death domain-containing proteins such as FADD and RIP.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRADD", "entity_1_idx": [[18, 23]], "entity_1_idx_in_text_with_entity_marker": [22, 27], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TNFR1", "entity_2_idx": [[92, 97]], "entity_2_idx_in_text_with_entity_marker": [105, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d601.s0_BioInfer.d601.s0.p2", "text": "The C-terminal of TRADD comprises the \"death domain\" that is responsible for association of TNFR1 and other death domain-containing proteins such as FADD and RIP.", "text_with_entity_marker": "The C-terminal of [E1]TRADD[/E1] comprises the \"death domain\" that is responsible for association of TNFR1 and other death domain-containing proteins such as FADD and [E2]RIP[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRADD", "entity_1_idx": [[18, 23]], "entity_1_idx_in_text_with_entity_marker": [22, 27], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RIP", "entity_2_idx": [[158, 161]], "entity_2_idx_in_text_with_entity_marker": [171, 174], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d601.s0_BioInfer.d601.s0.p3", "text": "The C-terminal of TRADD comprises the \"death domain\" that is responsible for association of TNFR1 and other death domain-containing proteins such as FADD and RIP.", "text_with_entity_marker": "The C-terminal of TRADD comprises the \"death domain\" that is responsible for association of [E1]TNFR1[/E1] and other death domain-containing proteins such as [E2]FADD[/E2] and RIP.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TNFR1", "entity_1_idx": [[92, 97]], "entity_1_idx_in_text_with_entity_marker": [96, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[149, 153]], "entity_2_idx_in_text_with_entity_marker": [162, 166], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d601.s0_BioInfer.d601.s0.p4", "text": "The C-terminal of TRADD comprises the \"death domain\" that is responsible for association of TNFR1 and other death domain-containing proteins such as FADD and RIP.", "text_with_entity_marker": "The C-terminal of TRADD comprises the \"death domain\" that is responsible for association of TNFR1 and other death domain-containing proteins such as [E1]FADD[/E1] and [E2]RIP[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[149, 153]], "entity_1_idx_in_text_with_entity_marker": [153, 157], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP", "entity_2_idx": [[158, 161]], "entity_2_idx_in_text_with_entity_marker": [171, 174], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d601.s0_BioInfer.d601.s0.p5", "text": "The C-terminal of TRADD comprises the \"death domain\" that is responsible for association of TNFR1 and other death domain-containing proteins such as FADD and RIP.", "text_with_entity_marker": "The C-terminal of TRADD comprises the \"death domain\" that is responsible for association of [E1]TNFR1[/E1] and other death domain-containing proteins such as FADD and [E2]RIP[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TNFR1", "entity_1_idx": [[92, 97]], "entity_1_idx_in_text_with_entity_marker": [96, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP", "entity_2_idx": [[158, 161]], "entity_2_idx_in_text_with_entity_marker": [171, 174], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p0", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin ([E1]SAC6[/E1]), Abp1p (ABP1), and capping protein (CAP1 and [E2]CAP2[/E2]) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SAC6", "entity_1_idx": [[107, 111]], "entity_1_idx_in_text_with_entity_marker": [111, 115], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "CAP2", "entity_2_idx": [[158, 162]], "entity_2_idx_in_text_with_entity_marker": [171, 175], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p1", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), [E1]fimbrin[/E1] (SAC6), Abp1p (ABP1), and capping protein (CAP1 and [E2]CAP2[/E2]) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fimbrin", "entity_1_idx": [[98, 105]], "entity_1_idx_in_text_with_entity_marker": [102, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CAP2", "entity_2_idx": [[158, 162]], "entity_2_idx_in_text_with_entity_marker": [171, 175], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p2", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the [E1]tropomyosin[/E1] (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and [E2]CAP2[/E2]) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tropomyosin", "entity_1_idx": [[78, 89]], "entity_1_idx_in_text_with_entity_marker": [82, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CAP2", "entity_2_idx": [[158, 162]], "entity_2_idx_in_text_with_entity_marker": [171, 175], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p3", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the [E1]actin[/E1] gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and [E2]CAP2[/E2]) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[23, 28]], "entity_1_idx_in_text_with_entity_marker": [27, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CAP2", "entity_2_idx": [[158, 162]], "entity_2_idx_in_text_with_entity_marker": [171, 175], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p4", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein ([E1]CAP1[/E1] and [E2]CAP2[/E2]) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CAP1", "entity_1_idx": [[149, 153]], "entity_1_idx_in_text_with_entity_marker": [153, 157], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "CAP2", "entity_2_idx": [[158, 162]], "entity_2_idx_in_text_with_entity_marker": [171, 175], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p5", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), [E1]Abp1p[/E1] (ABP1), and capping protein (CAP1 and [E2]CAP2[/E2]) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Abp1p", "entity_1_idx": [[114, 119]], "entity_1_idx_in_text_with_entity_marker": [118, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CAP2", "entity_2_idx": [[158, 162]], "entity_2_idx_in_text_with_entity_marker": [171, 175], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p6", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and [E1]capping protein[/E1] (CAP1 and [E2]CAP2[/E2]) genes have relatively mild or no effects.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "capping protein", "entity_1_idx": [[132, 147]], "entity_1_idx_in_text_with_entity_marker": [136, 151], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CAP2", "entity_2_idx": [[158, 162]], "entity_2_idx_in_text_with_entity_marker": [171, 175], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p7", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p ([E1]ABP1[/E1]), and capping protein (CAP1 and [E2]CAP2[/E2]) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ABP1", "entity_1_idx": [[121, 125]], "entity_1_idx_in_text_with_entity_marker": [125, 129], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "CAP2", "entity_2_idx": [[158, 162]], "entity_2_idx_in_text_with_entity_marker": [171, 175], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p8", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene ([E1]ACT1[/E1]) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and [E2]CAP2[/E2]) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ACT1", "entity_1_idx": [[35, 39]], "entity_1_idx_in_text_with_entity_marker": [39, 43], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "CAP2", "entity_2_idx": [[158, 162]], "entity_2_idx_in_text_with_entity_marker": [171, 175], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p9", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin ([E1]TPM1[/E1]), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and [E2]CAP2[/E2]) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TPM1", "entity_1_idx": [[91, 95]], "entity_1_idx_in_text_with_entity_marker": [95, 99], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "CAP2", "entity_2_idx": [[158, 162]], "entity_2_idx_in_text_with_entity_marker": [171, 175], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p40", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), [E1]Abp1p[/E1] (ABP1), and capping protein ([E2]CAP1[/E2] and CAP2) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Abp1p", "entity_1_idx": [[114, 119]], "entity_1_idx_in_text_with_entity_marker": [118, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CAP1", "entity_2_idx": [[149, 153]], "entity_2_idx_in_text_with_entity_marker": [162, 166], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p41", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and [E1]capping protein[/E1] ([E2]CAP1[/E2] and CAP2) genes have relatively mild or no effects.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "capping protein", "entity_1_idx": [[132, 147]], "entity_1_idx_in_text_with_entity_marker": [136, 151], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CAP1", "entity_2_idx": [[149, 153]], "entity_2_idx_in_text_with_entity_marker": [162, 166], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p42", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p ([E1]ABP1[/E1]), and capping protein ([E2]CAP1[/E2] and CAP2) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ABP1", "entity_1_idx": [[121, 125]], "entity_1_idx_in_text_with_entity_marker": [125, 129], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "CAP1", "entity_2_idx": [[149, 153]], "entity_2_idx_in_text_with_entity_marker": [162, 166], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p43", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene ([E1]ACT1[/E1]) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein ([E2]CAP1[/E2] and CAP2) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ACT1", "entity_1_idx": [[35, 39]], "entity_1_idx_in_text_with_entity_marker": [39, 43], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "CAP1", "entity_2_idx": [[149, 153]], "entity_2_idx_in_text_with_entity_marker": [162, 166], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p44", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin ([E1]TPM1[/E1]), fimbrin (SAC6), Abp1p (ABP1), and capping protein ([E2]CAP1[/E2] and CAP2) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TPM1", "entity_1_idx": [[91, 95]], "entity_1_idx_in_text_with_entity_marker": [95, 99], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "CAP1", "entity_2_idx": [[149, 153]], "entity_2_idx_in_text_with_entity_marker": [162, 166], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p45", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), [E1]Abp1p[/E1] (ABP1), and [E2]capping protein[/E2] (CAP1 and CAP2) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Abp1p", "entity_1_idx": [[114, 119]], "entity_1_idx_in_text_with_entity_marker": [118, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "capping protein", "entity_2_idx": [[132, 147]], "entity_2_idx_in_text_with_entity_marker": [145, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p46", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), [E1]Abp1p[/E1] ([E2]ABP1[/E2]), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Abp1p", "entity_1_idx": [[114, 119]], "entity_1_idx_in_text_with_entity_marker": [118, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ABP1", "entity_2_idx": [[121, 125]], "entity_2_idx_in_text_with_entity_marker": [134, 138], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p47", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene ([E1]ACT1[/E1]) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), [E2]Abp1p[/E2] (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ACT1", "entity_1_idx": [[35, 39]], "entity_1_idx_in_text_with_entity_marker": [39, 43], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "Abp1p", "entity_2_idx": [[114, 119]], "entity_2_idx_in_text_with_entity_marker": [127, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p48", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin ([E1]TPM1[/E1]), fimbrin (SAC6), [E2]Abp1p[/E2] (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TPM1", "entity_1_idx": [[91, 95]], "entity_1_idx_in_text_with_entity_marker": [95, 99], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "Abp1p", "entity_2_idx": [[114, 119]], "entity_2_idx_in_text_with_entity_marker": [127, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p49", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p ([E1]ABP1[/E1]), and [E2]capping protein[/E2] (CAP1 and CAP2) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ABP1", "entity_1_idx": [[121, 125]], "entity_1_idx_in_text_with_entity_marker": [125, 129], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "capping protein", "entity_2_idx": [[132, 147]], "entity_2_idx_in_text_with_entity_marker": [145, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p50", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene ([E1]ACT1[/E1]) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and [E2]capping protein[/E2] (CAP1 and CAP2) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ACT1", "entity_1_idx": [[35, 39]], "entity_1_idx_in_text_with_entity_marker": [39, 43], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "capping protein", "entity_2_idx": [[132, 147]], "entity_2_idx_in_text_with_entity_marker": [145, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p51", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin ([E1]TPM1[/E1]), fimbrin (SAC6), Abp1p (ABP1), and [E2]capping protein[/E2] (CAP1 and CAP2) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TPM1", "entity_1_idx": [[91, 95]], "entity_1_idx_in_text_with_entity_marker": [95, 99], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "capping protein", "entity_2_idx": [[132, 147]], "entity_2_idx_in_text_with_entity_marker": [145, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p52", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene ([E1]ACT1[/E1]) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p ([E2]ABP1[/E2]), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ACT1", "entity_1_idx": [[35, 39]], "entity_1_idx_in_text_with_entity_marker": [39, 43], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "ABP1", "entity_2_idx": [[121, 125]], "entity_2_idx_in_text_with_entity_marker": [134, 138], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p53", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin ([E1]TPM1[/E1]), fimbrin (SAC6), Abp1p ([E2]ABP1[/E2]), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TPM1", "entity_1_idx": [[91, 95]], "entity_1_idx_in_text_with_entity_marker": [95, 99], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "ABP1", "entity_2_idx": [[121, 125]], "entity_2_idx_in_text_with_entity_marker": [134, 138], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d67.s0_BioInfer.d67.s0.p54", "text": "A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "text_with_entity_marker": "A null mutation of the actin gene ([E1]ACT1[/E1]) is lethal, but null mutations in the tropomyosin ([E2]TPM1[/E2]), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ACT1", "entity_1_idx": [[35, 39]], "entity_1_idx_in_text_with_entity_marker": [39, 43], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "TPM1", "entity_2_idx": [[91, 95]], "entity_2_idx_in_text_with_entity_marker": [104, 108], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d590.s0_BioInfer.d590.s0.p0", "text": "The cardiac myosin heavy chain Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the actin- or ATP-binding capacities of two size-limited recombinant myosin heavy chain fragments.", "text_with_entity_marker": "The cardiac myosin heavy chain Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the [E1]actin[/E1]- or ATP-binding capacities of two size-limited recombinant [E2]myosin heavy chain[/E2] fragments.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[114, 119]], "entity_1_idx_in_text_with_entity_marker": [118, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chain", "entity_2_idx": [[179, 197]], "entity_2_idx_in_text_with_entity_marker": [192, 210], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d590.s0_BioInfer.d590.s0.p1", "text": "The cardiac myosin heavy chain Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the actin- or ATP-binding capacities of two size-limited recombinant myosin heavy chain fragments.", "text_with_entity_marker": "The [E1]cardiac myosin heavy chain[/E1] Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the [E2]actin[/E2]- or ATP-binding capacities of two size-limited recombinant myosin heavy chain fragments.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cardiac myosin heavy chain", "entity_1_idx": [[4, 30]], "entity_1_idx_in_text_with_entity_marker": [8, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[114, 119]], "entity_2_idx_in_text_with_entity_marker": [127, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d590.s0_BioInfer.d590.s0.p2", "text": "The cardiac myosin heavy chain Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the actin- or ATP-binding capacities of two size-limited recombinant myosin heavy chain fragments.", "text_with_entity_marker": "The [E1]cardiac myosin heavy chain[/E1] Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the actin- or ATP-binding capacities of two size-limited recombinant [E2]myosin heavy chain[/E2] fragments.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cardiac myosin heavy chain", "entity_1_idx": [[4, 30]], "entity_1_idx_in_text_with_entity_marker": [8, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chain", "entity_2_idx": [[179, 197]], "entity_2_idx_in_text_with_entity_marker": [192, 210], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d238.s0_BioInfer.d238.s0.p0", "text": "Here we demonstrate that accessory receptor triggering induces the transient association of cofilin with the actin cytoskeleton.", "text_with_entity_marker": "Here we demonstrate that accessory receptor triggering induces the transient association of [E1]cofilin[/E1] with the [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[92, 99]], "entity_1_idx_in_text_with_entity_marker": [96, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[109, 114]], "entity_2_idx_in_text_with_entity_marker": [122, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d238.s1_BioInfer.d238.s1.p0", "text": "Recently, we have shown that the small actin-depolymerizing protein cofilin represents a component of a co-stimulatory signaling pathway in human T cells.", "text_with_entity_marker": "Recently, we have shown that the small [E1]actin[/E1]-depolymerizing protein [E2]cofilin[/E2] represents a component of a co-stimulatory signaling pathway in human T cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[39, 44]], "entity_1_idx_in_text_with_entity_marker": [43, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[68, 75]], "entity_2_idx_in_text_with_entity_marker": [81, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d238.s2_BioInfer.d238.s2.p0", "text": "These results suggest that cofilin provides an as yet missing link between functionally crucial T cell surface receptors and rearrangements of the actin cytoskeleton.", "text_with_entity_marker": "These results suggest that [E1]cofilin[/E1] provides an as yet missing link between functionally crucial T cell surface receptors and rearrangements of the [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[27, 34]], "entity_1_idx_in_text_with_entity_marker": [31, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d74.s0_BioInfer.d74.s0.p10", "text": "Archaeal histones are most similar to the globular histone fold region of eukaryal histone H4, and the results reported are consistent with archaeal nucleosomes resembling the structure formed by eukaryal histone (H3+H4)2tetramers.", "text_with_entity_marker": "Archaeal [E1]histones[/E1] are most similar to the globular histone fold region of eukaryal histone [E2]H4[/E2], and the results reported are consistent with archaeal nucleosomes resembling the structure formed by eukaryal histone (H3+H4)2tetramers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[91, 93]], "entity_2_idx_in_text_with_entity_marker": [104, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d74.s0_BioInfer.d74.s0.p11", "text": "Archaeal histones are most similar to the globular histone fold region of eukaryal histone H4, and the results reported are consistent with archaeal nucleosomes resembling the structure formed by eukaryal histone (H3+H4)2tetramers.", "text_with_entity_marker": "Archaeal [E1]histones[/E1] are most similar to the globular histone fold region of eukaryal histone H4, and the results reported are consistent with archaeal nucleosomes resembling the structure formed by eukaryal histone ([E2]H3[/E2]+H4)2tetramers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[214, 216]], "entity_2_idx_in_text_with_entity_marker": [227, 229], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d74.s0_BioInfer.d74.s0.p12", "text": "Archaeal histones are most similar to the globular histone fold region of eukaryal histone H4, and the results reported are consistent with archaeal nucleosomes resembling the structure formed by eukaryal histone (H3+H4)2tetramers.", "text_with_entity_marker": "Archaeal [E1]histones[/E1] are most similar to the globular histone fold region of eukaryal histone H4, and the results reported are consistent with archaeal nucleosomes resembling the structure formed by eukaryal [E2]histone[/E2] (H3+H4)2tetramers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[205, 212]], "entity_2_idx_in_text_with_entity_marker": [218, 225], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d74.s0_BioInfer.d74.s0.p13", "text": "Archaeal histones are most similar to the globular histone fold region of eukaryal histone H4, and the results reported are consistent with archaeal nucleosomes resembling the structure formed by eukaryal histone (H3+H4)2tetramers.", "text_with_entity_marker": "Archaeal histones are most similar to the globular [E1]histone[/E1] fold region of eukaryal histone H4, and the results reported are consistent with archaeal [E2]nucleosomes[/E2] resembling the structure formed by eukaryal histone (H3+H4)2tetramers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[51, 58]], "entity_1_idx_in_text_with_entity_marker": [55, 62], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "nucleosomes", "entity_2_idx": [[149, 160]], "entity_2_idx_in_text_with_entity_marker": [162, 173], "entity_2_type": "Protein_complex", "entity_2_type_id": 5}], "directed": false, "reverse": false}
{"id": "BioInfer.d74.s0_BioInfer.d74.s0.p14", "text": "Archaeal histones are most similar to the globular histone fold region of eukaryal histone H4, and the results reported are consistent with archaeal nucleosomes resembling the structure formed by eukaryal histone (H3+H4)2tetramers.", "text_with_entity_marker": "Archaeal histones are most similar to the globular [E1]histone[/E1] fold region of eukaryal histone H4, and the results reported are consistent with archaeal nucleosomes resembling the structure formed by eukaryal histone (H3+[E2]H4[/E2])2tetramers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[51, 58]], "entity_1_idx_in_text_with_entity_marker": [55, 62], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[217, 219]], "entity_2_idx_in_text_with_entity_marker": [230, 232], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d74.s0_BioInfer.d74.s0.p15", "text": "Archaeal histones are most similar to the globular histone fold region of eukaryal histone H4, and the results reported are consistent with archaeal nucleosomes resembling the structure formed by eukaryal histone (H3+H4)2tetramers.", "text_with_entity_marker": "Archaeal histones are most similar to the globular [E1]histone[/E1] fold region of eukaryal histone [E2]H4[/E2], and the results reported are consistent with archaeal nucleosomes resembling the structure formed by eukaryal histone (H3+H4)2tetramers.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[51, 58]], "entity_1_idx_in_text_with_entity_marker": [55, 62], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[91, 93]], "entity_2_idx_in_text_with_entity_marker": [104, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d74.s0_BioInfer.d74.s0.p16", "text": "Archaeal histones are most similar to the globular histone fold region of eukaryal histone H4, and the results reported are consistent with archaeal nucleosomes resembling the structure formed by eukaryal histone (H3+H4)2tetramers.", "text_with_entity_marker": "Archaeal histones are most similar to the globular [E1]histone[/E1] fold region of eukaryal histone H4, and the results reported are consistent with archaeal nucleosomes resembling the structure formed by eukaryal histone ([E2]H3[/E2]+H4)2tetramers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[51, 58]], "entity_1_idx_in_text_with_entity_marker": [55, 62], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[214, 216]], "entity_2_idx_in_text_with_entity_marker": [227, 229], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d74.s0_BioInfer.d74.s0.p17", "text": "Archaeal histones are most similar to the globular histone fold region of eukaryal histone H4, and the results reported are consistent with archaeal nucleosomes resembling the structure formed by eukaryal histone (H3+H4)2tetramers.", "text_with_entity_marker": "Archaeal histones are most similar to the globular [E1]histone[/E1] fold region of eukaryal histone H4, and the results reported are consistent with archaeal nucleosomes resembling the structure formed by eukaryal [E2]histone[/E2] (H3+H4)2tetramers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[51, 58]], "entity_1_idx_in_text_with_entity_marker": [55, 62], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[205, 212]], "entity_2_idx_in_text_with_entity_marker": [218, 225], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d74.s0_BioInfer.d74.s0.p18", "text": "Archaeal histones are most similar to the globular histone fold region of eukaryal histone H4, and the results reported are consistent with archaeal nucleosomes resembling the structure formed by eukaryal histone (H3+H4)2tetramers.", "text_with_entity_marker": "Archaeal histones are most similar to the globular histone fold region of eukaryal histone H4, and the results reported are consistent with archaeal [E1]nucleosomes[/E1] resembling the structure formed by eukaryal histone (H3+[E2]H4[/E2])2tetramers.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "nucleosomes", "entity_1_idx": [[149, 160]], "entity_1_idx_in_text_with_entity_marker": [153, 164], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "H4", "entity_2_idx": [[217, 219]], "entity_2_idx_in_text_with_entity_marker": [230, 232], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d74.s0_BioInfer.d74.s0.p19", "text": "Archaeal histones are most similar to the globular histone fold region of eukaryal histone H4, and the results reported are consistent with archaeal nucleosomes resembling the structure formed by eukaryal histone (H3+H4)2tetramers.", "text_with_entity_marker": "Archaeal histones are most similar to the globular histone fold region of eukaryal histone [E1]H4[/E1], and the results reported are consistent with archaeal [E2]nucleosomes[/E2] resembling the structure formed by eukaryal histone (H3+H4)2tetramers.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[91, 93]], "entity_1_idx_in_text_with_entity_marker": [95, 97], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleosomes", "entity_2_idx": [[149, 160]], "entity_2_idx_in_text_with_entity_marker": [162, 173], "entity_2_type": "Protein_complex", "entity_2_type_id": 5}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p0", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase ([E1]TS[/E1]), dihydrofolate reductase ([E2]DHFR[/E2]), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TS", "entity_1_idx": [[81, 83]], "entity_1_idx_in_text_with_entity_marker": [85, 87], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "DHFR", "entity_2_idx": [[111, 115]], "entity_2_idx_in_text_with_entity_marker": [124, 128], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p1", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase ([E1]DHFR[/E1]), ribonucleotide reductase (PNR), proliferating cell nuclear antigen ([E2]PCNA[/E2]), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DHFR", "entity_1_idx": [[111, 115]], "entity_1_idx_in_text_with_entity_marker": [115, 119], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PCNA", "entity_2_idx": [[186, 190]], "entity_2_idx_in_text_with_entity_marker": [199, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p2", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase ([E1]DHFR[/E1]), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, [E2]histone[/E2] H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DHFR", "entity_1_idx": [[111, 115]], "entity_1_idx_in_text_with_entity_marker": [115, 119], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[205, 212]], "entity_2_idx_in_text_with_entity_marker": [218, 225], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p3", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase ([E1]DHFR[/E1]), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), [E2]histone[/E2] H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DHFR", "entity_1_idx": [[111, 115]], "entity_1_idx_in_text_with_entity_marker": [115, 119], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[193, 200]], "entity_2_idx_in_text_with_entity_marker": [206, 213], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p4", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase ([E1]DHFR[/E1]), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and [E2]histone[/E2] H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DHFR", "entity_1_idx": [[111, 115]], "entity_1_idx_in_text_with_entity_marker": [115, 119], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[239, 246]], "entity_2_idx_in_text_with_entity_marker": [252, 259], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p5", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase ([E1]DHFR[/E1]), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, [E2]histone[/E2] H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DHFR", "entity_1_idx": [[111, 115]], "entity_1_idx_in_text_with_entity_marker": [115, 119], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[223, 230]], "entity_2_idx_in_text_with_entity_marker": [236, 243], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p6", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase ([E1]DHFR[/E1]), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone [E2]H[/E2]2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DHFR", "entity_1_idx": [[111, 115]], "entity_1_idx_in_text_with_entity_marker": [115, 119], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[213, 214], [219, 221]], "entity_2_idx_in_text_with_entity_marker": [226, 227], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p7", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase ([E1]DHFR[/E1]), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone [E2]H4[/E2], was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DHFR", "entity_1_idx": [[111, 115]], "entity_1_idx_in_text_with_entity_marker": [115, 119], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[247, 249]], "entity_2_idx_in_text_with_entity_marker": [260, 262], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p8", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase ([E1]DHFR[/E1]), ribonucleotide reductase ([E2]PNR[/E2]), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DHFR", "entity_1_idx": [[111, 115]], "entity_1_idx_in_text_with_entity_marker": [115, 119], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PNR", "entity_2_idx": [[144, 147]], "entity_2_idx_in_text_with_entity_marker": [157, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p9", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including [E1]thymidylate synthase[/E1] (TS), dihydrofolate reductase ([E2]DHFR[/E2]), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thymidylate synthase", "entity_1_idx": [[59, 79]], "entity_1_idx_in_text_with_entity_marker": [63, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "DHFR", "entity_2_idx": [[111, 115]], "entity_2_idx_in_text_with_entity_marker": [124, 128], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p40", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), [E1]ribonucleotide reductase[/E1] (PNR), proliferating cell nuclear antigen ([E2]PCNA[/E2]), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ribonucleotide reductase", "entity_1_idx": [[118, 142]], "entity_1_idx_in_text_with_entity_marker": [122, 146], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PCNA", "entity_2_idx": [[186, 190]], "entity_2_idx_in_text_with_entity_marker": [199, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p41", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen ([E1]PCNA[/E1]), histone H1, histone [E2]H2A[/E2] + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PCNA", "entity_1_idx": [[186, 190]], "entity_1_idx_in_text_with_entity_marker": [190, 194], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A", "entity_2_idx": [[213, 216]], "entity_2_idx_in_text_with_entity_marker": [226, 229], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p42", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen ([E1]PCNA[/E1]), histone [E2]H1[/E2], histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PCNA", "entity_1_idx": [[186, 190]], "entity_1_idx_in_text_with_entity_marker": [190, 194], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H1", "entity_2_idx": [[201, 203]], "entity_2_idx_in_text_with_entity_marker": [214, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p43", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), [E1]proliferating cell nuclear antigen[/E1] ([E2]PCNA[/E2]), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "proliferating cell nuclear antigen", "entity_1_idx": [[150, 184]], "entity_1_idx_in_text_with_entity_marker": [154, 188], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PCNA", "entity_2_idx": [[186, 190]], "entity_2_idx_in_text_with_entity_marker": [199, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p44", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen ([E1]PCNA[/E1]), histone H1, histone H2A + 2B, histone [E2]H3[/E2], and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PCNA", "entity_1_idx": [[186, 190]], "entity_1_idx_in_text_with_entity_marker": [190, 194], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[231, 233]], "entity_2_idx_in_text_with_entity_marker": [244, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p45", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), [E1]histone[/E1] H1, [E2]histone[/E2] H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[193, 200]], "entity_1_idx_in_text_with_entity_marker": [197, 204], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[205, 212]], "entity_2_idx_in_text_with_entity_marker": [218, 225], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p46", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, [E1]histone[/E1] H2A + 2B, histone H3, and [E2]histone[/E2] H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[205, 212]], "entity_1_idx_in_text_with_entity_marker": [209, 216], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[239, 246]], "entity_2_idx_in_text_with_entity_marker": [252, 259], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p47", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, [E1]histone[/E1] H2A + 2B, [E2]histone[/E2] H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[205, 212]], "entity_1_idx_in_text_with_entity_marker": [209, 216], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[223, 230]], "entity_2_idx_in_text_with_entity_marker": [236, 243], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p48", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, [E1]histone[/E1] [E2]H[/E2]2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[205, 212]], "entity_1_idx_in_text_with_entity_marker": [209, 216], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H", "entity_2_idx": [[213, 214], [219, 221]], "entity_2_idx_in_text_with_entity_marker": [226, 227], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p49", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, [E1]histone[/E1] H2A + 2B, histone H3, and histone [E2]H4[/E2], was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[205, 212]], "entity_1_idx_in_text_with_entity_marker": [209, 216], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[247, 249]], "entity_2_idx_in_text_with_entity_marker": [260, 262], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p70", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, [E1]histone[/E1] H3, and [E2]histone[/E2] H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[223, 230]], "entity_1_idx_in_text_with_entity_marker": [227, 234], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[239, 246]], "entity_2_idx_in_text_with_entity_marker": [252, 259], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p71", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone [E1]H[/E1]2A + 2B, histone H3, and [E2]histone[/E2] H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H", "entity_1_idx": [[213, 214], [219, 221]], "entity_1_idx_in_text_with_entity_marker": [217, 218], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[239, 246]], "entity_2_idx_in_text_with_entity_marker": [252, 259], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p72", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and [E1]histone[/E1] [E2]H4[/E2], was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[239, 246]], "entity_1_idx_in_text_with_entity_marker": [243, 250], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[247, 249]], "entity_2_idx_in_text_with_entity_marker": [260, 262], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p73", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase ([E1]PNR[/E1]), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and [E2]histone[/E2] H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PNR", "entity_1_idx": [[144, 147]], "entity_1_idx_in_text_with_entity_marker": [148, 151], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[239, 246]], "entity_2_idx_in_text_with_entity_marker": [252, 259], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p74", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including [E1]thymidylate synthase[/E1] (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and [E2]histone[/E2] H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thymidylate synthase", "entity_1_idx": [[59, 79]], "entity_1_idx_in_text_with_entity_marker": [63, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[239, 246]], "entity_2_idx_in_text_with_entity_marker": [252, 259], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p75", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), [E1]dihydrofolate reductase[/E1] (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and [E2]histone[/E2] H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "dihydrofolate reductase", "entity_1_idx": [[86, 109]], "entity_1_idx_in_text_with_entity_marker": [90, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[239, 246]], "entity_2_idx_in_text_with_entity_marker": [252, 259], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p76", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), [E1]ribonucleotide reductase[/E1] (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and [E2]histone[/E2] H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ribonucleotide reductase", "entity_1_idx": [[118, 142]], "entity_1_idx_in_text_with_entity_marker": [122, 146], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[239, 246]], "entity_2_idx_in_text_with_entity_marker": [252, 259], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p77", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone [E1]H2A[/E1] + 2B, histone H3, and [E2]histone[/E2] H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A", "entity_1_idx": [[213, 216]], "entity_1_idx_in_text_with_entity_marker": [217, 220], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[239, 246]], "entity_2_idx_in_text_with_entity_marker": [252, 259], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p78", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone [E1]H1[/E1], histone H2A + 2B, histone H3, and [E2]histone[/E2] H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H1", "entity_1_idx": [[201, 203]], "entity_1_idx_in_text_with_entity_marker": [205, 207], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[239, 246]], "entity_2_idx_in_text_with_entity_marker": [252, 259], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p79", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), [E1]proliferating cell nuclear antigen[/E1] (PCNA), histone H1, histone H2A + 2B, histone H3, and [E2]histone[/E2] H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "proliferating cell nuclear antigen", "entity_1_idx": [[150, 184]], "entity_1_idx_in_text_with_entity_marker": [154, 188], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[239, 246]], "entity_2_idx_in_text_with_entity_marker": [252, 259], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d706.s0_BioInfer.d706.s0.p20", "text": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.", "text_with_entity_marker": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/[E1]Armadillo[/E1], and [E2]classical cadherin[/E2], respectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Armadillo", "entity_1_idx": [[134, 143]], "entity_1_idx_in_text_with_entity_marker": [138, 147], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "classical cadherin", "entity_2_idx": [[149, 167]], "entity_2_idx_in_text_with_entity_marker": [162, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d706.s0_BioInfer.d706.s0.p21", "text": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.", "text_with_entity_marker": "The sequences of the predicted [E1]HMP-1[/E1], HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and [E2]classical cadherin[/E2], respectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HMP-1", "entity_1_idx": [[31, 36]], "entity_1_idx_in_text_with_entity_marker": [35, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "classical cadherin", "entity_2_idx": [[149, 167]], "entity_2_idx_in_text_with_entity_marker": [162, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d706.s0_BioInfer.d706.s0.p22", "text": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.", "text_with_entity_marker": "The sequences of the predicted HMP-1, [E1]HMP-2[/E1], and [E2]HMR-1[/E2] proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HMP-2", "entity_1_idx": [[38, 43]], "entity_1_idx_in_text_with_entity_marker": [42, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HMR-1", "entity_2_idx": [[49, 54]], "entity_2_idx_in_text_with_entity_marker": [62, 67], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d706.s0_BioInfer.d706.s0.p23", "text": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.", "text_with_entity_marker": "The sequences of the predicted HMP-1, [E1]HMP-2[/E1], and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/[E2]Armadillo[/E2], and classical cadherin, respectively.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "HMP-2", "entity_1_idx": [[38, 43]], "entity_1_idx_in_text_with_entity_marker": [42, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Armadillo", "entity_2_idx": [[134, 143]], "entity_2_idx_in_text_with_entity_marker": [147, 156], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d706.s0_BioInfer.d706.s0.p24", "text": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.", "text_with_entity_marker": "The sequences of the predicted [E1]HMP-1[/E1], [E2]HMP-2[/E2], and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HMP-1", "entity_1_idx": [[31, 36]], "entity_1_idx_in_text_with_entity_marker": [35, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HMP-2", "entity_2_idx": [[38, 43]], "entity_2_idx_in_text_with_entity_marker": [51, 56], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d706.s0_BioInfer.d706.s0.p25", "text": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.", "text_with_entity_marker": "The sequences of the predicted HMP-1, HMP-2, and [E1]HMR-1[/E1] proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/[E2]Armadillo[/E2], and classical cadherin, respectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HMR-1", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Armadillo", "entity_2_idx": [[134, 143]], "entity_2_idx_in_text_with_entity_marker": [147, 156], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d706.s0_BioInfer.d706.s0.p26", "text": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.", "text_with_entity_marker": "The sequences of the predicted [E1]HMP-1[/E1], HMP-2, and [E2]HMR-1[/E2] proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HMP-1", "entity_1_idx": [[31, 36]], "entity_1_idx_in_text_with_entity_marker": [35, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HMR-1", "entity_2_idx": [[49, 54]], "entity_2_idx_in_text_with_entity_marker": [62, 67], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d706.s0_BioInfer.d706.s0.p27", "text": "The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.", "text_with_entity_marker": "The sequences of the predicted [E1]HMP-1[/E1], HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/[E2]Armadillo[/E2], and classical cadherin, respectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HMP-1", "entity_1_idx": [[31, 36]], "entity_1_idx_in_text_with_entity_marker": [35, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Armadillo", "entity_2_idx": [[134, 143]], "entity_2_idx_in_text_with_entity_marker": [147, 156], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d791.s0_BioInfer.d791.s0.p0", "text": "Vascular endothelial cadherin (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.", "text_with_entity_marker": "Vascular endothelial cadherin ([E1]VE-cadherin[/E1]) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "VE-cadherin", "entity_1_idx": [[31, 42]], "entity_1_idx_in_text_with_entity_marker": [35, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[215, 220]], "entity_2_idx_in_text_with_entity_marker": [228, 233], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d791.s0_BioInfer.d791.s0.p1", "text": "Vascular endothelial cadherin (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.", "text_with_entity_marker": "[E1]Vascular endothelial cadherin[/E1] ([E2]VE-cadherin[/E2]) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Vascular endothelial cadherin", "entity_1_idx": [[0, 29]], "entity_1_idx_in_text_with_entity_marker": [4, 33], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VE-cadherin", "entity_2_idx": [[31, 42]], "entity_2_idx_in_text_with_entity_marker": [44, 55], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d791.s0_BioInfer.d791.s0.p2", "text": "Vascular endothelial cadherin (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.", "text_with_entity_marker": "Vascular endothelial cadherin ([E1]VE-cadherin[/E1]) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with [E2]alpha-catenin[/E2], which is thought to link the complex to the peri-junctional actin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "VE-cadherin", "entity_1_idx": [[31, 42]], "entity_1_idx_in_text_with_entity_marker": [35, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[140, 153]], "entity_2_idx_in_text_with_entity_marker": [153, 166], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d791.s0_BioInfer.d791.s0.p3", "text": "Vascular endothelial cadherin (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.", "text_with_entity_marker": "Vascular endothelial cadherin ([E1]VE-cadherin[/E1]) clusters were co-localized with [E2]beta-catenin[/E2], an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "VE-cadherin", "entity_1_idx": [[31, 42]], "entity_1_idx_in_text_with_entity_marker": [35, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[76, 88]], "entity_2_idx_in_text_with_entity_marker": [89, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d791.s0_BioInfer.d791.s0.p4", "text": "Vascular endothelial cadherin (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.", "text_with_entity_marker": "[E1]Vascular endothelial cadherin[/E1] (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Vascular endothelial cadherin", "entity_1_idx": [[0, 29]], "entity_1_idx_in_text_with_entity_marker": [4, 33], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[215, 220]], "entity_2_idx_in_text_with_entity_marker": [228, 233], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d791.s0_BioInfer.d791.s0.p5", "text": "Vascular endothelial cadherin (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.", "text_with_entity_marker": "Vascular endothelial cadherin (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with [E1]alpha-catenin[/E1], which is thought to link the complex to the peri-junctional [E2]actin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[140, 153]], "entity_1_idx_in_text_with_entity_marker": [144, 157], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[215, 220]], "entity_2_idx_in_text_with_entity_marker": [228, 233], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d791.s0_BioInfer.d791.s0.p6", "text": "Vascular endothelial cadherin (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.", "text_with_entity_marker": "Vascular endothelial cadherin (VE-cadherin) clusters were co-localized with [E1]beta-catenin[/E1], an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[76, 88]], "entity_1_idx_in_text_with_entity_marker": [80, 92], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[215, 220]], "entity_2_idx_in_text_with_entity_marker": [228, 233], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d791.s0_BioInfer.d791.s0.p7", "text": "Vascular endothelial cadherin (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.", "text_with_entity_marker": "[E1]Vascular endothelial cadherin[/E1] (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with [E2]alpha-catenin[/E2], which is thought to link the complex to the peri-junctional actin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Vascular endothelial cadherin", "entity_1_idx": [[0, 29]], "entity_1_idx_in_text_with_entity_marker": [4, 33], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[140, 153]], "entity_2_idx_in_text_with_entity_marker": [153, 166], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d791.s0_BioInfer.d791.s0.p8", "text": "Vascular endothelial cadherin (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.", "text_with_entity_marker": "[E1]Vascular endothelial cadherin[/E1] (VE-cadherin) clusters were co-localized with [E2]beta-catenin[/E2], an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Vascular endothelial cadherin", "entity_1_idx": [[0, 29]], "entity_1_idx_in_text_with_entity_marker": [4, 33], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[76, 88]], "entity_2_idx_in_text_with_entity_marker": [89, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d791.s0_BioInfer.d791.s0.p9", "text": "Vascular endothelial cadherin (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.", "text_with_entity_marker": "Vascular endothelial cadherin (VE-cadherin) clusters were co-localized with [E1]beta-catenin[/E1], an important signal transduction ligand, and with [E2]alpha-catenin[/E2], which is thought to link the complex to the peri-junctional actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[76, 88]], "entity_1_idx_in_text_with_entity_marker": [80, 92], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[140, 153]], "entity_2_idx_in_text_with_entity_marker": [153, 166], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d174.s0_BioInfer.d174.s0.p0", "text": "Direct binding of the verprolin-homology domain in N-WASP to actin is essential for cytoskeletal reorganization.", "text_with_entity_marker": "Direct binding of the [E1]verprolin[/E1]-homology domain in N-WASP to [E2]actin[/E2] is essential for cytoskeletal reorganization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "verprolin", "entity_1_idx": [[22, 31]], "entity_1_idx_in_text_with_entity_marker": [26, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[61, 66]], "entity_2_idx_in_text_with_entity_marker": [74, 79], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d174.s0_BioInfer.d174.s0.p1", "text": "Direct binding of the verprolin-homology domain in N-WASP to actin is essential for cytoskeletal reorganization.", "text_with_entity_marker": "Direct binding of the [E1]verprolin[/E1]-homology domain in [E2]N-WASP[/E2] to actin is essential for cytoskeletal reorganization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "verprolin", "entity_1_idx": [[22, 31]], "entity_1_idx_in_text_with_entity_marker": [26, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N-WASP", "entity_2_idx": [[51, 57]], "entity_2_idx_in_text_with_entity_marker": [64, 70], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d174.s0_BioInfer.d174.s0.p2", "text": "Direct binding of the verprolin-homology domain in N-WASP to actin is essential for cytoskeletal reorganization.", "text_with_entity_marker": "Direct binding of the verprolin-homology domain in [E1]N-WASP[/E1] to [E2]actin[/E2] is essential for cytoskeletal reorganization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "N-WASP", "entity_1_idx": [[51, 57]], "entity_1_idx_in_text_with_entity_marker": [55, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[61, 66]], "entity_2_idx_in_text_with_entity_marker": [74, 79], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d174.s1_BioInfer.d174.s1.p0", "text": "Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.", "text_with_entity_marker": "Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein ([E1]WASP[/E1]) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of [E2]verprolin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "WASP", "entity_1_idx": [[120, 124]], "entity_1_idx_in_text_with_entity_marker": [124, 128], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "verprolin", "entity_2_idx": [[242, 251]], "entity_2_idx_in_text_with_entity_marker": [255, 264], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d174.s1_BioInfer.d174.s1.p1", "text": "Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.", "text_with_entity_marker": "Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein ([E1]WASP[/E1]) and its homolog expressed in neurons ([E2]N-WASP[/E2]), were found to possess short peptide motifs homologous to one part of verprolin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "WASP", "entity_1_idx": [[120, 124]], "entity_1_idx_in_text_with_entity_marker": [124, 128], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N-WASP", "entity_2_idx": [[164, 170]], "entity_2_idx_in_text_with_entity_marker": [177, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d174.s1_BioInfer.d174.s1.p2", "text": "Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.", "text_with_entity_marker": "Recently, two mammalian proteins previously shown to regulate the [E1]actin[/E1] cytoskeleton, Wiskott-Aldrich Syndrome Protein ([E2]WASP[/E2]) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[66, 71]], "entity_1_idx_in_text_with_entity_marker": [70, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "WASP", "entity_2_idx": [[120, 124]], "entity_2_idx_in_text_with_entity_marker": [133, 137], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d174.s1_BioInfer.d174.s1.p3", "text": "Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.", "text_with_entity_marker": "Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, [E1]Wiskott-Aldrich Syndrome Protein[/E1] ([E2]WASP[/E2]) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Wiskott-Aldrich Syndrome Protein", "entity_1_idx": [[86, 118]], "entity_1_idx_in_text_with_entity_marker": [90, 122], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "WASP", "entity_2_idx": [[120, 124]], "entity_2_idx_in_text_with_entity_marker": [133, 137], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d174.s1_BioInfer.d174.s1.p4", "text": "Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.", "text_with_entity_marker": "Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons ([E1]N-WASP[/E1]), were found to possess short peptide motifs homologous to one part of [E2]verprolin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "N-WASP", "entity_1_idx": [[164, 170]], "entity_1_idx_in_text_with_entity_marker": [168, 174], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "verprolin", "entity_2_idx": [[242, 251]], "entity_2_idx_in_text_with_entity_marker": [255, 264], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d174.s1_BioInfer.d174.s1.p5", "text": "Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.", "text_with_entity_marker": "Recently, two mammalian proteins previously shown to regulate the [E1]actin[/E1] cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of [E2]verprolin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[66, 71]], "entity_1_idx_in_text_with_entity_marker": [70, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "verprolin", "entity_2_idx": [[242, 251]], "entity_2_idx_in_text_with_entity_marker": [255, 264], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d174.s1_BioInfer.d174.s1.p6", "text": "Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.", "text_with_entity_marker": "Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, [E1]Wiskott-Aldrich Syndrome Protein[/E1] (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of [E2]verprolin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Wiskott-Aldrich Syndrome Protein", "entity_1_idx": [[86, 118]], "entity_1_idx_in_text_with_entity_marker": [90, 122], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "verprolin", "entity_2_idx": [[242, 251]], "entity_2_idx_in_text_with_entity_marker": [255, 264], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d174.s1_BioInfer.d174.s1.p7", "text": "Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.", "text_with_entity_marker": "Recently, two mammalian proteins previously shown to regulate the [E1]actin[/E1] cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons ([E2]N-WASP[/E2]), were found to possess short peptide motifs homologous to one part of verprolin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[66, 71]], "entity_1_idx_in_text_with_entity_marker": [70, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N-WASP", "entity_2_idx": [[164, 170]], "entity_2_idx_in_text_with_entity_marker": [177, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d174.s1_BioInfer.d174.s1.p8", "text": "Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.", "text_with_entity_marker": "Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, [E1]Wiskott-Aldrich Syndrome Protein[/E1] (WASP) and its homolog expressed in neurons ([E2]N-WASP[/E2]), were found to possess short peptide motifs homologous to one part of verprolin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Wiskott-Aldrich Syndrome Protein", "entity_1_idx": [[86, 118]], "entity_1_idx_in_text_with_entity_marker": [90, 122], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N-WASP", "entity_2_idx": [[164, 170]], "entity_2_idx_in_text_with_entity_marker": [177, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d174.s1_BioInfer.d174.s1.p9", "text": "Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.", "text_with_entity_marker": "Recently, two mammalian proteins previously shown to regulate the [E1]actin[/E1] cytoskeleton, [E2]Wiskott-Aldrich Syndrome Protein[/E2] (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[66, 71]], "entity_1_idx_in_text_with_entity_marker": [70, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Wiskott-Aldrich Syndrome Protein", "entity_2_idx": [[86, 118]], "entity_2_idx_in_text_with_entity_marker": [99, 131], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p10", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM [E1]insulin[/E1] also had no effect on [E2]vinculin[/E2] or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "insulin", "entity_1_idx": [[250, 257]], "entity_1_idx_in_text_with_entity_marker": [254, 261], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[280, 288]], "entity_2_idx_in_text_with_entity_marker": [293, 301], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p11", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml [E1]somatomedin C[/E1], or 10 microM insulin also had no effect on [E2]vinculin[/E2] or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "somatomedin C", "entity_1_idx": [[222, 235]], "entity_1_idx_in_text_with_entity_marker": [226, 239], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[280, 288]], "entity_2_idx_in_text_with_entity_marker": [293, 301], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p12", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor ([E1]EGF[/E1]), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on [E2]vinculin[/E2] or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "EGF", "entity_1_idx": [[207, 210]], "entity_1_idx_in_text_with_entity_marker": [211, 214], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[280, 288]], "entity_2_idx_in_text_with_entity_marker": [293, 301], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p13", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "[E1]PDGF[/E1] treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on [E2]vinculin[/E2] or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PDGF", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[280, 288]], "entity_2_idx_in_text_with_entity_marker": [293, 301], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p14", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml [E1]epidermal growth factor[/E1] (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on [E2]vinculin[/E2] or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "epidermal growth factor", "entity_1_idx": [[182, 205]], "entity_1_idx_in_text_with_entity_marker": [186, 209], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[280, 288]], "entity_2_idx_in_text_with_entity_marker": [293, 301], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p15", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on [E1]talin[/E1], vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or [E2]actin[/E2] distribution.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[32, 37]], "entity_1_idx_in_text_with_entity_marker": [36, 41], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[292, 297]], "entity_2_idx_in_text_with_entity_marker": [305, 310], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p16", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on [E1]talin[/E1], vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM [E2]insulin[/E2] also had no effect on vinculin or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[32, 37]], "entity_1_idx_in_text_with_entity_marker": [36, 41], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[250, 257]], "entity_2_idx_in_text_with_entity_marker": [263, 270], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p17", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on [E1]talin[/E1], vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml [E2]somatomedin C[/E2], or 10 microM insulin also had no effect on vinculin or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[32, 37]], "entity_1_idx_in_text_with_entity_marker": [36, 41], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "somatomedin C", "entity_2_idx": [[222, 235]], "entity_2_idx_in_text_with_entity_marker": [235, 248], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p18", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "PDGF treatment had no effect on [E1]talin[/E1], vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor ([E2]EGF[/E2]), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[32, 37]], "entity_1_idx_in_text_with_entity_marker": [36, 41], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "EGF", "entity_2_idx": [[207, 210]], "entity_2_idx_in_text_with_entity_marker": [220, 223], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d483.s0_BioInfer.d483.s0.p19", "text": "PDGF treatment had no effect on talin, vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "text_with_entity_marker": "[E1]PDGF[/E1] treatment had no effect on [E2]talin[/E2], vimentin, or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 microM insulin also had no effect on vinculin or actin distribution.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PDGF", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[32, 37]], "entity_2_idx_in_text_with_entity_marker": [45, 50], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d786.s0_BioInfer.d786.s0.p0", "text": "Using a complementary sequence or antipeptide to selectively neutralize the stretch of residues 633-642 of skeletal myosin heavy chain, we recently demonstrated that this segment is an actin binding site operating in the absence as in the presence of nucleotide and that this stretch 633-642 is not part of the nucleotide binding site [Chaussepied & Morales (1988) Proc. Natl. Acad. Sci. U.S.A. 85, 7471-7475].", "text_with_entity_marker": "Using a complementary sequence or antipeptide to selectively neutralize the stretch of residues 633-642 of [E1]skeletal myosin heavy chain[/E1], we recently demonstrated that this segment is an [E2]actin[/E2] binding site operating in the absence as in the presence of nucleotide and that this stretch 633-642 is not part of the nucleotide binding site [Chaussepied & Morales (1988) Proc. Natl. Acad. Sci. U.S.A. 85, 7471-7475].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "skeletal myosin heavy chain", "entity_1_idx": [[107, 134]], "entity_1_idx_in_text_with_entity_marker": [111, 138], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[185, 190]], "entity_2_idx_in_text_with_entity_marker": [198, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
